
<html lang="en"     class="pb-page"  data-request-id="860c3a9d-bb51-437e-9c89-41ad43874d52"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";article:article:10.1021/acs.jmedchem.7b00141;requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text;issue:issue:10.1021/jmcmar.2017.60.issue-7"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Scaffold Repurposing of Nucleosides (Adenosine Receptor Agonists): Enhanced Activity at the Human Dopamine and Norepinephrine Sodium Symporters" /></meta><meta name="dc.Creator" content="Dilip K.  Tosh" /></meta><meta name="dc.Creator" content="Aaron  Janowsky" /></meta><meta name="dc.Creator" content="Amy J.  Eshleman" /></meta><meta name="dc.Creator" content="Eugene  Warnick" /></meta><meta name="dc.Creator" content="Zhan-Guo  Gao" /></meta><meta name="dc.Creator" content="Zhoumou  Chen" /></meta><meta name="dc.Creator" content="Elizabeth  Gizewski" /></meta><meta name="dc.Creator" content="John A.  Auchampach" /></meta><meta name="dc.Creator" content="Daniela  Salvemini" /></meta><meta name="dc.Creator" content="Kenneth A.  Jacobson" /></meta><meta name="dc.Description" content="We have repurposed (N)-methanocarba adenosine derivatives (A3 adenosine receptor (AR) agonists) to enhance radioligand binding allosterically at the human dopamine (DA) transporter (DAT) and inhibi..." /></meta><meta name="Description" content="We have repurposed (N)-methanocarba adenosine derivatives (A3 adenosine receptor (AR) agonists) to enhance radioligand binding allosterically at the human dopamine (DA) transporter (DAT) and inhibi..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="March 20, 2017" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.7b00141" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2017 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.7b00141" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.7b00141" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.7b00141" /></link>
        
    
    

<title>Scaffold Repurposing of Nucleosides (Adenosine Receptor Agonists): Enhanced Activity at the Human Dopamine and Norepinephrine Sodium Symporters | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.7b00141" /></meta><meta property="og:title" content="Scaffold Repurposing of Nucleosides (Adenosine Receptor Agonists): Enhanced Activity at the Human Dopamine and Norepinephrine Sodium Symporters" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.7b00141/20170407/images/large/jm-2017-00141h_0009.jpeg" /></meta><meta property="og:description" content="We have repurposed (N)-methanocarba adenosine derivatives (A3 adenosine receptor (AR) agonists) to enhance radioligand binding allosterically at the human dopamine (DA) transporter (DAT) and inhibit DA uptake. We extended the structure–activity relationship of this series with small N6-alkyl substitution, 5′-esters, deaza modifications of adenine, and ribose restored in place of methanocarba. C2-(5-Halothien-2-yl)-ethynyl 5′-methyl 9 (MRS7292) and 5′-ethyl 10 (MRS7232) esters enhanced binding at DAT (EC50 ∼ 35 nM) and at the norepinephrine transporter (NET). 9 and 10 were selective for DAT compared to A3AR in the mouse but not in humans. At DAT, the binding of two structurally dissimilar radioligands was enhanced; NET binding of only one radioligand was enhanced; SERT radioligand binding was minimally affected. 10 was more potent than cocaine at inhibiting DA uptake (IC50 = 107 nM). Ribose analogues were weaker in DAT interaction than the corresponding bicyclics. Thus, we enhanced the neurotransmitter transporter activity of rigid nucleosides while reducing A3AR affinity." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.7b00141"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.7b00141">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.7b00141&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.7b00141&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.7b00141&amp;href=/doi/10.1021/acs.jmedchem.7b00141" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2017</span><span class="cit-fg-volume">, 60</span><span class="cit-fg-issue">, 7</span><span class="cit-fg-pageRange">, 3109-3123</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/60/7" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.7b00124" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.7b00179" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Scaffold Repurposing of Nucleosides (Adenosine Receptor Agonists): Enhanced Activity at the Human Dopamine and Norepinephrine Sodium Symporters</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Dilip+K.++Tosh">Dilip K. Tosh</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Aaron++Janowsky">Aaron Janowsky</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Amy+J.++Eshleman">Amy J. Eshleman</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Eugene++Warnick">Eugene Warnick</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Zhan-Guo++Gao">Zhan-Guo Gao</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Zhoumou++Chen">Zhoumou Chen</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Elizabeth++Gizewski">Elizabeth Gizewski</a></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=John+A.++Auchampach">John A. Auchampach</a></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Daniela++Salvemini">Daniela Salvemini</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Kenneth+A.++Jacobson">Kenneth A. Jacobson</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="loa-info-orcid"><a href="http://orcid.org/0000-0001-8104-1493" title="Orcid link"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img></a></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-symbol">†</span> <span class="aff-text">Molecular Recognition Section, Laboratory of Bioorganic Chemistry, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland 20892, United States</span></div><div class="aff-info" id="aff2"><span class="aff-symbol">‡</span> <span class="aff-text">VA Portland Health Care System, Research Service (R&D-22), and Departments of Psychiatry and Behavioral Neuroscience, Oregon Health and Science University, Portland, Oregon 97239, United States</span></div><div class="aff-info" id="aff3"><span class="aff-symbol">§</span> <span class="aff-text">Department of Pharmacology and Physiology, Saint Louis University School of Medicine, St. Louis, Missouri 63104, United States</span></div><div class="aff-info" id="aff4"><span class="aff-symbol">∥</span> <span class="aff-text">Department of Pharmacology, Medical College of Wisconsin, 8701 Watertown Plank Road, Milwaukee, Wisconsin 53226, United States</span></div><div class="corresp-info"><strong>*</strong>Laboratory of Bioorganic Chemistry, National Institute of Diabetes and Digestive and Kidney Diseases, NIH, Bethesda, MD 20892-0810, USA. Phone: 301-496-9024. Fax: 301-496-8422. E-mail: <a href="/cdn-cgi/l/email-protection#a8c3c9c2c9cbc7cadbe8c0cdc4c1d086c6c1c086cfc7de"><span class="__cf_email__" data-cfemail="08636962696b676a7b48606d64617026666160266f677e">[email protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.7b00141&amp;href=/doi/10.1021%2Facs.jmedchem.7b00141" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2017</span></span><span class="cit-volume">, 60</span><span class="cit-issue">, 7</span><span class="cit-pageRange">, 3109–3123</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">March 20, 2017</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>26 January 2017</li><li><span class="item_label"><b>Published</b> online</span>20 March 2017</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 13 April 2017</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.7b00141" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.7b00141</a></div><div class="article_header-article-copyright"><strong>Copyright © 2017 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D3109%26pageCount%3D15%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DDilip%2BK.%2BTosh%252C%2BAaron%2BJanowsky%252C%2BAmy%2BJ.%2BEshleman%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D60%26issueNum%3D7%26contentID%3Dacs.jmedchem.7b00141%26title%3DScaffold%2BRepurposing%2Bof%2BNucleosides%2B%2528Adenosine%2BReceptor%2BAgonists%2529%253A%2BEnhanced%2BActivity%2Bat%2Bthe%2BHuman%2BDopamine%2Band%2BNorepinephrine%2BSodium%2BSymporters%26numPages%3D15%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D3123%26publicationDate%3DApril%2B2017">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.7b00141"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">926</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">12</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.7b00141" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Scaffold Repurposing of Nucleosides (Adenosine Receptor Agonists): Enhanced Activity at the Human Dopamine and Norepinephrine Sodium Symporters&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Dilip&quot;,&quot;last_name&quot;:&quot;K. Tosh&quot;},{&quot;first_name&quot;:&quot;Aaron&quot;,&quot;last_name&quot;:&quot;Janowsky&quot;},{&quot;first_name&quot;:&quot;Amy&quot;,&quot;last_name&quot;:&quot;J. Eshleman&quot;},{&quot;first_name&quot;:&quot;Eugene&quot;,&quot;last_name&quot;:&quot;Warnick&quot;},{&quot;first_name&quot;:&quot;Zhan-Guo&quot;,&quot;last_name&quot;:&quot;Gao&quot;},{&quot;first_name&quot;:&quot;Zhoumou&quot;,&quot;last_name&quot;:&quot;Chen&quot;},{&quot;first_name&quot;:&quot;Elizabeth&quot;,&quot;last_name&quot;:&quot;Gizewski&quot;},{&quot;first_name&quot;:&quot;John&quot;,&quot;last_name&quot;:&quot;A. Auchampach&quot;},{&quot;first_name&quot;:&quot;Daniela&quot;,&quot;last_name&quot;:&quot;Salvemini&quot;},{&quot;first_name&quot;:&quot;Kenneth&quot;,&quot;last_name&quot;:&quot;A. Jacobson&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2017&quot;,&quot;month&quot;:&quot;03&quot;,&quot;day&quot;:&quot;20&quot;,&quot;issue&quot;:&quot;7&quot;,&quot;volume&quot;:&quot;60&quot;,&quot;pages&quot;:&quot;3109-3123&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.7b00141&quot;},&quot;abstract&quot;:&quot;We have repurposed (N)-methanocarba adenosine derivatives (A3 adenosine receptor (AR) agonists) to enhance radioligand binding allosterically at the human dopamine (DA) transporter (DAT) and inhibit DA uptake. We extended the structure–activity relationship of this series with small N6-alkyl substitution, 5′-esters, deaza modifications of adenine, and ribose restored in place of methanocarba. C2-(5-Halothien-2-yl)-ethynyl 5′-methyl 9 (MRS7292) and 5′-ethyl 10 (MRS7232) esters enhanced binding at DAT (EC50 ∼ 35 nM) and at the norepinephrine transporter (NET). 9 and 10 were selective for DAT compared to A3AR in the mouse but not in humans. At DAT, the binding of two structurally dissimilar radioligands was enhanced; NET binding of only one radioligand was enhanced; SERT radioligand binding was minimally affected. 10 was more potent than cocaine at inhibiting DA uptake (IC50 = 107 nM). Ribose analogues were weaker in DAT interaction than the corresponding bicyclics. Thus, we enhanced the neurotransmitter transpo&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.7b00141&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b00141" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.7b00141&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b00141" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.7b00141&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b00141" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.7b00141&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b00141&amp;href=/doi/10.1021/acs.jmedchem.7b00141" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.7b00141" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.7b00141" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (2 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.7b00141&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.7b00141%26sid%3Dliteratum%253Aachs%26pmid%3D28319392%26genre%3Darticle%26aulast%3DTosh%26date%3D2017%26atitle%3DScaffold%2BRepurposing%2Bof%2BNucleosides%2B%2528Adenosine%2BReceptor%2BAgonists%2529%253A%2BEnhanced%2BActivity%2Bat%2Bthe%2BHuman%2BDopamine%2Band%2BNorepinephrine%2BSodium%2BSymporters%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D60%26issue%3D7%26spage%3D3109%26epage%3D3123%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (2)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=291308" title="Nucleic acids">Nucleic acids</a>,</li><li><a href="/action/doSearch?ConceptID=291788" title="Reaction products">Reaction products</a>,</li><li><a href="/action/doSearch?ConceptID=292589" title="Agonists">Agonists</a>,</li><li><a href="/action/doSearch?ConceptID=292178" title="Organic compounds">Organic compounds</a>,</li><li><a href="/action/doSearch?ConceptID=292186" title="Receptors">Receptors</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/60/7" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/jmcmar.2017.60.issue-7/20170413/jmcmar.2017.60.issue-7.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.7b00141/20170407/images/medium/jm-2017-00141h_0009.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.7b00141/20170407/images/large/jm-2017-00141h_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00141&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">We have repurposed (<i>N</i>)-methanocarba adenosine derivatives (A<sub>3</sub> adenosine receptor (AR) agonists) to enhance radioligand binding allosterically at the human dopamine (DA) transporter (DAT) and inhibit DA uptake. We extended the structure–activity relationship of this series with small <i>N</i><sup>6</sup>-alkyl substitution, 5′-esters, deaza modifications of adenine, and ribose restored in place of methanocarba. <i>C</i>2-(5-Halothien-2-yl)-ethynyl 5′-methyl <b>9</b> (MRS7292) and 5′-ethyl <b>10</b> (MRS7232) esters enhanced binding at DAT (EC<sub>50</sub> ∼ 35 nM) and at the norepinephrine transporter (NET). <b>9</b> and <b>10</b> were selective for DAT compared to A<sub>3</sub>AR in the mouse but not in humans. At DAT, the binding of two structurally dissimilar radioligands was enhanced; NET binding of only one radioligand was enhanced; SERT radioligand binding was minimally affected. <b>10</b> was more potent than cocaine at inhibiting DA uptake (IC<sub>50</sub> = 107 nM). Ribose analogues were weaker in DAT interaction than the corresponding bicyclics. Thus, we enhanced the neurotransmitter transporter activity of rigid nucleosides while reducing A<sub>3</sub>AR affinity.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_18114" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_18114" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">In the course of examining off-target activities of potent A<sub>3</sub> adenosine receptor (AR) agonists for their novel application to the treatment of chronic neuropathic pain,<a onclick="showRef(event, 'ref1 ref2'); return false;" href="javascript:void(0);" class="ref ref1 ref2">(1, 2)</a> we discovered a new class of allosteric ligands with low nanomolar affinity at the human (h) dopamine (DA) transporter (DAT, SLC6A3).<a onclick="showRef(event, 'ref3 ref4'); return false;" href="javascript:void(0);" class="ref ref3 ref4">(3, 4)</a> DAT function is inhibited by cocaine, which increases the levels of DA at the synapse by a combination of mechanisms.<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> Micromolar activity of the same substituted nucleosides at the structurally related norepinephrine transporter (NET, SLC6A2), and weaker interactions with the serotonin transporter (SERT, SLC6A4) were also noted. These transporters are important drug targets for the treatment of depression and other behavioral disorders and belong to the much larger class of sodium symporters, which transport diverse solute molecules across the cell membrane. X-ray structures of members of this family of transmembrane proteins have been determined, thus shedding light on the nature of their gating and substrate/inhibitor recognition.<a onclick="showRef(event, 'ref4 ref6 ref7'); return false;" href="javascript:void(0);" class="ref ref4 ref6 ref7">(4, 6, 7)</a></div><div class="NLM_p">The medicinal chemistry of diverse classes of DAT modulators has been explored toward the goal of treating drug abuse.<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> Conventional inhibitors of DAT in the CNS are psychostimulants that are of interest for the treatment of addiction to cocaine, heroin, or nicotine, and for obesity, narcolepsy, and ADHD, but there is a potential for their abuse as recreational drugs.<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> On the basis of pharmacological<a onclick="showRef(event, 'ref10 ref11 ref12'); return false;" href="javascript:void(0);" class="ref ref10 ref11 ref12">(10-12)</a> and genetic data,<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> decreased dopaminergic signaling in the mesocorticolimbic pathway is suggested to play a role in a wide range of behavioral disorders: depression, mood disorders, anhedonia, post-traumatic stress disorder (PTSD), addiction, attention deficit hyperactive disorder (ADHD), autism, and pain. Antidepressant treatments that include DAT inhibition, including triple reuptake inhibitors (TRIs) that combine the inhibition of SERT and NET with DAT, are being developed because of their expected higher efficacy in treating depression.<a onclick="showRef(event, 'ref12 ref14 ref15 ref16'); return false;" href="javascript:void(0);" class="ref ref12 ref14 ref15 ref16">(12, 14-16)</a> The classical inhibitors of DAT, such as methylphenidate, are being considered as cotherapy for treating depression, but there is a risk of side effects, such as inducing mania in patients with bipolar disorder.<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> However, an allosteric inhibitor of DAT that has a more subtle action might have an advantage over stimulant drugs that are orthosteric DAT inhibitors in the treatment of behavioral disorders associated with DA deficiency.</div><div class="NLM_p">We have utilized a bicyclo[3.1.0]hexane ring (methanocarba) system in place of ribose in numerous nucleoside derivatives and noted that high affinity and selectivity at the A<sub>3</sub>AR could be achieved with the retention of full agonism.<a onclick="showRef(event, 'ref2 ref18 ref19'); return false;" href="javascript:void(0);" class="ref ref2 ref18 ref19">(2, 18, 19)</a> Because this rigid, bicyclic ring system offers the opportunity for systematic substitution at multiple positions with defined geometry, we have explored its use as a component of a repurposed scaffold: shifting adenine nucleosides from ARs to other target proteins, such as receptors and transporters.<a onclick="showRef(event, 'ref3 ref20'); return false;" href="javascript:void(0);" class="ref ref3 ref20">(3, 20)</a> For example, (<i>1S,2R,3S,4R,5S</i>)-4-(2-((5-chlorothiophen-2-yl)ethynyl)-6-(methylamino)-9<i>H</i>-purin-9-yl)-2,3-dihydroxy-<i>N</i>-methylbicyclo[3.1.0]hexane-1-carboxamide (MRS5980, <b>1</b>, <a class="ref internalNav" href="#cht1" aria-label="Chart 1">Chart 1</a>), which displays >10,000-fold greater affinity for the hA<sub>3</sub>AR (<i>K</i><sub>i</sub> = 0.70 nM) than at other ARs, also inhibited DA uptake with an IC<sub>50</sub> of 253 nM.<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> Contrary to effects on uptake, however, <b>1</b> enhanced the binding of a tropane radioligand [<sup>125</sup>I]methyl (1<i>R</i>,2<i>S</i>,3<i>S</i>)-3-(4-iodophenyl)-8-methyl-8-azabicyclo[3.2.1]octane-2-carboxylate (RTI-55, <b>23</b>)<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> to hDAT with an EC<sub>50</sub> of 35 nM. The closely related derivatives <b>2</b> and <b>3</b> differing only in the terminal aryl group enhanced the binding of [<sup>125</sup>I]<b>23</b> with EC<sub>50</sub> values of 9.1 and 70 nM, respectively. Compound <b>1</b> enhanced the affinity of radioligand binding at hDAT, with 100 nM of <b>1</b> reducing the <i>K</i><sub>d</sub> of [<sup>125</sup>I]<b>23</b> from 1.3 nM to 0.39 nM. We now report the synthesis and in vitro structure–activity relationship (SAR) of an expanded class of nucleosides. Results indicate that disparate nucleoside structures are effective A<sub>3</sub>AR and transporter ligands with a unique pharmacology.</div><figure id="cht1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Chart 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.7b00141/20170407/images/medium/jm-2017-00141h_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.7b00141/20170407/images/large/jm-2017-00141h_0001.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Chart 1. Structures of Potent A<sub>3</sub>AR Agonists That Displayed Activity at hDAT</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.7b00141/20170407/images/large/jm-2017-00141h_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00141&amp;id=cht1"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Results</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_15836" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_15836" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i4" class="anchor-spacer"></div><h3 class="article-section__title" id="_i4"> Chemical Synthesis</h3><div class="NLM_p">The class of nucleosides initially examined was based on our earlier report that (<i>N</i>)-methanocarba nucleosides, containing a rigid C2-arylethynyl group and 5′-carbonyl and <i>N</i><sup>6</sup>-methyl substitution, allosterically modulate hDAT.<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> Compounds <b>4</b>,<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a><b>6</b>, and <b>8</b>–<b>16</b>, <b>22</b>, and <b>27</b>–<b>29</b> were synthesized by the routes shown in <a class="ref internalNav" href="#sch1" aria-label="Schemes 1">Schemes 1</a>–<a class="ref internalNav" href="#sch3" aria-label="3">3</a>. Known nucleosides <b>1</b>–<b>3</b>, <b>5</b>, and <b>7</b> were prepared as reported.<a onclick="showRef(event, 'ref2 ref21'); return false;" href="javascript:void(0);" class="ref ref2 ref21">(2, 21)</a> The novel modifications included extended small <i>N</i><sup>6</sup>-alkyl substitution (<b>7</b>, <b>28</b>), 5′-esters (<b>9</b>–<b>21</b>), 5′-carboxylate (<b>22</b>), 5′ extended amide (<b>8</b>), deaza modifications of adenine (<b>5</b>, <b>6</b>, and <b>13</b>), and ribose restored in place of methanocarba (<b>27</b>–<b>29</b>), and combinations thereof (<a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>). For the (<i>N</i>)-methanocarba adenosine derivatives, 5′-ethyl ester intermediate <b>32</b> was prepared by a reported method,<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> which upon Sonogashira reaction with 5-chloro or 5-bromo-2-ethynylthiophene gave compounds <b>33</b> and <b>34</b> (<a class="ref internalNav" href="#sch1" aria-label="Scheme1">Scheme1</a>). Deprotection of the acetonide group of compounds <b>33</b> and <b>34</b>, with 10% aqueous TFA provided the ethyl ester derivatives <b>10</b> and <b>12</b>. Compound <b>12</b> was subjected to transesterification with sodium methoxide to give compound <b>11</b>. Compound <b>12</b> was saponified to provide carboxylic acid <b>22</b> or aminolyzed with ethylenediamine to yield extended amide <b>8</b>. Acid derivative <b>22</b> was esterified with various alcohols in the presence of DCC and DMAP to afford 5′-esters <b>14</b>–<b>21</b>.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Structures, Initial Screening Results at hDAT<a class="ref internalNav" href="#tbl1-fn1" aria-label="a">a</a>,<a class="ref internalNav" href="#t1fn1" aria-label="b">b</a>,<a class="ref internalNav" href="#t1fn2" aria-label="c">c</a> ([<sup>3</sup>H]<b>24</b>, unless Noted) and Binding Affinity at A<sub>3</sub>AR<a class="ref internalNav" href="#t1fn4" aria-label="d">d</a> of (<i>N</i>)-Methanocarba Adenosine Derivatives (<b>1</b>–<b>22</b>) and Ribose Derivatives (<b>27</b>–<b>29</b>)</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.7b00141/20170407/images/medium/jm-2017-00141h_0008.gif" alt="" id="fx1" /></img><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">no.</th><th class="colsep0 rowsep0" align="center">R<sup>1</sup> and other changes as noted</th><th class="colsep0 rowsep0" align="center">hDAT binding enhancement, unless noted<a class="ref internalNav" href="#t1fn1" aria-label="b">b</a>, % of control (n)</th><th class="colsep0 rowsep0" align="center">hDAT binding inhibition, unless noted<a class="ref internalNav" href="#t1fn2" aria-label="c">c</a>, % of control</th><th class="colsep0 rowsep0" align="center">A<sub>3</sub>AR binding <i>K</i><sub>i</sub>, nM (species), or % at 10 μM<a class="ref internalNav" href="#t1fn4" aria-label="d">d</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1</b><a class="ref internalNav" href="#t1fn4" aria-label="d">d</a></td><td class="colsep0 rowsep0" align="left">NHCH<sub>3</sub></td><td class="colsep0 rowsep0" align="left"><i>556%</i></td><td class="colsep0 rowsep0" align="left">NE<a class="ref internalNav" href="#t1fn6" aria-label="g">g</a></td><td class="colsep0 rowsep0" align="left">0.70 ± 0.11 (h), 36.1 ± 4.7 (m)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>2</b><a class="ref internalNav" href="#t1fn4" aria-label="d">d</a></td><td class="colsep0 rowsep0" align="left">NHCH<sub>3</sub>, R<sup>2</sup> = Br</td><td class="colsep0 rowsep0" align="left"><i>235%</i></td><td class="colsep0 rowsep0" align="left">NE</td><td class="colsep0 rowsep0" align="left">0.44 ± 0.12 (h), 43.7 ± 2.1 (m)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>3</b><a class="ref internalNav" href="#t1fn4" aria-label="d">d</a></td><td class="colsep0 rowsep0" align="left">NHCH<sub>3</sub><a class="ref internalNav" href="#t1fn5" aria-label="f">f</a></td><td class="colsep0 rowsep0" align="left"><i>322%</i></td><td class="colsep0 rowsep0" align="left">NE</td><td class="colsep0 rowsep0" align="left">1.65 ± 0.08 (h), 86 ± 6 (m)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4</b><a class="ref internalNav" href="#t1fn4" aria-label="d">d</a></td><td class="colsep0 rowsep0" align="left">NHCH<sub>3</sub>, R<sup>4</sup> = CH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">NE</td><td class="colsep0 rowsep0" align="left"><i>25%</i></td><td class="colsep0 rowsep0" align="left">23.5 ± 10.6 (h), 597 ± 63 (m)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5a</b><a class="ref internalNav" href="#t1fn4" aria-label="d">d</a></td><td class="colsep0 rowsep0" align="left">NHCH<sub>3</sub>, X = CH</td><td class="colsep0 rowsep0" align="left"><a class="ref internalNav" href="#t1fn3" aria-label="e">e</a></td><td class="colsep0 rowsep0" align="left"><a class="ref internalNav" href="#t1fn3" aria-label="e">e</a></td><td class="colsep0 rowsep0" align="left">2.34 ± 0.20 (h), 31.3 ± 1.9 (m)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5b</b></td><td class="colsep0 rowsep0" align="left">NHCH<sub>3</sub>, X = CH, R<sup>3</sup> = CH<sub>2</sub>CH<sub>3</sub></td><td class="colsep0 rowsep0" align="left"><a class="ref internalNav" href="#t1fn3" aria-label="e">e</a></td><td class="colsep0 rowsep0" align="left"><a class="ref internalNav" href="#t1fn3" aria-label="e">e</a></td><td class="colsep0 rowsep0" align="left">1.69 ± 0.44 (h), 16.2 ± 3.0 (m)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>6</b></td><td class="colsep0 rowsep0" align="left">NHCH<sub>3</sub>, Y = CH</td><td class="colsep0 rowsep0" align="left"><i>334 ± 35%</i> (5)</td><td class="colsep0 rowsep0" align="left">NE</td><td class="colsep0 rowsep0" align="left">9.33 (h), <i>38 ± 1%</i> (m)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>7</b><a class="ref internalNav" href="#t1fn4" aria-label="d">d</a></td><td class="colsep0 rowsep0" align="left">NHCH<sub>3</sub>, R<sup>3</sup> = (CH<sub>2</sub>)<sub>2</sub>CH<sub>3</sub></td><td class="colsep0 rowsep0" align="left"><i>159%</i></td><td class="colsep0 rowsep0" align="left">NE</td><td class="colsep0 rowsep0" align="left">1.11 ± 0.34 (h), 6.79 ± 0.28 (m)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>8</b></td><td class="colsep0 rowsep0" align="left">NH(CH<sub>2</sub>)<sub>2</sub>NH<sub>2</sub></td><td class="colsep0 rowsep0" align="left"><i>136 ± 15%</i> (5)</td><td class="colsep0 rowsep0" align="left">NE</td><td class="colsep0 rowsep0" align="left">156 ± 8 (h), <i>0%</i> (m)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>9</b></td><td class="colsep0 rowsep0" align="left">OCH<sub>3</sub></td><td class="colsep0 rowsep0" align="left"><i>352 ± 50%</i> (4)</td><td class="colsep0 rowsep0" align="left">NE</td><td class="colsep0 rowsep0" align="left">5.38 ± 0.03 (h), <i>36 ± 1%</i> (m)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>10</b></td><td class="colsep0 rowsep0" align="left">OCH<sub>2</sub>CH<sub>3</sub></td><td class="colsep0 rowsep0" align="left"><i>539 ± 106%</i> (4)</td><td class="colsep0 rowsep0" align="left">NE</td><td class="colsep0 rowsep0" align="left">14.5 ± 2.3 (h), <i>45 ± 5%</i> (m)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>11</b></td><td class="colsep0 rowsep0" align="left">OCH<sub>3</sub>, R<sup>2</sup> = Br</td><td class="colsep0 rowsep0" align="left"><i>370 ± 91%</i> (5)</td><td class="colsep0 rowsep0" align="left">NE</td><td class="colsep0 rowsep0" align="left">8.56 ± 0.10 (h), <i>57 ± 1%</i> (m)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12</b></td><td class="colsep0 rowsep0" align="left">OCH<sub>2</sub>CH<sub>3</sub>, R<sup>2</sup> = Br</td><td class="colsep0 rowsep0" align="left"><i>430 ± 86%</i> (3)</td><td class="colsep0 rowsep0" align="left">NE</td><td class="colsep0 rowsep0" align="left">6.42 ± 0.35 (h), 1800 ± 90 (m)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>13</b></td><td class="colsep0 rowsep0" align="left">OCH<sub>2</sub>CH<sub>3</sub>, Y = CH</td><td class="colsep0 rowsep0" align="left"><i>354%</i></td><td class="colsep0 rowsep0" align="left">NE</td><td class="colsep0 rowsep0" align="left">169 ± 24 (h), <i>18 ± 4%</i> (m)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>14</b></td><td class="colsep0 rowsep0" align="left">O(CH<sub>2</sub>)<sub>2</sub>CH<sub>3</sub></td><td class="colsep0 rowsep0" align="left"><i>426 ± 14%</i> (2)</td><td class="colsep0 rowsep0" align="left">NE</td><td class="colsep0 rowsep0" align="left">5.78 ± 1.45 (h), 2810 ± 150 (m)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>15</b></td><td class="colsep0 rowsep0" align="left">OCH(CH<sub>3</sub>)<sub>2</sub></td><td class="colsep0 rowsep0" align="left">NE</td><td class="colsep0 rowsep0" align="left"><i>36%</i></td><td class="colsep0 rowsep0" align="left">42.9 ± 22.8 (h), <i>30 ± 1%</i> (m)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>16</b></td><td class="colsep0 rowsep0" align="left">O(CH<sub>2</sub>)<sub>3</sub>CH<sub>3</sub></td><td class="colsep0 rowsep0" align="left"><i>285 ± 35%</i> (2)</td><td class="colsep0 rowsep0" align="left">NE</td><td class="colsep0 rowsep0" align="left">17.5 ± 1.6 (h), <i>54 ± 1%</i> (m)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>17</b></td><td class="colsep0 rowsep0" align="left">O(CH<sub>2</sub>)<sub>2</sub>–CH(CH<sub>3</sub>)<sub>2</sub></td><td class="colsep0 rowsep0" align="left"><i>196 ± 58%</i></td><td class="colsep0 rowsep0" align="left">NE</td><td class="colsep0 rowsep0" align="left">24.4 ± 2.8 (h), <i>32 ± 2%</i> (m)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>18</b></td><td class="colsep0 rowsep0" align="left">O(CH<sub>2</sub>)<sub>2</sub>–cHex</td><td class="colsep0 rowsep0" align="left"><a class="ref internalNav" href="#t1fn3" aria-label="e">e</a></td><td class="colsep0 rowsep0" align="left"><a class="ref internalNav" href="#t1fn3" aria-label="e">e</a></td><td class="colsep0 rowsep0" align="left">770 ± 75 (h), <i>5 ± 1%</i> (m)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>19</b></td><td class="colsep0 rowsep0" align="left">OCH<sub>2</sub>–Ph</td><td class="colsep0 rowsep0" align="left"><a class="ref internalNav" href="#t1fn3" aria-label="e">e</a></td><td class="colsep0 rowsep0" align="left"><a class="ref internalNav" href="#t1fn3" aria-label="e">e</a></td><td class="colsep0 rowsep0" align="left">7.31 ± 0.29 (h), <i>48 ± 2%</i> (m)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>20</b></td><td class="colsep0 rowsep0" align="left">O(CH<sub>2</sub>)<sub>2</sub>–Ph</td><td class="colsep0 rowsep0" align="left"><a class="ref internalNav" href="#t1fn3" aria-label="e">e</a></td><td class="colsep0 rowsep0" align="left"><a class="ref internalNav" href="#t1fn3" aria-label="e">e</a></td><td class="colsep0 rowsep0" align="left">262 ± 44 (h), <i>3 ± 2%</i> (m)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>21</b></td><td class="colsep0 rowsep0" align="left">O(CH<sub>2</sub>)<sub>3</sub>-Ph</td><td class="colsep0 rowsep0" align="left"><a class="ref internalNav" href="#t1fn3" aria-label="e">e</a></td><td class="colsep0 rowsep0" align="left"><a class="ref internalNav" href="#t1fn3" aria-label="e">e</a></td><td class="colsep0 rowsep0" align="left">255 ± 30 (h), <i>9 ± 1%</i> (m)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>22</b></td><td class="colsep0 rowsep0" align="left">OH</td><td class="colsep0 rowsep0" align="left"><i>50 ± 32%</i> (4)</td><td class="colsep0 rowsep0" align="left">NE</td><td class="colsep0 rowsep0" align="left">684 ± 195 (h), <i>0%</i> (m)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>27</b></td><td class="colsep0 rowsep0" align="left">NHCH<sub>3</sub></td><td class="colsep0 rowsep0" align="left"><i>321 ± 49%</i> (4)</td><td class="colsep0 rowsep0" align="left">NE</td><td class="colsep0 rowsep0" align="left">1.55 ± 0.03 (h), 1170 ± 40 (m)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>28</b></td><td class="colsep0 rowsep0" align="left">NHCH<sub>3</sub>, R<sup>3</sup> = (CH<sub>2</sub>)<sub>2</sub>CH<sub>3</sub></td><td class="colsep0 rowsep0" align="left"><i>84 ± 35%</i> (4)</td><td class="colsep0 rowsep0" align="left">NE</td><td class="colsep0 rowsep0" align="left">6.25 ± 1.55 (h), 597 ± 63 (m)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>29</b></td><td class="colsep0 rowsep0" align="left">OCH<sub>3</sub></td><td class="colsep0 rowsep0" align="left"><i>220 ± 54%</i> (4)</td><td class="colsep0 rowsep0" align="left">NE</td><td class="colsep0 rowsep0" align="left">11.5 ± 0.9 (h), 34 ± 2 (m)</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl1-fn1"><div class="footnote" id="tbl1-fn1"><sup>a</sup><p class="last">R<sup>2</sup> = Cl; R<sup>3</sup> = CH<sub>3</sub>; R<sup>4</sup> = H; and X and Y = N, unless noted.</p></div><div class="footnote" id="t1fn1"><sup>b</sup><p class="last">Values indicate enhancement at 10 μM of [<sup>3</sup>H]<b>24</b> binding at hDAT by PDSP, i.e., a negative percent inhibition in that screen is shown as a positive % here. Full curves for selected compounds appear in <a class="ref internalNav" href="#fig1" aria-label="Figures 1">Figures 1</a> and <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a> and in <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>. Nonspecific binding was determined using 10 μM <b>30</b>. Values are expressed as the mean ± SEM.</p></div><div class="footnote" id="t1fn2"><sup>c</sup><p class="last">Values indicate inhibition at 10 μM of [<sup>3</sup>H]<b>24</b> binding at hDAT by PDSP. Full curves for selected compounds appear in the <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>. Nonspecific binding was determined using 10 μM <b>30</b>. Values are expressed as the mean ± SEM.</p></div><div class="footnote" id="t1fn4"><sup>d</sup><p class="last">Data for hA<sub>3</sub>AR and mA<sub>3</sub>AR affinity (<i>n</i> = 2–3) of <b>1</b> – <b>5</b> and <b>7</b> are from Tosh et al.<a onclick="showRef(event, 'ref2 ref18'); return false;" href="javascript:void(0);" class="ref ref2 ref18">(2, 18)</a> and PDSP data (except for <b>5b</b>) are from Janowsky et al.<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> The radioligand used for A<sub>3</sub>AR in both species was [<sup>125</sup>I]<i>N</i><sup>6</sup>-(4-amino-3-iodobenzyl)adenosine-5′-<i>N</i>-methyluronamide <b>25</b>. Values are expressed as the mean ± SEM. Nonspecific binding was determined using 10 μM adenosine-5′-<i>N</i>-ethyluronamide.</p></div><div class="footnote" id="t1fn3"><sup>e</sup><p class="last">Found to have negligible or no modulation of [<sup>3</sup>H]<b>24</b> binding at hDAT by PDSP, i.e,. % inhibition at 10 μM was between −20% and 20% (see <a class="ref internalNav" href="#fig1" aria-label="Figures 1">Figures 1</a> and <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>).</p></div><div class="footnote" id="t1fn5"><sup>f</sup><p class="last">Structure is in <a class="ref internalNav" href="#cht1" aria-label="Chart 1">Chart 1</a>.</p></div><div class="footnote" id="t1fn6"><sup>g</sup><p class="last">NE: no effect.</p></div></div></div><figure id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.7b00141/20170407/images/medium/jm-2017-00141h_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.7b00141/20170407/images/large/jm-2017-00141h_0005.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of (<i>N</i>)-Methanocarba 5′-Esters <b>9</b>–<b>21</b>, Carboxylate <b>22</b>, and Extended Amide <b>8</b> Derivatives<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.7b00141/20170407/images/large/jm-2017-00141h_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00141&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions (% yields): (i) 2-chloro or 2-bromo-5-ethynylthiophene, Pd(Ph<sub>3</sub>P)<sub>2</sub>Cl<sub>2</sub>, CuI, Et<sub>3</sub>N, DMF, rt, 82–83%; (ii) 10%TFA, MeOH, 70 °C, 90–91%; (iii) for <b>22</b>, 1 N NaOH, MeOH, rt, 82%; (iv) for <b>8</b>, ethylenediamine, MeOH, rt, 71%; (v) for <b>14</b>–<b>21</b>, ROH, DCC, DMAP, DMF, rt, 51–59%; (vi) for <b>9</b>, <b>11</b>, MeONa, MeOH, rt, 69%.</p></p></figure><div class="NLM_p">9-Riboside analogues were prepared as shown in <a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a> from the intermediate <b>35a</b>.<a onclick="showRef(event, 'cit22a'); return false;" href="javascript:void(0);" class="ref cit22a">(22a)</a> Protection of the 2′ and 3′-hydroxy groups provided an acetonide derivative <b>35b</b>, which underwent C6 substitution with alkyl amines to give compounds <b>37</b> and <b>38</b>. PDC oxidation of the 5′-hydroxy group of compounds, <b>37</b> and <b>38</b>, and coupling of resulting carboxylic acids, <b>39</b> and <b>40</b>, with methylamine in the presence of HATU afforded the methylamide derivatives <b>41</b> and <b>42</b>. Compound <b>39</b> was also condensed with MeOH in the presence DCC and DMAP to give the ester derivative <b>43</b>. Sonogashira coupling of compounds <b>41</b>–<b>43</b> with 5-chloro-2-ethynylthiophene and subsequent acid hydrolysis provided compounds <b>27</b>–<b>29</b>.</div><figure id="sch2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.7b00141/20170407/images/medium/jm-2017-00141h_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.7b00141/20170407/images/large/jm-2017-00141h_0006.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of 5′-Ester and 5′-Methylamides <b>27</b>–<b>29</b> in the Riboside Series<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.7b00141/20170407/images/large/jm-2017-00141h_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00141&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions (% yields): (i) 2,2-dimethoxypropane, acetone, <i>p</i>-TSA, rt, 91%; (ii) RNH<sub>2</sub>, Et<sub>3</sub>N, MeOH, rt, 83–85%; (iii) PDC, DMF, 40 °C, 67–68%; (iv) for <b>41</b>, <b>42</b>, RNH<sub>2</sub>, HATU, DIPEA, DMF, rt, 68–69%; (v) for <b>43</b>, MeOH, DCC, DMAP, DMF, rt, 52%; (vi) 2-chloro-5-ethynylthiophene, Pd(Ph<sub>3</sub>P)<sub>2</sub>Cl<sub>2</sub>, CuI, Et<sub>3</sub>N, DMF, rt, 82-84%; (iv) 10% TFA, MeOH, 70 °C, 90–91%.</p></p></figure><div class="NLM_p">The 3-deazaadenine derivatives (<b>6</b> and <b>13</b>) were synthesized from key bicyclo[3.1.0]hexane intermediate <b>36</b><a onclick="showRef(event, 'cit22b'); return false;" href="javascript:void(0);" class="ref cit22b">(22b)</a> as depicted in <a class="ref internalNav" href="#sch3" aria-label="Scheme 3">Scheme 3</a>. A Mitsunobu condensation of compound <b>35</b> with 3-deaza-2-bromo-6-chloropurine gave compound <b>47</b>, which underwent a C6 substitution with MeNH<sub>2</sub> under microwave conditions at 125 °C to give compound <b>48</b>. Aminolysis of compound <b>48</b> with aqueous MeNH<sub>2</sub> solution gave the methylamide <b>49</b>, which was subjected to Sonogashira coupling with 5-chloro-2-ethynylthiophene under microwave conditions at 130 °C to provide compound <b>51</b>, and subsequent acid hydrolysis afforded the 3-deaza derivative <b>6</b>. Acid hydrolysis of compound <b>48</b> gave the nucleoside derivative <b>50</b>, which also underwent Sonogashira coupling with 5-chloro-2-ethynylthiophene under microwave conditions to afford compound <b>13</b>.</div><figure id="sch3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.7b00141/20170407/images/medium/jm-2017-00141h_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.7b00141/20170407/images/large/jm-2017-00141h_0007.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of 3-Deaza-(<i>N</i>)-methanocarbanucleosides <b>6</b> and <b>13</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.7b00141/20170407/images/large/jm-2017-00141h_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00141&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions (% yields): (i) 3-deaza-2-bromo-6-chloropurine, Ph<sub>3</sub>P, DIAD, THF, 69%; (ii) MeNH<sub>2</sub>·HCl, DIPEA, isopropanol, 125 °C, microwave, 76%; (iii) 40% MeNH<sub>2</sub>, MeOH, rt; (iv) 5-chloro-2-ethynylthiophene, PdCl<sub>2</sub>(Ph<sub>3</sub>P)<sub>2</sub>, CuI, DMF, 130 °C, μwave, 63%; (v) 10%TFA, MeOH, 70 °C, 90–91%.</p></p></figure></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i9" class="anchor-spacer"></div><h3 class="article-section__title" id="_i9"> Biological Testing</h3><div id="sec2_2_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i10" class="anchor-spacer"></div><h4 class="article-section__title" id="_i10"> In Vitro Assays</h4><div id="sec2_2_1_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i11" class="anchor-spacer"></div><h5 class="article-section__title" id="_i11"> DAT Binding Screen</h5><div class="NLM_p">The nucleoside derivatives were screened initially by the Psychoactive Drug Screening Program (PDSP) for binding interactions at diverse receptors, ion channels, and transporters (<a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a> and <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>).<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> A fixed concentration of 10 μM was used in the primary screen for inhibition of radioligand binding at the hDAT. Because (<i>N</i>)-methanocarba nucleosides may enhance binding of a high affinity tropane derivative, [<sup>3</sup><i>H</i>]methyl (1<i>R</i>,2<i>S</i>,3<i>S</i>)-3-(4-fluorophenyl)-8-methyl-8-azabicyclo[3.2.1]octane-2-carboxylate (WIN35,428, <b>24</b>), at hDAT,<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> a significant negative value for the % inhibition of radioligand binding, i.e., greater binding than the control, was also interpreted as a hit. The radioligands used for NET and SERT binding were [<sup>3</sup>H](<i>R,S</i>)-3-(2-methoxyphenoxy)-<i>N</i>-methyl-3-phenylpropan-1-amine (nisoxetine, <b>52</b>) and [<sup>3</sup>H](<i>R,S</i>)-1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-1,3-dihydroisobenzofuran-5-carbonitrile (citalopram, <b>53</b>), respectively. In the secondary screen by the PDSP, compounds that inhibited binding by >50% or significantly enhanced binding were characterized in full concentration–response curves.</div><div class="NLM_p">A secondary screen of selected binding enhancers allowed a more precise comparison of their interaction with hDAT and in a few cases other transporters. <a class="ref internalNav" href="#fig1" aria-label="Figures 1">Figures 1</a> and <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a> show the full concentration–response curves for % enhancement of [<sup>3</sup>H]<b>24</b> binding by selected nucleosides (<b>6</b>, <b>8</b>, <b>10</b>, <b>11</b>, <b>14</b>, <b>15</b>, <b>22</b>, and <b>27</b>–<b>29</b>) in comparison to known inhibitor <b>30</b>. EC<sub>50</sub> values for <b>7</b>, <b>8</b>, <b>15</b>, <b>22</b>, and <b>28</b> were >10<sup>–6</sup> M; 1.2 μM for <b>16</b>; and 400 nM for <b>12</b>. Significant (>200%) enhancement of binding (% at 10 μM) was seen with compounds <b>6</b> (334%), <b>9</b> (352%), <b>10</b> (539%), <b>11</b> (370%), <b>12</b> (430%), <b>13</b> (354%), <b>14</b> (426%), <b>16</b> (285%), <b>27</b> (321%), and <b>29</b> (220%). <i>i</i>-Propyl (<b>15</b>) ester slightly inhibited the binding of [<sup>3</sup>H]<b>24</b> at 10 μM, while 5′-propyl ester <b>14</b> enhanced binding; thus, branching of the α-carbon in 5′-esters was not tolerated. Among extended 5′-alkyl and 5′-alkylaryl esters (<b>17</b>–<b>21</b>), only the <i>i</i>-pentyl analogue <b>17</b> significantly interacted with hDAT (196% enhancement at 10 μM). 5′-Carboxylate (<b>22</b>) and <i>N</i><sup>6</sup>-propyl riboside (<b>28</b>) interacted only weakly at hDAT at 10 μM, indicated by enhancement of [<sup>3</sup>H]<b>24</b> binding of <100%. 5′-<i>N</i>-(2-Aminoethyl)-carboxamide <b>8</b> (133% enhancement of [<sup>3</sup>H]<b>24</b> binding) was not comparable in efficacy to the corresponding 5′-methylamide <b>1</b> at hDAT. 5-Bromothien-2-yl 5′-ethyl ester derivative <b>12</b> appeared to be comparable to reference 5-chlorothien-2-yl derivative <b>1</b> in enhancing hDAT binding. Thus, 5-bromo is a suitable substitution for 5-chloro with respect to hDAT interaction (also evident in <b>2</b> compared to <b>1</b>).<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> Curiously, benzyl ester <b>19</b> inhibited binding at SERT with a <i>K</i><sub>i</sub> value of 5.6 μM, and <b>28</b> inhibited NET binding with a <i>K</i><sub>i</sub> of 3.1 μM, and none of the other newly synthesized nucleosides inhibited binding at these two transporters with <i>K</i><sub>i</sub> < 10 μM.</div><figure id="fig1" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.7b00141/20170407/images/medium/jm-2017-00141h_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.7b00141/20170407/images/large/jm-2017-00141h_0002.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Drug-induced enhancement of [<sup>3</sup>H]<b>24</b> binding to hDAT (PDSP) by (<i>N</i>)-methanocarba analogues (representative of 2–5 determinations): (A) 3-deaza-5′-methylamide <b>6</b>; (B) 5′-ethyl ester <b>10</b> and 2-(5-bromothienylethynyl)-5′-methyl ester <b>11</b>; (C) 2-(5-chlorothienylethynyl)-5′-<i>N</i>-(2-aminoethyl)-carboxamide <b>8</b> and its 5′-ethyl ester analogue <b>10</b>; (D) 5′-<i>n</i>-propyl ester <b>14</b> and 5′-carboxylic acid <b>22</b>. Comparison with binding inhibition by 1-[2-[bis(4-fluorophenyl)methoxy]ethyl]-4-(3 phenylpropyl)-piperazine (GBR12909, <b>30</b>) is shown.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.7b00141/20170407/images/large/jm-2017-00141h_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00141&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig2" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.7b00141/20170407/images/medium/jm-2017-00141h_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.7b00141/20170407/images/large/jm-2017-00141h_0003.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. (A) Drug-induced enhancement of [<sup>3</sup>H]<b>24</b> binding to hDAT (PDSP) by ribosides <b>27</b>–<b>29</b> (representative of 4 determinations) in comparison to weak enhancers (<i>N</i>)-methanocarba 5′-<i>N</i>-(2-aminoethyl)-carboxamide <b>8</b> and 5′-isopropyl ester <b>15</b>. Comparison with binding inhibition by <b>30</b> is shown.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.7b00141/20170407/images/large/jm-2017-00141h_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00141&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Various 1- or 3-deaza derivatives (<b>5</b>, <b>6</b>, and <b>13</b>) were compared to probe the participation of these H-bond acceptor nitrogens of adenine for recognition at hDAT. The 1-deaza modification (<b>5a</b> and <b>5b</b>) prevented enhancement of [<sup>3</sup>H]<b>24</b> binding at hDAT but not A<sub>3</sub>AR activation.<a onclick="showRef(event, 'ref3 ref21'); return false;" href="javascript:void(0);" class="ref ref3 ref21">(3, 21)</a> The corresponding 3-deaza 5′-methylamide <b>6</b> significantly enhanced [<sup>3</sup>H]<b>24</b> binding at hDAT, but with less efficacy than <b>1</b>. Thus, the N1, but not N3, nitrogen atom was essential for interaction with hDAT.</div><div class="NLM_p last">Ribosides <b>27</b> and <b>29</b> displayed % enhancement of [<sup>3</sup>H]<b>24</b> binding at 10 μM of 321% and 220%, respectively, which were less than the corresponding (<i>N</i>)-methanocarba analogues (<b>1</b> and <b>9</b>, with enhancement of 556% and 391%, respectively). Compound <b>28</b> inhibited NET binding with a <i>K</i><sub>i</sub> value of 3.1 μM (<a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>).</div></div><div id="sec2_2_1_2" class="NLM_sec NLM_sec_level_4"><div id="ac_i12" class="anchor-spacer"></div><h5 class="article-section__title" id="_i12"> Detailed Characterization at DAT, NET, and SERT</h5><div class="NLM_p">The PDSP screen led to a selection of strongly enhancing compounds that were further characterized in greater detail at hDAT and the other transporters (e.g., binding of [<sup>125</sup>I]<b>23</b> at DAT, NET, and SERT and functional activity at each). Selected compounds were also characterized for their effect on binding of [<sup>3</sup>H](±)-5-(4-chlorophenyl)-3,5-dihydro-2<i>H</i>-imidazo[2,1-<i>a</i>]isoindol-5-ol (mazindol, <b>26</b>). The latter detailed pharmacological parameters for the novel compounds are reported in <a class="ref internalNav" href="#tbl2" aria-label="Table 2">Table 2</a> in comparison to compounds <b>1</b>, <b>2</b>, <b>3</b>, and <b>7</b>, which were characterized in our previous study.<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a></div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Affinities, Potencies and Efficacies of Adenosine Derivatives for hDAT, hNET, and hSERT (<i>n</i> = 3–6)</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="rowsep1 colsep0" align="center">no.</th><th class="rowsep1 colsep0" colspan="3" align="center">hDAT</th><th class="rowsep1 colsep0" colspan="3" align="center">hNET</th><th class="rowsep1 colsep0" colspan="3" align="center">hSERT</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center">[<sup>125</sup>I]<b>23</b></th><th class="colsep0 rowsep0" align="center">[<sup>3</sup>H]<b>26</b></th><th class="colsep0 rowsep0" align="center">[<sup>3</sup>H]DA</th><th class="colsep0 rowsep0" align="center">[<sup>125</sup>I]<b>23</b></th><th class="colsep0 rowsep0" align="center">[<sup>3</sup>H]<b>26</b></th><th class="colsep0 rowsep0" align="center">[<sup>3</sup>H]NE</th><th class="colsep0 rowsep0" align="center">[<sup>125</sup>I]<b>23</b></th><th class="colsep0 rowsep0" align="center">[<sup>3</sup>H]<b>26</b></th><th class="colsep0 rowsep0" align="center">[<sup>3</sup>H]5-HT</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center">binding, EC<sub>50</sub><a class="ref internalNav" href="#t2fn1" aria-label="a">a</a> or <i>K</i><sub>i</sub> (nM), <i>% control</i><i>binding</i></th><th class="colsep0 rowsep0" align="center">binding, EC<sub>50</sub> or <i>K</i><sub>i</sub> (nM), <i>% control</i><i>binding</i></th><th class="colsep0 rowsep0" align="center">uptake, IC<sub>50</sub> (nM)</th><th class="colsep0 rowsep0" align="center">binding, EC<sub>50</sub> or <i>K</i><sub>i</sub> (nM), <i>% control</i><i>binding</i></th><th class="colsep0 rowsep0" align="center">binding, EC<sub>50</sub> or <i>K</i><sub>i</sub> (nM),<a class="ref internalNav" href="#t2fn3" aria-label="c">c</a><i>% contol</i><i>binding</i></th><th class="colsep0 rowsep0" align="center">uptake, IC<sub>50</sub> (nM)</th><th class="colsep0 rowsep0" align="center">binding, EC<sub>50</sub> or <i>K</i><sub>i</sub> (nM),<a class="ref internalNav" href="#t2fn3" aria-label="c">c</a><i>% contol</i><i>binding</i></th><th class="colsep0 rowsep0" align="center">binding, EC<sub>50</sub> or <i>K</i><sub>i</sub> (nM),<a class="ref internalNav" href="#t2fn3" aria-label="c">c</a><i>% control</i><i>binding</i></th><th class="colsep0 rowsep0" align="center">uptake, IC<sub>50</sub> (nM)<a class="ref internalNav" href="#t2fn3" aria-label="c">c</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>l</b><a class="ref internalNav" href="#t2fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">35.1 ± 8.4<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0" align="left">131 ± 31<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0" align="left">253 ± 92</td><td class="colsep0 rowsep0" align="left">1180 ± 360<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0" align="left">>10 μM</td><td class="colsep0 rowsep0" align="left">>10 μM</td><td class="colsep0 rowsep0" align="left">>10 μM</td><td class="colsep0 rowsep0" align="left">>10 μM</td><td class="colsep0 rowsep0" align="left">>10 μM</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"><i>550 ± 110%</i></td><td class="colsep0 rowsep0" align="left"><i>403 ± 33%</i></td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"><i>386 ± 73%</i></td><td class="colsep0 rowsep0" align="left">NE<a class="ref internalNav" href="#t2fn4" aria-label="d">d</a></td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">NE</td><td class="colsep0 rowsep0" align="left">NE</td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>2</b><a class="ref internalNav" href="#t2fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">9.1 ± l.7<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0" align="left">870 ± 130<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0" align="left">229 ± 30</td><td class="colsep0 rowsep0" align="left">670 ± 200<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0" align="left">>10 μM</td><td class="colsep0 rowsep0" align="left">6110 ± 570</td><td class="colsep0 rowsep0" align="left">>10 μM</td><td class="colsep0 rowsep0" align="left">>10 μM</td><td class="colsep0 rowsep0" align="left">>10 μM</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"><i>217 ± 24%</i></td><td class="colsep0 rowsep0" align="left"><i>369 ± 31%</i></td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"><i>285 ± 22%</i></td><td class="colsep0 rowsep0" align="left">NE</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">NE</td><td class="colsep0 rowsep0" align="left">NE</td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>3</b><a class="ref internalNav" href="#t2fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">70 ± 26<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0" align="left">128 ± 18<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0" align="left">92 ± 16</td><td class="colsep0 rowsep0" align="left">1760 ± 640<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0" align="left">>10 μM</td><td class="colsep0 rowsep0" align="left">>10 μM</td><td class="colsep0 rowsep0" align="left">>10 μM</td><td class="colsep0 rowsep0" align="left">>10 μM</td><td class="colsep0 rowsep0" align="left">>10 μM</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"><i>690 ± 180%</i></td><td class="colsep0 rowsep0" align="left"><i>438 ± 41%</i></td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"><i>371 ± 67%</i></td><td class="colsep0 rowsep0" align="left">NE</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">NE</td><td class="colsep0 rowsep0" align="left">NE</td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>6</b></td><td class="colsep0 rowsep0" align="left">239 ± 79<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0" align="left">550 ± 180<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0" align="left">163 ± 42</td><td class="colsep0 rowsep0" align="left">740 ± 190<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0" align="left">>10 μM</td><td class="colsep0 rowsep0" align="left">5060 ± 360</td><td class="colsep0 rowsep0" align="left">>10 μM</td><td class="colsep0 rowsep0" align="left">>10 μM</td><td class="colsep0 rowsep0" align="left">>10 μM</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"><i>437 ± 60%</i></td><td class="colsep0 rowsep0" align="left"><i>405 ± 18%</i></td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"><i>318 ± 22%</i></td><td class="colsep0 rowsep0" align="left">NE</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">NE</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>7</b><a class="ref internalNav" href="#t2fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">1120 ± 220<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0" align="left">ND<a class="ref internalNav" href="#t2fn5" aria-label="e">e</a></td><td class="colsep0 rowsep0" align="left">>8700</td><td class="colsep0 rowsep0" align="left">900 ± 320<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0" align="left">ND</td><td class="colsep0 rowsep0" align="left">ND</td><td class="colsep0 rowsep0" align="left">ND</td><td class="colsep0 rowsep0" align="left">ND</td><td class="colsep0 rowsep0" align="left">ND</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"><i>268 ± 32%</i></td><td class="colsep0 rowsep0" align="left">ND</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"><i>159 ± 1%</i></td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>9</b></td><td class="colsep0 rowsep0" align="left">35 ± 13<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0" align="left">124 ± 21<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0" align="left">127 ± 40</td><td class="colsep0 rowsep0" align="left">310 ± 110<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0" align="left">>10 μM</td><td class="colsep0 rowsep0" align="left">3380 ± 290</td><td class="colsep0 rowsep0" align="left">>10 μM</td><td class="colsep0 rowsep0" align="left">>10 μM</td><td class="colsep0 rowsep0" align="left">>10 μM</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"><i>458 ± 71%</i></td><td class="colsep0 rowsep0" align="left"><i>540 ± 33%</i></td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"><i>375 ± 24%</i></td><td class="colsep0 rowsep0" align="left">NE</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">NE</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>10</b></td><td class="colsep0 rowsep0" align="left">34 ± 13<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0" align="left">267 ± 80<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0" align="left">107 ± 14</td><td class="colsep0 rowsep0" align="left">490 ± 120<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0" align="left">>8,400</td><td class="colsep0 rowsep0" align="left">3980 ± 330</td><td class="colsep0 rowsep0" align="left">>10 μM</td><td class="colsep0 rowsep0" align="left">>10 μM</td><td class="colsep0 rowsep0" align="left">>10 μM</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"><i>434 ± 64%</i></td><td class="colsep0 rowsep0" align="left"><i>455 ± 39%</i></td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"><i>365 ± 11%</i></td><td class="colsep0 rowsep0" align="left">NE</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">NE</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>11</b></td><td class="colsep0 rowsep0" align="left">53.5 ± 9.8<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0" align="left">308 ± 20<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0" align="left">246 ± 10</td><td class="colsep0 rowsep0" align="left">400 ± 130<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0" align="left">>10 μM</td><td class="colsep0 rowsep0" align="left">3560 ± 500</td><td class="colsep0 rowsep0" align="left">>10 μM</td><td class="colsep0 rowsep0" align="left">>10 μM</td><td class="colsep0 rowsep0" align="left">>10 μM</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"><i>374 ± 50%</i></td><td class="colsep0 rowsep0" align="left"><i>520 ± 100%</i></td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"><i>293 ± 32%</i></td><td class="colsep0 rowsep0" align="left">NE</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">NE</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>14</b></td><td class="colsep0 rowsep0" align="left">294 ± 82<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0" align="left">535 ± 29<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0" align="left">1145 ± 52</td><td class="colsep0 rowsep0" align="left">980 ± 270<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0" align="left">>10 μM</td><td class="colsep0 rowsep0" align="left">7900 ± 1400</td><td class="colsep0 rowsep0" align="left">>10 μM</td><td class="colsep0 rowsep0" align="left">>10 μM</td><td class="colsep0 rowsep0" align="left">>10 μM</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"><i>461 ± 67%</i></td><td class="colsep0 rowsep0" align="left"><i>347 ± 60%</i></td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"><i>302 ± 24%</i></td><td class="colsep0 rowsep0" align="left">NE</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">NE</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>29</b></td><td class="colsep0 rowsep0" align="left">127 ± 32<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0" align="left">860 ± 180<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0" align="left">396 ± 83</td><td class="colsep0 rowsep0" align="left">1520 ± 180<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0" align="left">>10 μM</td><td class="colsep0 rowsep0" align="left">2690 ± 220</td><td class="colsep0 rowsep0" align="left">>10 μM</td><td class="colsep0 rowsep0" align="left">>10 μM</td><td class="colsep0 rowsep0" align="left">>10 μM</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"><i>312 ± 45%</i></td><td class="colsep0 rowsep0" align="left"><i>269 ± 28%</i></td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"><i>227 ± 18%</i></td><td class="colsep0 rowsep0" align="left">NE</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">NE</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">cocaine</td><td class="colsep0 rowsep0" align="left">720 ± 140</td><td class="colsep0 rowsep0" align="left">1270 ± 530</td><td class="colsep0 rowsep0" align="left">274 ± 31</td><td class="colsep0 rowsep0" align="left">2410 ± 590</td><td class="colsep0 rowsep0" align="left">10,700 ± 1100</td><td class="colsep0 rowsep0" align="left">221 ± 13</td><td class="colsep0 rowsep0" align="left">657 ± 56</td><td class="colsep0 rowsep0" align="left">229 ± 56</td><td class="colsep0 rowsep0" align="left">277 ± 24</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">NE</td><td class="colsep0 rowsep0" align="left">NE</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">NE</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">NE</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>23</b></td><td class="colsep0 rowsep0" align="left">ND</td><td class="colsep0 rowsep0" align="left">11.0 ± 2.9</td><td class="colsep0 rowsep0" align="left">ND</td><td class="colsep0 rowsep0" align="left">ND</td><td class="colsep0 rowsep0" align="left">70.0 ± 8.8</td><td class="colsep0 rowsep0" align="left">ND</td><td class="colsep0 rowsep0" align="left">ND</td><td class="colsep0 rowsep0" align="left">1.27 ± 0.29</td><td class="colsep0 rowsep0" align="left">ND</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">NE</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">NE</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>26</b></td><td class="colsep0 rowsep0" align="left">34.6 ± 5.7</td><td class="colsep0 rowsep0" align="left">74.2 ± 8.4</td><td class="colsep0 rowsep0" align="left">13.0 ± 0.6</td><td class="colsep0 rowsep0" align="left">11.3 ± 3.5</td><td class="colsep0 rowsep0" align="left">13.5 ± 1.5</td><td class="colsep0 rowsep0" align="left">0.92 ± 0.10</td><td class="colsep0 rowsep0" align="left">136 ± 15</td><td class="colsep0 rowsep0" align="left">45 ± 10</td><td class="colsep0 rowsep0" align="left">54 ± 11</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">NE</td><td class="colsep0 rowsep0" align="left">NE</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">NE</td><td class="colsep0 rowsep0" align="left">NE</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">NE</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup>a</sup><p class="last">The EC<sub>50</sub> value for drugs that enhanced radioligand binding.</p></div><div class="footnote" id="t2fn2"><sup>b</sup><p class="last">Data are from Janowsky et al.<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a></p></div><div class="footnote" id="t2fn3"><sup>c</sup><p class="last"><i>K</i><sub>i</sub> values are provided for drugs that inhibited binding.</p></div><div class="footnote" id="t2fn4"><sup>d</sup><p class="last">NE, no enhancement of binding.</p></div><div class="footnote" id="t2fn5"><sup>e</sup><p class="last">ND, not determined.</p></div></div></div><div class="NLM_p">5′-Methyl (<b>9</b>) and ethyl (<b>10</b>) esters containing a 5-chlorothienyl moiety enhanced [<sup>125</sup>I]<b>23</b> binding to hDAT equipotently to a maximal level ∼450% of control binding (absence of drug), with EC<sub>50</sub> values of ∼35 nM (<a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>). Interestingly, <b>9</b> and <b>10</b> also enhanced [<sup>125</sup>I]<b>23</b> binding to NET to a maximal level ∼370% of control, with EC<sub>50</sub> values of 310 and 490 nM, respectively (<a class="ref internalNav" href="#tbl2" aria-label="Table 2">Table 2</a>). The effects of <b>9</b> and <b>10</b> on SERT binding of [<sup>125</sup>I]<b>23</b> were small (inhibition at >10 μM). Contrary to their enhancing effects on radioligand binding to hDAT, compounds <b>9</b> and <b>10</b> were potent DA uptake inhibitors, with IC<sub>50</sub> values of 127 and 107 nM, respectively, compared with 274 nM for cocaine and 13.0 nM for <b>26</b>. Thus, the potencies of esters <b>9</b> and <b>10</b> in inhibiting DA uptake were ∼2-fold greater than the corresponding methylamide <b>1</b>. Compounds <b>9</b> and <b>10</b> were less potent at inhibiting norepinephrine uptake by the NET with IC<sub>50</sub> values of 3.38 and 3.98 μM, respectively, compared with 221 nM for cocaine and 0.92 nM for <b>26</b>. The inhibitory effect of both compounds on 5HT uptake was estimated as >10 μM.</div><figure id="fig3" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.7b00141/20170407/images/medium/jm-2017-00141h_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.7b00141/20170407/images/large/jm-2017-00141h_0004.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Drug-induced enhancement or inhibition of [<sup>125</sup>I]<b>23</b> binding and [<sup>3</sup>H]<b>26</b> binding to HEK-hDAT, HEK-hNET, and HEK-hSERT cell membranes.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.7b00141/20170407/images/large/jm-2017-00141h_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00141&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Compounds with intermediate potency in enhancing the binding of [<sup>125</sup>I]<b>23</b> at hDAT (in order of increasing EC<sub>50</sub>, nM) were: 5-bromothienyl 5′-ethyl ester <b>11</b> (53.5), ribose 5′-methyl ester <b>29</b> (127), 3-deaza 5′-methylamide <b>6</b> (239), and 5′-propyl ester <b>14</b> (294). At NET, compounds <b>6</b>, <b>11</b>, and <b>14</b> were roughly proportionately weaker at NET (EC<sub>50</sub> ∼ 400 nM–1 μM) than at hDAT, except the ribose derivative <b>29</b> was disproportionately weak with EC<sub>50</sub> > 1 μM. However, the newly synthesized 5′-ester compounds tended to be more potent in enhancement of [<sup>125</sup>I]<b>23</b> binding to NET than the previous set of 5′-methylamides <b>1</b>–<b>3</b>.</div><div class="NLM_p">Five nucleoside derivatives were tested in binding and functional assays at the mouse (m) DAT expressed in HEK-293 cells (<a class="ref internalNav" href="#tbl3" aria-label="Table 3">Table 3</a>).<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> Cocaine was comparable in inhibiting binding at mDAT and at hDAT, but <b>26</b> was 12-fold more potent at hDAT than mDAT. The radioligand [<sup>125</sup>I]<b>23</b> was less potent in binding to mDAT than hDAT with a 3-fold higher <i>K</i><sub>d</sub> value (3.9 vs 1.3 nM). Qualitatively, the nucleosides acted similarly at mDAT and hDAT in that they enhanced [<sup>125</sup>I]<b>23</b> binding and inhibited [<sup>3</sup>H]DA uptake. At the fixed concentration of radioligand, the percent of maximal binding enhancement by all of the compounds in the mDAT experiments was greater than that at hDAT. However, all of the adenosine derivatives were less potent at mDAT than at hDAT in both enhancing binding and inhibiting uptake. The rank order of EC<sub>50</sub> values (decreasing affinity in binding) was <b>9</b> > <b>2</b>, <b>10</b> > <b>1</b> > <b>6</b> at mDAT compared to <b>2</b> > <b>1</b>, <b>9</b>, <b>10</b> > <b>6</b> at hDAT. The factors for inhibition by the nucleosides of DA uptake, between hDAT and mDAT, were 7- to 26-fold. The two 5′-amide derivatives <b>1</b> and <b>2</b> displayed affinity and potency of 1–3 μM at mDAT. Thus, those compounds remain somewhat selective for the A<sub>3</sub>AR compared to DAT in both humans and mice. However, two nucleoside 5′-esters <b>9</b> and <b>10</b> and one 5′-amide <b>6</b>, which were inactive in binding to the mA<sub>3</sub>AR (<50% inhibition at 10 μM), still displayed considerable activity (1–4 μM) at mDAT. Thus, moderate DAT selectivity was indicated, at least in one species.</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Affinities, Potencies and Efficacies of Adenosine Derivatives for mDAT Expressed in HEK-293 Cells</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">no.</th><th class="colsep0 rowsep0" align="center">[<sup>125</sup>I]<b>23</b> binding, EC<sub>50</sub> ± SEM (nM)</th><th class="colsep0 rowsep0" align="center">maximal % control [<sup>125</sup>I]<b>23</b> binding</th><th class="colsep0 rowsep0" align="center">[<sup>3</sup>H]DA uptake, IC<sub>50</sub> ± SEM (nM)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1</b></td><td class="colsep0 rowsep0" align="left">2230 ± 430</td><td class="colsep0 rowsep0" align="left">1150 ± 60%</td><td class="colsep0 rowsep0" align="left">2290 ± 470</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>2</b></td><td class="colsep0 rowsep0" align="left">1100 ± 290</td><td class="colsep0 rowsep0" align="left">810 ± 110%</td><td class="colsep0 rowsep0" align="left">3260 ± 830</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>6</b></td><td class="colsep0 rowsep0" align="left">2760 ± 310</td><td class="colsep0 rowsep0" align="left">1000 ± 0%</td><td class="colsep0 rowsep0" align="left">4300 ± 1000</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>9</b></td><td class="colsep0 rowsep0" align="left">810 ± 270</td><td class="colsep0 rowsep0" align="left">1440 ± 190%</td><td class="colsep0 rowsep0" align="left">940 ± 130</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>10</b></td><td class="colsep0 rowsep0" align="left">1070 ± 320</td><td class="colsep0 rowsep0" align="left">1560 ± 200%</td><td class="colsep0 rowsep0" align="left">1170 ± 150</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">[<sup>125</sup>I]<b>23</b> binding <i>K</i><sub>i</sub> ± SEM (nM)</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">cocaine</td><td class="colsep0 rowsep0" align="left">850 ± 170</td><td class="colsep0 rowsep0" align="left">NA<a class="ref internalNav" href="#t3fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0" align="left">200 ± 24</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>26</b></td><td class="colsep0 rowsep0" align="left">404 ± 88</td><td class="colsep0 rowsep0" align="left">NA</td><td class="colsep0 rowsep0" align="left">13.0 ± 2.6</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup>a</sup><p class="last">NA, not applicable.</p></div></div></div><div class="NLM_p">5′-Esters <b>9</b>, <b>10</b>, and <b>29</b> were also compared for their effect on hDAT binding of a nontropane radioligand, [<sup>3</sup>H]<b>26</b> (<a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>). The enhancement of [<sup>3</sup>H]<b>26</b> binding by riboside 5′-methyl ester <b>29</b> was weaker and less efficacious, with a 7-fold higher EC<sub>50</sub> value and half the maximal effect, compared to the corresponding (<i>N</i>)-methanocarba analogue <b>9</b>. Furthermore, riboside <b>28</b> inhibited the binding of nontropane radlioligand [<sup>3</sup>H]<b>52</b> to NET with a <i>K</i><sub>i</sub> value of 3.1 μM (data not shown).</div><div class="NLM_p last">Effects of the nucleosides on uptake of radiolabeled neurotransmitters were measured in the cell lines expressing hDAT and hNET. The order of potency in inhibiting DA uptake was: <b>3</b>, <b>10</b>, <b>9</b> > <b>1</b>, <b>2</b>, <b>11</b> > <b>14</b>. The order of potency in inhibiting norepinephrine uptake was <b>9</b>, <b>10</b>, <b>11</b> > <b>6</b>, <b>2</b> > <b>1</b>, <b>3</b>, and there was no significant inhibition of 5HT uptake. Thus, 5′-esters <b>9</b> and <b>10</b> were among the most potent to inhibit uptake of both catecholamines. <b>10</b> was more potent than cocaine at inhibiting DA uptake (IC<sub>50</sub> = 107 nM).</div></div><div id="sec2_2_1_3" class="NLM_sec NLM_sec_level_4"><div id="ac_i15" class="anchor-spacer"></div><h5 class="article-section__title" id="_i15"> A<sub>3</sub>AR Binding in Two Species</h5><div class="NLM_p">Because the reference compounds <b>1</b>–<b>3</b>, <b>5</b>, and <b>7</b> were highly selective agonists for the hA<sub>3</sub>AR with nanomolar affinity and were nearly inactive at the other AR subtypes, we measured the binding affinity at recombinant hA<sub>3</sub>AR (<a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>). The nucleosides were also tested at the mouse (m) A<sub>3</sub>AR because of the known phenomenon of species-dependent variation of affinity at this receptor.<a onclick="showRef(event, 'ref2 ref18'); return false;" href="javascript:void(0);" class="ref ref2 ref18">(2, 18)</a> A standard agonist radioligand ([<sup>125</sup>I]<i>N</i><sup>6</sup>-(4-amino-3-iodobenzyl)adenosine-5′-<i>N</i>-methyluronamide <b>25</b>) binding assay was used,<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> and IC<sub>50</sub> values were converted to <i>K</i><sub>i</sub> values as reported.<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a></div><div class="NLM_p">Among 5′-ester derivatives, considerable affinity was observed at the hA<sub>3</sub>AR, but the mA<sub>3</sub>AR affinity was greatly reduced compared to that of amides. For example, 5′-methylamide <b>1</b> was 8-fold more potent than the corresponding 5′-methyl ester <b>9</b> at the hA<sub>3</sub>AR, but >300-fold at the mA<sub>3</sub>AR (extrapolated <i>K</i><sub>i</sub> of <b>9</b> > 10 μM). Similarly, larger esters that contained the full complement of the adenine nitrogens <b>10</b>–<b>12</b> and <b>14</b>–<b>16</b> were weak or inactive at the mA<sub>3</sub>AR. The <i>n</i>-propyl ester <b>14</b> displayed a <i>K</i><sub>i</sub> value of 2.81 μM at the mA<sub>3</sub>AR.</div><div class="NLM_p">Replacement of the adenine 3-nitrogen atom with a CH group in <b>6</b> prevented recognition at the mA<sub>3</sub>AR but not at the hA<sub>3</sub>AR, which registered only a 13-fold reduction of affinity compared to that of <b>1</b>. In general, adenine ring-modified analogues displayed affinity at the hA<sub>3</sub>AR in the order: adenine ≥ 1-deaza > 3-deaza.</div><div class="NLM_p">This expanded set of nucleoside analogues also provided an opportunity to compare (<i>N</i>)-methanocarba nucleosides directly with the corresponding ribose analogues at the A<sub>3</sub>AR in two species. In general, 2- to 5-fold greater hA<sub>3</sub>AR affinity was associated with the methanocarba analogues compared to that of the equivalent ribose derivatives (cf. <b>1</b> versus <b>27</b>; <b>7</b> versus <b>28</b>; <b>9</b> versus <b>29</b>). At the mA<sub>3</sub>AR, the differences in affinity were even greater, for example, 88-fold greater affinity of bicyclic 5′-amide <b>7</b> compared to that of ribose 5′-amide <b>28</b>. Curiously, in the ribose series, the mA<sub>3</sub>AR affinity was at least 1 order of magnitude higher for 5′-ester <b>29</b> than for the conventional 5′-methylamide agonists of this receptor, i.e., <b>27</b> and <b>28</b>. The same comparison in the (<i>N</i>)-methanocarba series showed the opposite; in contrast to the potent 5′-methylamide <b>1</b>, 5′-ester <b>9</b> was nearly inactive at the mA<sub>3</sub>AR, but it still bound with high affinity at the hA<sub>3</sub>AR (<i>K</i><sub>i</sub> = 5.38 nM). Thus, the dependence of mA<sub>3</sub>AR affinity on the (<i>N</i>)-methanocarba modification vs ribose was dramatically reversed between amides and esters.</div><div class="NLM_p last">In a functional assay of hA<sub>3</sub>AR-mediated inhibition of cAMP formation (<i>n</i> = 3),<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> methyl ester <b>9</b> was a low efficacy partial agonist, and 3-deaza ester <b>13</b> had no significant activity with maximal efficacies (at 10 μM) of 11.6 ± 1.0% and 3.6 ± 3.0%, respectively, compared to reference agonist adenosine-5′-<i>N</i>-ethyluronamide set at 100%. However, the 3-deaza analogue <b>6</b> of full A<sub>3</sub>AR agonist <b>4</b> was also a full agonist (116.5 ± 14.6%).</div></div><div id="sec2_2_1_4" class="NLM_sec NLM_sec_level_4"><div id="ac_i16" class="anchor-spacer"></div><h5 class="article-section__title" id="_i16"> In Vivo Testing</h5><div class="NLM_p last">Since some of these nucleosides still displayed moderate affinity at the A<sub>3</sub>AR, although diminished affinity compared to reference compound <b>1</b>, several compounds were evaluated in the mouse chronic constriction injury (CCI) model of neuropathic pain<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> (Figure S2, <a href="/doi/suppl/10.1021/acs.jmedchem.7b00141/suppl_file/jm7b00141_si_001.pdf" class="ext-link">Supporting Information</a>). This activity was shown in our previous studies to associate closely with the activity of nucleosides as A<sub>3</sub>AR agonists at peripheral and/or central sites.<a onclick="showRef(event, 'ref1 ref2 ref18 ref19 ref20'); return false;" href="javascript:void(0);" class="ref ref1 ref2 ref18 ref19 ref20">(1, 2, 18-20)</a> Mice were treated with an adenosine derivative at 7 d postinjury, i.e., the time of peak mechanoallodynia. Riboside analogues <b>27</b> and <b>28</b> (3 μmol/kg, p.o.) were fully efficacious with a long duration of action (>6 h) in increasing the paw withdrawal threshold (PWT), i.e., reducing pain.</div></div><div id="sec2_2_1_5" class="NLM_sec NLM_sec_level_4"><div id="ac_i17" class="anchor-spacer"></div><h5 class="article-section__title" id="_i17"> Other Off-target Binding</h5><div class="NLM_p last">Other off-target interactions at receptors and channels were detected for the derivatives in the PDSP screening (Figure S1, <a href="/doi/suppl/10.1021/acs.jmedchem.7b00141/suppl_file/jm7b00141_si_001.pdf" class="ext-link">Supporting Information</a>). Compounds <b>11</b> (<i>K</i><sub>i</sub> = 258 nM), <b>13</b> (<i>K</i><sub>i</sub> = 395 nM), <b>15</b> (<i>K</i><sub>i</sub> = 430 nM), and <b>29</b> (<i>K</i><sub>i</sub> = 3.24 ± 1.05 μM) bound to the h5HT<sub>2C</sub> serotonin receptor. By analogy to other methanocarba nucleoside derivatives,<a onclick="showRef(event, 'ref20 ref28'); return false;" href="javascript:void(0);" class="ref ref20 ref28">(20, 28)</a> we expect these compounds to act as 5HT<sub>2C</sub> antagonists. At the α-adrenergic receptors (α-Rs), ribosides but not the corresponding methanocarba analogues bound weakly to hα<sub>2A</sub>-R (<b>27</b>), hα<sub>2B</sub>-R (<b>29</b>), or both (<b>28</b>) with <i>K</i><sub>i</sub> values in the 5–10 μM range. <i>K</i><sub>i</sub> values at all other α-adrenergic receptors were >10 μM. Compounds <b>7</b> (<i>K</i><sub>i</sub> = 1.44 μM) bound to the hβ<sub>3</sub> adrenergic receptor. Compounds <b>13</b> also bound to hM<sub>5</sub> muscarinic (<i>K</i><sub>i</sub> = 3.8 μM) and rat sigma<sub>1</sub> (<i>K</i><sub>i</sub> = 1.04 μM) and rat sigma<sub>2</sub> (<i>K</i><sub>i</sub> = 1.90 μM) receptors; <b>20</b> bound to sigma<sub>2</sub> (<i>K</i><sub>i</sub> = 5.9 μM) receptors.</div></div></div></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i18">Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_37782" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_37782" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Adenosine derivatives have been designed as agonists and in some cases partial agonists or antagonists of the ARs. A<sub>3</sub>AR agonists are being developed for the treatment of cancer, inflammation, and pain,<a onclick="showRef(event, 'ref1 ref29 ref30 ref31'); return false;" href="javascript:void(0);" class="ref ref1 ref29 ref30 ref31">(1, 29-31)</a> but they also display off-target activities at higher concentrations.<a onclick="showRef(event, 'ref3 ref9'); return false;" href="javascript:void(0);" class="ref ref3 ref9">(3, 9)</a> We have explored and enhanced the off-target activity of nucleosides, especially those having rigid methanocarba rings, and found them to serve as a privileged scaffold<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> for a variety of targets. Targets other than neurotransmitter symporters that appear to be binding sites of moderate affinity in this chemical series are GPCRs for biogenic amines, TSPO, and sigma receptors.<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a></div><div class="NLM_p">The SAR in this study extends our previous findings that (<i>N</i>)-methanocarba adenosine derivatives enhance DAT radioligand affinity and inhibit DA uptake. Most of the compounds synthesized here contain <i>C</i>2-(5-halothien-2-yl)-ethynyl and <i>N</i><sup>6</sup>-methyl substitution, which were determined to promote DAT interaction in the previous study.<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a></div><div class="NLM_p">The three transporters for neurotransmitters examined in this study possess closely related structures, each having 12 transmembrane helices.<a onclick="showRef(event, 'ref6 ref7 ref33'); return false;" href="javascript:void(0);" class="ref ref6 ref7 ref33">(6, 7, 33)</a> The cocaine-competitive tropane ligands that display high affinity at DAT also tend to interact with NET and SERT.<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> Our previous study of the off-target activity of (<i>N</i>)-methanocarba nucleoside derivatives at DAT was consistent with allosteric modulation of radioligand binding.<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> We found similar results in this study, in which potent DAT modulation remained, while the AR potency of key analogues was reduced in comparison to <b>1</b>, by structural changes. Percent enhancement of binding at DAT was similar using two different tropane radioligands. These nucleosides had differing interactions with the transporters: at DAT they enhanced both [<sup>125</sup>I]<b>23</b> and [<sup>3</sup>H]<b>26</b> binding, and at NET, only [<sup>125</sup>I]<b>23</b> binding was enhanced, while they had minimal effect on radioligand binding to SERT. Thus, as is characteristic of allosteric modulators, there was a probe-dependence of the interaction of these nucleosides at DAT and NET. Allosteric modulation of SERT is well validated structurally,<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> and that of NET has been described; for example, a peptide inhibitor was suggested to bind to the extracellular vestibule of the transporter.<a onclick="showRef(event, 'ref35 ref36'); return false;" href="javascript:void(0);" class="ref ref35 ref36">(35, 36)</a></div><div class="NLM_p">Nevertheless, many of the compounds still interact with the A<sub>3</sub>AR, as evident from their binding affinity and protective effects, as agonists, in a pain model. Reference compounds <b>1</b>–<b>3</b>, <b>5</b>, and <b>7</b> were shown previously to be potent A<sub>3</sub>AR agonists and to reduce chronic pain in the CCI model, an effect of A<sub>3</sub>AR agonists that was shown to depend entirely on the A<sub>3</sub>AR as demonstrated using A<sub>3</sub><sup>–/–</sup> mice.<a onclick="showRef(event, 'ref1 ref21'); return false;" href="javascript:void(0);" class="ref ref1 ref21">(1, 21)</a> However, in this study we have characterized the simultaneous activity at transporters of various A<sub>3</sub>AR ligands of nanomolar affinity. The potency of <b>1</b>, for example, as an allosteric enhancer of hDAT binding is 50-fold weaker than its potency at the hA<sub>3</sub>AR. One objective of this study was to preserve or enhance DAT potency while decreasing A<sub>3</sub>AR affinity, so we modified the nucleosides at positions that might be predicted to lower the A<sub>3</sub>AR affinity. This was accomplished for the 5′-ester series, for which the DAT potency was maintained, and the A<sub>3</sub>AR affinity was reduced (human) or absent (mouse). 5′-Esters reduced A<sub>3</sub>AR affinity in general, compared to 5′-monoalkyl amides.<a onclick="showRef(event, 'ref28 ref37 ref49'); return false;" href="javascript:void(0);" class="ref ref28 ref37 ref49">(28, 37, 49)</a> Consistently, compound <b>9</b> was 8-fold less potent than <b>1</b> at the hA<sub>3</sub>AR, and the difference was even greater at the mA<sub>3</sub>AR. Also, the ribose 5′ binding region of ARs is limited sterically, based on X-ray structures.<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a> Thus, the extended, charged 5′-(2-aminoethyl)-amide <b>8</b> displayed only moderate affinity at the hA<sub>3</sub>AR and was completely inactive at the mA<sub>3</sub>AR. However, it interacted only weakly with DAT.</div><div class="NLM_p">Furthermore, dimethylation of the exocyclic amine in <b>4</b>, as noted previously,<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> was more detrimental to DAT interaction than to A<sub>3</sub>AR affinity. The deaza analogues displayed differential effects at the two primary targets compared in this study. The 1-deaza (<b>5</b>) modification is a means of introducing A<sub>3</sub>AR selectivity compared to that of DAT with no loss of A<sub>3</sub>AR affinity.<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> The 3-deaza (<b>6</b>) modification of 5′-methylamide <b>1</b> decreased A<sub>3</sub>AR affinity (13-fold lower than <b>1</b> in humans and nearly inactive in mice), while at DAT significant binding enhancement was present. The 3-deaza modification in the 5′-amide series (<b>6</b>) improved NET potency, but reduced DAT potency 7-fold (cf. <b>1</b>). The EC<sub>50</sub> of <b>6</b> for [<sup>125</sup>I]<b>23</b> binding at DAT was only 6.8-fold higher than <b>1</b> and 4.2-fold higher for [<sup>3</sup>H]<b>26</b> binding. Thus, the 1-deaza (<b>5</b>), but not the 3-deaza (<b>6</b> and <b>13</b>) modifications are a means of eliminating DAT activity in this series. We speculate that N1 might serve as an energetically important H-bond acceptor in DAT.</div><div class="NLM_p">5′-Methyl, ethyl and <i>n</i>-propyl esters, but not larger esters, maintained efficacious DAT interaction. The substitution of a 5-bromo in the <i>C</i>2-thienylethynyl group (<b>11</b>) maintained NET and DAT potency in the 5′-ester series but did not improve DAT potency as it did in the amides (cf. <b>2</b>). The enhancing activity at mDAT of selected compounds was examined for a comparison with the A<sub>3</sub>AR within the same species.<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a> 3-Deaza 5′-amide <b>6</b>, 5′-methyl ester <b>9</b>, and 5′-ethyl ester <b>10</b> were selective for the enhancement of binding at the mDAT with respect to the mA<sub>3</sub>AR. These compounds were nearly inactive at mA<sub>3</sub>AR, indicating that the 5′-ester group is not tolerated in general (except for bromo derivative <b>12</b> and propyl ester <b>14</b>). The potency of <i>N</i><sup>6</sup>-propyl derivative <b>7</b> was slightly enhanced compared to that of <b>1</b> at NET but greatly reduced at DAT. Therefore, at DAT there appear to be sterically limited binding subpockets surrounding the 5′-alkylamide, 5′-alkyl ester, and <i>N</i><sup>6</sup>-alkyl substituents. Future studies of DAT modeling will distinguish the specific amino acids and molecular interactions involved in radioligand binding as compared to transporter function.</div><div class="NLM_p">At the A<sub>3</sub>AR, we established importantly that the (<i>N</i>)-methanocarba modification enhances affinity in direct comparison to the riboside. However, there was no advantage to the DAT interaction upon restoring the ribose moiety because the potency of ribosides was also diminished, by ∼5-fold, at the DAT and NET. Our present results establish that various 5′-ester derivatives with extended C2 substituents can display potent affinity at the hA<sub>3</sub>AR, which was not anticipated from our earlier report on 2-Cl derivatives.<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a> Although the ester derivatives <b>9</b>–<b>16</b> bound at the hA<sub>3</sub>AR with <i>K</i><sub>i</sub> values of 5–43 nM (<b>13</b>: 169 nM), two of them (<b>9</b> and <b>13</b>) were shown to have little or no ability to activate the receptor, suggesting that they may be A<sub>3</sub>AR antagonists. Similarly, several weakly binding adenosine 5′-ester derivatives (methanocarba series) were shown to be either partial agonist or antagonist at the hA<sub>3</sub>AR;<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> thus, 5′-amides but not 5′-esters tend to fully activate the hA<sub>3</sub>AR.</div><div class="NLM_p">Additional structural modification would likely be required before this nucleoside series could be considered for therapeutic use. We reported that mixed DAT enhancer/A<sub>3</sub>AR agonist <b>1</b> at 10 mg/kg did not significantly stimulate locomotor activity in the mouse and at 30 mg/kg reduced locomotor activity.<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a> The observed locomotor depression can be attributed to a peripheral action of <b>1</b> at a peripheral A<sub>3</sub>AR. Our earlier study showed that decreased physical activity with high doses A<sub>3</sub>AR agonists in the mouse correlated with histamine release by peripheral mast cells upon A<sub>3</sub>AR activation.<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a> Also, we predict that nucleoside <b>1</b> (MW 459, total polar surface area, tPSA = 121.9 Å<sup>2</sup>) and related congeners will display a low brain concentration that is typical of peripherally administered nucleosides.<a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a> Thus, in order to study the CNS effects<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> of these modulators, especially <b>9</b> and <b>10</b> (both having tPSA = 119.1 Å<sup>2</sup>) that are DAT-selective in the mouse, it would be more informative to infuse them intracerebroventricularly in rodents.</div><div class="NLM_p">Peripherally selective inhibitors of DA and norepinephrine uptake might be useful as an emergency treatment of lung edema to act as an inotropic agent in the heart and to increase kidney/splanchnic circulation, similar to the currently used injection of biogenic amine receptor agonists, notably DA at medium doses.<a onclick="showRef(event, 'ref43 ref44 ref45'); return false;" href="javascript:void(0);" class="ref ref43 ref44 ref45">(43-45)</a> Alternatively, an allosteric modulator of DAT that did act centrally might have less evident behavioral stimulant effects than orthosteric inhibitors.</div><div class="NLM_p">We have not yet studied the pharmacokinetics of 5′-esters that were shown here to be allosteric modulators of DAT. However, the in vivo stability of the corresponding 5′-ester group was shown for another member of this series of rigid (<i>N</i>)-methanocarba nucleosides in the context of 5HT<sub>2B</sub>R antagonists.<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> Also, amide derivatives in the present set of compounds, such as orally administered <b>1</b>, were shown to be bioavailable and have long lasting in vivo effects in mice and are not rapidly metabolized.<a onclick="showRef(event, 'ref2 ref19'); return false;" href="javascript:void(0);" class="ref ref2 ref19">(2, 19)</a> These rigid nucleosides, such as <b>1</b>, typically do not inhibit cytochrome P450 (5 isozymes) and are stable in the presence of liver microsomes, plasma and simulated body fluids.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> A metabolomic study of <b>1</b> indicated that the compound was well tolerated in vivo.<a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">(46)</a></div><div class="NLM_p last">In conclusion, following structural modification of our previous series of nucleoside modulators of DAT, we maintained or enhanced the activity of rigid nucleosides at DAT and NET while reducing A<sub>3</sub>AR affinity. Two nucleoside 5′-esters <b>9</b> and <b>10</b> and one 5′-amide <b>6</b> that were inactive at the mA<sub>3</sub>AR were shown to allosterically modulate mDAT in the micromolar range. These compounds, such as <b>9</b> and <b>10</b>, will be useful as research tools for studying the structure and function of DAT and NET.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i19">Experimental Procedures</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_28008" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_28008" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> Chemical Synthesis</h3><div id="sec4_1_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i21" class="anchor-spacer"></div><h4 class="article-section__title" id="_i21"> Materials and Instrumentation</h4><div class="NLM_p">All reagents and solvents were purchased from Sigma-Aldrich (St. Louis, MO). <sup>1</sup>H NMR spectra were obtained with a Bruker 400 spectrometer using CDCl<sub>3</sub>, CD<sub>3</sub>OD, and DMSO as solvents. Chemical shifts are expressed in δ values (ppm) with tetramethylsilane (δ 0.00) for CDCl<sub>3</sub> and water (δ 3.30) for CD<sub>3</sub>OD. NMR spectra were collected with a Bruker AV spectrometer equipped with a z-gradient [<sup>1</sup>H,<sup>13</sup>C,<sup>15</sup>N]-cryoprobe. TLC analysis was carried out on glass sheets precoated with silica gel F254 (0.2 mm) from Sigma-Aldrich. The purity of final nucleoside derivatives was checked using a Hewlett–Packard 1100 HPLC equipped with a Zorbax SB-Aq 5 μm analytical column (50 × 4.6 mm; Agilent Technologies Inc., Palo Alto, CA). Mobile phase: linear gradient solvent system, 5 mM tetrabutylammonium dihydrogen phosphate–CH<sub>3</sub>CN from 80:20 to 0:100 in 13 min; the flow rate was 0.5 mL/min. Peaks were detected by UV absorption with a diode array detector at 230, 254, and 280 nm. All derivatives tested for biological activity showed >95% purity by HPLC analysis (detection at 254 nm). The nucleoside products tested in biological assays do not contain any functional groups associated with assay interference compounds,<a onclick="showRef(event, 'ref47'); return false;" href="javascript:void(0);" class="ref ref47">(47)</a> and they display self-consistent potent structure–activity relationships, with very few off-target hits in broad screening. Low-resolution mass spectrometry was performed with a JEOL SX102 spectrometer with 6 kV Xe atoms following desorption from a glycerol matrix or on an Agilent LC/MS 1100 MSD, with a Waters (Milford, MA) Atlantis C18 column. High resolution mass spectroscopic (HRMS) measurements were performed on a proteomics optimized Q-TOF-2 (Micromass-Waters) using external calibration with polyalanine, unless noted. Observed mass accuracies are those expected based on known performance of the instrument as well as trends in masses of standard compounds observed at intervals during the series of measurements. Reported masses are observed masses uncorrected for this time-dependent drift in mass accuracy. 6-Chloro-2-iodopurine-9-riboside <b>35a</b> was purchased from Matrix Scientific, Inc. (Columbia, SC). All other reagents were purchased from Sigma-Aldrich (St. Louis, MO), Small Molecules, Inc. (Hoboken, NJ), Anichem (North Brunswick, NJ), PharmaBlock, Inc. (Sunnyvale, CA), Frontier Scientific (Logan, UT), and Tractus (Perrineville, NJ). Calculation of total polar surface area was performed using ChemDraw Professional (v. 15.1, PerkinElmer, Boston, MA).</div><div id="sec4_1_1_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i22" class="anchor-spacer"></div><h5 class="article-section__title" id="_i22"> (1<i>S</i>,2<i>R</i>,3<i>S</i>,4<i>R</i>,5<i>S</i>)-4-(6-((5-Chlorothiophen-2-yl)ethynyl)-4-(methylamino)-1<i>H</i>-imidazo[4,5-<i>c</i>]pyridin-1-yl)-2,3-dihydroxy-<i>N</i>-methylbicyclo[3.1.0]hexane-1-carboxamide (<b>6</b>)</h5><div class="NLM_p last">Compound <b>6</b> (90%) was prepared from compound <b>51</b> following the same method as those for compound <b>50</b>. <sup>1</sup>H NMR (CD<sub>3</sub>OD, 400 MHz) δ 8.11 (s, 1H), 7.20 (d, <i>J</i> = 4.0 Hz, 1H), 7.17 (s, 1H), 6.98 (d, <i>J</i> = 4.0 Hz, 1H), 4.81 (d, <i>J</i> = 6.4 Hz, 1H), 4.74 (s, 1H), 3.93 (d, <i>J</i> = 6.4 Hz, 1H), 3.10 (s, 3H), 2.87 (s, 3H), 2.25–2.21 (m, 1H), 1.94 (t, <i>J</i> = 5.2 Hz, 1H), 1.46–1.44 (m, 1H). HRMS calculated for C<sub>21</sub>H<sub>21</sub>N<sub>5</sub>O<sub>3</sub>SCl (M + H) <sup>+</sup>: 458.1054; found 458.1058.</div></div><div id="sec4_1_1_2" class="NLM_sec NLM_sec_level_4"><div id="ac_i23" class="anchor-spacer"></div><h5 class="article-section__title" id="_i23"> (1<i>S</i>,2<i>R</i>,3<i>S</i>,4<i>R</i>,5<i>S</i>)-<i>N</i>-(2-Aminoethyl)-4-(2-((5-chlorothiophen-2-yl)ethynyl)-6-(methylamino)-9<i>H</i>-purin-9-yl)-2,3-dihydroxybicyclo[3.1.0]hexane-1-carboxamide (<b>8</b>)</h5><div class="NLM_p last">Ethylenediamine (1.5 mL) was added to a solution of compound <b>10</b> (13 mg, 0.027 mmol) in MeOH (0.1 mL) and stirred for 2d at room temperature. The solvent was evaporated, and the residue was purified on flash silica gel column chromatography (CH<sub>2</sub>Cl<sub>2</sub>/MeOH/NH<sub>4</sub>OH = 5:1:0.1) to give compound <b>8</b> (9 mg, 71%) as a colorless syrup. <sup>1</sup>H NMR (CD<sub>3</sub>OD, 400 MHz) δ 8.12 (s, 1H), 7.33 (d, <i>J</i> = 4.0 Hz, 1H), 7.04 (d, <i>J</i> = 4.0 Hz, 1H), 5.08 (d, <i>J</i> = 6.8 Hz, 1H), 4.83 (s, 1H), 4.05 (d, <i>J</i> = 6.8 Hz, 1H), 3.60–3.49 (m, 2H), 3.19–3.09 (m, 3H), 2.19–2.16 (m, 1H), 1.94 (t, <i>J</i> = 4.8 Hz, 1H), 1.49–1.46 (m, 1H). HRMS calculated for C<sub>21</sub>H<sub>23</sub>N<sub>7</sub>O<sub>3</sub>SCl (M + H) <sup>+</sup>: 488.1272; found 488.1273.</div></div><div id="sec4_1_1_3" class="NLM_sec NLM_sec_level_4"><div id="ac_i24" class="anchor-spacer"></div><h5 class="article-section__title" id="_i24"> Methyl (1<i>S</i>,2<i>R</i>,3<i>S</i>,4<i>R</i>,5<i>S</i>)-4-(2-((5-Chlorothiophen-2-yl)ethynyl)-6-(methylamino)-9<i>H</i>-purin-9-yl)-2,3-dihydroxybicyclo[3.1.0]hexane-1-carboxylate (<b>9</b>)</h5><div class="NLM_p last">DCC (32 mg, 0.15 mmol), DMAP (2.5 mg, 0.02 mmol), and MeOH (10 μL, 0.15 mmol) were added to a solution of compound <b>22</b> (23 mg, 0.05 mmol) in DMF (1 mL) and stirred at room temperature overnight. The solvent was evaporated, and the residue was purified on flash silica gel column chromatography (CH<sub>2</sub>Cl<sub>2</sub>/MeOH = 30:1) to afford compound <b>9</b> (12 mg, 51%) as a colorless syrup. <sup>1</sup>H NMR (CD<sub>3</sub>OD, 400 MHz) δ 8.03 (s, 1H), 7.33 (d, <i>J</i> = 4.0 Hz, 1H), 7.02 (d, <i>J</i> = 4.0 Hz, 1H), 5.22 (d, <i>J</i> = 6.8 Hz, 1H), 4.84 (s, 1H), 4.09 (d, <i>J</i> = 6.8 Hz, 1H), 3.79 (s, 3H), 3.13 (br s, 3H), 2.23–2.20 (m, 1H), 1.92 (t, <i>J</i> = 5.2 Hz, 1H), 1.66–1.62 (m, 1H). HRMS calculated for C<sub>20</sub>H<sub>19</sub>N<sub>5</sub>O<sub>4</sub>SCl (M + H) <sup>+</sup>: 460.0846; found 460.0850.</div></div><div id="sec4_1_1_4" class="NLM_sec NLM_sec_level_4"><div id="ac_i25" class="anchor-spacer"></div><h5 class="article-section__title" id="_i25"> Ethyl (1<i>S</i>,2<i>R</i>,3<i>S</i>,4<i>R</i>,5S)-4-(2-((5-Chlorothiophen-2-yl)ethynyl)-6-(methylamino)-9<i>H</i>-purin-9-yl)-2,3-dihydroxybicyclo[3.1.0]hexane-1-carboxylate (<b>10</b>)</h5><div class="NLM_p last">A solution of compound <b>33</b> (103 mg, 0.2 mmol) in methanol (3 mL) and 10% trifluoromethanesulfonic acid (3 mL) was heated at 70 °C for 4 h. The solvent was evaporated under vacuum, and the residue was purified on flash silica gel column chromatography (CH<sub>2</sub>Cl<sub>2</sub>/MeOH = 30:1) to give the compound <b>10</b> (86 mg, 91%) as a colorless syrup. <sup>1</sup>H NMR (CD<sub>3</sub>OD, 400 MHz) δ 8.08 (s, 1H), 7.35 (d, <i>J</i> = 4.0 Hz, 1H), 7.04 (d, <i>J</i> = 4.0 Hz, 1H), 5.21 (d, <i>J</i> = 6.8 Hz, 1H), 4.84 (s, 1H), 4.27–4.22 (m, 2H), 4.12 (d, <i>J</i> = 6.4 Hz, 1H), 3.14 (br s, 3H), 2.23–2.20 (m, 1H), 1.91 (t, <i>J</i> = 5.2 Hz, 1H), 1.67–1.63 (m, 1H), 1.29 (t, <i>J</i> = 7.2 Hz, 3H). HRMS calculated for C<sub>21</sub>H<sub>21</sub>N<sub>5</sub>O<sub>4</sub>SCl (M + H) <sup>+</sup>: 474.1003; found 474.1007.</div></div><div id="sec4_1_1_5" class="NLM_sec NLM_sec_level_4"><div id="ac_i26" class="anchor-spacer"></div><h5 class="article-section__title" id="_i26"> Methyl (1<i>S</i>,2<i>R</i>,3<i>S</i>,4<i>R</i>,5<i>S</i>)-4-(2-((5-Bromothiophen-2-yl)ethynyl)-6-(methylamino)-9<i>H</i>-purin-9-yl)-2,3-dihydroxybicyclo[3.1.0]hexane-1-carboxylate (<b>11</b>)</h5><div class="NLM_p last">MeONa (7.6 mg, 0.14 mmol) was added to a solution of compound <b>12</b> (25 mg, 0.048 mmol) in MeOH (3 mL) and stirred at room temperature overnight. The solvent was evaporated, and the residue was purified on flash silica gel column chromatography (hexane/ethyl acetate = 1:1) to give the methyl ester derivative <b>11</b> (16 mg, 69%) as a colorless syrup. <sup>1</sup>H NMR (CD<sub>3</sub>OD, 400 MHz) δ 8.02 (s, 1H), 7.28 (d, <i>J</i> = 4.0 Hz, 1H), 7.14 (d, <i>J</i> = 4.0 Hz, 1H), 5.22 (d, <i>J</i> = 7.2 Hz, 1H), 4.83 (s, 1H), 4.09 (d, <i>J</i> = 7.2 Hz, 1H), 3.78 (s, 3H), 3.13 (br s, 3H), 2.23–2.20 (m, 1H), 1.92 (t, <i>J</i> = 5.2 Hz, 1H), 1.65–1.61 (m, 1H). HRMS calculated for C<sub>20</sub>H<sub>19</sub>N<sub>5</sub>O<sub>4</sub>SBr (M + H) <sup>+</sup>: 504.0341; found 504.0345.</div></div><div id="sec4_1_1_6" class="NLM_sec NLM_sec_level_4"><div id="ac_i27" class="anchor-spacer"></div><h5 class="article-section__title" id="_i27"> Ethyl (1<i>S</i>,2<i>R</i>,3<i>S</i>,4<i>R</i>,5<i>S</i>)-4-(2-((5-Bromothiophen-2-yl)ethynyl)-6-(methylamino)-9<i>H</i>-purin-9-yl)-2,3-dihydroxybicyclo[3.1.0]hexane-1-carboxylate (<b>12</b>)</h5><div class="NLM_p last">Compound <b>12</b> (90%) was prepared from compound <b>34</b> following the same method as that for compound <b>10</b>. <sup>1</sup>H NMR (CD<sub>3</sub>OD, 400 MHz) δ 8.02 (s, 1H), 7.28 (d, <i>J</i> = 4.0 Hz, 1H), 7.14 (d, <i>J</i> = 4.0 Hz, 1H), 5.20 (d, <i>J</i> = 6.6 Hz, 1H), 4.84 (s, 1H), 4.27–4.22 (m, 2H), 4.13 (d, <i>J</i> = 6.6 Hz, 1H), 3.13 (br s, 3H), 2.23–2.20 (m, 1H), 1.92 (t, <i>J</i> = 5.2 Hz, 1H), 1.66–1.63 (m, 1H), 1.29 (t, <i>J</i> = 7.2 Hz, 3H). HRMS calculated for C<sub>21</sub>H<sub>21</sub>N<sub>5</sub>O<sub>4</sub>SBr (M + H) <sup>+</sup>: 518.0498; found 518.0494.</div></div><div id="sec4_1_1_7" class="NLM_sec NLM_sec_level_4"><div id="ac_i28" class="anchor-spacer"></div><h5 class="article-section__title" id="_i28"> Ethyl (1<i>S</i>,2<i>R</i>,3<i>S</i>,4<i>R</i>,5<i>S</i>)-4-(6-((5-Chlorothiophen-2-yl)ethynyl)-4-(methylamino)-1<i>H</i>-imidazo[4,5-<i>c</i>]pyridin-1-yl)-2,3-dihydroxybicyclo[3.1.0]hexane-1-carboxylate (<b>13</b>)</h5><div class="NLM_p last">Compound <b>13</b> (71%) was prepared from compound <b>50</b> following the same method as that for compound <b>51</b>. <sup>1</sup>H NMR (CD<sub>3</sub>OD, 400 MHz) δ 8.03 (s, 1H), 7.19 (d, <i>J</i> = 4.0 Hz, 1H), 7.11 (s, 1H), 6.98 (d, <i>J</i> = 4.0 Hz, 1H), 5.02 (d, <i>J</i> = 7.6 Hz, 1H), 4.70 (s, 1H), 4.30–4.25 (m, 2H), 4.02 (d, <i>J</i> = 6.4 Hz, 1H), 3.10 (s, 3H), 2.30–2.26 (m, 1H), 1.95 (t, <i>J</i> = 5.2 Hz, 1H), 1.74–1.71 (m, 1H), 1.33 (t, <i>J</i> = 7.2 Hz, 3H). HRMS calculated for C<sub>22</sub>H<sub>22</sub>N<sub>4</sub>O<sub>4</sub>SCl (M + H) <sup>+</sup>: 473.1050; found 473.1056.</div></div><div id="sec4_1_1_8" class="NLM_sec NLM_sec_level_4"><div id="ac_i29" class="anchor-spacer"></div><h5 class="article-section__title" id="_i29"> <i>n</i>-Propyl (1<i>S</i>,2<i>R</i>,3<i>S</i>,4<i>R</i>,5<i>S</i>)-4-(2-((5-Chlorothiophen-2-yl)ethynyl)-6-(methylamino)-9<i>H</i>-purin-9-yl)-2,3-dihydroxybicyclo[3.1.0]hexane-1-carboxylate (<b>14</b>)</h5><div class="NLM_p last">Compound <b>14</b> (53%) was prepared from compound <b>22</b> following the same method as that for compound <b>9</b>. <sup>1</sup>H NMR (CD<sub>3</sub>OD, 400 MHz) δ 8.01 (s, 1H), 7.33 (d, <i>J</i> = 4.0 Hz, 1H), 7.02 (d, <i>J</i> = 4.0 Hz, 1H), 5.21 (d, <i>J</i> = 6.8 Hz, 1H), 4.83 (s, 1H), 4.18–4.11 (m, 3H), 3.13 (br s, 3H), 2.24–2.20 (m, 1H), 1.92 (t, <i>J</i> = 5.2 Hz, 1H), 1.72–1.63 (m, 3H), 0.94 (t, <i>J</i> = 7.2 Hz, 1H). HRMS calculated for C<sub>22</sub>H<sub>23</sub>N<sub>5</sub>O<sub>4</sub>SCl (M + H) <sup>+</sup>: 488.1159; found 488.1162.</div></div><div id="sec4_1_1_9" class="NLM_sec NLM_sec_level_4"><div id="ac_i30" class="anchor-spacer"></div><h5 class="article-section__title" id="_i30"> Isopropyl (1<i>S</i>,2<i>R</i>,3<i>S</i>,4<i>R</i>,5<i>S</i>)-4-(2-((5-Chlorothiophen-2-yl)ethynyl)-6-(methylamino)-9<i>H</i>-purin-9-yl)-2,3-dihydroxybicyclo[3.1.0]hexane-1-carboxylate (<b>15</b>)</h5><div class="NLM_p last">Compound <b>15</b> (52%) was prepared from compound <b>22</b> following the same method as that for compound <b>9</b>. <sup>1</sup>H NMR (CD<sub>3</sub>OD, 400 MHz) δ 7.99 (s, 1H), 7.33 (d, <i>J</i> = 4.0 Hz, 1H), 7.02 (d, <i>J</i> = 4.0 Hz, 1H), 5.20 (d, <i>J</i> = 6.4 Hz, 1H), 5.14–5.08 (m, 1H), 4.82 (s, 1H), 4.13 (d, <i>J</i> = 5.2 Hz, 1H), 3.13 (br s, 3H), 2.21–2.18 (m, 1H), 1.90 (t, <i>J</i> = 4.8 Hz, 1H), 1.66–1.62 (m, 1H), 1.27 (d, <i>J</i> = 8.0 Hz, 6H). HRMS calculated for C<sub>22</sub>H<sub>23</sub>N<sub>5</sub>O<sub>4</sub>SCl (M + H) <sup>+</sup>: 488.1159; found 488.1156.</div></div><div id="sec4_1_1_10" class="NLM_sec NLM_sec_level_4"><div id="ac_i31" class="anchor-spacer"></div><h5 class="article-section__title" id="_i31"> Butyl (1<i>S</i>,2<i>R</i>,3<i>S</i>,4<i>R</i>,5<i>S</i>)-4-(2-((5-Chlorothiophen-2-yl)ethynyl)-6-(methylamino)-9<i>H</i>-purin-9-yl)-2,3-dihydroxybicyclo[3.1.0]hexane-1-carboxylate (<b>16</b>)</h5><div class="NLM_p last">Compound <b>16</b> (53%) was prepared from compound <b>22</b> following the same method as that for compound <b>9</b>. <sup>1</sup>H NMR (CD<sub>3</sub>OD, 400 MHz) δ 8.01 (s, 1H), 7.33 (d, <i>J</i> = 4.0 Hz, 1H), 7.02 (d, <i>J</i> = 4.0 Hz, 1H), 5.22 (d, <i>J</i> = 6.4 Hz, 1H), 4.84 (s, 1H), 4.24–4.17 (m, 2H), 4.12 (d, <i>J</i> = 6.4 Hz, 1H), 3.13 (br s, 3H), 2.23–2.19 (m, 1H), 1.91 (t, <i>J</i> = 5.2 Hz, 1H), 1.69–1.62 (m, 3H), 1.43–1.34 (m, 2H), 0.92 (t, <i>J</i> = 7.2 Hz, 3H). HRMS calculated for C<sub>23</sub>H<sub>25</sub>N<sub>5</sub>O<sub>4</sub>SCl (M + H) <sup>+</sup>: 502.1316; found 502.1308.</div></div><div id="sec4_1_1_11" class="NLM_sec NLM_sec_level_4"><div id="ac_i32" class="anchor-spacer"></div><h5 class="article-section__title" id="_i32"> Isopentyl (1<i>S</i>,2<i>R</i>,3<i>S</i>,4<i>R</i>,5<i>S</i>)-4-(2-((5-Chlorothiophen-2-yl)ethynyl)-6-(methylamino)-9<i>H</i>-purin-9-yl)-2,3-dihydroxybicyclo[3.1.0]hexane-1-carboxylate (<b>17</b>)</h5><div class="NLM_p last">Compound <b>17</b> (51%) was prepared from compound <b>22</b> following the same method as that for compound <b>9</b>. <sup>1</sup>H NMR (CD<sub>3</sub>OD, 400 MHz) δ 8.01 (s, 1H), 7.34 (d, <i>J</i> = 4.0 Hz, 1H), 7.02 (d, <i>J</i> = 4.0 Hz, 1H), 5.22 (d, <i>J</i> = 6.8 Hz, 1H), 4.83 (s, 1H), 4.29–4.21 (m, 2H), 4.12 (d, <i>J</i> = 6.4 Hz, 1H), 3.14 (br s, 3H), 2.22–2.18 (m, 1H), 1.91 (t, <i>J</i> = 5.2 Hz, 1H), 1.68–1.62 (m, 2H), 1.59–1.54 (m, 2H), 0.90 (d, <i>J</i> = 6.0 Hz, 6H). HRMS calculated for C<sub>24</sub>H<sub>27</sub>N<sub>5</sub>O<sub>4</sub>SCl (M + H) <sup>+</sup>: 516.1472; found 516.1467.</div></div><div id="sec4_1_1_12" class="NLM_sec NLM_sec_level_4"><div id="ac_i33" class="anchor-spacer"></div><h5 class="article-section__title" id="_i33"> 2-Cyclohexylethyl (1<i>S</i>,2<i>R</i>,3<i>S</i>,4<i>R</i>,5<i>S</i>)-4-(2-((5-Chlorothiophen-2-yl)ethynyl)-6-(methylamino)-9<i>H</i>-purin-9-yl)-2,3-dihydroxybicyclo[3.1.0]hexane-1-carboxylate (<b>18</b>)</h5><div class="NLM_p last">Compound <b>18</b> (54%) was prepared from compound <b>22</b> following the same method as that for compound <b>9</b>. <sup>1</sup>H NMR (CD<sub>3</sub>OD, 400 MHz) δ 8.02 (s, 1H), 7.34 (d, <i>J</i> = 4.0 Hz, 1H), 7.03 (d, <i>J</i> = 4.0 Hz, 1H), 5.24 (d, <i>J</i> = 7.6 Hz, 1H), 4.83 (s, 1H), 4.30–4.17 (m, 2H), 4.13 (d, <i>J</i> = 6.4 Hz, 1H), 3.13 (br s, 3H), 2.21–2.18 (m, 1H), 1.90 (t, <i>J</i> = 5.2 Hz, 1H), 1.70–1.61 (m, 6H), 1.58–1.53 (m, 2H), 1.32–1.26 (m, 2H), 1.19–1.15 (m, 2H), 0.94–0.85 (m, 2H). HRMS calculated for C<sub>27</sub>H<sub>31</sub>N<sub>5</sub>O<sub>4</sub>SCl (M + H) <sup>+</sup>: 556.1785; found 556.1786.</div></div><div id="sec4_1_1_13" class="NLM_sec NLM_sec_level_4"><div id="ac_i34" class="anchor-spacer"></div><h5 class="article-section__title" id="_i34"> Benzyl (1<i>S</i>,2<i>R</i>,3<i>S</i>,4<i>R</i>,5<i>S</i>)-4-(2-((5-Chlorothiophen-2-yl)ethynyl)-6-(methylamino)-9<i>H</i>-purin-9-yl)-2,3-dihydroxybicyclo[3.1.0]hexane-1-carboxylate (<b>19</b>)</h5><div class="NLM_p last">Compound <b>19</b> (59%) was prepared from compound <b>22</b> following the same method as that for compound <b>9</b>. <sup>1</sup>H NMR (CD<sub>3</sub>OD, 400 MHz) δ 7.96 (s, 1H), 7.38–7.15 (m, 6H), 6.98 (d, <i>J</i> = 4.0 Hz, 1H), 5.24 (d, <i>J</i> = 4.8 Hz, 1H), 4.83 (s, 1H), 4.11 (d, <i>J</i> = 6.4 Hz, 1H), 3.57 (t, <i>J</i> = 6.8 Hz, 1H), 3.13 (br s, 3H), 2.68 (t, <i>J</i> = 8.0 Hz, 1H), 2.26–2.23 (m, 1H), 1.95 (t, <i>J</i> = 5.2 Hz, 1H), 1.70–1.66 (m, 1H). HRMS calculated for C<sub>26</sub>H<sub>23</sub>N<sub>5</sub>O<sub>4</sub>SCl (M + H) <sup>+</sup>: 536.1159; found 536.1153.</div></div><div id="sec4_1_1_14" class="NLM_sec NLM_sec_level_4"><div id="ac_i35" class="anchor-spacer"></div><h5 class="article-section__title" id="_i35"> 2-Phenylethyl (1<i>S</i>,2<i>R</i>,3<i>S</i>,4<i>R</i>,5<i>S</i>)-4-(2-((5-Chlorothiophen-2-yl)ethynyl)-6-(methylamino)-9<i>H</i>-purin-9-yl)-2,3-dihydroxybicyclo[3.1.0]hexane-1-carboxylate (<b>20</b>)</h5><div class="NLM_p last">Compound <b>20</b> (58%) was prepared from compound <b>22</b> following the same method as that for compound <b>9</b>. <sup>1</sup>H NMR (CD<sub>3</sub>OD, 400 MHz) δ 7.93 (s, 1H), 7.30 (d, <i>J</i> = 4.0 Hz, 1H), 7.18–7.00 (m, 5H), 6.99 (d, <i>J</i> = 4.0 Hz, 1H), 5.19 (d, <i>J</i> = 6.8 Hz, 1H), 4.78 (s, 1H), 4.46–4.42 (m, 1H), 4.35–4.29 (m, 1H), 4.10 (d, <i>J</i> = 6.8 Hz, 1H), 3.14 (br s, 3H), 2.95 (t, <i>J</i> = 6.4 Hz, 2H), 2.07–2.03 (m, 1H), 1.86 (d, <i>J</i> = 5.2 Hz, 1H), 1.60–1.56 (m, 1H). HRMS calculated for C<sub>27</sub>H<sub>25</sub>N<sub>5</sub>O<sub>4</sub>SCl (M + H) <sup>+</sup>: 550.1316; found 550.1308.</div></div><div id="sec4_1_1_15" class="NLM_sec NLM_sec_level_4"><div id="ac_i36" class="anchor-spacer"></div><h5 class="article-section__title" id="_i36"> 3-Phenylpropyl (1<i>S</i>,2<i>R</i>,3<i>S</i>,4<i>R</i>,5<i>S</i>)-4-(2-((5-Chlorothiophen-2-yl)ethynyl)-6-(methylamino)-9<i>H</i>-purin-9-yl)-2,3-dihydroxybicyclo[3.1.0]hexane-1-carboxylate (<b>21</b>)</h5><div class="NLM_p last">Compound <b>21</b> (59%) was prepared from compound <b>22</b> following the same method as that for compound <b>9</b>. <sup>1</sup>H NMR (CD<sub>3</sub>OD, 400 MHz) δ 8.03 (s, 1H), 7.30 (d, <i>J</i> = 4.0 Hz, 1H), 7.22–7.11 (m, 5H), 7.01 (d, <i>J</i> = 4.0 Hz, 1H), 5.25 (d, <i>J</i> = 6.4 Hz, 1H), 4.83 (s, 1H), 4.27–4.11 (m, 3H), 3.13 (br s, 3H), 2.67 (t, <i>J</i> = 7.6 Hz, 2H), 2.18–2.14 (m, 1H), 2.02–1.95 (m, 2H), 1.90 (t, <i>J</i> = 5.2 Hz, 1H), 1.65–1.61 (m, 1H). HRMS calculated for C<sub>28</sub>H<sub>27</sub>N<sub>5</sub>O<sub>4</sub>SCl (M + H) <sup>+</sup>: 564.1472; found 564.1463.</div></div><div id="sec4_1_1_16" class="NLM_sec NLM_sec_level_4"><div id="ac_i37" class="anchor-spacer"></div><h5 class="article-section__title" id="_i37"> (1<i>S</i>,2<i>R</i>,3<i>S</i>,4<i>R</i>,5<i>S</i>)-4-(2-((5-Chlorothiophen-2-yl)ethynyl)-6-(methylamino)-9<i>H</i>-purin-9-yl)-2,3-dihydroxybicyclo[3.1.0]hexane-1-carboxylic Acid (<b>22</b>)</h5><div class="NLM_p last">2 N NaOH solution (1.5 mL) was added to a solution of compound <b>10</b> (29.2 mg, 0.06 mmol) in MeOH (1.5 mL) and stirred for 1 h at room temperature. The reaction mixture was neutralized with aceteic acid and evaporated under vacuum. The residue was purified on flash silica gel column chromatography (CH<sub>2</sub>Cl<sub>2</sub>/MeOH/TFA= 10:1:0.1) to give compound <b>22</b> (22 mg, 82%) as a colorless syrup. <sup>1</sup>H NMR (DMSO, 400 MHz) δ 8.12 (s, 1H), 7.98 (s, 1H), 7.48 (d, <i>J</i> = 4.0 Hz, 1H), 7.22 (d, <i>J</i> = 4.0 Hz, 1H), 4.92 (d, <i>J</i> = 6.0 Hz, 1H), 4.65 (s, 1H), 4.06–4.04 (m, 1H), 2.95 (br s, 3H), 2.03–2.00 (m, 1H), 1.69 (t, <i>J</i> = 4.8 Hz, 1H), 1.48–1.44 (m, 1H). HRMS calculated for C<sub>19</sub>H<sub>17</sub>N<sub>5</sub>O<sub>4</sub>SCl (M + H) <sup>+</sup>: 446.0690; found 446.0694.</div></div><div id="sec4_1_1_17" class="NLM_sec NLM_sec_level_4"><div id="ac_i38" class="anchor-spacer"></div><h5 class="article-section__title" id="_i38"> (2<i>S</i>,3<i>S</i>,4<i>R</i>,5<i>R</i>)-5-(2-((5-Chlorothiophen-2-yl)ethynyl)-6-(methylamino)-9<i>H</i>-purin-9-yl)-3,4-dihydroxy-<i>N</i>-methyltetrahydrofuran-2-carboxamide (<b>27</b>)</h5><div class="NLM_p last">Compound <b>27</b> (91%) was prepared from compound <b>44</b> following the same method as that for compound <b>10</b>. <sup>1</sup>H NMR (DMSO, 400 MHz) δ 8.56 (d, <i>J</i> = 4.4 Hz, 1H), 8.50 (s, 1H), 8.14 (d, <i>J</i> = 4.0 Hz, 1H), 7.49 (d, <i>J</i> = 4.0 Hz, 1H), 7.23 (d, <i>J</i> = 4.0 Hz, 1H), 5.96 (d, <i>J</i> = 7.6 Hz, 1H), 5.76 (d, <i>J</i> = 4.0 Hz, 1H), 5.57 (d, <i>J</i> = 6.4 Hz, 1H), 4.60–4.56 (m, 1H), 4.33 (s, 1H), 4.17–4.14 (m, 1H), 2.97 (br s, 3H), 2.78 (s, 3H). HRMS calculated for C<sub>18</sub>H<sub>18</sub>N<sub>6</sub>O<sub>4</sub>SCl (M + H) <sup>+</sup>: 449.0799; found 449.0806.</div></div><div id="sec4_1_1_18" class="NLM_sec NLM_sec_level_4"><div id="ac_i39" class="anchor-spacer"></div><h5 class="article-section__title" id="_i39"> (2<i>S</i>,3<i>S</i>,4<i>R</i>,5<i>R</i>)-5-(2-((5-Chlorothiophen-2-yl)ethynyl)-6-(<i>n</i>-propylamino)-9<i>H</i>-purin-9-yl)-3,4-dihydroxy-<i>N</i>-methyltetrahydrofuran-2-carboxamide (<b>28</b>)</h5><div class="NLM_p last">Compound <b>28</b> (90%) was prepared from compound <b>45</b> following the same method as that for compound <b>10</b>. <sup>1</sup>H NMR (CD<sub>3</sub>OD, 400 MHz) δ 8.27 (s, 1H), 7.31 (d, <i>J</i> = 4.0 Hz, 1H), 7.03 (d, <i>J</i> = 4.0 Hz, 1H), 5.98 (d, <i>J</i> = 7.6 Hz, 1H), 4.78–4.75 (m, 1H), 4.50 (s, 1H), 4.32 (d, <i>J</i> = 6.0 Hz, 1H), 3.59 (br s, 3H), 1.77–1.71 (m, 2H), 1.05 (t, <i>J</i> = 7.6 Hz, 3H). HRMS calculated for C<sub>20</sub>H<sub>22</sub>N<sub>6</sub>O<sub>4</sub>SCl (M + H) <sup>+</sup>: 477.1112; found 477.1115.</div></div><div id="sec4_1_1_19" class="NLM_sec NLM_sec_level_4"><div id="ac_i40" class="anchor-spacer"></div><h5 class="article-section__title" id="_i40"> Methyl (2<i>S</i>,3<i>S</i>,4<i>R</i>,5<i>R</i>)-5-(2-((5-Chlorothiophen-2-yl)ethynyl)-6-(methylamino)-9<i>H</i>-purin-9-yl)-3,4-dihydroxytetrahydrofuran-2-carboxylate (<b>29</b>)</h5><div class="NLM_p last">PdCl<sub>2</sub>(PPh<sub>3</sub>)<sub>2</sub> (1.77 mg, 0.002 mmol), CuI (1.0 mg, 0.001 mmol), 2-chloro-5-ethynylthiophene (10.8 mg, 0.075 mmol), and triethylamine (17 μL, 0.12 mmol) was added to a solution of compound <b>43</b> (6 mg, 0.012 mmol) in anhydrous DMF (0.6 mL), and stirred at room temperature overnight. Solvent was evaporated under vacuum, and the residue was roughly purified on flash silica gel column chromatography (hexane/ethyl acetate = 1:1) to give the compound <b>46</b>, which was subsequently stirred with 10% TFA (1 mL) and MeOH (1 mL) at 70 °C for 2 h. The solvent was evaporated, and the residue was purified on flash silica gel column chromatography (CH<sub>2</sub>Cl<sub>2</sub>/MeOH = 50:1) to afford compound <b>29</b> (3.8 mg, 68%) as a colorless syrup. <sup>1</sup>H NMR (CD<sub>3</sub>OD, 400 MHz) δ 8.58 (s, 1H), 7.31 (d, <i>J</i> = 4.0 Hz, 1H), 7.02 (d, <i>J</i> = 4.0 Hz, 1H), 6.20 (d, <i>J</i> = 4.8 Hz, 1H), 4.64–4.60 (m, 2H), 4.48 (m, 1H), 3.84 (s, 3H), 3.14 (br s, 3H). HRMS calculated for C<sub>18</sub>H<sub>17</sub>N<sub>5</sub>O<sub>5</sub>SCl (M + H) <sup>+</sup>: 450.0639; found 450.0645.</div></div><div id="sec4_1_1_20" class="NLM_sec NLM_sec_level_4"><div id="ac_i41" class="anchor-spacer"></div><h5 class="article-section__title" id="_i41"> Ethyl (3a<i>R</i>,3b<i>S</i>,4a<i>S</i>,5<i>R</i>,5a<i>S</i>)-5-(2-((5-Chlorothiophen-2-yl)ethynyl)-6-(methylamino)-9<i>H</i>-purin-9-yl)-2,2-dimethyltetrahydrocyclopropa[3,4]cyclopenta[1,2-<i>d</i>][1,3]dioxole-3b(3a<i>H</i>)-carboxylate (<b>33</b>)</h5><div class="NLM_p last">PdCl<sub>2</sub>(PPh<sub>3</sub>)<sub>2</sub> (23.3 mg, 0.033 mmol), CuI (3.1 mg, 0.033 mmol), 2-chloro-5-ethynylthiophene (142 mg, 0.99 mmol), and triethylamine (0.23 mL, 1.66 mmol) were added to a solution of compound <b>32</b> (83 mg, 0.16 mmol) in anhydrous DMF (3 mL) and stirred at room temperature overnight. The solvent was evaporated under vacuum, and the residue was purified on flash silica gel column chromatography (hexane/ethyl acetate = 1:1) to give compound <b>33</b> (71 mg, 83%) as a brownish glassy syrup. <sup>1</sup>H NMR (CD<sub>3</sub>OD, 400 MHz) δ 8.11 (s, 1H), 7.37 (d, <i>J</i> = 4.0 Hz, 1H), 7.03 (d, <i>J</i> = 4.0 Hz, 1H), 5.89 (d, <i>J</i> = 6.8 Hz, 1H), 5.02 (s, 1H), 4.82 (d, <i>J</i> = 6.0 Hz, 1H), 4.29–4.19 (m, 2H), 3.12 (br s, 3H), 2.31–2.27 (m, 1H), 1.71–1.67 (m, 1H), 1.57–1.54 (m, 4H), 1.29 (s, 3H), 1.23 (t, <i>J</i> = 7.2 Hz, 3H). HRMS calculated for C<sub>24</sub>H<sub>25</sub>N<sub>5</sub>O<sub>4</sub>SCl (M + H) <sup>+</sup>: 514.1316; found 514.1318.</div></div><div id="sec4_1_1_21" class="NLM_sec NLM_sec_level_4"><div id="ac_i42" class="anchor-spacer"></div><h5 class="article-section__title" id="_i42"> Ethyl (3a<i>R</i>,3b<i>S</i>,4a<i>S</i>,5<i>R</i>,5a<i>S</i>)-5-(2-((5-Bromothiophen-2-yl)ethynyl)-6-(methylamino)-9<i>H</i>-purin-9-yl)-2,2-dimethyltetrahydrocyclopropa[3,4]cyclopenta[1,2-<i>d</i>][1,3]dioxole-3b(3a<i>H</i>)-carboxylate (<b>34</b>)</h5><div class="NLM_p last">Compound <b>34</b> (82%) was prepared from compound <b>32</b> following the same method as that for compound <b>33</b>. <sup>1</sup>H NMR (CD<sub>3</sub>OD, 400 MHz) δ 8.11 (s, 1H), 7.33 (d, <i>J</i> = 4.0 Hz, 1H), 7.15 (d, <i>J</i> = 4.0 Hz, 1H), 5.89 (d, <i>J</i> = 7.2 Hz, 1H), 5.02 (s, 1H), 4.83 (d, <i>J</i> = 7.2 Hz, 1H), 4.28–4.18 (m, 2H), 3.14 (br s, 3H), 2.31–2.27 (m, 1H), 1.71–1.67 (m, 1H), 1.57–1.54 (m, 4H), 1.29 (s, 3H), 1.23 (t, <i>J</i> = 7.2 Hz, 3H). HRMS calculated for C<sub>24</sub>H<sub>25</sub>N<sub>5</sub>O<sub>4</sub>SBr (M + H) <sup>+</sup>: 558.0811; found 558.0814.</div></div><div id="sec4_1_1_22" class="NLM_sec NLM_sec_level_4"><div id="ac_i43" class="anchor-spacer"></div><h5 class="article-section__title" id="_i43"> ((3a<i>R</i>,4<i>R</i>,6<i>R</i>,6a<i>R</i>)-6-(6-Chloro-2-iodo-9<i>H</i>-purin-9-yl)-2,2-dimethyltetrahydrofuro[3,4-<i>d</i>][1,3]dioxol-4-yl)methanol (<b>35b</b>)</h5><div class="NLM_p last">To a suspension of compound <b>35a</b> (1 g, 2.42 mmol) in acetone (50 mL), 2,2-dimethoxypropane (1.5 mL, 12.1 mmol) and <i>p</i>-TSA were added and stirred at room temperature for 5 h. After completion of the starting material, the reaction mixture was neutralized by addition of solid NaHCO<sub>3</sub>. The reaction mixture was filtered, and the filtrate was evaporated under vacuum, and the residue was purified on flash silica gel column chromatography (hexane/ethyl acetate = 1:1) to give the compound <b>35b</b> (0.996 g, 91%) as a colorless syrup. <sup>1</sup>H NMR (CD<sub>3</sub>OD, 400 MHz) δ 8.71 (s, 1H), 6.27 (d, <i>J</i> = 2.8 Hz, 1H), 5.33 (d, <i>J</i> = 6.4 Hz, 1H), 5.03 (d, <i>J</i> = 6.4 Hz, 1H), 4.41–4.38 (m, 1H), 3.38–3.71 (m, 2H), 1.62 (s, 3H), 1.41 (s, 3H). HRMS calculated for C<sub>13</sub>H<sub>15</sub>N<sub>4</sub>O<sub>4</sub>ICl (M + H) <sup>+</sup>: 452.9827; found 452.9829.</div></div><div id="sec4_1_1_23" class="NLM_sec NLM_sec_level_4"><div id="ac_i44" class="anchor-spacer"></div><h5 class="article-section__title" id="_i44"> ((3a<i>R</i>,4<i>R</i>,6<i>R</i>,6a<i>R</i>)-6-(2-Iodo-6-(methylamino)-9<i>H</i>-purin-9-yl)-2,2-dimethyltetrahydrofuro [3,4-<i>d</i>][1,3]dioxol-4-yl)methanol (<b>37</b>)</h5><div class="NLM_p last">Methylamine hydrochloride (880 mg, 13 mmol) and triethylamine (3.6 mL, 26.1 mmol) were added to a solution of compound <b>35b</b> (1.18 g, 2.61 mmol) in methanol (25 mL) and stirred at room temperature overnight. The reaction mixture was evaporated under vacuum, and the residue was purified on flash column chromatography (hexane/ethyl acetate = 1:2) to give the desired product <b>37</b> (968 mg, 83%) as a colorless syrup. <sup>1</sup>H NMR (CD<sub>3</sub>OD, 400 MHz) δ 8.13 (s, 1H), 6.09 (d, <i>J</i> = 3.6 Hz, 1H), 5.24 (d, <i>J</i> = 6.0 Hz, 1H), 5.02 (d, <i>J</i> = 6.0 Hz, 1H), 4.36–4.34 (m, 1H), 3.03 (br s, 3H), 1.62 (s, 3H), 1.39 (s, 3H). HRMS calculated for C<sub>14</sub>H<sub>19</sub>N<sub>5</sub>O<sub>4</sub>I (M + H) <sup>+</sup>: 448.0482; found 448.0489.</div></div><div id="sec4_1_1_24" class="NLM_sec NLM_sec_level_4"><div id="ac_i45" class="anchor-spacer"></div><h5 class="article-section__title" id="_i45"> ((3a<i>R</i>,4<i>R</i>,6<i>R</i>,6a<i>R</i>)-6-(2-Iodo-6-(<i>n</i>-propylamino)-9<i>H</i>-purin-9-yl)-2,2-dimethyltetrahydrofuro [3,4-<i>d</i>][1,3]dioxol-4-yl)methanol (<b>38</b>)</h5><div class="NLM_p last">Compound <b>38</b> (85%) was prepared from compound <b>35b</b> following the same method as that for compound <b>37</b>. <sup>1</sup>H NMR (CD<sub>3</sub>OD, 400 MHz) δ 8.15 (s, 1H), 6.10 (d, <i>J</i> = 3.2 Hz, 1H), 5.24 (d, <i>J</i> = 6.0 Hz, 1H), 5.03 (d, <i>J</i> = 6.0 Hz, 1H), 4.36–4.34 (m, 1H), 3.79–3.71 (m, 2H), 3.52–3.49 (m, 2H), 1.72–1.62 (m, 2H), 1.62 (s, 3H), 1.40 (s, 3H), 1.01 (t, <i>J</i> = 7.6 Hz, 3H). HRMS calculated for C<sub>16</sub>H<sub>23</sub>N<sub>5</sub>O<sub>4</sub>I (M + H) <sup>+</sup>: 476.0716; found 476.0734.</div></div><div id="sec4_1_1_25" class="NLM_sec NLM_sec_level_4"><div id="ac_i46" class="anchor-spacer"></div><h5 class="article-section__title" id="_i46"> (3a<i>S</i>,4<i>S</i>,6<i>R</i>,6a<i>R</i>)-6-(2-Iodo-6-(methylamino)-9<i>H</i>-purin-9-yl)-2,2-dimethyltetrahydrofuro [3,4-<i>d</i>][1,3]dioxole-4-carboxylic Acid (<b>39</b>)</h5><div class="NLM_p last">PDC (530 mg, 1.4 mmol) was added to a solution of compound <b>37</b> (105 mg, 0.23 mmol) in dry DMF (2.5 mL) and heated at 40 °C overnight. After completion of the starting material, water (10 mL) was added into the reaction mixture and extracted with ethyl acetate (3 × 10 mL). The combined organic layer was washed with brine (15 mL), dried, filtered, evaporated, and the residue was purified on flash silica gel column chromatography (CH<sub>2</sub>Cl<sub>2</sub>/MeOH = 35:1) to give the compound <b>39</b> (73 mg, 68%) as a colorless syrup. <sup>1</sup>H NMR (CD<sub>3</sub>OD, 400 MHz) δ 8.08 (s, 1H), 6.29 (s, 1H), 5.66 (d, <i>J</i> = 6.0 Hz, 1H), 5.46 (d, <i>J</i> = 6.0 Hz, 1H), 4.75 (d, <i>J</i> = 1.6 Hz, 1H), 3.04 (br s, 3H), 1.58 (s, 3H), 1.43 (s, 3H). HRMS calculated for C<sub>14</sub>H<sub>17</sub>N<sub>5</sub>O<sub>5</sub>I (M + H) <sup>+</sup>: 462.0274; found 462.0265.</div></div><div id="sec4_1_1_26" class="NLM_sec NLM_sec_level_4"><div id="ac_i47" class="anchor-spacer"></div><h5 class="article-section__title" id="_i47"> (3a<i>S</i>,4<i>S</i>,6<i>R</i>,6a<i>R</i>)-6-(2-Iodo-6-(<i>n</i>-propylamino)-9<i>H</i>-purin-9-yl)-2,2-dimethyltetrahydrofuro [3,4-<i>d</i>][1,3]dioxole-4-carboxylic Acid (<b>40</b>)</h5><div class="NLM_p last">Compound <b>40</b> (67%) was prepared from compound <b>38</b> following the same method as that for compound <b>39</b>. <sup>1</sup>H NMR (CD<sub>3</sub>OD, 400 MHz) δ 8.10 (s, 1H), 6.29 (s, 1H), 5.65 (d, <i>J</i> = 6.0 Hz, 1H), 5.46 (d, <i>J</i> = 6.0 Hz, 1H), 4.76 (d, <i>J</i> = 1.6 Hz, 1H), 3.49 (br s, 2H), 1.71–1.65 (m 2H), 1.58 (s, 3H), 1.43 (s, 3H), 1.00 (d, <i>J</i> = 7.6 Hz, 3H). HRMS calculated for C<sub>16</sub>H<sub>21</sub>N<sub>5</sub>O<sub>5</sub>I (M + H) <sup>+</sup>: 490.0587; found 490.0583.</div></div><div id="sec4_1_1_27" class="NLM_sec NLM_sec_level_4"><div id="ac_i48" class="anchor-spacer"></div><h5 class="article-section__title" id="_i48"> (3a<i>S</i>,4<i>S</i>,6<i>R</i>,6a<i>R</i>)-6-(2-Iodo-6-(methylamino)-9<i>H</i>-purin-9-yl)-<i>N</i>,2,2-trimethyltetrahydrofuro [3,4-<i>d</i>][1,3]dioxole-4-carboxamide (<b>41</b>)</h5><div class="NLM_p last">MeNH<sub>2</sub> (48 μL, 2 M solution in THF) and DIPEA (14 μL, 0.084 mmol) were added to a solution of compound <b>39</b> (30 mg, 0.065 mmol) and HATU (32 mg, 0.078 mmol) in dry DMF (1.3 mL). The reaction mixture was stirred at room temperature overnight. The solvent was evaporated under vacuum, and the residue was purified on flash silica gel column chromatography (CH<sub>2</sub>Cl<sub>2</sub>/MeOH = 35:1) to give compound <b>41</b> (21 mg, 68%) as a colorless syrup. <sup>1</sup>H NMR (CD<sub>3</sub>OD, 400 MHz) δ 8.05 (s, 1H), 6.27 (d, <i>J</i> = 1.2 Hz, 1H), 5.51 (d, <i>J</i> = 6.2 Hz, 1H), 5.35 (d, <i>J</i> = 6.2 Hz, 1H), 4.63 (d, <i>J</i> = 2.0 Hz, 1H), 3.05 (br s, 3H), 2.49 (s, 3H), 1.59 (s, 3H), 1.41 (s, 3H). HRMS calculated for C<sub>15</sub>H<sub>20</sub>N<sub>6</sub>O<sub>4</sub>I (M + H) <sup>+</sup>: 475.0591; found 475.0600.</div></div><div id="sec4_1_1_28" class="NLM_sec NLM_sec_level_4"><div id="ac_i49" class="anchor-spacer"></div><h5 class="article-section__title" id="_i49"> (3a<i>S</i>,4<i>S</i>,6<i>R</i>,6a<i>R</i>)-6-(2-Iodo-6-(<i>n</i>-propylamino)-9<i>H</i>-purin-9-yl)-<i>N</i>,2,2-trimethyltetrahydrofuro [3,4-<i>d</i>][1,3]dioxole-4-carboxamide (<b>42</b>)</h5><div class="NLM_p last">Compound <b>42</b> (69%) was prepared from compound <b>40</b> following the same method as that for compound <b>41</b>. <sup>1</sup>H NMR (CD<sub>3</sub>OD, 400 MHz) δ 8.05 (s, 1H), 6.27 (d, <i>J</i> = 1.6 Hz, 1H), 5.51 (d, <i>J</i> = 6.0 Hz, 1H), 5.35 (d, <i>J</i> = 6.0 Hz, 1H), 4.63 (d, <i>J</i> = 2.0 Hz, 1H), 3.49 (br s, 2H), 2.48 (s, 3H), 1.71–1.66 (m, 2H), 1.59 (s, 3H), 1.41 (s, 3H), 1.00 (t, <i>J</i> = 7.6 Hz, 3H). HRMS calculated for C<sub>17</sub>H<sub>24</sub>N<sub>6</sub>O<sub>4</sub>I (M + H) <sup>+</sup>: 503.0904; found 503.0912.</div></div><div id="sec4_1_1_29" class="NLM_sec NLM_sec_level_4"><div id="ac_i50" class="anchor-spacer"></div><h5 class="article-section__title" id="_i50"> Methyl (3a<i>S</i>,4<i>S</i>,6<i>R</i>,6a<i>R</i>)-6-(2-iodo-6-(<i>n</i>-Propylamino)-9<i>H</i>-purin-9-yl)-2,2-dimethyltetrahydro furo[3,4-<i>d</i>][1,3]dioxole-4-carboxylate (<b>43</b>)</h5><div class="NLM_p last">DCC (24 mg, 0.117 mmol), DMAP (2.38 mg, 0.019 mmol), and MeOH (10 μL, 0.19 mmol) were added to a solution of compound <b>39</b> (18 mg, 0.039 mmol) in DMF (0.8 mL) and stirred at room temperature overnight. The solvent was evaporated, and the residue was purified on flash silica gel column chromatography (CH<sub>2</sub>Cl<sub>2</sub>/MeOH = 35:1) to afford compound <b>43</b> (9.6 mg, 52%) as a colorless syrup. <sup>1</sup>H NMR (CD<sub>3</sub>OD, 400 MHz) δ 8.06 (s, 1H), 6.29 (s, 1H) 5.65 (d, <i>J</i> = 6.0 Hz, 1H), 5.45 (d, <i>J</i> = 6.0 Hz, 1H), 4.81 (s, 1H), 3.59 (s, 3H), 3.05 (br s, 3H), 1.57 (s, 3H), 1.43 (s, 3H). HRMS calculated for C<sub>15</sub>H<sub>19</sub>N<sub>5</sub>O<sub>5</sub>I (M + H) <sup>+</sup>: 476.0431; found 476.0433.</div></div><div id="sec4_1_1_30" class="NLM_sec NLM_sec_level_4"><div id="ac_i51" class="anchor-spacer"></div><h5 class="article-section__title" id="_i51"> (3a<i>S</i>,4<i>S</i>,6<i>R</i>,6a<i>R</i>)-6-(2-((5-Chlorothiophen-2-yl)ethynyl)-6-(methylamino)-9<i>H</i>-purin-9-yl)-<i>N</i>,2,2-trimethyltetrahydrofuro[3,4-<i>d</i>][1,3]dioxole-4-carboxamide (<b>44</b>)</h5><div class="NLM_p last">Compound <b>44</b> (84%) was prepared from compound <b>41</b> following the same method as that for compound <b>33</b>. <sup>1</sup>H NMR (CD<sub>3</sub>OD, 400 MHz) δ 8.22 (s, 1H), 7.35 (d, <i>J</i> = 4.0 Hz, 1H), 7.02 (d, <i>J</i> = 4.0 Hz, 1H), 6.31 (d, <i>J</i> = 2.0 Hz, 1H), 5.51 (d, <i>J</i> = 6.0 Hz, 1H), 5.39 (d, <i>J</i> = 6.0 Hz, 1H), 4.66 (d, <i>J</i> = 2.0 Hz, 1H), 3.12 (br s, 3H), 2.52 (s, 3H), 1.62 (s, 3H), 1.42 (s, 3H). HRMS calculated for C<sub>21</sub>H<sub>22</sub>N<sub>6</sub>O<sub>4</sub>SCl (M + H) <sup>+</sup>: 489.1112; found 489.1120.</div></div><div id="sec4_1_1_31" class="NLM_sec NLM_sec_level_4"><div id="ac_i52" class="anchor-spacer"></div><h5 class="article-section__title" id="_i52"> (3a<i>S</i>,4<i>S</i>,6<i>R</i>,6a<i>R</i>)-6-(2-((5-Chlorothiophen-2-yl)ethynyl)-6-(<i>n</i>-propylamino)-9<i>H</i>-purin-9-yl)-<i>N</i>,2,2-trimethyltetrahydrofuro[3,4-<i>d</i>][1,3]dioxole-4-carboxamide (<b>45</b>)</h5><div class="NLM_p last">Compound <b>45</b> (82%) was prepared from compound <b>42</b> following the same method as that for compound <b>33</b>. <sup>1</sup>H NMR (CD<sub>3</sub>OD, 400 MHz) δ 8.22 (s, 1H), 7.35 (d, <i>J</i> = 4.0 Hz, 1H), 7.02 (d, <i>J</i> = 4.0 Hz, 1H), 6.31 (d, <i>J</i> = 2.0 Hz, 1H), 5.50 (d, <i>J</i> = 6.0 Hz, 1H), 5.38 (d, <i>J</i> = 6.0 Hz, 1H), 4.66 (d, <i>J</i> = 2.0 Hz, 1H), 3.57 (br s, 2H), 2.52 (s, 3H), 1.75–1.70 (m, 2H), 1.62 (s, 3H), 1.42 (s, 3H), 1.03 (d, <i>J</i> = 7.6 Hz, 3H). HRMS calculated for C<sub>23</sub>H<sub>26</sub>N<sub>6</sub>O<sub>4</sub>SCl (M + H) <sup>+</sup>: 517.1425; found 517.1422.</div></div><div id="sec4_1_1_32" class="NLM_sec NLM_sec_level_4"><div id="ac_i53" class="anchor-spacer"></div><h5 class="article-section__title" id="_i53"> Ethyl (3a<i>R</i>,3b<i>S</i>,4a<i>S</i>,5<i>R</i>,5a<i>S</i>)-5-(6-Bromo-4-chloro-1<i>H</i>-imidazo[4,5-<i>c</i>]pyridin-1-yl)-2,2-dimethyltetrahydrocyclopropa[3,4]cyclopenta[1,2-<i>d</i>][1,3]dioxole-3b(3a<i>H</i>)-carboxylate (<b>47</b>)</h5><div class="NLM_p last">DIAD (0.22 mL, 1.13 mmol) was added to a solution of triphenylphosphine (0.296 g, 1.13 mmol) and 3-deaza-2-bromo-6-chloro-purine (0.197 g, 0.845 mmol) in dry THF (4 mL) at 0 °C, and after addition, it was stirred at room temperature for 10 min. A solution of compound <b>36</b> (0.137 g, 0.566 mmol) in THF (2 mL) was added to the reaction mixture and stirred overnight at room temperature. The solvent was evaporated, and the residue was purified on flash silica gel column chromatography (hexane/ethyl acetate = 2:1) to give compound <b>47</b> (0.178 g, 69%) as a colorless foamy solid. <sup>1</sup>H NMR (CD<sub>3</sub>OD, 400 MHz) δ 8.41 (s, 1H), 7.74 (s, 1H), 5.74 (d, <i>J</i> = 7.2 Hz, 1H), 4.92 (s, 1H), 4.80 (d, <i>J</i> = 6.8 Hz, 1H), 3.79–3.71 (m, 2H), 2.52–2.48 (m, 1H), 1.87–1.83 (m, 1), 1.66 (t, <i>J</i> = 5.2 Hz, 1H), 1.54 (s, 3H), 1.34 (t, <i>J</i> = 7.2 Hz, 1H), 1.29 (s, 3H). HRMS calculated for C<sub>18</sub>H<sub>20</sub>N<sub>3</sub>O<sub>4</sub>Br (M + H) <sup>+</sup>: 456.0326; found 456.0329.</div></div><div id="sec4_1_1_33" class="NLM_sec NLM_sec_level_4"><div id="ac_i54" class="anchor-spacer"></div><h5 class="article-section__title" id="_i54"> Ethyl (3a<i>R</i>,3b<i>S</i>,4a<i>S</i>,5<i>R</i>,5a<i>S</i>)-5-(6-Bromo-4-(methylamino)-1<i>H</i>-imidazo[4,5-<i>c</i>]pyridin-1-yl)-2,2-dimethyltetrahydrocyclopropa[3,4]cyclopenta[1,2-<i>d</i>][1,3]dioxole-3b(3a<i>H</i>)-carboxylate (<b>48</b>)</h5><div class="NLM_p last">MeNH<sub>2</sub>·HCl (78.32 mg, 1.16 mmol) and DIPEA (0.4 mL, 2.32 mmol) were added to a solution of compound <b>47</b> (106 mg, 0.232 mmol) in an isopropanol (2.5 mL) tube and heated at 125 °C under microwave conditions in a sealed for 2.5 h. The reaction mixture was evaporated under vacuum, and the residue was purified on flash silica gel column chromatography (hexane/ethyl acetate = 1:1) to give the compound 4<b>8</b> (80 mg, 76%) as a syrup. <sup>1</sup>H NMR (CD<sub>3</sub>OD, 400 MHz) δ 7.98 (s, 1H), 6.83 (s, 1H), 5.70 (d, <i>J</i> = 7.2 Hz, 1H), 4.81 (s, 1H), 4.70 (d, <i>J</i> = 6.8 Hz, 1H), 4.33–4.25 (m, 2H), 3.06 (s, 3H), 2.43–2.39 (m, 1H), 1.85–1.81 (m, 1H), 1.59 (t, <i>J</i> = 5.2 Hz, 1H), 1.54 (s, 3H), 1.35 (t, <i>J</i> = 7.2 Hz, 3H), 1.28 (s, 3H). HRMS calculated for C<sub>19</sub>H<sub>24</sub>N<sub>4</sub>O<sub>4</sub>Br (M + H) <sup>+</sup>: 451.0981; found 451.0977.</div></div><div id="sec4_1_1_34" class="NLM_sec NLM_sec_level_4"><div id="ac_i55" class="anchor-spacer"></div><h5 class="article-section__title" id="_i55"> (3a<i>R</i>,3b<i>S</i>,4a<i>S</i>,5<i>R</i>,5a<i>S</i>)-5-(6-Bromo-4-(methylamino)-1<i>H</i>-imidazo[4,5-<i>c</i>]pyridin-1-yl)-<i>N</i>,2,2-trimethyltetrahydrocyclopropa[3,4]cyclopenta[1,2-<i>d</i>][1,3]dioxole-3b(3a<i>H</i>)-carboxamide (<b>49</b>)</h5><div class="NLM_p last">40% Methylamine solution (aqueous, 2.0 mL) was added to a solution of compound <b>48</b> (55 mg, 0.12 mmol) in methanol (3 mL) and stirred at room temperature overnight. The solvent was evaporated under vacuum, and the residue was purified on flash silica gel column chromatography (CH<sub>2</sub>Cl<sub>2</sub>/MeOH = 40:1) to give compound <b>49</b> (37g, 71%) as a colorless syrup. <sup>1</sup>H NMR (CD<sub>3</sub>OD, 400 MHz) δ 8.01 (s, 1H), 6.88 (s, 1H), 5.56 (d, <i>J</i> = 7.2 Hz, 1H), 4.95 (s, 1H), 4.65 (d, <i>J</i> = 6.8 Hz, 1H), 3.05 (s, 3H), 2.86 (s, 3H), 2.37–2.33 (m, 1H), 1.69–1.65 (m, 1H), 1.55 (s, 3H), 1.50 (d, <i>J</i> = 5.2 Hz, 1H), 1.28 (s, 3H). HRMS calculated for C<sub>18</sub>H<sub>23</sub>N<sub>5</sub>O<sub>3</sub>Br (M + H) <sup>+</sup>: 436.0984; found 436.0987.</div></div><div id="sec4_1_1_35" class="NLM_sec NLM_sec_level_4"><div id="ac_i56" class="anchor-spacer"></div><h5 class="article-section__title" id="_i56"> Ethyl (1<i>S</i>,2<i>R</i>,3<i>S</i>,4<i>R</i>,5<i>S</i>)-4-(6-Bromo-4-(methylamino)-1<i>H</i>-imidazo[4,5-<i>c</i>]pyridin-1-yl)-2,3-dihydroxybicyclo[3.1.0]hexane-1-carboxylate (<b>50</b>)</h5><div class="NLM_p last">10% TFA (2 mL) was added to a solution of compound <b>48</b> (22 mg, 0.048 mmol) in MeOH (2 mL) and heated at 70 °C for 3 h. The solvent was evaporated, and the residue was purified on flash silica gel column chromatography (CH<sub>2</sub>Cl<sub>2</sub>/MeOH = 30:1) to give compound <b>50</b> (18 mg, 91%) as a colorless syrup. <sup>1</sup>H NMR (CD<sub>3</sub>OD, 400 MHz) δ 7.91 (s, 1H), 6.95 (s, 1H), 5.02 (d, <i>J</i> = 6.8 Hz, 1H), 4.63 (s, 1H), 4.30–4.24 (m, 2H), 4.02 (d, <i>J</i> = 6.4 Hz, 1H), 3.06 (s, 3H), 2.26–2.23 (m, 1H), 1.94 (t, <i>J</i> = 5.2 Hz, 1H), 1.73–1.69 (m, 1H), 1.33 (t, <i>J</i> = 7.2 Hz, 3H). HRMS calculated for C<sub>16</sub>H<sub>20</sub>N<sub>4</sub>O<sub>4</sub>Br (M + H) <sup>+</sup>: 411.0668; found 411.0667.</div></div><div id="sec4_1_1_36" class="NLM_sec NLM_sec_level_4"><div id="ac_i57" class="anchor-spacer"></div><h5 class="article-section__title" id="_i57"> (3a<i>R</i>,3b<i>S</i>,4a<i>S</i>,5<i>R</i>,5a<i>S</i>)-5-(6-((5-Chlorothiophen-2-yl)ethynyl)-4-(methylamino)-1<i>H</i>-imidazo[4,5-<i>c</i>]pyridin-1-yl)-<i>N</i>,2,2-trimethyltetrahydrocyclopropa[3,4]cyclopenta[1,2-<i>d</i>][1,3]dioxole-3b(3a<i>H</i>)-carboxamide (<b>51</b>)</h5><div class="NLM_p last">PdCl<sub>2</sub>(PPh<sub>3</sub>)<sub>2</sub> (10.3 mg, 0.014 mmol), CuI (1.4 mg, 0.007 mmol), 2-chloro-5-ethynylthiophene (63 mg, 0.44 mmol), and triethylamine (0.1 mL, 0.73 mmol) were added to a solution of compound <b>49</b> (32 mg, 0.073 mmol) in anhydrous DMF (1.2 mL) and were heated in a sealed tube at 130 °C under microwave conditions. The solvent was evaporated under vacuum, and the residue was purified on flash silica gel column chromatography (CH<sub>2</sub>Cl<sub>2</sub>/MeOH = 40:1) to give the compound <b>51</b> (23 mg, 63%) as a yellow syrup. <sup>1</sup>H NMR (CD<sub>3</sub>OD, 400 MHz) δ 8.14 (s, 1H), 7.22 (d, <i>J</i> = 4.0 Hz, 1H), 7.03 (s, 1H), 6.98 (d, <i>J</i> = 4.0 Hz, 1H), 5.59 (d, <i>J</i> = 7.2 Hz, 1H), 5.01 (s, 1H), 4.69 (d, <i>J</i> = 6.8 Hz, 1H), 3.10 (s, 3H), 2.86 (s, 3H), 2.39–2.37 (m, 1H), 1.71–1.67 (m, 1H), 1.56 (s, 3H), 1.52 (t, <i>J</i> = 5.2 Hz, 1H), 1.28 (s, 3H). HRMS calculated for C<sub>24</sub>H<sub>25</sub>N<sub>5</sub>O<sub>3</sub>SCl (M + H) <sup>+</sup>: 498.1367; found 498.1360.</div></div></div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i58" class="anchor-spacer"></div><h3 class="article-section__title" id="_i58"> Pharmacological Procedures</h3><div id="sec4_2_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i59" class="anchor-spacer"></div><h4 class="article-section__title" id="_i59"> Cell Lines and Radioligand Binding</h4><div class="NLM_p">Initial screening at hDAT and other drug targets was performed by the PDSP. <i>K</i><sub>i</sub> determinations using 96-well plates and binding profiles in a broad screen of receptors and channels were generously provided by the National Institute of Mental Health’s Psychoactive Drug Screening Program, Contract # HHSN-271-2008-00025-C (NIMH PDSP). For experimental details, please refer to the PDSP Web site <a href="http://pdsp.med.unc.edu/" class="extLink">http://pdsp.med.unc.edu/</a> and click on “Binding Assay” on the menu bar. The cell line used for preparing membranes for hDAT binding is HEK cells stably expressing hDAT, grown in DMEM medium containing 350 μg/mL Geneticin and 10% fetal bovine serum. The buffer used for binding and washing was 10 mM HEPES, 135 mM NaCl, 5 mM KCl, 0.8 mM MgCl<sub>2</sub>, and 1 mM EGTA, pH 7.4, at room temperature. The <i>K</i><sub>d</sub> of radioligand <b>24</b> was determined to be 11.1 ± 1.4 nM. Reference ligand <b>30</b> had a <i>K</i><sub>i</sub> value of 3.04 ± 0.21 nM. The radioligands used by PDSP for NET and SERT binding were [<sup>3</sup>H]<b>52</b> and [<sup>3</sup>H]<b>53</b>, respectively.</div><div class="NLM_p">The detailed comparisons of binding enhancement at human DAT, NET, and SERT were performed as described.<a onclick="showRef(event, 'ref3 ref48'); return false;" href="javascript:void(0);" class="ref ref3 ref48">(3, 48)</a> Membranes from human embryonic kidney (HEK)-293 cells stably expressing the recombinant hDAT (HEK-hDAT), hSERT (HEK-hSERT), or hNET (HEK-hNET) were used. Transporter binding assays were performed in Krebs-HEPES assay buffer (25 mM HEPES, 122 mM NaCl, 5 mM KCl, 1.2 mM MgSO<sub>4</sub>, 2.5 mM CaCl<sub>2</sub>, 1 μM pargyline, 100 μM tropolone, 2 mg glucose/mL, and 0.2 mg ascorbic acid/mL, pH 7.4). Membranes were preincubated at room temperature for 10 min with the test compound before the radioligand (either [<sup>125</sup>I]<b>23</b>, 40–80 pM final concentration, or [<sup>3</sup>H]<b>26</b>) was added. Concentrations of [<sup>3</sup>H]<b>26</b> were 1–3 nM for DAT and NET and 10–13 nM for SERT. The assay mixture was then incubated with the radioligand for 90 min at room temperature in the dark before filtration. Nonspecific binding was defined using 5 μM mazindol (HEK-hDAT and HEK-NET) or 5 μM imipramine (HEK-hSERT). In a typical hDAT binding experiment, the basal specific binding was ∼2900 cpm, and the maximal stimulated specific binding was 7000–8000 cpm.</div><div class="NLM_p">The full length coding region of the mouse DA transporter (mDAT) cDNA in PCMV6 vector (OriGene, Rockville, MD) was prepared using a Qiagen (Chatsworth, CA) miniprep kit following the transformation of One–Shot Top 10 chemically competent <i>Escherichia coli</i> (Invitrogen, Carlsbad, CA). HEK-293 cells were transfected with 10 μg of mDAT cDNA using Lipofectamine 2000 (Invitrogen). Cells were plated in DMEM supplemented with 10% Fetal Clone I (HyClone, South Logan, UT), then selected for G418 resistance (600 μg/mL G418). Forty-eight surviving colonies were chosen and plated in the above media with 300 μg/mL G418, 10 units/mL penicillin, and 10 μg/mL streptomycin (HyClone). Clonal lines that had high levels of specific [<sup>3</sup>H]DA (20 nM) uptake, defined as the difference between uptake in the absence and presence of mazindol (5 μM), were tested using [<sup>125</sup>I]<b>23</b> saturation binding assays (0.05 nM–16.6 nM) and competitive [<sup>125</sup>I]<b>23</b> (40 pM) binding against mazindol and cocaine (1 nM–10 μM). The HEK-mDAT line used for the binding and uptake assays herein had a <i>K</i><sub>d</sub> value in [<sup>125</sup>I]<b>23</b> binding of 3.9 ± 1.8 nM and a <i>B</i><sub>max</sub> value of 2410 ± 630 fmol/mg protein. In the binding enhancement experiments, the fixed concentration of [<sup>125</sup>I]<b>23</b> was 45–50 pM. In a typical mDAT binding experiment, the basal specific binding was 750–900 cpm, and the maximal stimulated specific binding was 7000–8000 cpm.</div><div class="NLM_p last">A<sub>3</sub>AR affinity was measured in two species as described using [<sup>125</sup>I]<i>N</i><sup>6</sup>-(4-amino-3-iodobenzyl)adenosine-5′-<i>N</i>-methyluronamide as radioligand.<a onclick="showRef(event, 'ref2 ref18 ref19'); return false;" href="javascript:void(0);" class="ref ref2 ref18 ref19">(2, 18, 19)</a> Protein was determined as reported.<a onclick="showRef(event, 'ref49'); return false;" href="javascript:void(0);" class="ref ref49">(49)</a> In all of the binding experiments, EC<sub>50</sub> values of <i>K</i><sub>i</sub> values were calculated using GraphPad Prism software (San Diego, CA). Values are expressed as the mean ± SEM.</div></div><div id="sec4_2_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i60" class="anchor-spacer"></div><h4 class="article-section__title" id="_i60"> Uptake Assays</h4><div class="NLM_p last">Assays of uptake of [<sup>3</sup>H]-neurotransmitters (DA, norepinephrine, or 5HT; each 20 nM final concentration) in the same transporter-expressing HEK cell lines as described above, used as intact and detached cells, were preformed as described.<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> The assay used Krebs HEPES assay buffer and was incubated for 10 min at 25 °C before termination by filtration. Values are expressed as the mean ± SEM.</div></div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i61"><a href="/doi/suppl/10.1021/acs.jmedchem.7b00141">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_57371" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_57371" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a href="/" class="ext-link">ACS Publications website</a> at DOI: <a href="/doi/abs/10.1021/acs.jmedchem.7b00141" class="ext-link">10.1021/acs.jmedchem.7b00141</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">NMR analysis and mass spectra of selected synthesized compounds, additional synthetic schemes and procedures, and off-target (PDSP) screening results (<a href="/doi/suppl/10.1021/acs.jmedchem.7b00141/suppl_file/jm7b00141_si_001.pdf" class="ext-link">PDF</a>)</p></li><li><p class="inline">SMILES data (<a href="/doi/suppl/10.1021/acs.jmedchem.7b00141/suppl_file/jm7b00141_si_002.csv" class="ext-link">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b00141/suppl_file/jm7b00141_si_001.pdf">jm7b00141_si_001.pdf (2.54 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b00141/suppl_file/jm7b00141_si_002.csv">jm7b00141_si_002.csv (2.57 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/acs.jmedchem.7b00141" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_52112" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_52112" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kenneth A. Jacobson</span> - <span class="hlFld-Affiliation affiliation">Molecular
Recognition Section, Laboratory of Bioorganic Chemistry, National
Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland 20892, United States</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-8104-1493" title="Orcid link">http://orcid.org/0000-0001-8104-1493</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#2c474d464d4f434e5f6c444940455402424544024b435a"><span class="__cf_email__" data-cfemail="b9d2d8d3d8dad6dbcaf9d1dcd5d0c197d7d0d197ded6cf">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Dilip K. Tosh</span> - <span class="hlFld-Affiliation affiliation">Molecular
Recognition Section, Laboratory of Bioorganic Chemistry, National
Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland 20892, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Aaron Janowsky</span> - <span class="hlFld-Affiliation affiliation">VA
Portland Health Care System, Research Service (R&D-22), and Departments
of Psychiatry and Behavioral Neuroscience, Oregon Health and Science University, Portland, Oregon 97239, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Amy J. Eshleman</span> - <span class="hlFld-Affiliation affiliation">VA
Portland Health Care System, Research Service (R&D-22), and Departments
of Psychiatry and Behavioral Neuroscience, Oregon Health and Science University, Portland, Oregon 97239, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Eugene Warnick</span> - <span class="hlFld-Affiliation affiliation">Molecular
Recognition Section, Laboratory of Bioorganic Chemistry, National
Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland 20892, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Zhan-Guo Gao</span> - <span class="hlFld-Affiliation affiliation">Molecular
Recognition Section, Laboratory of Bioorganic Chemistry, National
Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland 20892, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Zhoumou Chen</span> - <span class="hlFld-Affiliation affiliation">Department
of Pharmacology and Physiology, Saint Louis
University School of Medicine, St. Louis, Missouri 63104, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Elizabeth Gizewski</span> - <span class="hlFld-Affiliation affiliation">Department
of Pharmacology, Medical College of Wisconsin, 8701 Watertown Plank Road, Milwaukee, Wisconsin 53226, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">John A. Auchampach</span> - <span class="hlFld-Affiliation affiliation">Department
of Pharmacology, Medical College of Wisconsin, 8701 Watertown Plank Road, Milwaukee, Wisconsin 53226, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Daniela Salvemini</span> - <span class="hlFld-Affiliation affiliation">Department
of Pharmacology and Physiology, Saint Louis
University School of Medicine, St. Louis, Missouri 63104, United States</span></div></li></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ACK-d132e8339-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i62">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_50118" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_50118" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">We acknowledge support from the NIH Intramural Research Program (NIDDK, ZIA DK031117-28); National Cancer Institute (R01CA169519) and National Heart, Lung, and Blood Institute (R01HL077707). We also thank the NIH National Institute on Drug Abuse (NIDA)/VA Interagency Agreement #ADA12013; the Methamphetamine Abuse Research Center (P50 DA018165-06), and the Department of Veterans Affairs Research Career Scientist and Merit Review Programs. We thank John Lloyd (NIDDK) for mass spectral determinations and Robert O’Connor (NIDDK) for NMR spectra. We thank Dr. Bryan L. Roth (University of North Carolina at Chapel Hill) and National Institute of Mental Health’s Psychoactive Drug Screening Program (Contract # HHSN-271-2008-00025-C) for screening data.</p></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i63" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i63"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i64" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i64"> Abbreviations Used</h2><tr><td class="NLM_term">AR</td><td class="NLM_def"><p class="first last">adenosine receptor</p></td></tr><tr><td class="NLM_term">CCI</td><td class="NLM_def"><p class="first last">chronic constriction injury</p></td></tr><tr><td class="NLM_term">DA</td><td class="NLM_def"><p class="first last">dopamine</p></td></tr><tr><td class="NLM_term">DAT</td><td class="NLM_def"><p class="first last">dopamine transporter (SLC6A3)</p></td></tr><tr><td class="NLM_term">DCC</td><td class="NLM_def"><p class="first last">dicyclohexylcarbodiimide</p></td></tr><tr><td class="NLM_term">DHTB</td><td class="NLM_def"><p class="first last">dihydrotetrabenezine</p></td></tr><tr><td class="NLM_term">DMAP</td><td class="NLM_def"><p class="first last">4-(dimethylamino)pyridine</p></td></tr><tr><td class="NLM_term">DMF</td><td class="NLM_def"><p class="first last">dimethylformamide</p></td></tr><tr><td class="NLM_term">DIPEA</td><td class="NLM_def"><p class="first last">diisoproylethylamine</p></td></tr><tr><td class="NLM_term">DIAD</td><td class="NLM_def"><p class="first last">diisopropyl azodicarboxylate</p></td></tr><tr><td class="NLM_term">GPCR</td><td class="NLM_def"><p class="first last">G protein-coupled receptor</p></td></tr><tr><td class="NLM_term">HATU</td><td class="NLM_def"><p class="first last">1-[bis(dimethylamino)methylene]-1<i>H</i>-1,2,3-triazolo[4,5-<i>b</i>]pyridinium 3-oxid hexafluorophosphate</p></td></tr><tr><td class="NLM_term">HEK</td><td class="NLM_def"><p class="first last">human embryonic kidney 293</p></td></tr><tr><td class="NLM_term">HEPES</td><td class="NLM_def"><p class="first last">4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid</p></td></tr><tr><td class="NLM_term">HRMS</td><td class="NLM_def"><p class="first last">high resolution mass spectroscopy</p></td></tr><tr><td class="NLM_term">5HT</td><td class="NLM_def"><p class="first last">serotonin</p></td></tr><tr><td class="NLM_term">mazindol</td><td class="NLM_def"><p class="first last">(±)-5-(4-chlorophenyl)-3,5-dihydro-2<i>H</i>-imidazo[2,1-<i>a</i>]isoindol-5-ol</p></td></tr><tr><td class="NLM_term">METH</td><td class="NLM_def"><p class="first last">methamphetamine</p></td></tr><tr><td class="NLM_term">NET</td><td class="NLM_def"><p class="first last">norepinephrine transporter (SLC6A2)</p></td></tr><tr><td class="NLM_term">nisoxetine</td><td class="NLM_def"><p class="first last">(<i>R,S</i>)-3-(2-methoxyphenoxy)-<i>N</i>-methyl-3-phenylpropan-1-amine</p></td></tr><tr><td class="NLM_term">PDC</td><td class="NLM_def"><p class="first last">pyridinium dichromate</p></td></tr><tr><td class="NLM_term">PDSP</td><td class="NLM_def"><p class="first last">Psychoactive Drug Screening Program</p></td></tr><tr><td class="NLM_term">SERT</td><td class="NLM_def"><p class="first last">serotonin transporter (SLC6A4)</p></td></tr><tr><td class="NLM_term">TSPO</td><td class="NLM_def"><p class="first last">translocator protein</p></td></tr><tr><td class="NLM_term">p-TSA</td><td class="NLM_def"><p class="first last"><i>p</i>-toluenesulfonic acid</p></td></tr><tr><td class="NLM_term">VMAT2</td><td class="NLM_def"><p class="first last">vesicular monoamine transporter 2 (SLC18A2)</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i65">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_11165" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_11165" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 49 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Little, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ford, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Symons-Liguori, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Janes, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doyle, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xie, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luongo, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tosh, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maione, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bannister, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dickenson, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vanderah, T. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Porreca, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobson, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salvemini, D.</span><span> </span><span class="NLM_article-title">Endogenous adenosine A<sub>3</sub> receptor activation selectively alleviates persistent pain states</span> <span class="citation_source-journal">Brain</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">138</span><span class="NLM_x">, </span> <span class="NLM_fpage">28</span><span class="NLM_x">–</span> <span class="NLM_lpage">35</span><span class="refDoi"> DOI: 10.1093/brain/awu330</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00141&amp;key=10.1093%2Fbrain%2Fawu330" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00141&amp;key=25414036" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00141&amp;key=1%3ACAS%3A280%3ADC%252BC2M3pvFersw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=138&publication_year=2015&pages=28-35&author=J.+W.+Littleauthor=A.+Fordauthor=A.+M.+Symons-Liguoriauthor=Z.+Chenauthor=K.+Janesauthor=T.+Doyleauthor=J.+Xieauthor=L.+Luongoauthor=D.+K.+Toshauthor=S.+Maioneauthor=K.+Bannisterauthor=A.+Dickensonauthor=T.+W.+Vanderahauthor=F.+Porrecaauthor=K.+A.+Jacobsonauthor=D.+Salvemini&title=Endogenous+adenosine+A3+receptor+activation+selectively+alleviates+persistent+pain+states&doi=10.1093%2Fbrain%2Fawu330"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Endogenous adenosine A3 receptor activation selectively alleviates persistent pain states</span></div><div class="casAuthors">Little Joshua W; Ford Amanda; Chen Zhoumou; Janes Kali; Doyle Timothy; Salvemini Daniela; Symons-Liguori Ashley M; Xie Jennifer; Vanderah Todd W; Porreca Frank; Luongo Livio; Maione Sabatino; Tosh Dillip K; Jacobson Kenneth A; Bannister Kirsty; Dickenson Anthony H</div><div class="citationInfo"><span class="NLM_cas:title">Brain : a journal of neurology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">138</span>
        (<span class="NLM_cas:issue">Pt 1</span>),
    <span class="NLM_cas:pages">28-35</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Chronic pain is a global burden that promotes disability and unnecessary suffering.  To date, efficacious treatment of chronic pain has not been achieved.  Thus, new therapeutic targets are needed.  Here, we demonstrate that increasing endogenous adenosine levels through selective adenosine kinase inhibition produces powerful analgesic effects in rodent models of experimental neuropathic pain through the A3 adenosine receptor (A3AR, now known as ADORA3) signalling pathway.  Similar results were obtained by the administration of a novel and highly selective A3AR agonist.  These effects were prevented by blockade of spinal and supraspinal A3AR, lost in A3AR knock-out mice, and independent of opioid and endocannabinoid mechanisms.  A3AR activation also relieved non-evoked spontaneous pain behaviours without promoting analgesic tolerance or inherent reward.  Further examination revealed that A3AR activation reduced spinal cord pain processing by decreasing the excitability of spinal wide dynamic range neurons and producing supraspinal inhibition of spinal nociception through activation of serotonergic and noradrenergic bulbospinal circuits.  Critically, engaging the A3AR mechanism did not alter nociceptive thresholds in non-neuropathy animals and therefore produced selective alleviation of persistent neuropathic pain states.  These studies reveal A3AR activation by adenosine as an endogenous anti-nociceptive pathway and support the development of A3AR agonists as novel therapeutics to treat chronic pain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTV_nDN4yfcy0Q0lWbKiCflfW6udTcc2ebfSSlueUogfLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2M3pvFersw%253D%253D&md5=85411b662ffef21c0fc58f0549845716</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1093%2Fbrain%2Fawu330&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fbrain%252Fawu330%26sid%3Dliteratum%253Aachs%26aulast%3DLittle%26aufirst%3DJ.%2BW.%26aulast%3DFord%26aufirst%3DA.%26aulast%3DSymons-Liguori%26aufirst%3DA.%2BM.%26aulast%3DChen%26aufirst%3DZ.%26aulast%3DJanes%26aufirst%3DK.%26aulast%3DDoyle%26aufirst%3DT.%26aulast%3DXie%26aufirst%3DJ.%26aulast%3DLuongo%26aufirst%3DL.%26aulast%3DTosh%26aufirst%3DD.%2BK.%26aulast%3DMaione%26aufirst%3DS.%26aulast%3DBannister%26aufirst%3DK.%26aulast%3DDickenson%26aufirst%3DA.%26aulast%3DVanderah%26aufirst%3DT.%2BW.%26aulast%3DPorreca%26aufirst%3DF.%26aulast%3DJacobson%26aufirst%3DK.%2BA.%26aulast%3DSalvemini%26aufirst%3DD.%26atitle%3DEndogenous%2520adenosine%2520A3%2520receptor%2520activation%2520selectively%2520alleviates%2520persistent%2520pain%2520states%26jtitle%3DBrain%26date%3D2015%26volume%3D138%26spage%3D28%26epage%3D35%26doi%3D10.1093%2Fbrain%2Fawu330" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Tosh, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Finley, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paoletta, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moss, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, Z. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gizewski, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Auchampach, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salvemini, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobson, K. A.</span><span> </span><span class="NLM_article-title">In vivo phenotypic screening for treating chronic neuropathic pain: Modification of C2-arylethynyl group of conformationally constrained A<sub>3</sub> adenosine receptor agonists</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">9901</span><span class="NLM_x">–</span> <span class="NLM_lpage">9914</span><span class="refDoi"> DOI: 10.1021/jm501021n</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm501021n" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00141&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvFOhtrjF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=9901-9914&author=D.+K.+Toshauthor=A.+Finleyauthor=S.+Paolettaauthor=S.+M.+Mossauthor=Z.+G.+Gaoauthor=E.+Gizewskiauthor=J.+Auchampachauthor=D.+Salveminiauthor=K.+A.+Jacobson&title=In+vivo+phenotypic+screening+for+treating+chronic+neuropathic+pain%3A+Modification+of+C2-arylethynyl+group+of+conformationally+constrained+A3+adenosine+receptor+agonists&doi=10.1021%2Fjm501021n"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">In Vivo Phenotypic Screening for Treating Chronic Neuropathic Pain: Modification of C2-Arylethynyl Group of Conformationally Constrained A3 Adenosine Receptor Agonists</span></div><div class="casAuthors">Tosh, Dilip K.; Finley, Amanda; Paoletta, Silvia; Moss, Steven M.; Gao, Zhan-Guo; Gizewski, Elizabeth T.; Auchampach, John A.; Salvemini, Daniela; Jacobson, Kenneth A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">9901-9914</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">(N)-Methanocarba adenosine 5'-methyluronamides contg. 2-arylethynyl groups were synthesized as A3 adenosine receptor (AR) agonists and screened in vivo (po) for redn. of neuropathic pain.  A small N6-Me group maintained binding affinity, with human > mouse A3AR and MW < 500 and other favorable physicochem. properties.  Emax (maximal efficacy in a mouse chronic constriction injury pain model) of previously characterized A3AR agonist, 2-(3,4-difluorophenylethynyl)-N6-(3-chlorobenzyl) deriv. 6a, MRS5698, was surpassed.  More efficacious analogs (in vivo) contained the following C2-arylethynyl groups: pyrazin-2-yl 23 (binding Ki, hA3AR, nM 1.8), fur-2-yl 27 (0.6), thien-2-yl 32 (0.6) and its 5-chloro 33, MRS5980 (0.7) and 5-bromo 34 (0.4) equiv., and physiol. unstable ferrocene 36, MRS5979 (2.7). 33 and 36 displayed particularly long in vivo duration (>3 h).  Selected analogs were docked to an A3AR homol. model to explore the environment of receptor-bound C2 and N6 groups.  Various analogs bound with μM affinity at off-target biogenic amine (M2, 5HT2A, β3, 5HT2B, 5HT2C, and α2C) or other receptors.  Thus, we have expanded the structural range of orally active A3AR agonists for chronic pain treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoQCo4JjAXTTLVg90H21EOLACvtfcHk0lh-dE-MLjAf2w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvFOhtrjF&md5=d9f3f36c4c107a289cef7f4deb9b70ce</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1021%2Fjm501021n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm501021n%26sid%3Dliteratum%253Aachs%26aulast%3DTosh%26aufirst%3DD.%2BK.%26aulast%3DFinley%26aufirst%3DA.%26aulast%3DPaoletta%26aufirst%3DS.%26aulast%3DMoss%26aufirst%3DS.%2BM.%26aulast%3DGao%26aufirst%3DZ.%2BG.%26aulast%3DGizewski%26aufirst%3DE.%26aulast%3DAuchampach%26aufirst%3DJ.%26aulast%3DSalvemini%26aufirst%3DD.%26aulast%3DJacobson%26aufirst%3DK.%2BA.%26atitle%3DIn%2520vivo%2520phenotypic%2520screening%2520for%2520treating%2520chronic%2520neuropathic%2520pain%253A%2520Modification%2520of%2520C2-arylethynyl%2520group%2520of%2520conformationally%2520constrained%2520A3%2520adenosine%2520receptor%2520agonists%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D9901%26epage%3D9914%26doi%3D10.1021%2Fjm501021n" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Janowsky, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eshleman, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tosh, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobson, K. A.</span><span> </span><span class="NLM_article-title">Rigid adenine nucleoside derivatives as novel modulators of the human sodium symporters for dopamine and other neurotransmitters</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">357</span><span class="NLM_x">, </span> <span class="NLM_fpage">24</span><span class="NLM_x">–</span> <span class="NLM_lpage">35</span><span class="refDoi"> DOI: 10.1124/jpet.115.229666</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00141&amp;key=10.1124%2Fjpet.115.229666" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00141&amp;key=26813929" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00141&amp;key=1%3ACAS%3A528%3ADC%252BC28XpvVeksLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=357&publication_year=2016&pages=24-35&author=A.+Janowskyauthor=A.+Eshlemanauthor=D.+K.+Toshauthor=K.+A.+Jacobson&title=Rigid+adenine+nucleoside+derivatives+as+novel+modulators+of+the+human+sodium+symporters+for+dopamine+and+other+neurotransmitters&doi=10.1124%2Fjpet.115.229666"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Rigid adenine nucleoside derivatives as novel modulators of the human sodium symporters for dopamine and norepinephrine</span></div><div class="casAuthors">Janowsky, Aaron; Tosh, Dilip K.; Eshleman, Amy J.; Jacobson, Kenneth A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">357</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">24-35</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">1521-0103</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Thirty-two congeneric rigid adenine nucleoside derivs. contg. a North (N)-methanocarba ribose substitution and a 2-arylethynyl group either enhanced (up to 760% of control) or inhibited [125I] Me (1R,2S,3S)-3-(4-iodophenyl)-8-methyl-8-azabicyclo[3.2.1]octane-2-carboxylate (RTI-55) binding at the human dopamine (DA) transporter (DAT) and inhibited DA uptake.  Several nucleosides also enhanced [3H]mazindol [(±)-5-(4-chlorophenyl)-3,5-dihydro-2H-imidazo[2,1-a]isoindol-5-ol] binding to the DAT.  The combination of binding enhancement and functional inhibition suggests possible allosteric interaction with the tropanes.  The structure-activity relationship of this novel class of DAT ligands was explored: small N6-substition (Me or ethyl) was favored, while the N1 of the adenine ring was essential.  Effective terminal aryl groups include thien-2-yl (compds. 9 and 16), with EC50 values of 35.1 and 9.1 nM, resp., in [125I]RTI-55 binding enhancement, and 3,4-difluorophenyl as in the most potent DA uptake inhibitor (compd. 6) with an IC50 value of 92 nM (3-fold more potent than cocaine), but not nitrogen heterocycles.  Several compds. inhibited or enhanced binding at the norepinephrine transporter (NET) and serotonin transporter (SERT) and inhibited function in the micromolar range; truncation at the 4'-position in compd. 23 allowed for weak inhibition of the SERT.  We have not yet eliminated adenosine receptor affinity from this class of DAT modulators, but we identified modifications that remove DAT inhibition as an off-target effect of potent adenosine receptor agonists.  Thus, we have identified a new class of allosteric DAT ligands, rigidified adenosine derivs., and explored their initial structural requirements.  They display a very atypical pharmacol. profile, i.e., either enhancement by increasing affinity or inhibition of radioligand binding at the DAT, and in some cases the NET and SERT, and inhibition of neurotransmitter uptake.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpPsPBvjbGFirVg90H21EOLACvtfcHk0lh-dE-MLjAf2w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XpvVeksLk%253D&md5=85e74bccf374daae3cf785982a35cabb</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1124%2Fjpet.115.229666&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.115.229666%26sid%3Dliteratum%253Aachs%26aulast%3DJanowsky%26aufirst%3DA.%26aulast%3DEshleman%26aufirst%3DA.%26aulast%3DTosh%26aufirst%3DD.%2BK.%26aulast%3DJacobson%26aufirst%3DK.%2BA.%26atitle%3DRigid%2520adenine%2520nucleoside%2520derivatives%2520as%2520novel%2520modulators%2520of%2520the%2520human%2520sodium%2520symporters%2520for%2520dopamine%2520and%2520other%2520neurotransmitters%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2016%26volume%3D357%26spage%3D24%26epage%3D35%26doi%3D10.1124%2Fjpet.115.229666" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">LeVine, M. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cuendet, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khelashvili, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weinstein, H.</span><span> </span><span class="NLM_article-title">Allosteric mechanisms of molecular machines at the membrane: Transport by sodium-coupled symporters</span> <span class="citation_source-journal">Chem. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">116</span><span class="NLM_x">, </span> <span class="NLM_fpage">6552</span><span class="NLM_x">–</span> <span class="NLM_lpage">6587</span><span class="refDoi"> DOI: 10.1021/acs.chemrev.5b00627</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.chemrev.5b00627" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00141&amp;key=1%3ACAS%3A528%3ADC%252BC28XislCisro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=116&publication_year=2016&pages=6552-6587&author=M.+V.+LeVineauthor=M.+A.+Cuendetauthor=G.+Khelashviliauthor=H.+Weinstein&title=Allosteric+mechanisms+of+molecular+machines+at+the+membrane%3A+Transport+by+sodium-coupled+symporters&doi=10.1021%2Facs.chemrev.5b00627"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Allosteric mechanisms of molecular machines at the membrane: Transport by sodium-coupled symporters</span></div><div class="casAuthors">LeVine, Michael V.; Cuendet, Michel A.; Khelashvili, George; Weinstein, Harel</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Reviews (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">116</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">6552-6587</span>CODEN:
                <span class="NLM_cas:coden">CHREAY</span>;
        ISSN:<span class="NLM_cas:issn">0009-2665</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review. Solute transport across cell.  Membranes is ubiquitous in biol. as an essential physiol. process.  Secondary active transporters couple the unfavorable process of solute transport against its concn. gradient to the energetically favorable transport of one or several ions.  The study of such transporters over several decades indicates that their function involves complex allosteric mechanisms that are progressively being revealed in atomistic detail.  The authors focus on 2 well-characterized Na+-coupled symporters: the bacterial amino acid transporter LeuT, which is the prototype for the "gated pore" mechanism in the mammalian synaptic monoamine transporters, and the archaeal GltPh, which is the prototype for the "elevator" mechanism in the mammalian excitatory amino acid transporters.  The authors present evidence for the role of allostery in the context of a quant. formalism that can reconcile biochem. and biophys. data and thereby connects directly to recent insights into the mol. structure and dynamics of these proteins.  The authors demonstrate that, while the structures and mechanisms of these transporters are very different, the available data suggest a common role of specific models of allostery in their functions.  The authors argue that such allosteric mechanisms appear essential not only for Na+-coupled symport in general but also for the function of other types of mol. machines in the membrane.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqOq5BWdTGA1rVg90H21EOLACvtfcHk0ljq-C_W0m6C1Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XislCisro%253D&md5=2c8581906caf99f8c962e60dc2401181</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1021%2Facs.chemrev.5b00627&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.chemrev.5b00627%26sid%3Dliteratum%253Aachs%26aulast%3DLeVine%26aufirst%3DM.%2BV.%26aulast%3DCuendet%26aufirst%3DM.%2BA.%26aulast%3DKhelashvili%26aufirst%3DG.%26aulast%3DWeinstein%26aufirst%3DH.%26atitle%3DAllosteric%2520mechanisms%2520of%2520molecular%2520machines%2520at%2520the%2520membrane%253A%2520Transport%2520by%2520sodium-coupled%2520symporters%26jtitle%3DChem.%2520Rev.%26date%3D2016%26volume%3D116%26spage%3D6552%26epage%3D6587%26doi%3D10.1021%2Facs.chemrev.5b00627" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Vaughan, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Foster, J. D.</span><span> </span><span class="NLM_article-title">Mechanisms of dopamine transporter regulation in normal and disease states</span> <span class="citation_source-journal">Trends Pharmacol. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">34</span><span class="NLM_x">, </span> <span class="NLM_fpage">489</span><span class="NLM_x">–</span> <span class="NLM_lpage">496</span><span class="refDoi"> DOI: 10.1016/j.tips.2013.07.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00141&amp;key=10.1016%2Fj.tips.2013.07.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00141&amp;key=23968642" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00141&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtlWjurvM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2013&pages=489-496&author=R.+A.+Vaughanauthor=J.+D.+Foster&title=Mechanisms+of+dopamine+transporter+regulation+in+normal+and+disease+states&doi=10.1016%2Fj.tips.2013.07.005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Mechanisms of dopamine transporter regulation in normal and disease states</span></div><div class="casAuthors">Vaughan, Roxanne A.; Foster, James D.</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Pharmacological Sciences</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">489-496</span>CODEN:
                <span class="NLM_cas:coden">TPHSDY</span>;
        ISSN:<span class="NLM_cas:issn">0165-6147</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  The dopamine (DA) transporter (DAT) controls the spatial and temporal dynamics of DA neurotransmission by driving reuptake of extracellular transmitter into presynaptic neurons.  Many diseases such as depression, bipolar disorder, Parkinson's disease (PD), and attention deficit hyperactivity disorder (ADHD) are assocd. with abnormal DA levels, implicating DAT as a factor in their etiol.  Medications used to treat these disorders and many addictive drugs target DAT and enhance dopaminergic signaling by suppressing transmitter reuptake.  We now understand that the transport and binding properties of DAT are regulated by complex and overlapping mechanisms that provide neurons with the ability to modulate DA clearance in response to physiol. demands.  These processes are controlled by endogenous signaling pathways and affected by exogenous transporter ligands, demonstrating their importance for normal neurotransmission, drug abuse, and disease treatments.  Increasing evidence supports the disruption of these mechanisms in DA disorders, implicating dysregulation of transport in disease etiologies and suggesting these processes as potential points for therapeutic manipulation of DA availability.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoINuFoGhhzULVg90H21EOLACvtfcHk0ljq-C_W0m6C1Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtlWjurvM&md5=c6618175177119359f7af0987e2e0b37</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1016%2Fj.tips.2013.07.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tips.2013.07.005%26sid%3Dliteratum%253Aachs%26aulast%3DVaughan%26aufirst%3DR.%2BA.%26aulast%3DFoster%26aufirst%3DJ.%2BD.%26atitle%3DMechanisms%2520of%2520dopamine%2520transporter%2520regulation%2520in%2520normal%2520and%2520disease%2520states%26jtitle%3DTrends%2520Pharmacol.%2520Sci.%26date%3D2013%26volume%3D34%26spage%3D489%26epage%3D496%26doi%3D10.1016%2Fj.tips.2013.07.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Wang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goehring, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, K. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Penmatsa, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ressler, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gouaux, E.</span><span> </span><span class="NLM_article-title">Structural basis for action by diverse antidepressants on biogenic amine transporters</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">503</span><span class="NLM_x">, </span> <span class="NLM_fpage">141</span><span class="NLM_x">–</span> <span class="NLM_lpage">145</span><span class="refDoi"> DOI: 10.1038/nature12648</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00141&amp;key=10.1038%2Fnature12648" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00141&amp;key=24121440" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00141&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhslSnsLrE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=503&publication_year=2013&pages=141-145&author=H.+Wangauthor=A.+Goehringauthor=K.+H.+Wangauthor=A.+Penmatsaauthor=R.+Resslerauthor=E.+Gouaux&title=Structural+basis+for+action+by+diverse+antidepressants+on+biogenic+amine+transporters&doi=10.1038%2Fnature12648"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Structural basis for action by diverse antidepressants on biogenic amine transporters</span></div><div class="casAuthors">Wang, Hui; Goehring, April; Wang, Kevin H.; Penmatsa, Aravind; Ressler, Ryan; Gouaux, Eric</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">503</span>
        (<span class="NLM_cas:issue">7474</span>),
    <span class="NLM_cas:pages">141-145</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The biogenic amine transporters (BATs) regulate endogenous neurotransmitter concns. and are targets for a broad range of therapeutic agents including selective serotonin reuptake inhibitors (SSRIs), serotonin-noradrenaline reuptake inhibitors (SNRIs) and tricyclic antidepressants (TCAs).  Because eukaryotic BATs are recalcitrant to crystallog. anal., the authors' understanding of the mechanism of these inhibitors and antidepressants is limited.  LeuT is a bacterial homolog of BATs and has proven to be a valuable paradigm for understanding relationships between their structure and function.  However, because only approx. 25% of the amino acid sequence of LeuT is in common with that of BATs, and as LeuT is a promiscuous amino acid transporter, it does not recapitulate the pharmacol. properties of BATs.  Indeed, SSRIs and TCAs bind in the extracellular vestibule of LeuT and act as non-competitive inhibitors of transport.  By contrast, multiple studies demonstrate that both TCAs and SSRIs are competitive inhibitors for eukaryotic BATs and bind to the primary binding pocket.  Here the authors engineered LeuT to harbor human BAT-like pharmacol. by mutating key residues around the primary binding pocket.  The final LeuBAT mutant binds the SSRI sertraline with a binding const. of 18 nM and displays high-affinity binding to a range of SSRIs, SNRIs and a TCA.  The authors detd. 12 crystal structures of LeuBAT in complex with four classes of antidepressants.  The chem. diverse inhibitors have a remarkably similar mode of binding in which they straddle transmembrane helix (TM) 3, wedge between TM3/TM8 and TM1/TM6, and lock the transporter in a sodium- and chloride-bound outward-facing open conformation.  Together, these studies define common and simple principles for the action of SSRIs, SNRIs and TCAs on BATs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp8AMnfh2-Af7Vg90H21EOLACvtfcHk0ljq-C_W0m6C1Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhslSnsLrE&md5=26cc6cf173fdf20ec20d928d02f05193</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1038%2Fnature12648&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature12648%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DH.%26aulast%3DGoehring%26aufirst%3DA.%26aulast%3DWang%26aufirst%3DK.%2BH.%26aulast%3DPenmatsa%26aufirst%3DA.%26aulast%3DRessler%26aufirst%3DR.%26aulast%3DGouaux%26aufirst%3DE.%26atitle%3DStructural%2520basis%2520for%2520action%2520by%2520diverse%2520antidepressants%2520on%2520biogenic%2520amine%2520transporters%26jtitle%3DNature%26date%3D2013%26volume%3D503%26spage%3D141%26epage%3D145%26doi%3D10.1038%2Fnature12648" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Wang, K. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Penamasta, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gouaux, E.</span><span> </span><span class="NLM_article-title">Neurotransmitter and psychostimulant recognition by the dopamine transporter</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">521</span><span class="NLM_x">, </span> <span class="NLM_fpage">322</span><span class="NLM_x">–</span> <span class="NLM_lpage">327</span><span class="refDoi"> DOI: 10.1038/nature14431</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00141&amp;key=10.1038%2Fnature14431" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00141&amp;key=25970245" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00141&amp;key=1%3ACAS%3A528%3ADC%252BC2MXht1WltbbK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=521&publication_year=2015&pages=322-327&author=K.+H.+Wangauthor=A.+Penamastaauthor=E.+Gouaux&title=Neurotransmitter+and+psychostimulant+recognition+by+the+dopamine+transporter&doi=10.1038%2Fnature14431"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Neurotransmitter and psychostimulant recognition by the dopamine transporter</span></div><div class="casAuthors">Wang, Kevin H.; Penmatsa, Aravind; Gouaux, Eric</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">521</span>
        (<span class="NLM_cas:issue">7552</span>),
    <span class="NLM_cas:pages">322-327</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Na+/Cl--coupled biogenic amine transporters are the primary targets of therapeutic and abused drugs, ranging from antidepressants to the psychostimulants cocaine and amphetamines, and to their cognate substrates.  Here we det. X-ray crystal structures of the Drosophila melanogaster dopamine transporter (dDAT) bound to its substrate dopamine, a substrate analog 3,4-dichlorophenethylamine, the psychostimulants D-amphetamine and methamphetamine, or to cocaine and cocaine analogs.  All ligands bind to the central binding site, located approx. halfway across the membrane bilayer, in close proximity to bound sodium and chloride ions.  The central binding site recognizes three chem. distinct classes of ligands via conformational changes that accommodate varying sizes and shapes, thus illustrating mol. principles that distinguish substrates from inhibitors in biogenic amine transporters.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrWbqTaT0RDD7Vg90H21EOLACvtfcHk0lhETmGoxnDwOQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXht1WltbbK&md5=1784d5fd0e7e1ddbe8346c96aaf98a00</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1038%2Fnature14431&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature14431%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DK.%2BH.%26aulast%3DPenamasta%26aufirst%3DA.%26aulast%3DGouaux%26aufirst%3DE.%26atitle%3DNeurotransmitter%2520and%2520psychostimulant%2520recognition%2520by%2520the%2520dopamine%2520transporter%26jtitle%3DNature%26date%3D2015%26volume%3D521%26spage%3D322%26epage%3D327%26doi%3D10.1038%2Fnature14431" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Newman, A. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kulkarni, S.</span><span> </span><span class="NLM_article-title">Probes for the dopamine transporter: New leads toward a cocaine-abuse therapeutic—A focus on analogues of benztropine and rimcazole</span> <span class="citation_source-journal">Med. Res. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">429</span><span class="NLM_x">–</span> <span class="NLM_lpage">464</span><span class="refDoi"> DOI: 10.1002/med.10014</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00141&amp;key=10.1002%2Fmed.10014" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00141&amp;key=12210554" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00141&amp;key=1%3ACAS%3A528%3ADC%252BD38XntFSlsrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2002&pages=429-464&author=A.+H.+Newmanauthor=S.+Kulkarni&title=Probes+for+the+dopamine+transporter%3A+New+leads+toward+a+cocaine-abuse+therapeutic%E2%80%94A+focus+on+analogues+of+benztropine+and+rimcazole&doi=10.1002%2Fmed.10014"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Probes for the dopamine transporter: new leads toward a cocaine-abuse therapeutic-a focus on analogues of benztropine and rimcazole</span></div><div class="casAuthors">Newman, Amy Hauck; Kulkarni, Santosh</div><div class="citationInfo"><span class="NLM_cas:title">Medicinal Research Reviews</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">429-464</span>CODEN:
                <span class="NLM_cas:coden">MRREDD</span>;
        ISSN:<span class="NLM_cas:issn">0198-6325</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">A review.  To discover a cocaine-abuse pharmacotherapeutic, extensive investigation has been directed toward elucidating the mol. mechanisms underlying the reinforcing effects of this psychostimulant drug.  The results of these studies have been consistent with the inhibition of dopamine uptake, at the dopamine transporter (DAT), which results in a rapid and excessive accumulation of extracellular dopamine in the synapse as being the mechanism primarily responsible for the locomotor stimulant actions of cocaine.  Nevertheless, investigation of the serotonin (SERT) and norepinephrine (NET) transporters, as well as other receptor systems, with which cocaine either directly or indirectly interacts, has suggested that the DAT is not solely responsible for the reinforcing effects of cocaine.  To further elucidate the roles of these systems in the reinforcing effects of cocaine, selective mol. probes, in the form of drug mols., have been designed, synthesized, and characterized.  Many of these compds. bind potently and selectively to the DAT, block dopamine reuptake, and are behaviorally cocaine-like in animal models of psychostimulant abuse.  However, there have been exceptions noted in several classes of dopamine uptake inhibitors that demonstrate behavioral profiles that are distinctive from cocaine.  Structure-activity relationships between chem. diverse dopamine uptake inhibitors have suggested that different binding interactions, at the mol. level on the DAT, as well as divergent actions at the other monoamine transporters may be related to the differing pharmacol. actions of these compds., in vivo.  These studies suggest that novel dopamine uptake inhibitors, which are structurally and pharmacol. distinct from cocaine, may be developed as potential cocaine-abuse therapeutics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpOGbPZx-2NDLVg90H21EOLACvtfcHk0lhETmGoxnDwOQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XntFSlsrY%253D&md5=cf29fc5d8ae60b5aed61055c64c10888</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1002%2Fmed.10014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fmed.10014%26sid%3Dliteratum%253Aachs%26aulast%3DNewman%26aufirst%3DA.%2BH.%26aulast%3DKulkarni%26aufirst%3DS.%26atitle%3DProbes%2520for%2520the%2520dopamine%2520transporter%253A%2520New%2520leads%2520toward%2520a%2520cocaine-abuse%2520therapeutic%25E2%2580%2594A%2520focus%2520on%2520analogues%2520of%2520benztropine%2520and%2520rimcazole%26jtitle%3DMed.%2520Res.%2520Rev.%26date%3D2002%26volume%3D22%26spage%3D429%26epage%3D464%26doi%3D10.1002%2Fmed.10014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Carroll, F. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Howard, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Howell, L. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fox, B. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuhar, M. J.</span><span> </span><span class="NLM_article-title">Development of the dopamine transporter selective RTI-336 as a pharmacotherapy for cocaine abuse</span> <span class="citation_source-journal">AAPS J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">E196</span><span class="NLM_x">–</span> <span class="NLM_lpage">E203</span><span class="refDoi"> DOI: 10.1208/aapsj080124</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00141&amp;key=10.1208%2Faapsj080124" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2006&pages=E196-E203&author=F.+I.+Carrollauthor=J.+L.+Howardauthor=L.+L.+Howellauthor=B.+S.+Foxauthor=M.+J.+Kuhar&title=Development+of+the+dopamine+transporter+selective+RTI-336+as+a+pharmacotherapy+for+cocaine+abuse&doi=10.1208%2Faapsj080124"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1208%2Faapsj080124&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1208%252Faapsj080124%26sid%3Dliteratum%253Aachs%26aulast%3DCarroll%26aufirst%3DF.%2BI.%26aulast%3DHoward%26aufirst%3DJ.%2BL.%26aulast%3DHowell%26aufirst%3DL.%2BL.%26aulast%3DFox%26aufirst%3DB.%2BS.%26aulast%3DKuhar%26aufirst%3DM.%2BJ.%26atitle%3DDevelopment%2520of%2520the%2520dopamine%2520transporter%2520selective%2520RTI-336%2520as%2520a%2520pharmacotherapy%2520for%2520cocaine%2520abuse%26jtitle%3DAAPS%2520J.%26date%3D2006%26volume%3D8%26spage%3DE196%26epage%3DE203%26doi%3D10.1208%2Faapsj080124" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Enman, N. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arthur, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ward, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perrine, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Unterwald, E. M.</span><span> </span><span class="NLM_article-title">Anhedonia, reduced cocaine reward, and dopamine dysfunction in a rat model of posttraumatic stress disorder</span> <span class="citation_source-journal">Biol. Psychiatry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">78</span><span class="NLM_x">, </span> <span class="NLM_fpage">871</span><span class="NLM_x">–</span> <span class="NLM_lpage">879</span><span class="refDoi"> DOI: 10.1016/j.biopsych.2015.04.024</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00141&amp;key=10.1016%2Fj.biopsych.2015.04.024" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00141&amp;key=26115790" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00141&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtVKmtL7E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=78&publication_year=2015&pages=871-879&author=N.+M.+Enmanauthor=K.+Arthurauthor=S.+J.+Wardauthor=S.+A.+Perrineauthor=E.+M.+Unterwald&title=Anhedonia%2C+reduced+cocaine+reward%2C+and+dopamine+dysfunction+in+a+rat+model+of+posttraumatic+stress+disorder&doi=10.1016%2Fj.biopsych.2015.04.024"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Anhedonia, Reduced Cocaine Reward, and Dopamine Dysfunction in a Rat Model of Posttraumatic Stress Disorder</span></div><div class="casAuthors">Enman, Nicole M.; Arthur, Kayti; Ward, Sara J.; Perrine, Shane A.; Unterwald, Ellen M.</div><div class="citationInfo"><span class="NLM_cas:title">Biological Psychiatry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">78</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">871-879</span>CODEN:
                <span class="NLM_cas:coden">BIPCBF</span>;
        ISSN:<span class="NLM_cas:issn">0006-3223</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Posttraumatic stress disorder (PTSD) co-occurs with substance use disorders at high rates, but the neurobiol. basis of this relationship is largely unknown.  PTSD and drug addiction each involve dysregulation of brain reward circuitry; therefore, the identification of pathol. of the mesolimbic dopamine system may aid in understanding their functional relationship.  Dopamine reward dysfunction also may be relevant to the mechanisms underlying the PTSD symptoms of anhedonia and emotional numbing.  Single-prolonged stress (SPS) was used as a rat model of PTSD, and a series of behavioral and neuropharmacol. assays were applied to assess the impact of SPS on reward, cocaine intake, and components of the striatal dopamine system.  Exposure to SPS increased anhedonia-like behaviors and decreased the rewarding properties of cocaine compared with control handling.  Altered cocaine intake during extended access self-administration sessions was obsd. in rats exposed to SPS, further suggesting a difference in the reinforcing properties of cocaine following severe stress.  SPS reduced tissue content of dopamine and its metabolites in the striatum, as well as altered striatal dopamine transporter and D2, but not D1, receptor densities.  These results support a role for altered dopaminergic transmission in reduced reward function in PTSD.  Pathol. of the dopamine system and the degrdn. of reward processes may contribute to PTSD symptomol. and have implications for co-occurring psychiatric disorders such as substance abuse or depression.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoW2c5VLzyCybVg90H21EOLACvtfcHk0lhETmGoxnDwOQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtVKmtL7E&md5=24343f7c7032fe261d1ff07c668c5dcf</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1016%2Fj.biopsych.2015.04.024&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.biopsych.2015.04.024%26sid%3Dliteratum%253Aachs%26aulast%3DEnman%26aufirst%3DN.%2BM.%26aulast%3DArthur%26aufirst%3DK.%26aulast%3DWard%26aufirst%3DS.%2BJ.%26aulast%3DPerrine%26aufirst%3DS.%2BA.%26aulast%3DUnterwald%26aufirst%3DE.%2BM.%26atitle%3DAnhedonia%252C%2520reduced%2520cocaine%2520reward%252C%2520and%2520dopamine%2520dysfunction%2520in%2520a%2520rat%2520model%2520of%2520posttraumatic%2520stress%2520disorder%26jtitle%3DBiol.%2520Psychiatry%26date%3D2015%26volume%3D78%26spage%3D871%26epage%3D879%26doi%3D10.1016%2Fj.biopsych.2015.04.024" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Sakrikar, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mazei-Robison, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mergy, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richtand, N. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Han, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamilton, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bowton, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Galli, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Veenstra-VanderWeele, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gill, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blakely, R. D.</span><span> </span><span class="NLM_article-title">Attention deficit/hyperactivity disorder-derived coding variation in the dopamine transporter disrupts microdomain targeting and trafficking regulation</span> <span class="citation_source-journal">J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">32</span><span class="NLM_x">, </span> <span class="NLM_fpage">5385</span><span class="NLM_x">–</span> <span class="NLM_lpage">5397</span><span class="refDoi"> DOI: 10.1523/JNEUROSCI.6033-11.2012</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00141&amp;key=10.1523%2FJNEUROSCI.6033-11.2012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00141&amp;key=22514303" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00141&amp;key=1%3ACAS%3A528%3ADC%252BC38Xms1akt70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2012&pages=5385-5397&author=D.+Sakrikarauthor=M.+S.+Mazei-Robisonauthor=M.+A.+Mergyauthor=N.+W.+Richtandauthor=Q.+Hanauthor=P.+J.+Hamiltonauthor=E.+Bowtonauthor=A.+Galliauthor=J.+Veenstra-VanderWeeleauthor=M.+Gillauthor=R.+D.+Blakely&title=Attention+deficit%2Fhyperactivity+disorder-derived+coding+variation+in+the+dopamine+transporter+disrupts+microdomain+targeting+and+trafficking+regulation&doi=10.1523%2FJNEUROSCI.6033-11.2012"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Attention deficit/hyperactivity disorder-derived coding variation in the dopamine transporter disrupts microdomain targeting and trafficking regulation</span></div><div class="casAuthors">Sakrikar, Dhananjay; Mazei-Robison, Michelle S.; Mergy, Marc A.; Richtand, Nathan W.; Han, Qiao; Hamilton, Peter J.; Bowton, Erica; Galli, Aurelio; Veenstra-VanderWeele, Jeremy; Gill, Michael; Blakely, Randy D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">5385-5397</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">Attention deficit/hyperactivity disorder (ADHD) is the most commonly diagnosed disorder of school-age children.  Although genetic and brain-imaging studies suggest a contribution of altered dopamine (DA) signaling in ADHD, evidence of signaling perturbations contributing to risk is largely circumstantial.  The presynaptic, cocaine- and amphetamine (AMPH)-sensitive DA transporter (DAT) constrains DA availability at presynaptic and postsynaptic receptors following vesicular release and is targeted by the most commonly prescribed ADHD therapeutics.  Using polymorphism discovery approaches with an ADHD cohort, we identified a hDAT (human DAT) coding variant, R615C, located in the distal C terminus of the transporter, a region previously implicated in constitutive and regulated transporter trafficking.  Here, we demonstrate that, whereas wild-type DAT proteins traffic in a highly regulated manner, DAT 615C proteins recycle constitutively and demonstrate insensitivity to the endocytic effects of AMPH and PKC (protein kinase C) activation.  The disrupted regulation of DAT 615C parallels a redistribution of the transporter variant away from GM1 ganglioside- and flotillin1-enriched membranes, and is accompanied by altered CaMKII (calcium/calmodulin-dependent protein kinase II) and flotillin-1 interactions.  Using C-terminal peptides derived from wild-type DAT and the R615C variant, we establish that the DAT 615C C terminus can act dominantly to preclude AMPH regulation of wild-type DAT.  Mutagenesis of DAT C-terminal sequences suggests that phosphorylation of T613 may be important in sorting DAT between constitutive and regulated pathways.  Together, our studies support a coupling of DAT microdomain localization with transporter regulation and provide evidence of perturbed DAT activity and DA signaling as a risk determinant for ADHD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp031GMAXShX7Vg90H21EOLACvtfcHk0lgobtmqio4ezw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xms1akt70%253D&md5=cbac9ba57278990fd07a30a328f8cef2</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.6033-11.2012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.6033-11.2012%26sid%3Dliteratum%253Aachs%26aulast%3DSakrikar%26aufirst%3DD.%26aulast%3DMazei-Robison%26aufirst%3DM.%2BS.%26aulast%3DMergy%26aufirst%3DM.%2BA.%26aulast%3DRichtand%26aufirst%3DN.%2BW.%26aulast%3DHan%26aufirst%3DQ.%26aulast%3DHamilton%26aufirst%3DP.%2BJ.%26aulast%3DBowton%26aufirst%3DE.%26aulast%3DGalli%26aufirst%3DA.%26aulast%3DVeenstra-VanderWeele%26aufirst%3DJ.%26aulast%3DGill%26aufirst%3DM.%26aulast%3DBlakely%26aufirst%3DR.%2BD.%26atitle%3DAttention%2520deficit%252Fhyperactivity%2520disorder-derived%2520coding%2520variation%2520in%2520the%2520dopamine%2520transporter%2520disrupts%2520microdomain%2520targeting%2520and%2520trafficking%2520regulation%26jtitle%3DJ.%2520Neurosci.%26date%3D2012%26volume%3D32%26spage%3D5385%26epage%3D5397%26doi%3D10.1523%2FJNEUROSCI.6033-11.2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Miller, L. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leitl, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Banks, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blough, B. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Negus, S. S.</span><span> </span><span class="NLM_article-title">Effects of the triple monoamine uptake inhibitor amitifadine on pain-related depression of behavior and mesolimbic dopamine release in rats</span> <span class="citation_source-journal">Pain</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">156</span><span class="NLM_x">, </span> <span class="NLM_fpage">175</span><span class="NLM_x">–</span> <span class="NLM_lpage">184</span><span class="refDoi"> DOI: 10.1016/j.pain.0000000000000018</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00141&amp;key=10.1016%2Fj.pain.0000000000000018" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=156&publication_year=2015&pages=175-184&author=L.+L.+Millerauthor=M.+D.+Leitlauthor=M.+L.+Banksauthor=B.+E.+Bloughauthor=S.+S.+Negus&title=Effects+of+the+triple+monoamine+uptake+inhibitor+amitifadine+on+pain-related+depression+of+behavior+and+mesolimbic+dopamine+release+in+rats&doi=10.1016%2Fj.pain.0000000000000018"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1016%2Fj.pain.0000000000000018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pain.0000000000000018%26sid%3Dliteratum%253Aachs%26aulast%3DMiller%26aufirst%3DL.%2BL.%26aulast%3DLeitl%26aufirst%3DM.%2BD.%26aulast%3DBanks%26aufirst%3DM.%2BL.%26aulast%3DBlough%26aufirst%3DB.%2BE.%26aulast%3DNegus%26aufirst%3DS.%2BS.%26atitle%3DEffects%2520of%2520the%2520triple%2520monoamine%2520uptake%2520inhibitor%2520amitifadine%2520on%2520pain-related%2520depression%2520of%2520behavior%2520and%2520mesolimbic%2520dopamine%2520release%2520in%2520rats%26jtitle%3DPain%26date%3D2015%26volume%3D156%26spage%3D175%26epage%3D184%26doi%3D10.1016%2Fj.pain.0000000000000018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Wu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bellvé, K. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fogarty, K. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haley, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Melikian, H. E.</span><span> </span><span class="NLM_article-title">Ack1 is a dopamine transporter endocytic brake that rescues a trafficking-dysregulated ADHD coding variant</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">112</span><span class="NLM_x">, </span> <span class="NLM_fpage">15480</span><span class="NLM_x">–</span> <span class="NLM_lpage">15485</span><span class="refDoi"> DOI: 10.1073/pnas.1512957112</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00141&amp;key=10.1073%2Fpnas.1512957112" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=112&publication_year=2015&pages=15480-15485&author=S.+Wuauthor=K.+D.+Bellv%C3%A9author=K.+E.+Fogartyauthor=E.+Haleyauthor=H.+E.+Melikian&title=Ack1+is+a+dopamine+transporter+endocytic+brake+that+rescues+a+trafficking-dysregulated+ADHD+coding+variant&doi=10.1073%2Fpnas.1512957112"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1512957112&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1512957112%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DS.%26aulast%3DBellv%25C3%25A9%26aufirst%3DK.%2BD.%26aulast%3DFogarty%26aufirst%3DK.%2BE.%26aulast%3DHaley%26aufirst%3DE.%26aulast%3DMelikian%26aufirst%3DH.%2BE.%26atitle%3DAck1%2520is%2520a%2520dopamine%2520transporter%2520endocytic%2520brake%2520that%2520rescues%2520a%2520trafficking-dysregulated%2520ADHD%2520coding%2520variant%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2015%26volume%3D112%26spage%3D15480%26epage%3D15485%26doi%3D10.1073%2Fpnas.1512957112" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Sharma, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Santra, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dutta, A.</span><span> </span><span class="NLM_article-title">Triple reuptake inhibitors as potential next-generation antidepressants: a new hope?</span> <span class="citation_source-journal">Future Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">2385</span><span class="NLM_x">–</span> <span class="NLM_lpage">2406</span><span class="refDoi"> DOI: 10.4155/fmc.15.134</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00141&amp;key=10.4155%2Ffmc.15.134" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00141&amp;key=26619226" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00141&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhvFKlu77I" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2015&pages=2385-2406&author=H.+Sharmaauthor=S.+Santraauthor=A.+Dutta&title=Triple+reuptake+inhibitors+as+potential+next-generation+antidepressants%3A+a+new+hope%3F&doi=10.4155%2Ffmc.15.134"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Triple reuptake inhibitors as potential next-generation antidepressants: a new hope?</span></div><div class="casAuthors">Sharma, Horrick; Santra, Soumava; Dutta, Aloke</div><div class="citationInfo"><span class="NLM_cas:title">Future Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">2385-2406</span>CODEN:
                <span class="NLM_cas:coden">FMCUA7</span>;
        ISSN:<span class="NLM_cas:issn">1756-8919</span>.
    
            (<span class="NLM_cas:orgname">Future Science Ltd.</span>)
        </div><div class="casAbstract">The current therapy for depression is less than ideal with remission rates of only 25-35% and a slow onset of action with other assocd. side effects.  The persistence of anhedonia originating from depressed dopaminergic activity is one of the most treatment-resistant symptoms of depression.  Therefore, it has been hypothesized that triple reuptake inhibitors (TRIs) with potency to block dopamine reuptake in addn. to serotonin and norepinephrine transporters should produce higher efficacy.  The current review comprehensively describes the development of TRIs and discusses the importance of evaluation of in vivo transporter occupancy of TRIs, which should correlate with efficacy in humans.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrShosMLktZJbVg90H21EOLACvtfcHk0lgobtmqio4ezw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhvFKlu77I&md5=1130f331ad0e8ecfcdf5a8c3fe915596</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.4155%2Ffmc.15.134&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4155%252Ffmc.15.134%26sid%3Dliteratum%253Aachs%26aulast%3DSharma%26aufirst%3DH.%26aulast%3DSantra%26aufirst%3DS.%26aulast%3DDutta%26aufirst%3DA.%26atitle%3DTriple%2520reuptake%2520inhibitors%2520as%2520potential%2520next-generation%2520antidepressants%253A%2520a%2520new%2520hope%253F%26jtitle%3DFuture%2520Med.%2520Chem.%26date%3D2015%26volume%3D7%26spage%3D2385%26epage%3D2406%26doi%3D10.4155%2Ffmc.15.134" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Santra, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sharma, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vedachalam, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Antonio, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reith, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dutta, A.</span><span> </span><span class="NLM_article-title">Development of potent dopamine-norepinephrine uptake inhibitors (DNRIs) based on a (2S,4R,5R)-2-benzhydryl-5-((4-methoxybenzyl)amino)tetrahydro-2H-pyran-4-ol molecular template</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">821</span><span class="NLM_x">–</span> <span class="NLM_lpage">828</span><span class="refDoi"> DOI: 10.1016/j.bmc.2014.12.040</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00141&amp;key=10.1016%2Fj.bmc.2014.12.040" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00141&amp;key=25593099" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00141&amp;key=1%3ACAS%3A528%3ADC%252BC2MXltVClsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2015&pages=821-828&author=S.+Santraauthor=H.+Sharmaauthor=S.+Vedachalamauthor=T.+Antonioauthor=M.+Reithauthor=A.+Dutta&title=Development+of+potent+dopamine-norepinephrine+uptake+inhibitors+%28DNRIs%29+based+on+a+%282S%2C4R%2C5R%29-2-benzhydryl-5-%28%284-methoxybenzyl%29amino%29tetrahydro-2H-pyran-4-ol+molecular+template&doi=10.1016%2Fj.bmc.2014.12.040"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Development of potent dopamine-norepinephrine uptake inhibitors (DNRIs) based on a (2S,4R,5R)-2-benzhydryl-5-((4-methoxybenzyl)amino)tetrahydro-2H-pyran-4-ol molecular template</span></div><div class="casAuthors">Santra, Soumava; Sharma, Horrick; Vedachalam, Seenuvasan; Antonio, Tamara; Reith, Maarten; Dutta, Aloke</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">821-828</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Current therapy of depression is less than ideal with remission rates of only 25-35% and response rates of 45-60%.  It has been hypothesized that a dysfunctional dopaminergic system in the mesocorticolimbic pathway in depressive disorder may lead to development of anhedonia assocd. with loss of pleasure and interest along with loss of motivation.  The current antidepressants do not address dopamine dysfunction which might explain their low efficacy.  In this report, we have described an SAR study on our pyran-based triple reuptake inhibitors (TRIs) which are being investigated as the next-generation antidepressants.  In the present work we demonstrate that our lead TRIs can be modified with appropriate arom. substitutions to display a highly potent SSRI profile for compds. 2a and 4a (Ki (SERT); 0.71 and 2.68 nM, resp.) or a potent DNRI profile for compds. 6b and 6h (Ki (DAT/NET); 8.94/4.76 and 13/7.37 nM, resp.).  Compds. 4g-4i exhibited potencies at all three monoamine transporters.  The results provide insights into the structural requirements for developing selective dual- and triple-uptake inhibitors from a unique pyran mol. template for an effective management of depression and related disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpIEOmzHoWe3bVg90H21EOLACvtfcHk0lgP1ie7c-iK7Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXltVClsQ%253D%253D&md5=0a5a3ddbf26efdc8e9dc9c6664a4a962</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2014.12.040&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2014.12.040%26sid%3Dliteratum%253Aachs%26aulast%3DSantra%26aufirst%3DS.%26aulast%3DSharma%26aufirst%3DH.%26aulast%3DVedachalam%26aufirst%3DS.%26aulast%3DAntonio%26aufirst%3DT.%26aulast%3DReith%26aufirst%3DM.%26aulast%3DDutta%26aufirst%3DA.%26atitle%3DDevelopment%2520of%2520potent%2520dopamine-norepinephrine%2520uptake%2520inhibitors%2520%2528DNRIs%2529%2520based%2520on%2520a%2520%25282S%252C4R%252C5R%2529-2-benzhydryl-5-%2528%25284-methoxybenzyl%2529amino%2529tetrahydro-2H-pyran-4-ol%2520molecular%2520template%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2015%26volume%3D23%26spage%3D821%26epage%3D828%26doi%3D10.1016%2Fj.bmc.2014.12.040" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Lavretsky, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reinlieb, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">St. Cyr, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siddarth, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ercoli, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Senturk, D.</span><span> </span><span class="NLM_article-title">Combined citalopram and methylphenidate improved treatment response compared to either drug alone in geriatric depression: a randomized double-blind, placebo-controlled trial</span> <span class="citation_source-journal">Am. J. Psychiatry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">172</span><span class="NLM_x">, </span> <span class="NLM_fpage">561</span><span class="NLM_x">–</span> <span class="NLM_lpage">569</span><span class="refDoi"> DOI: 10.1176/appi.ajp.2014.14070889</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00141&amp;key=10.1176%2Fappi.ajp.2014.14070889" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00141&amp;key=25677354" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00141&amp;key=1%3ACAS%3A280%3ADC%252BC2MrltVyrsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=172&publication_year=2015&pages=561-569&author=H.+Lavretskyauthor=M.+Reinliebauthor=N.+St.+Cyrauthor=P.+Siddarthauthor=L.+M.+Ercoliauthor=D.+Senturk&title=Combined+citalopram+and+methylphenidate+improved+treatment+response+compared+to+either+drug+alone+in+geriatric+depression%3A+a+randomized+double-blind%2C+placebo-controlled+trial&doi=10.1176%2Fappi.ajp.2014.14070889"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Citalopram, methylphenidate, or their combination in geriatric depression: a randomized, double-blind, placebo-controlled trial</span></div><div class="casAuthors">Lavretsky Helen; Reinlieb Michelle; St Cyr Natalie; Siddarth Prabha; Ercoli Linda M; Senturk Damla</div><div class="citationInfo"><span class="NLM_cas:title">The American journal of psychiatry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">172</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">561-9</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">OBJECTIVE:  The authors evaluated the potential of methylphenidate to improve antidepressant response to citalopram, as assessed by clinical and cognitive outcomes, in elderly depressed patients.  METHOD:  The authors conducted a 16-week randomized double-blind placebo-controlled trial for geriatric depression in 143 older outpatients diagnosed with major depression comparing treatment response in three treatment groups: methylphenidate plus placebo (N=48), citalopram plus placebo (N=48), and citalopram plus methylphenidate (N=47).  The primary outcome measure was change in depression severity.  Remission was defined as a score of 6 or less on the Hamilton Depression Rating Scale.  Secondary outcomes included measures of anxiety, apathy, quality of life, and cognition.  RESULTS:  Daily doses ranged from 20 mg to 60 mg for citalopram (mean=32 mg) and from 5 mg to 40 mg for methylphenidate (mean=16 mg).  All groups showed significant improvement in depression severity and in cognitive performance.  However, the improvement in depression severity and the Clinical Global Impressions improvement score was more prominent in the citalopram plus methylphenidate group compared with the other two groups.  Additionally, the rate of improvement in the citalopram plus methylphenidate group was significantly higher than that in the citalopram plus placebo group in the first 4 weeks of the trial.  The groups did not differ in cognitive improvement or number of side effects.  CONCLUSIONS:  Combined treatment with citalopram and methylphenidate demonstrated an enhanced clinical response profile in mood and well-being, as well as a higher rate of remission, compared with either drug alone.  All treatments led to an improvement in cognitive functioning, although augmentation with methylphenidate did not offer additional benefits.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSxB3aT0-0XOHqj_yg7twvpfW6udTcc2earrNAchQLeeLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2MrltVyrsA%253D%253D&md5=0b3a2039c3f946ab4fc0d4a575b90e14</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1176%2Fappi.ajp.2014.14070889&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1176%252Fappi.ajp.2014.14070889%26sid%3Dliteratum%253Aachs%26aulast%3DLavretsky%26aufirst%3DH.%26aulast%3DReinlieb%26aufirst%3DM.%26aulast%3DSt.%2BCyr%26aufirst%3DN.%26aulast%3DSiddarth%26aufirst%3DP.%26aulast%3DErcoli%26aufirst%3DL.%2BM.%26aulast%3DSenturk%26aufirst%3DD.%26atitle%3DCombined%2520citalopram%2520and%2520methylphenidate%2520improved%2520treatment%2520response%2520compared%2520to%2520either%2520drug%2520alone%2520in%2520geriatric%2520depression%253A%2520a%2520randomized%2520double-blind%252C%2520placebo-controlled%2520trial%26jtitle%3DAm.%2520J.%2520Psychiatry%26date%3D2015%26volume%3D172%26spage%3D561%26epage%3D569%26doi%3D10.1176%2Fappi.ajp.2014.14070889" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Malhi, G. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Byrow, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bassett, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boyce, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hopwood, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lyndon, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mulder, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Porter, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Singh, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murray, G.</span><span> </span><span class="NLM_article-title">Stimulants for depression: On the up and up?</span> <span class="citation_source-journal">Aust. N. Z. J. Psychiatry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">203</span><span class="NLM_x">–</span> <span class="NLM_lpage">207</span><span class="refDoi"> DOI: 10.1177/0004867416634208</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00141&amp;key=10.1177%2F0004867416634208" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00141&amp;key=26906078" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00141&amp;key=1%3ACAS%3A280%3ADC%252BC28jjsFGgtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2016&pages=203-207&author=G.+S.+Malhiauthor=Y.+Byrowauthor=D.+Bassettauthor=P.+Boyceauthor=M.+Hopwoodauthor=W.+Lyndonauthor=R.+Mulderauthor=R.+Porterauthor=A.+Singhauthor=G.+Murray&title=Stimulants+for+depression%3A+On+the+up+and+up%3F&doi=10.1177%2F0004867416634208"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Stimulants for depression: On the up and up?</span></div><div class="casAuthors">Malhi Gin S; Byrow Yulisha; Bassett Darryl; Boyce Philip; Hopwood Malcolm; Lyndon William; Mulder Roger; Porter Richard; Singh Ajeet; Murray Greg</div><div class="citationInfo"><span class="NLM_cas:title">The Australian and New Zealand journal of psychiatry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">203-7</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The use of traditional psychostimulants (methylphenidate and dexamphetamine) and stimulant-like drugs (modafinil and armodafinil) for the treatment of depression is a growing concern given the lack of research evidence supporting their effectiveness.  The current article describes the role of stimulants in treating depression--specifically their risks and benefits and their potential use alongside antidepressants.  Clinically, the rapid amelioration of depressive symptoms with traditional psychostimulants is often dramatic but short-lived, and this suggests that they likely operate via different mechanisms to conventional antidepressants.  More importantly, there is little evidence from randomised controlled trials supporting their efficacy in treating depression, although modafinil has been shown to be effective in reducing prominent depressive symptoms, such as fatigue.  Research is urgently required to clarify psychostimulants' mechanisms of action and to evaluate their long-term benefits and risks in the treatment of major and bipolar depression.  Ultimately, specificity of action needs to be determined to inform the sophisticated clinical use of psychostimulants in the management of depression.  Until then they should only be prescribed if absolutely necessary, and even then their prescription should be facilitatory and time limited unless it is for investigational purposes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcS-EuZu54KphsuCWE5mhx1RfW6udTcc2earrNAchQLeeLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC28jjsFGgtw%253D%253D&md5=f7319212793eb64084c011264cc9fc70</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1177%2F0004867416634208&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F0004867416634208%26sid%3Dliteratum%253Aachs%26aulast%3DMalhi%26aufirst%3DG.%2BS.%26aulast%3DByrow%26aufirst%3DY.%26aulast%3DBassett%26aufirst%3DD.%26aulast%3DBoyce%26aufirst%3DP.%26aulast%3DHopwood%26aufirst%3DM.%26aulast%3DLyndon%26aufirst%3DW.%26aulast%3DMulder%26aufirst%3DR.%26aulast%3DPorter%26aufirst%3DR.%26aulast%3DSingh%26aufirst%3DA.%26aulast%3DMurray%26aufirst%3DG.%26atitle%3DStimulants%2520for%2520depression%253A%2520On%2520the%2520up%2520and%2520up%253F%26jtitle%3DAust.%2520N.%2520Z.%2520J.%2520Psychiatry%26date%3D2016%26volume%3D50%26spage%3D203%26epage%3D207%26doi%3D10.1177%2F0004867416634208" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Tosh, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deflorian, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Phan, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, Z. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wan, T. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gizewski, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Auchampach, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobson, K. A.</span><span> </span><span class="NLM_article-title">Structure-guided design of A<sub>3</sub> adenosine receptor-selective nucleosides: Combination of 2-arylethynyl and bicyclo[3.1.0]hexane substitutions</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">4847</span><span class="NLM_x">–</span> <span class="NLM_lpage">4860</span><span class="refDoi"> DOI: 10.1021/jm300396n</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm300396n" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00141&amp;key=1%3ACAS%3A528%3ADC%252BC38XmsFygu74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=4847-4860&author=D.+K.+Toshauthor=F.+Deflorianauthor=K.+Phanauthor=Z.+G.+Gaoauthor=T.+C.+Wanauthor=E.+Gizewskiauthor=J.+A.+Auchampachauthor=K.+A.+Jacobson&title=Structure-guided+design+of+A3+adenosine+receptor-selective+nucleosides%3A+Combination+of+2-arylethynyl+and+bicyclo%5B3.1.0%5Dhexane+substitutions&doi=10.1021%2Fjm300396n"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-Guided Design of A3 Adenosine Receptor-Selective Nucleosides: Combination of 2-Arylethynyl and Bicyclo[3.1.0]hexane Substitutions</span></div><div class="casAuthors">Tosh, Dilip K.; Deflorian, Francesca; Phan, Khai; Gao, Zhan-Guo; Wan, Tina C.; Gizewski, Elizabeth; Auchampach, John A.; Jacobson, Kenneth A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">4847-4860</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">(N)-Methanocarba adenosine 5'-methyluronamides contg. known A3 AR (adenosine receptor)-enhancing modifications, i.e., 2-(arylethynyl)adenine and N6-Me or N6-(3-substituted-benzyl), were nanomolar full agonists of human (h) A3AR and highly selective (Ki ∼0.6 nM, N6-Me 2-(halophenylethynyl) analogs).  Combined 2-arylethynyl-N6-3-chlorobenzyl substitutions preserved A3AR affinity/selectivity in the (N)-methanocarba series (e.g., 3,4-difluoro full agonist MRS5698, Ki 3 nM, human and mouse A3) better than that for ribosides.  Polyarom. 2-ethynyl N6-3-chlorobenzyl analogs, such as potent linearly extended 2-p-biphenylethynyl MRS5679 (Ki hA3 3.1 nM; A1, A2A, inactive) and fluorescent 1-pyrene adduct MRS5704 (Ki hA3 68.3 nM), were conformationally rigid; receptor docking identified a large, mainly hydrophobic binding region.  The vicinity of receptor-bound C2 groups was probed by homol. modeling based on recent x-ray structure of an agonist-bound A2AAR, with a predicted helical rearrangement requiring an agonist-specific outward displacement of TM2 resembling opsin.  Thus, the x-ray structure of related A2AAR is useful in guiding the design of new A3AR agonists.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpMpTThMrry7bVg90H21EOLACvtfcHk0lhnAPO7T6-OyA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XmsFygu74%253D&md5=e01c27247742c9d20ee7ff753a2de88c</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1021%2Fjm300396n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm300396n%26sid%3Dliteratum%253Aachs%26aulast%3DTosh%26aufirst%3DD.%2BK.%26aulast%3DDeflorian%26aufirst%3DF.%26aulast%3DPhan%26aufirst%3DK.%26aulast%3DGao%26aufirst%3DZ.%2BG.%26aulast%3DWan%26aufirst%3DT.%2BC.%26aulast%3DGizewski%26aufirst%3DE.%26aulast%3DAuchampach%26aufirst%3DJ.%2BA.%26aulast%3DJacobson%26aufirst%3DK.%2BA.%26atitle%3DStructure-guided%2520design%2520of%2520A3%2520adenosine%2520receptor-selective%2520nucleosides%253A%2520Combination%2520of%25202-arylethynyl%2520and%2520bicyclo%255B3.1.0%255Dhexane%2520substitutions%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D4847%26epage%3D4860%26doi%3D10.1021%2Fjm300396n" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Tosh, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Padia, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salvemini, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobson, K. A.</span><span> </span><span class="NLM_article-title">Efficient, large-scale synthesis and preclinical studies of MRS5698, a highly selective A<sub>3</sub> adenosine receptor agonist that protects against chronic neuropathic pain</span> <span class="citation_source-journal">Purinergic Signalling</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">371</span><span class="NLM_x">–</span> <span class="NLM_lpage">387</span><span class="refDoi"> DOI: 10.1007/s11302-015-9459-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00141&amp;key=10.1007%2Fs11302-015-9459-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00141&amp;key=26111639" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00141&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtVyhsL7J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2015&pages=371-387&author=D.+K.+Toshauthor=J.+Padiaauthor=D.+Salveminiauthor=K.+A.+Jacobson&title=Efficient%2C+large-scale+synthesis+and+preclinical+studies+of+MRS5698%2C+a+highly+selective+A3+adenosine+receptor+agonist+that+protects+against+chronic+neuropathic+pain&doi=10.1007%2Fs11302-015-9459-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Efficient, large-scale synthesis and preclinical studies of MRS5698, a highly selective A3 adenosine receptor agonist that protects against chronic neuropathic pain</span></div><div class="casAuthors">Tosh, Dilip K.; Padia, Janak; Salvemini, Daniela; Jacobson, Kenneth A.</div><div class="citationInfo"><span class="NLM_cas:title">Purinergic Signalling</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">371-387</span>CODEN:
                <span class="NLM_cas:coden">PSUIA9</span>;
        ISSN:<span class="NLM_cas:issn">1573-9538</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">We reported that 2-(3,4-difluorophenylethynyl)-N6-3-chlorobenzyl (N)-methanocarba adenosine deriv. 1 (MRS5698) binds selectively to human and mouse A3 adenosine receptors (A3ARs, Ki 3 nM).  It is becoming an important pharmacol. tool for defining A3AR effects and is orally active in a chronic neuropathic pain model.  Here, we introduce a new synthetic route for MRS5698 from D-ribose, suitable for a scale-up on a multi-gram scale, and we measure in vitro and in vivo ADME-Tox parameters.  MRS5698 was very stable in vitro, failed to inhibit CYPs at <10 μM, and was largely bound to plasma proteins.  It was well tolerated in the rat at doses of ≤200 mg/kg i.p.  A 1 mg/kg i.p. dose in the mouse displayed t1/2 of 1.09 h and plasma Cmax of 204 nM at 1 h with an AUC of 213 ng × h/mL.  CACO-2 bidirectional transport studies suggested intestinal efflux of MRS5698 (efflux ratio 86).  Although the oral %F is only 5 %, the beneficial effect to reverse pain lasted for at least 2 h in the CCI model in rats, using the same vehicle for oral administration of a high dose.  The stability, low toxicity, lack of CYP interaction, pharmacokinetic half-life, and in vivo efficacy suggest that MRS5698 is a preferred compd. for further consideration as a treatment for neuropathic pain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqu82TREqapwLVg90H21EOLACvtfcHk0lhnAPO7T6-OyA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtVyhsL7J&md5=0d810ff59dc5011f0ae25e7f8d6d24c4</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1007%2Fs11302-015-9459-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs11302-015-9459-2%26sid%3Dliteratum%253Aachs%26aulast%3DTosh%26aufirst%3DD.%2BK.%26aulast%3DPadia%26aufirst%3DJ.%26aulast%3DSalvemini%26aufirst%3DD.%26aulast%3DJacobson%26aufirst%3DK.%2BA.%26atitle%3DEfficient%252C%2520large-scale%2520synthesis%2520and%2520preclinical%2520studies%2520of%2520MRS5698%252C%2520a%2520highly%2520selective%2520A3%2520adenosine%2520receptor%2520agonist%2520that%2520protects%2520against%2520chronic%2520neuropathic%2520pain%26jtitle%3DPurinergic%2520Signalling%26date%3D2015%26volume%3D11%26spage%3D371%26epage%3D387%26doi%3D10.1007%2Fs11302-015-9459-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Paoletta, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tosh, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salvemini, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobson, K. A.</span><span> </span><span class="NLM_article-title">Structural probing of off-target G protein-coupled receptor activities within a series of adenosine/adenine congeners</span> <span class="citation_source-journal">PLoS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">e97858</span><span class="refDoi"> DOI: 10.1371/journal.pone.0097858</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00141&amp;key=10.1371%2Fjournal.pone.0097858" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2014&pages=e97858&author=S.+Paolettaauthor=D.+K.+Toshauthor=D.+Salveminiauthor=K.+A.+Jacobson&title=Structural+probing+of+off-target+G+protein-coupled+receptor+activities+within+a+series+of+adenosine%2Fadenine+congeners&doi=10.1371%2Fjournal.pone.0097858"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0097858&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0097858%26sid%3Dliteratum%253Aachs%26aulast%3DPaoletta%26aufirst%3DS.%26aulast%3DTosh%26aufirst%3DD.%2BK.%26aulast%3DSalvemini%26aufirst%3DD.%26aulast%3DJacobson%26aufirst%3DK.%2BA.%26atitle%3DStructural%2520probing%2520of%2520off-target%2520G%2520protein-coupled%2520receptor%2520activities%2520within%2520a%2520series%2520of%2520adenosine%252Fadenine%2520congeners%26jtitle%3DPLoS%2520One%26date%3D2014%26volume%3D9%26spage%3De97858%26doi%3D10.1371%2Fjournal.pone.0097858" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Tosh, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crane, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paoletta, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, Z. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gizewski, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Auchampach, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salvemini, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobson, K. A.</span><span> </span><span class="NLM_article-title">Rigidified A<sub>3</sub> adenosine receptor agonists: 1-Deaza modification maintains high in vivo efficacy</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">804</span><span class="NLM_x">–</span> <span class="NLM_lpage">808</span><span class="refDoi"> DOI: 10.1021/acsmedchemlett.5b00150</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsmedchemlett.5b00150" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00141&amp;key=1%3ACAS%3A528%3ADC%252BC2MXovVSiurY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2015&pages=804-808&author=D.+K.+Toshauthor=S.+Craneauthor=Z.+Chenauthor=S.+Paolettaauthor=Z.+G.+Gaoauthor=E.+Gizewskiauthor=J.+A.+Auchampachauthor=D.+Salveminiauthor=K.+A.+Jacobson&title=Rigidified+A3+adenosine+receptor+agonists%3A+1-Deaza+modification+maintains+high+in+vivo+efficacy&doi=10.1021%2Facsmedchemlett.5b00150"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Rigidified A3 Adenosine Receptor Agonists: 1-Deazaadenine Modification Maintains High in Vivo Efficacy</span></div><div class="casAuthors">Tosh, Dilip K.; Crane, Steven; Chen, Zhoumou; Paoletta, Silvia; Gao, Zhan-Guo; Gizewski, Elizabeth; Auchampach, John A.; Salvemini, Daniela; Jacobson, Kenneth A.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">804-808</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Substitution of rigidified A3 adenosine receptor (AR) agonists with a 2-((5-chlorothiophen-2-yl)ethynyl) or a 2-(4-(5-chlorothiophen-2-yl)-1H-1,2,3-triazol-1-yl) group provides prolonged protection in a model of chronic neuropathic pain.  These agonists contain a bicyclo[3.1.0]hexane ((N)-methanocarba) ring system in place of ribose, which adopts a receptor-preferred conformation.  N6-Small alkyl derivs. were newly optimized for A3AR affinity and the effects of a 1-deaza-adenine modification probed.  1-Deaza-N6-Et alkyne MRS7144 (Ki 1.7 nM) and 1-aza N6-Pr alkyne (I; MRS7154, Ki 1.1 nM) were highly efficacious in vivo.  Thus, the presence of N1 is not required for nanomolar binding affinity or potent, long-lasting functional activity.  Docking of 1-deaza compds. to a receptor homol. model confirmed a similar binding mode as previously reported 1-aza derivs.  This is the first demonstration in nonribose adenosine analogs that the 1-deaza modification can maintain high A3AR affinity, selectivity, and efficacy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrN4NlfzNSFvrVg90H21EOLACvtfcHk0lj1EFnZggUy4A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXovVSiurY%253D&md5=837fb9f8bbbe84ce0de05b4bcb793b1a</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1021%2Facsmedchemlett.5b00150&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsmedchemlett.5b00150%26sid%3Dliteratum%253Aachs%26aulast%3DTosh%26aufirst%3DD.%2BK.%26aulast%3DCrane%26aufirst%3DS.%26aulast%3DChen%26aufirst%3DZ.%26aulast%3DPaoletta%26aufirst%3DS.%26aulast%3DGao%26aufirst%3DZ.%2BG.%26aulast%3DGizewski%26aufirst%3DE.%26aulast%3DAuchampach%26aufirst%3DJ.%2BA.%26aulast%3DSalvemini%26aufirst%3DD.%26aulast%3DJacobson%26aufirst%3DK.%2BA.%26atitle%3DRigidified%2520A3%2520adenosine%2520receptor%2520agonists%253A%25201-Deaza%2520modification%2520maintains%2520high%2520in%2520vivo%2520efficacy%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2015%26volume%3D6%26spage%3D804%26epage%3D808%26doi%3D10.1021%2Facsmedchemlett.5b00150" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Bressi, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choe, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hough, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buckner, F. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">VanVoorhis, W. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verlinde, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hol, W. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gelb, M. H.</span><span> </span><span class="NLM_article-title">Adenosine analogues as inhibitors of Trypanosoma brucei phosphoglycerate kinase: elucidation of a novel binding mode for a 2-amino-<i>N</i><sup>6</sup>-substituted adenosine</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">43</span><span class="NLM_x">, </span> <span class="NLM_fpage">4135</span><span class="NLM_x">–</span> <span class="NLM_lpage">4150</span><span class="refDoi"> DOI: 10.1021/jm000287a</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm000287a" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2000&pages=4135-4150&author=J.+C.+Bressiauthor=J.+Choeauthor=M.+T.+Houghauthor=F.+S.+Bucknerauthor=W.+C.+VanVoorhisauthor=C.+L.+Verlindeauthor=W.+G.+Holauthor=M.+H.+Gelb&title=Adenosine+analogues+as+inhibitors+of+Trypanosoma+brucei+phosphoglycerate+kinase%3A+elucidation+of+a+novel+binding+mode+for+a+2-amino-N6-substituted+adenosine&doi=10.1021%2Fjm000287a"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22a&amp;dbid=16384&amp;doi=10.1021%2Fjm000287a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm000287a%26sid%3Dliteratum%253Aachs%26aulast%3DBressi%26aufirst%3DJ.%2BC.%26aulast%3DChoe%26aufirst%3DJ.%26aulast%3DHough%26aufirst%3DM.%2BT.%26aulast%3DBuckner%26aufirst%3DF.%2BS.%26aulast%3DVanVoorhis%26aufirst%3DW.%2BC.%26aulast%3DVerlinde%26aufirst%3DC.%2BL.%26aulast%3DHol%26aufirst%3DW.%2BG.%26aulast%3DGelb%26aufirst%3DM.%2BH.%26atitle%3DAdenosine%2520analogues%2520as%2520inhibitors%2520of%2520Trypanosoma%2520brucei%2520phosphoglycerate%2520kinase%253A%2520elucidation%2520of%2520a%2520novel%2520binding%2520mode%2520for%2520a%25202-amino-N6-substituted%2520adenosine%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2000%26volume%3D43%26spage%3D4135%26epage%3D4150%26doi%3D10.1021%2Fjm000287a" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit22b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Joshi, B. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Melman, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mackman, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobson, K. A.</span><span> </span><span class="NLM_article-title">Synthesis of ethyl (1<i>S</i>,2<i>R</i>,3<i>S</i>,4<i>S,</i>5<i>S</i>)-2,3-<i>O</i>-(isopropylidene)-4-hydroxy-bicyclo[3.1.0]hexane-carboxylate from L-ribose: A versatile chiral synthon for preparation of adenosine and P2 receptor ligands</span> <span class="citation_source-journal">Nucleosides, Nucleotides Nucleic Acids</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">279</span><span class="NLM_x">–</span> <span class="NLM_lpage">291</span><span class="refDoi"> DOI: 10.1080/15257770701845253</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00141&amp;key=10.1080%2F15257770701845253" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00141&amp;key=18260011" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00141&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhs1WmsL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2008&pages=279-291&author=B.+V.+Joshiauthor=A.+Melmanauthor=R.+L.+Mackmanauthor=K.+A.+Jacobson&title=Synthesis+of+ethyl+%281S%2C2R%2C3S%2C4S%2C5S%29-2%2C3-O-%28isopropylidene%29-4-hydroxy-bicyclo%5B3.1.0%5Dhexane-carboxylate+from+L-ribose%3A+A+versatile+chiral+synthon+for+preparation+of+adenosine+and+P2+receptor+ligands&doi=10.1080%2F15257770701845253"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22bR"><div class="casContent"><span class="casTitleNuber">22b</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of Ethyl (1S,2R,3S,4S,5S)-2,3-O-(Isopropylidene)-4-Hydroxy-Bicyclo[3.1.0]Hexane-Carboxylate from L-Ribose: A Versatile Chiral Synthon for Preparation of Adenosine and P2 Receptor Ligands</span></div><div class="casAuthors">Joshi, Bhalchandra V.; Melman, Artem; Mackman, Richard L.; Jacobson, Kenneth A.</div><div class="citationInfo"><span class="NLM_cas:title">Nucleosides, Nucleotides & Nucleic Acids</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">279-291</span>CODEN:
                <span class="NLM_cas:coden">NNNAFY</span>;
        ISSN:<span class="NLM_cas:issn">1525-7770</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis, Inc.</span>)
        </div><div class="casAbstract">Substitution of the ribose moiety of various nucleosides and nucleotides with the (N)-methanocarba ring system increases the potency and selectivity as ligands at certain subtypes of adenosine and P2 receptors.  A key intermediate, Et (1S,2R,3S,4S,5S)-2,3-O-(isopropylidene)-4-hydroxybicyclo[3.1.0]hexane-carboxylate (I), has been prepd. starting from L-ribose as a readily available, enantiopure building block.  L-Ribose was converted to the corresponding 5'-iodo deriv., which was cleaved reductively with Zn.  Improvements were made in subsequent steps corresponding to a published route to biol. important (N)-methanocarba 5'-uronamido nucleoside II, and new steps were added to prep. related 5'-nucleotide III.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrsF6DdREPJmrVg90H21EOLACvtfcHk0lj1EFnZggUy4A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhs1WmsL4%253D&md5=5ef140fa1779a146d0a1700d352c9720</span></div><a href="/servlet/linkout?suffix=cit22b&amp;dbid=16384&amp;doi=10.1080%2F15257770701845253&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F15257770701845253%26sid%3Dliteratum%253Aachs%26aulast%3DJoshi%26aufirst%3DB.%2BV.%26aulast%3DMelman%26aufirst%3DA.%26aulast%3DMackman%26aufirst%3DR.%2BL.%26aulast%3DJacobson%26aufirst%3DK.%2BA.%26atitle%3DSynthesis%2520of%2520ethyl%2520%25281S%252C2R%252C3S%252C4S%252C5S%2529-2%252C3-O-%2528isopropylidene%2529-4-hydroxy-bicyclo%255B3.1.0%255Dhexane-carboxylate%2520from%2520L-ribose%253A%2520A%2520versatile%2520chiral%2520synthon%2520for%2520preparation%2520of%2520adenosine%2520and%2520P2%2520receptor%2520ligands%26jtitle%3DNucleosides%252C%2520Nucleotides%2520Nucleic%2520Acids%26date%3D2008%26volume%3D27%26spage%3D279%26epage%3D291%26doi%3D10.1080%2F15257770701845253" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Besnard, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruda, G. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Setola, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abecassis, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodriguiz, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, X. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Norval, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sassano, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shin, A. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Webster, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simeons, F. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stojanovski, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prat, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seidah, N. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Constam, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bickerton, G. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Read, K. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wetsel, W. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gilbert, I. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roth, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hopkins, A. L.</span><span> </span><span class="NLM_article-title">Automated design of ligands to polypharmacological profiles</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">492</span><span class="NLM_x">, </span> <span class="NLM_fpage">215</span><span class="NLM_x">–</span> <span class="NLM_lpage">220</span><span class="refDoi"> DOI: 10.1038/nature11691</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00141&amp;key=10.1038%2Fnature11691" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00141&amp;key=23235874" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00141&amp;key=1%3ACAS%3A528%3ADC%252BC38XhvVamurfN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=492&publication_year=2012&pages=215-220&author=J.+Besnardauthor=G.+F.+Rudaauthor=V.+Setolaauthor=K.+Abecassisauthor=R.+M.+Rodriguizauthor=X.+P.+Huangauthor=S.+Norvalauthor=M.+F.+Sassanoauthor=A.+I.+Shinauthor=L.+A.+Websterauthor=F.+R.+Simeonsauthor=L.+Stojanovskiauthor=A.+Pratauthor=N.+G.+Seidahauthor=D.+B.+Constamauthor=G.+R.+Bickertonauthor=K.+D.+Readauthor=W.+C.+Wetselauthor=I.+H.+Gilbertauthor=B.+L.+Rothauthor=A.+L.+Hopkins&title=Automated+design+of+ligands+to+polypharmacological+profiles&doi=10.1038%2Fnature11691"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Automated design of ligands to polypharmacological profiles</span></div><div class="casAuthors">Besnard, Jeremy; Ruda, Gian Filippo; Setola, Vincent; Abecassis, Keren; Rodriguiz, Ramona M.; Huang, Xi-Ping; Norval, Suzanne; Sassano, Maria F.; Shin, Antony I.; Webster, Lauren A.; Simeons, Frederick R. C.; Stojanovski, Laste; Prat, Annik; Seidah, Nabil G.; Constam, Daniel B.; Bickerton, G. Richard; Read, Kevin D.; Wetsel, William C.; Gilbert, Ian H.; Roth, Bryan L.; Hopkins, Andrew L.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">492</span>
        (<span class="NLM_cas:issue">7428</span>),
    <span class="NLM_cas:pages">215-220</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The clin. efficacy and safety of a drug is detd. by its activity profile across many proteins in the proteome.  However, designing drugs with a specific multi-target profile is both complex and difficult.  Therefore methods to design drugs rationally a priori against profiles of several proteins would have immense value in drug discovery.  Here is described a new approach for the automated design of ligands against profiles of multiple drug targets.  The method is demonstrated by the evolution of an approved acetylcholinesterase inhibitor drug donepezil (I) into brain-penetrable ligands with either specific polypharmacol. or exquisite selectivity profiles for G-protein-coupled receptors.  Overall, 800 ligand-target predictions of prospectively designed ligands were tested exptl., of which 75% were confirmed to be correct.  Target engagement in vivo is also demonstrated.  The approach can be a useful source of drug leads when multi-target profiles are required to achieve either selectivity over other drug targets or a desired polypharmacol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqNu5bwrBD3tbVg90H21EOLACvtfcHk0lgpsBku7p14Eg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhvVamurfN&md5=ace6cced250cf968d327b482a5bf1798</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1038%2Fnature11691&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature11691%26sid%3Dliteratum%253Aachs%26aulast%3DBesnard%26aufirst%3DJ.%26aulast%3DRuda%26aufirst%3DG.%2BF.%26aulast%3DSetola%26aufirst%3DV.%26aulast%3DAbecassis%26aufirst%3DK.%26aulast%3DRodriguiz%26aufirst%3DR.%2BM.%26aulast%3DHuang%26aufirst%3DX.%2BP.%26aulast%3DNorval%26aufirst%3DS.%26aulast%3DSassano%26aufirst%3DM.%2BF.%26aulast%3DShin%26aufirst%3DA.%2BI.%26aulast%3DWebster%26aufirst%3DL.%2BA.%26aulast%3DSimeons%26aufirst%3DF.%2BR.%26aulast%3DStojanovski%26aufirst%3DL.%26aulast%3DPrat%26aufirst%3DA.%26aulast%3DSeidah%26aufirst%3DN.%2BG.%26aulast%3DConstam%26aufirst%3DD.%2BB.%26aulast%3DBickerton%26aufirst%3DG.%2BR.%26aulast%3DRead%26aufirst%3DK.%2BD.%26aulast%3DWetsel%26aufirst%3DW.%2BC.%26aulast%3DGilbert%26aufirst%3DI.%2BH.%26aulast%3DRoth%26aufirst%3DB.%2BL.%26aulast%3DHopkins%26aufirst%3DA.%2BL.%26atitle%3DAutomated%2520design%2520of%2520ligands%2520to%2520polypharmacological%2520profiles%26jtitle%3DNature%26date%3D2012%26volume%3D492%26spage%3D215%26epage%3D220%26doi%3D10.1038%2Fnature11691" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Wu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gu, H. H.</span><span> </span><span class="NLM_article-title">Molecular cloning of the mouse dopamine transporter and pharmacological comparison with the human homologue</span> <span class="citation_source-journal">Gene</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">233</span><span class="NLM_x">, </span> <span class="NLM_fpage">163</span><span class="NLM_x">–</span> <span class="NLM_lpage">170</span><span class="refDoi"> DOI: 10.1016/S0378-1119(99)00143-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00141&amp;key=10.1016%2FS0378-1119%2899%2900143-2" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=233&publication_year=1999&pages=163-170&author=X.+Wuauthor=H.+H.+Gu&title=Molecular+cloning+of+the+mouse+dopamine+transporter+and+pharmacological+comparison+with+the+human+homologue&doi=10.1016%2FS0378-1119%2899%2900143-2"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1016%2FS0378-1119%2899%2900143-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0378-1119%252899%252900143-2%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DX.%26aulast%3DGu%26aufirst%3DH.%2BH.%26atitle%3DMolecular%2520cloning%2520of%2520the%2520mouse%2520dopamine%2520transporter%2520and%2520pharmacological%2520comparison%2520with%2520the%2520human%2520homologue%26jtitle%3DGene%26date%3D1999%26volume%3D233%26spage%3D163%26epage%3D170%26doi%3D10.1016%2FS0378-1119%2899%2900143-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Cheng, Y. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prusoff, W. H.</span><span> </span><span class="NLM_article-title">Relationship between inhibition constant (K1) and concentration of inhibitor which causes 50% inhibition (I50) of an enzymatic-reaction</span> <span class="citation_source-journal">Biochem. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1973</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">3099</span><span class="NLM_x">–</span> <span class="NLM_lpage">3108</span><span class="refDoi"> DOI: 10.1016/0006-2952(73)90196-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00141&amp;key=10.1016%2F0006-2952%2873%2990196-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00141&amp;key=4202581" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00141&amp;key=1%3ACAS%3A528%3ADyaE2cXhtVGgs7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=1973&pages=3099-3108&author=Y.+C.+Chengauthor=W.+H.+Prusoff&title=Relationship+between+inhibition+constant+%28K1%29+and+concentration+of+inhibitor+which+causes+50%25+inhibition+%28I50%29+of+an+enzymatic-reaction&doi=10.1016%2F0006-2952%2873%2990196-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Relation between the inhibition constant K1) and the concentration of inhibitor which causes fifty per cent inhibition (I50) of an enzymic reaction</span></div><div class="casAuthors">Cheng, Yung-Chi; Prusoff, William H.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Pharmacology</span>
        (<span class="NLM_cas:date">1973</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">3099-108</span>CODEN:
                <span class="NLM_cas:coden">BCPCA6</span>;
        ISSN:<span class="NLM_cas:issn">0006-2952</span>.
    </div><div class="casAbstract">The Ki and I50 values are equal where the kinetics are non- or uncompetitive, but not where they are competitive.  The relation between the 2 values was analyzed for non- and uncompetitive bi- and monosubstrate reactions and for competitive bisubstrate reactions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqodFY_8msz57Vg90H21EOLACvtfcHk0lgpsBku7p14Eg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE2cXhtVGgs7c%253D&md5=fe7175ca300d8f4085df87af37f8656c</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1016%2F0006-2952%2873%2990196-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0006-2952%252873%252990196-2%26sid%3Dliteratum%253Aachs%26aulast%3DCheng%26aufirst%3DY.%2BC.%26aulast%3DPrusoff%26aufirst%3DW.%2BH.%26atitle%3DRelationship%2520between%2520inhibition%2520constant%2520%2528K1%2529%2520and%2520concentration%2520of%2520inhibitor%2520which%2520causes%252050%2525%2520inhibition%2520%2528I50%2529%2520of%2520an%2520enzymatic-reaction%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D1973%26volume%3D22%26spage%3D3099%26epage%3D3108%26doi%3D10.1016%2F0006-2952%2873%2990196-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Beardsley, P. M.; Shelton, K. L.</span><span> </span><span class="NLM_article-title">Prime-, stress-, and cue-induced reinstatement of extinguished drug-reinforced responding in rats: cocaine as the prototypical drug of abuse</span>.  <span class="citation_source-journal">Curr. Protocols Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span>Chapter 9 (Unit 9.39),  <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">40</span>. DOI: <span class="refDoi"> DOI: 10.1002/0471142301.ns0939s61</span> .</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00141&amp;key=10.1002%2F0471142301.ns0939s61" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2012&pages=1-40&author=P.+M.+Beardsley&author=K.+L.+Shelton&title=Prime-%2C+stress-%2C+and+cue-induced+reinstatement+of+extinguished+drug-reinforced+responding+in+rats%3A+cocaine+as+the+prototypical+drug+of+abuse&doi=10.1002%2F0471142301.ns0939s61"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1002%2F0471142301.ns0939s61&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F0471142301.ns0939s61%26sid%3Dliteratum%253Aachs%26aulast%3DBeardsley%26aufirst%3DP.%2BM.%26atitle%3DPrime-%252C%2520stress-%252C%2520and%2520cue-induced%2520reinstatement%2520of%2520extinguished%2520drug-reinforced%2520responding%2520in%2520rats%253A%2520cocaine%2520as%2520the%2520prototypical%2520drug%2520of%2520abuse%26jtitle%3DCurr.%2520Protocols%2520Neurosci.%26date%3D2012%26spage%3D1%26epage%3D40%26doi%3D10.1002%2F0471142301.ns0939s61" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Bennett, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xie, Y. K.</span><span> </span><span class="NLM_article-title">A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man</span> <span class="citation_source-journal">Pain</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1988</span><span class="NLM_x">, </span> <span class="NLM_volume">33</span><span class="NLM_x">, </span> <span class="NLM_fpage">87</span><span class="NLM_x">–</span> <span class="NLM_lpage">107</span><span class="refDoi"> DOI: 10.1016/0304-3959(88)90209-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00141&amp;key=10.1016%2F0304-3959%2888%2990209-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00141&amp;key=2837713" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00141&amp;key=1%3ACAS%3A280%3ADyaL1c3kslGhsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=1988&pages=87-107&author=G.+J.+Bennettauthor=Y.+K.+Xie&title=A+peripheral+mononeuropathy+in+rat+that+produces+disorders+of+pain+sensation+like+those+seen+in+man&doi=10.1016%2F0304-3959%2888%2990209-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man</span></div><div class="casAuthors">Bennett Gary J; Xie Y-K</div><div class="citationInfo"><span class="NLM_cas:title">Pain</span>
        (<span class="NLM_cas:date">1988</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">87-107</span>
        ISSN:<span class="NLM_cas:issn">0304-3959</span>.
    </div><div class="casAbstract">A peripheral mononeuropathy was produced in adult rats by placing loosely constrictive ligatures around the common sciatic nerve.  The postoperative behavior of these rats indicated that hyperalgesia, allodynia and, possibly, spontaneous pain (or dysesthesia) were produced.  Hyperalgesic responses to noxious radiant heat were evident on the second postoperative day and lasted for over 2 months.  Hyperalgesic responses to chemogenic pain were also present.  The presence of allodynia was inferred from the nocifensive responses evoked by standing on an innocuous, chilled metal floor or by innocuous mechanical stimulation, and by the rats' persistence in holding the hind paw in a guarded position.  The presence of spontaneous pain was suggested by a suppression of appetite and by the frequent occurrence of apparently spontaneous nocifensive responses.  The affected hind paw was abnormally warm or cool in about one-third of the rats.  About one-half of the rats developed grossly overgrown claws on the affected side.  Experiments with this animal model may advance our understanding of the neural mechanisms of neuropathic pain disorders in humans.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSvFbgQgoOLbwWRJ3OJdH_qfW6udTcc2eanVoaEcp88jLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaL1c3kslGhsw%253D%253D&md5=b65eee81b7058ce686a014eee46ead80</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1016%2F0304-3959%2888%2990209-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0304-3959%252888%252990209-6%26sid%3Dliteratum%253Aachs%26aulast%3DBennett%26aufirst%3DG.%2BJ.%26aulast%3DXie%26aufirst%3DY.%2BK.%26atitle%3DA%2520peripheral%2520mononeuropathy%2520in%2520rat%2520that%2520produces%2520disorders%2520of%2520pain%2520sensation%2520like%2520those%2520seen%2520in%2520man%26jtitle%3DPain%26date%3D1988%26volume%3D33%26spage%3D87%26epage%3D107%26doi%3D10.1016%2F0304-3959%2888%2990209-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">Tosh, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ciancetta, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Warnick, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crane, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, Z. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobson, K. A.</span><span> </span><span class="NLM_article-title">Structure-based scaffold repurposing for G protein-coupled receptors: Transformation of adenosine derivatives into 5HT<sub>2B</sub>/5 HT<sub>2C</sub> serotonin receptor antagonists</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">59</span><span class="NLM_x">, </span> <span class="NLM_fpage">11006</span><span class="NLM_x">–</span> <span class="NLM_lpage">11026</span><span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b01183</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b01183" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=11006-11026&author=D.+K.+Toshauthor=A.+Ciancettaauthor=E.+Warnickauthor=S.+Craneauthor=Z.+G.+Gaoauthor=K.+A.+Jacobson&title=Structure-based+scaffold+repurposing+for+G+protein-coupled+receptors%3A+Transformation+of+adenosine+derivatives+into+5HT2B%2F5+HT2C+serotonin+receptor+antagonists&doi=10.1021%2Facs.jmedchem.6b01183"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b01183&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b01183%26sid%3Dliteratum%253Aachs%26aulast%3DTosh%26aufirst%3DD.%2BK.%26aulast%3DCiancetta%26aufirst%3DA.%26aulast%3DWarnick%26aufirst%3DE.%26aulast%3DCrane%26aufirst%3DS.%26aulast%3DGao%26aufirst%3DZ.%2BG.%26aulast%3DJacobson%26aufirst%3DK.%2BA.%26atitle%3DStructure-based%2520scaffold%2520repurposing%2520for%2520G%2520protein-coupled%2520receptors%253A%2520Transformation%2520of%2520adenosine%2520derivatives%2520into%25205HT2B%252F5%2520HT2C%2520serotonin%2520receptor%2520antagonists%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D11006%26epage%3D11026%26doi%3D10.1021%2Facs.jmedchem.6b01183" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Fishman, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cohen, S.</span><span> </span><span class="NLM_article-title">The A<sub>3</sub> adenosine receptor (A<sub>3</sub>AR): therapeutic target and predictive biological marker in rheumatoid arthritis</span> <span class="citation_source-journal">Clin. Rheumatol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">35</span><span class="NLM_x">, </span> <span class="NLM_fpage">2359</span><span class="refDoi"> DOI: 10.1007/s10067-016-3202-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00141&amp;key=10.1007%2Fs10067-016-3202-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00141&amp;key=26886128" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00141&amp;key=1%3ACAS%3A280%3ADC%252BC28jhsVCktA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2016&pages=2359&author=P.+Fishmanauthor=S.+Cohen&title=The+A3+adenosine+receptor+%28A3AR%29%3A+therapeutic+target+and+predictive+biological+marker+in+rheumatoid+arthritis&doi=10.1007%2Fs10067-016-3202-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">The A3 adenosine receptor (A3AR): therapeutic target and predictive biological marker in rheumatoid arthritis</span></div><div class="casAuthors">Fishman Pnina; Cohen Shira</div><div class="citationInfo"><span class="NLM_cas:title">Clinical rheumatology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">2359-62</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The Gi protein-associated A3 adenosine receptor (A3AR) is over-expressed in inflammatory cells, and this high expression is also reflected in the peripheral blood mononuclear cells of patients with autoimmune inflammatory diseases such as rheumatoid arthritis, psoriasis, and Crohn's disease.  CF101, a selective agonist with high affinity to the A3AR, is known to induce robust anti-inflammatory effect in experimental animal models of adjuvant-, collagen-, and tropomyosin-induced arthritis.  The effect is mediated via a definitive molecular mechanism entailing deregulation of the nuclear factor-κB (NF-κB) and the Wnt signal transduction pathways resulting in apoptosis of inflammatory cells.  CF101 was found to be safe and well tolerated in all preclinical, phase I, and phase II human clinical studies.  In two phase II clinical studies where CF101 was administered to rheumatoid arthritis (RA) patients as a stand-alone drug, a significant anti-rheumatic effect and a direct significant correlation were found between receptor expression at baseline and patients' response to the drug, suggesting that A3AR may be utilized as a predictive biomarker.  The A3AR is a promising therapeutic target in rheumatoid arthritis and can be used also as a biological marker to predict patients' response to CF101.  This is a unique type of a personalized medicine approach which may pave the way for a safe and efficacious treatment for this patient population.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQeChpzptz2mVHFYivNCdPRfW6udTcc2eanVoaEcp88jLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC28jhsVCktA%253D%253D&md5=0b2af53772d34d132cc949069d6744e6</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1007%2Fs10067-016-3202-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs10067-016-3202-4%26sid%3Dliteratum%253Aachs%26aulast%3DFishman%26aufirst%3DP.%26aulast%3DCohen%26aufirst%3DS.%26atitle%3DThe%2520A3%2520adenosine%2520receptor%2520%2528A3AR%2529%253A%2520therapeutic%2520target%2520and%2520predictive%2520biological%2520marker%2520in%2520rheumatoid%2520arthritis%26jtitle%3DClin.%2520Rheumatol.%26date%3D2016%26volume%3D35%26spage%3D2359%26doi%3D10.1007%2Fs10067-016-3202-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group">Borea, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gessi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Merighi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Varani, K.</span><span> </span><span class="NLM_article-title">Adenosine as a multi-signalling guardian angel in human diseases: When, where and how does it exert its protective effects?</span> <span class="citation_source-journal">Trends Pharmacol. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">37</span><span class="NLM_x">, </span> <span class="NLM_fpage">419</span><span class="NLM_x">–</span> <span class="NLM_lpage">434</span><span class="refDoi"> DOI: 10.1016/j.tips.2016.02.006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00141&amp;key=10.1016%2Fj.tips.2016.02.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00141&amp;key=26944097" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00141&amp;key=1%3ACAS%3A528%3ADC%252BC28XjtFCnsbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=2016&pages=419-434&author=P.+A.+Boreaauthor=S.+Gessiauthor=S.+Merighiauthor=K.+Varani&title=Adenosine+as+a+multi-signalling+guardian+angel+in+human+diseases%3A+When%2C+where+and+how+does+it+exert+its+protective+effects%3F&doi=10.1016%2Fj.tips.2016.02.006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">adenosine as a multi-signalling guardian angel in human diseases- when, where and how does it exert its protective effects?</span></div><div class="casAuthors">Borea, Pier Andrea; Gessi, Stefania; Merighi, Stefania; Varani, Katia</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Pharmacological Sciences</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">37</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">419-434</span>CODEN:
                <span class="NLM_cas:coden">TPHSDY</span>;
        ISSN:<span class="NLM_cas:issn">0165-6147</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">The importance of adenosine for human health cannot be overstated.  Indeed, this ubiquitous nucleoside is an integral component of ATP, and regulates the function of every tissue and organ in the body.  Acting via receptor-dependent and -independent mechanisms [the former mediated via four G-protein-coupled receptors (GPCRs), A1, A2A, A2B, and A3,], it has a significant role in protecting against cell damage in areas of increased tissue metab., and combating organ dysfunction in numerous pathol. states.  Accordingly, raised levels of adenosine have been demonstrated in epilepsy, ischemia, pain, inflammation, and cancer, in which its behavior can be likened to that of a guardian angel, even though there are instances in which overprodn. of adenosine is pathol.  In this review, we condense the current body of knowledge on the issue, highlighting when, where, and how adenosine exerts its protective effects in both the brain and the periphery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpgDDQVG7TTXbVg90H21EOLACvtfcHk0lhneGv7yDSNFg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XjtFCnsbo%253D&md5=f94a42e9f9bbb2bf41af97ed31649b22</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1016%2Fj.tips.2016.02.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tips.2016.02.006%26sid%3Dliteratum%253Aachs%26aulast%3DBorea%26aufirst%3DP.%2BA.%26aulast%3DGessi%26aufirst%3DS.%26aulast%3DMerighi%26aufirst%3DS.%26aulast%3DVarani%26aufirst%3DK.%26atitle%3DAdenosine%2520as%2520a%2520multi-signalling%2520guardian%2520angel%2520in%2520human%2520diseases%253A%2520When%252C%2520where%2520and%2520how%2520does%2520it%2520exert%2520its%2520protective%2520effects%253F%26jtitle%3DTrends%2520Pharmacol.%2520Sci.%26date%3D2016%26volume%3D37%26spage%3D419%26epage%3D434%26doi%3D10.1016%2Fj.tips.2016.02.006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group">Janes, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Symons-Liguori, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobson, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salvemini, D.</span><span> </span><span class="NLM_article-title">Identification of A<sub>3</sub> adenosine receptor agonists as novel non-narcotic analgesics</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">173</span><span class="NLM_x">, </span> <span class="NLM_fpage">1253</span><span class="NLM_x">–</span> <span class="NLM_lpage">1267</span><span class="refDoi"> DOI: 10.1111/bph.13446</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00141&amp;key=10.1111%2Fbph.13446" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00141&amp;key=26804983" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00141&amp;key=1%3ACAS%3A528%3ADC%252BC28Xjs1GntLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=173&publication_year=2016&pages=1253-1267&author=K.+Janesauthor=A.+M.+Symons-Liguoriauthor=K.+A.+Jacobsonauthor=D.+Salvemini&title=Identification+of+A3+adenosine+receptor+agonists+as+novel+non-narcotic+analgesics&doi=10.1111%2Fbph.13446"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of A3 adenosine receptor agonists as novel non-narcotic analgesics</span></div><div class="casAuthors">Janes, K.; Symons-Liguori, A. M.; Jacobson, K. A.; Salvemini, D.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">173</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1253-1267</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">1476-5381</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">A review.  Chronic pain neg. impacts the quality of life in a variety of patient populations.  The current therapeutic repertoire is inadequate in managing patient pain and warrants the development of new therapeutics.  Adenosine and its four cognate receptors (A1, A2A, A2B and A3) have important roles in physiol. and pathophysiol. states, including chronic pain.  Preclin. and clin. studies have revealed that while adenosine and agonists of the A1 and A2A receptors have antinociceptive properties, their therapeutic utility is limited by adverse cardiovascular side effects.  In contrast, our understanding of the A3 receptor is only in its infancy, but exciting preclin. observations of A3 receptor antinociception, which have been bolstered by clin. trials of A3 receptor agonists in other disease states, suggest pain relief without cardiovascular side effects and with sufficient tolerability.  Our goal herein is to briefly discuss adenosine and its receptors in the context of pathol. pain and to consider the current data regarding A3 receptor-mediated antinociception.  We will highlight recent findings regarding the impact of the A3 receptor on pain pathways and examine the current state of selective A3 receptor agonists used for these studies.  The adenosine-to-A3 receptor pathway represents an important endogenous system that can be targeted to provide safe, effective pain relief from chronic pain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoByiVq79FXFbVg90H21EOLACvtfcHk0lgG_IagE2V-bg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xjs1GntLk%253D&md5=57571a415519ba45b91ea6de738840dc</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1111%2Fbph.13446&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fbph.13446%26sid%3Dliteratum%253Aachs%26aulast%3DJanes%26aufirst%3DK.%26aulast%3DSymons-Liguori%26aufirst%3DA.%2BM.%26aulast%3DJacobson%26aufirst%3DK.%2BA.%26aulast%3DSalvemini%26aufirst%3DD.%26atitle%3DIdentification%2520of%2520A3%2520adenosine%2520receptor%2520agonists%2520as%2520novel%2520non-narcotic%2520analgesics%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2016%26volume%3D173%26spage%3D1253%26epage%3D1267%26doi%3D10.1111%2Fbph.13446" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group">Welsch, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Snyder, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stockwell, B. R.</span><span> </span><span class="NLM_article-title">Privileged scaffolds for library design and drug discovery</span> <span class="citation_source-journal">Curr. Opin. Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">347</span><span class="NLM_x">–</span> <span class="NLM_lpage">361</span><span class="refDoi"> DOI: 10.1016/j.cbpa.2010.02.018</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00141&amp;key=10.1016%2Fj.cbpa.2010.02.018" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00141&amp;key=20303320" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00141&amp;key=1%3ACAS%3A528%3ADC%252BC3cXmvVWqsLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2010&pages=347-361&author=M.+E.+Welschauthor=S.+A.+Snyderauthor=B.+R.+Stockwell&title=Privileged+scaffolds+for+library+design+and+drug+discovery&doi=10.1016%2Fj.cbpa.2010.02.018"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Privileged scaffolds for library design and drug discovery</span></div><div class="casAuthors">Welsch, Matthew E.; Snyder, Scott A.; Stockwell, Brent R.</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Chemical Biology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">347-361</span>CODEN:
                <span class="NLM_cas:coden">COCBF4</span>;
        ISSN:<span class="NLM_cas:issn">1367-5931</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">This review explores the concept of using privileged scaffolds to identify biol. active compds. through building chem. libraries.  We hope to accomplish three main objectives: to provide one of the most comprehensive listings of privileged scaffolds; to reveal through four selected examples the present state of the art in privileged scaffold library synthesis (in hopes of inspiring new and even more creative approaches); and also to offer some thoughts on how new privileged scaffolds might be identified and exploited.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqWQPxdsWawiLVg90H21EOLACvtfcHk0lgG_IagE2V-bg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXmvVWqsLs%253D&md5=fd0c2a642f063fd6f42f2c34fd186f8a</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1016%2Fj.cbpa.2010.02.018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cbpa.2010.02.018%26sid%3Dliteratum%253Aachs%26aulast%3DWelsch%26aufirst%3DM.%2BE.%26aulast%3DSnyder%26aufirst%3DS.%2BA.%26aulast%3DStockwell%26aufirst%3DB.%2BR.%26atitle%3DPrivileged%2520scaffolds%2520for%2520library%2520design%2520and%2520drug%2520discovery%26jtitle%3DCurr.%2520Opin.%2520Chem.%2520Biol.%26date%3D2010%26volume%3D14%26spage%3D347%26epage%3D361%26doi%3D10.1016%2Fj.cbpa.2010.02.018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group">Coleman, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Green, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gouaux, E.</span><span> </span><span class="NLM_article-title">X-ray structures and mechanism of the human serotonin transporter</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">532</span><span class="NLM_x">, </span> <span class="NLM_fpage">334</span><span class="NLM_x">–</span> <span class="NLM_lpage">339</span><span class="refDoi"> DOI: 10.1038/nature17629</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00141&amp;key=10.1038%2Fnature17629" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00141&amp;key=27049939" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00141&amp;key=1%3ACAS%3A528%3ADC%252BC28Xlsl2gtrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=532&publication_year=2016&pages=334-339&author=J.+A.+Colemanauthor=E.+M.+Greenauthor=E.+Gouaux&title=X-ray+structures+and+mechanism+of+the+human+serotonin+transporter&doi=10.1038%2Fnature17629"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">X-ray structures and mechanism of the human serotonin transporter</span></div><div class="casAuthors">Coleman, Jonathan A.; Green, Evan M.; Gouaux, Eric</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">532</span>
        (<span class="NLM_cas:issue">7599</span>),
    <span class="NLM_cas:pages">334-339</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The serotonin transporter (SERT) terminates serotonergic signaling through the sodium- and chloride-dependent reuptake of neurotransmitter into presynaptic neurons.  SERT is a target for antidepressant and psychostimulant drugs, which block reuptake and prolong neurotransmitter signaling.  Here the authors report x-ray crystallog. structures of human SERT at 3.15 Å resoln. bound to the antidepressants (S)-citalopram or paroxetine.  Antidepressants lock SERT in an outward-open conformation by lodging in the central binding site, located between transmembrane helixes 1, 3, 6, 8 and 10, directly blocking serotonin binding.  The authors further identify the location of an allosteric site in the complex as residing at the periphery of the extracellular vestibule, interposed between extracellular loops 4 and 6 and transmembrane helixes 1, 6, 10 and 11.  Occupancy of the allosteric site sterically hinders ligand unbinding from the central site, providing an explanation for the action of (S)-citalopram as an allosteric ligand.  These structures define the mechanism of antidepressant action in SERT, and provide blueprints for future drug design.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrYAxl5tROCorVg90H21EOLACvtfcHk0lgG_IagE2V-bg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xlsl2gtrY%253D&md5=e4fa11a1e5abdd7b39f44375506aa249</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1038%2Fnature17629&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature17629%26sid%3Dliteratum%253Aachs%26aulast%3DColeman%26aufirst%3DJ.%2BA.%26aulast%3DGreen%26aufirst%3DE.%2BM.%26aulast%3DGouaux%26aufirst%3DE.%26atitle%3DX-ray%2520structures%2520and%2520mechanism%2520of%2520the%2520human%2520serotonin%2520transporter%26jtitle%3DNature%26date%3D2016%26volume%3D532%26spage%3D334%26epage%3D339%26doi%3D10.1038%2Fnature17629" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group">Beuming, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kniazeff, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bergmann, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shi, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gracia, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raniszewska, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newman, A. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Javitch, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weinstein, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gether, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loland, C. J.</span><span> </span><span class="NLM_article-title">The binding sites for cocaine and dopamine in the dopamine transporter overlap</span> <span class="citation_source-journal">Nat. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">780</span><span class="NLM_x">–</span> <span class="NLM_lpage">789</span><span class="refDoi"> DOI: 10.1038/nn.2146</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00141&amp;key=10.1038%2Fnn.2146" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00141&amp;key=18568020" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00141&amp;key=1%3ACAS%3A528%3ADC%252BD1cXns1Omsrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2008&pages=780-789&author=T.+Beumingauthor=J.+Kniazeffauthor=M.+L.+Bergmannauthor=L.+Shiauthor=L.+Graciaauthor=K.+Raniszewskaauthor=A.+H.+Newmanauthor=J.+A.+Javitchauthor=H.+Weinsteinauthor=U.+Getherauthor=C.+J.+Loland&title=The+binding+sites+for+cocaine+and+dopamine+in+the+dopamine+transporter+overlap&doi=10.1038%2Fnn.2146"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">The binding sites for cocaine and dopamine in the dopamine transporter overlap</span></div><div class="casAuthors">Beuming, Thijs; Kniazeff, Julie; Bergmann, Marianne L.; Shi, Lei; Gracia, Luis; Raniszewska, Klaudia; Newman, Amy Hauck; Javitch, Jonathan A.; Weinstein, Harel; Gether, Ulrik; Loland, Claus J.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Neuroscience</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">780-789</span>CODEN:
                <span class="NLM_cas:coden">NANEFN</span>;
        ISSN:<span class="NLM_cas:issn">1097-6256</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Beuming and colleagues detd. that the binding site for cocaine overlaps with that of dopamine on the dopamine transporter.  Detailed modeling and mutagenesis expts. revealed that this site is deeply buried amongst several transmembrane domains.  Cocaine is a widely abused substance with psychostimulant effects that are attributed to inhibition of the dopamine transporter (DAT).  We present mol. models for DAT binding of cocaine and cocaine analogs constructed from the high-resoln. structure of the bacterial transporter homolog LeuT.  Our models suggest that the binding site for cocaine and cocaine analogs is deeply buried between transmembrane segments 1, 3, 6 and 8, and overlaps with the binding sites for the substrates dopamine and amphetamine, as well as for benztropine-like DAT inhibitors.  We validated our models by detailed mutagenesis and by trapping the radiolabeled cocaine analog [3H]CFT in the transporter, either by crosslinking engineered cysteines or with an engineered Zn2+-binding site that was situated extracellularly to the predicted common binding pocket.  Our data demonstrate the mol. basis for the competitive inhibition of dopamine transport by cocaine.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGogCWenpzRZ47Vg90H21EOLACvtfcHk0lgvXLTezJSpHw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXns1Omsrw%253D&md5=7f96344e92478939540d84a37eaf3a70</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1038%2Fnn.2146&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnn.2146%26sid%3Dliteratum%253Aachs%26aulast%3DBeuming%26aufirst%3DT.%26aulast%3DKniazeff%26aufirst%3DJ.%26aulast%3DBergmann%26aufirst%3DM.%2BL.%26aulast%3DShi%26aufirst%3DL.%26aulast%3DGracia%26aufirst%3DL.%26aulast%3DRaniszewska%26aufirst%3DK.%26aulast%3DNewman%26aufirst%3DA.%2BH.%26aulast%3DJavitch%26aufirst%3DJ.%2BA.%26aulast%3DWeinstein%26aufirst%3DH.%26aulast%3DGether%26aufirst%3DU.%26aulast%3DLoland%26aufirst%3DC.%2BJ.%26atitle%3DThe%2520binding%2520sites%2520for%2520cocaine%2520and%2520dopamine%2520in%2520the%2520dopamine%2520transporter%2520overlap%26jtitle%3DNat.%2520Neurosci.%26date%3D2008%26volume%3D11%26spage%3D780%26epage%3D789%26doi%3D10.1038%2Fnn.2146" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group">Mortensen, O. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kortagere, S.</span><span> </span><span class="NLM_article-title">Designing modulators of monoamine transporters using virtual screening techniques</span> <span class="citation_source-journal">Front. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">223</span><span class="refDoi"> DOI: 10.3389/fphar.2015.00223</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00141&amp;key=10.3389%2Ffphar.2015.00223" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00141&amp;key=26483692" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00141&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtFals7rL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2015&pages=223&author=O.+V.+Mortensenauthor=S.+Kortagere&title=Designing+modulators+of+monoamine+transporters+using+virtual+screening+techniques&doi=10.3389%2Ffphar.2015.00223"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Designing modulators of monoamine transporters using virtual screening techniques</span></div><div class="casAuthors">Mortensen, Ole V.; Kortagere, Sandhya</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in Pharmacology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">223/1-223/8</span>CODEN:
                <span class="NLM_cas:coden">FPRHAU</span>;
        ISSN:<span class="NLM_cas:issn">1663-9812</span>.
    
            (<span class="NLM_cas:orgname">Frontiers Media S.A.</span>)
        </div><div class="casAbstract">The plasma-membrane monoamine transporters (MATs), including the serotonin (SERT), norepinephrine (NET) and dopamine (DAT) transporters, serve a pivotal role in limiting monoamine-mediated neurotransmission through the reuptake of their resp. monoamine neurotransmitters.  The transporters are the main target of clin. used psychostimulants and antidepressants.  Despite the availability of several potent and selective MAT substrates and inhibitors the continuing need for therapeutic drugs to treat brain disorders involving aberrant monoamine signaling provides a compelling reason to identify novel ways of targeting and modulating the MATs.  Designing novel modulators of MAT function have been limited by the lack of three dimensional structure information of the individual MATs.  However, crystal structures of LeuT, a bacterial homolog of MATs, in a substrate-bound occluded, substrate-free outward-open, and an apo inward-open state and also with competitive and non-competitive inhibitors have been detd.  In addn., several structures of the Drosophila DAT have also been resolved.  Together with computational modeling and exptl. data gathered over the past decade, these structures have dramatically advanced our understanding of several aspects of SERT, NET, and DAT transporter function, including some of the mol. determinants of ligand interaction at orthosteric substrate and inhibitor binding pockets.  In addn. progress has been made in the understanding of how allosteric modulation of MAT function can be achieved.  Here we will review all the efforts up to date that has been made through computational approaches employing structural models of MATs to design small mol. modulators to the orthosteric and allosteric sites using virtual screening techniques.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpX21DhH3SLwbVg90H21EOLACvtfcHk0lgvXLTezJSpHw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtFals7rL&md5=6a51e8c9fc431c5ffa220c49129b0242</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.3389%2Ffphar.2015.00223&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffphar.2015.00223%26sid%3Dliteratum%253Aachs%26aulast%3DMortensen%26aufirst%3DO.%2BV.%26aulast%3DKortagere%26aufirst%3DS.%26atitle%3DDesigning%2520modulators%2520of%2520monoamine%2520transporters%2520using%2520virtual%2520screening%2520techniques%26jtitle%3DFront.%2520Pharmacol.%26date%3D2015%26volume%3D6%26spage%3D223%26doi%3D10.3389%2Ffphar.2015.00223" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group">Paczkowski, F. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sharpe, I. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dutertre, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewis, R. J.</span><span> </span><span class="NLM_article-title">chi-Conotoxin and tricyclic antidepressant interactions at the norepinephrine transporter define a new transporter model</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">282</span><span class="NLM_x">, </span> <span class="NLM_fpage">17837</span><span class="NLM_x">–</span> <span class="NLM_lpage">17844</span><span class="refDoi"> DOI: 10.1074/jbc.M610813200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00141&amp;key=10.1074%2Fjbc.M610813200" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=282&publication_year=2007&pages=17837-17844&author=F.+A.+Paczkowskiauthor=I.+A.+Sharpeauthor=S.+Dutertreauthor=R.+J.+Lewis&title=chi-Conotoxin+and+tricyclic+antidepressant+interactions+at+the+norepinephrine+transporter+define+a+new+transporter+model&doi=10.1074%2Fjbc.M610813200"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M610813200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M610813200%26sid%3Dliteratum%253Aachs%26aulast%3DPaczkowski%26aufirst%3DF.%2BA.%26aulast%3DSharpe%26aufirst%3DI.%2BA.%26aulast%3DDutertre%26aufirst%3DS.%26aulast%3DLewis%26aufirst%3DR.%2BJ.%26atitle%3Dchi-Conotoxin%2520and%2520tricyclic%2520antidepressant%2520interactions%2520at%2520the%2520norepinephrine%2520transporter%2520define%2520a%2520new%2520transporter%2520model%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2007%26volume%3D282%26spage%3D17837%26epage%3D17844%26doi%3D10.1074%2Fjbc.M610813200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group">Bruns, R. F.</span><span> </span><span class="NLM_article-title">Adenosine receptor activation in human fibroblasts: nucleoside agonists and antagonists</span> <span class="citation_source-journal">Can. J. Physiol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1980</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">673</span><span class="NLM_x">–</span> <span class="NLM_lpage">691</span><span class="refDoi"> DOI: 10.1139/y80-110</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00141&amp;key=10.1139%2Fy80-110" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00141&amp;key=6253037" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00141&amp;key=1%3ACAS%3A528%3ADyaL3cXls1Sqtb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=1980&pages=673-691&author=R.+F.+Bruns&title=Adenosine+receptor+activation+in+human+fibroblasts%3A+nucleoside+agonists+and+antagonists&doi=10.1139%2Fy80-110"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Adenosine receptor activation in human fibroblasts:  nucleoside agonists and antagonists</span></div><div class="casAuthors">Bruns, Robert F.</div><div class="citationInfo"><span class="NLM_cas:title">Canadian Journal of Physiology and Pharmacology</span>
        (<span class="NLM_cas:date">1980</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">673-91</span>CODEN:
                <span class="NLM_cas:coden">CJPPA3</span>;
        ISSN:<span class="NLM_cas:issn">0008-4212</span>.
    </div><div class="casAbstract">Adenosine  [58-61-7] (ED50 15 μM) causes a 50-fold increase in intracellular cyclic AMP in the VA13 human fibroblast line.  A total of 128 nucleosides was tested as agonists and antagonists.  Eight classes of compds. were found: full agonists (14 compds.), weak agonists (20), high-efficacy partial agonists (16), low-efficacy partial agonists (7), competitive inhibitors (11), noncompetitive inhibitors (3), partial agonist - noncompetitive inhibitors (3), and inactive compds. (54).  The noncompetitive inhibitors antagonized the responses to adenosine, isoproterenol, and prostaglandin E1 and thus may have been adenylate cyclase inhibitors.  The most potent noncompetitive inhibitor, 2',5'-dideoxyadenosine  [6698-26-6] was a partial inhibitor, reducing the response to isoproterenol by only 77% even at very high concns.  The most potent agonists, partial agonists, and pure antagonists had apparent affinities of about 5 μM.  Although all positions were important for affinity at the adenosine receptor, only the 3'- and 5'-positions and to a much lesser extent the 6- and 8-positions had an effect on efficacy.  The receptor tolerated bulky groups at the 6-position of adenosine, had an Et-sized pocket near the 5'-position, and had little bulk tolerance towards modifications at other positions.  Among the full agonists, only one 5'-deriv. and one 2-position deriv. had higher apparent affinity than adenosine.  Studies with conformationally restricted agonists and antagonists showed that adenosine must be in the anti conformation in order to bind to the receptor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoKRAqZBkQJY7Vg90H21EOLACvtfcHk0lihLwQqd20csg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL3cXls1Sqtb4%253D&md5=1851e7bb2c11b84bddafc934515169fb</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1139%2Fy80-110&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1139%252Fy80-110%26sid%3Dliteratum%253Aachs%26aulast%3DBruns%26aufirst%3DR.%2BF.%26atitle%3DAdenosine%2520receptor%2520activation%2520in%2520human%2520fibroblasts%253A%2520nucleoside%2520agonists%2520and%2520antagonists%26jtitle%3DCan.%2520J.%2520Physiol.%2520Pharmacol.%26date%3D1980%26volume%3D58%26spage%3D673%26epage%3D691%26doi%3D10.1139%2Fy80-110" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group">Tosh, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Phan, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, Z. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gakh, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deflorian, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abagyan, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stevens, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobson, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Katritch, V.</span><span> </span><span class="NLM_article-title">Optimization of adenosine 5′-carboxamide derivatives as adenosine receptor agonists using structure-based ligand design and fragment-based searching</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">4297</span><span class="NLM_x">–</span> <span class="NLM_lpage">4308</span><span class="refDoi"> DOI: 10.1021/jm300095s</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm300095s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=4297-4308&author=D.+K.+Toshauthor=K.+Phanauthor=Z.+G.+Gaoauthor=A.+Gakhauthor=F.+Xuauthor=F.+Deflorianauthor=R.+Abagyanauthor=R.+C.+Stevensauthor=K.+A.+Jacobsonauthor=V.+Katritch&title=Optimization+of+adenosine+5%E2%80%B2-carboxamide+derivatives+as+adenosine+receptor+agonists+using+structure-based+ligand+design+and+fragment-based+searching&doi=10.1021%2Fjm300095s"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1021%2Fjm300095s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm300095s%26sid%3Dliteratum%253Aachs%26aulast%3DTosh%26aufirst%3DD.%2BK.%26aulast%3DPhan%26aufirst%3DK.%26aulast%3DGao%26aufirst%3DZ.%2BG.%26aulast%3DGakh%26aufirst%3DA.%26aulast%3DXu%26aufirst%3DF.%26aulast%3DDeflorian%26aufirst%3DF.%26aulast%3DAbagyan%26aufirst%3DR.%26aulast%3DStevens%26aufirst%3DR.%2BC.%26aulast%3DJacobson%26aufirst%3DK.%2BA.%26aulast%3DKatritch%26aufirst%3DV.%26atitle%3DOptimization%2520of%2520adenosine%25205%25E2%2580%25B2-carboxamide%2520derivatives%2520as%2520adenosine%2520receptor%2520agonists%2520using%2520structure-based%2520ligand%2520design%2520and%2520fragment-based%2520searching%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D4297%26epage%3D4308%26doi%3D10.1021%2Fjm300095s" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group">Bruss, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wieland, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bonisch, H.</span><span> </span><span class="NLM_article-title">Molecular cloning and functional expression of the mouse dopamine transporter</span> <span class="citation_source-journal">J. Neural Transm.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">106</span><span class="NLM_x">, </span> <span class="NLM_fpage">657</span><span class="NLM_x">–</span> <span class="NLM_lpage">662</span><span class="refDoi"> DOI: 10.1007/s007020050187</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00141&amp;key=10.1007%2Fs007020050187" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=106&publication_year=1999&pages=657-662&author=M.+Brussauthor=A.+Wielandauthor=H.+Bonisch&title=Molecular+cloning+and+functional+expression+of+the+mouse+dopamine+transporter&doi=10.1007%2Fs007020050187"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1007%2Fs007020050187&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs007020050187%26sid%3Dliteratum%253Aachs%26aulast%3DBruss%26aufirst%3DM.%26aulast%3DWieland%26aufirst%3DA.%26aulast%3DBonisch%26aufirst%3DH.%26atitle%3DMolecular%2520cloning%2520and%2520functional%2520expression%2520of%2520the%2520mouse%2520dopamine%2520transporter%26jtitle%3DJ.%2520Neural%2520Transm.%26date%3D1999%26volume%3D106%26spage%3D657%26epage%3D662%26doi%3D10.1007%2Fs007020050187" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group">Melman, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joshi, B. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, Z. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Castro, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heller, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jeong, L. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobson, K. A.</span><span> </span><span class="NLM_article-title">Selective A<sub>3</sub> adenosine receptor antagonists derived from nucleosides containing a bicyclo[3.1.0]hexane ring system</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">8546</span><span class="NLM_x">–</span> <span class="NLM_lpage">8556</span><span class="refDoi"> DOI: 10.1016/j.bmc.2008.08.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00141&amp;key=10.1016%2Fj.bmc.2008.08.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00141&amp;key=18752961" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00141&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtFantL3K" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2008&pages=8546-8556&author=A.+Melmanauthor=B.+Wangauthor=B.+V.+Joshiauthor=Z.+G.+Gaoauthor=S.+de+Castroauthor=C.+L.+Hellerauthor=S.+K.+Kimauthor=L.+S.+Jeongauthor=K.+A.+Jacobson&title=Selective+A3+adenosine+receptor+antagonists+derived+from+nucleosides+containing+a+bicyclo%5B3.1.0%5Dhexane+ring+system&doi=10.1016%2Fj.bmc.2008.08.007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Selective A3 adenosine receptor antagonists derived from nucleosides containing a bicyclo[3.1.0]hexane ring system</span></div><div class="casAuthors">Melman, Artem; Wang, Ben; Joshi, Bhalchandra V.; Gao, Zhan-Guo; de Castro, Sonia; Heller, Cara L.; Kim, Soo-Kyung; Jeong, Lak Shin; Jacobson, Kenneth A.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">8546-8556</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">We have prepd. 5'-modified derivs. of adenosine and a corresponding (N)-methanocarba nucleoside series contg. a bicyclo[3.1.0]hexane ring system in place of the ribose moiety.  The compds. were examd. in binding assays at three subtypes of adenosine receptors (ARs) and in functional assays at the A3 AR.  The H-bonding ability of a group of 9-riboside derivs. contg. a 5'-uronamide moiety was reduced by modification of the NH; however these derivs. did not display the desired activity as selective A3 AR antagonists, as occurs with 5'-N,N-dimethyluronamides.  However, truncated (N)-methanocarba analogs lacking a 4'-hydroxymethyl group were highly potent and selective antagonists of the human A3 AR.  The compds. were synthesized from D-ribose using a reductive free radical decarboxylation of a 5'-carboxy intermediate.  A less efficient synthetic approach began with L-ribose, which was similar to the published synthesis of (N)-methanocarba A3AR agonists.  Compds. 33b-39b (N 6-3-halobenzyl and related arylalkyl derivs.) were potent A3AR antagonists with binding K i values of 0.7-1.4 nM.  In a functional assay of [35S]GTPγS binding, 33b (3-iodobenzyl) completely inhibited stimulation by NECA with a K B of 8.9 nM.  Thus, a highly potent and selective series of A3AR antagonists has been described.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoCKshPwkRmvbVg90H21EOLACvtfcHk0lihLwQqd20csg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtFantL3K&md5=8f2e48da21c5e8a1f3f067d30b03fcae</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2008.08.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2008.08.007%26sid%3Dliteratum%253Aachs%26aulast%3DMelman%26aufirst%3DA.%26aulast%3DWang%26aufirst%3DB.%26aulast%3DJoshi%26aufirst%3DB.%2BV.%26aulast%3DGao%26aufirst%3DZ.%2BG.%26aulast%3Dde%2BCastro%26aufirst%3DS.%26aulast%3DHeller%26aufirst%3DC.%2BL.%26aulast%3DKim%26aufirst%3DS.%2BK.%26aulast%3DJeong%26aufirst%3DL.%2BS.%26aulast%3DJacobson%26aufirst%3DK.%2BA.%26atitle%3DSelective%2520A3%2520adenosine%2520receptor%2520antagonists%2520derived%2520from%2520nucleosides%2520containing%2520a%2520bicyclo%255B3.1.0%255Dhexane%2520ring%2520system%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2008%26volume%3D16%26spage%3D8546%26epage%3D8556%26doi%3D10.1016%2Fj.bmc.2008.08.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group">Carlin, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tosh, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xiao, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piñol, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salvemini, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gavrilova, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobson, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reitman, M. L.</span><span> </span><span class="NLM_article-title">Peripheral adenosine A<sub>3</sub> receptor activation causes regulated hypothermia in mice that is dependent on central histamine H<sub>1</sub> receptors</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">356</span><span class="NLM_x">, </span> <span class="NLM_fpage">475</span><span class="NLM_x">–</span> <span class="NLM_lpage">483</span><span class="refDoi"> DOI: 10.1124/jpet.115.229872</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00141&amp;key=10.1124%2Fjpet.115.229872" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=356&publication_year=2016&pages=475-483&author=J.+L.+Carlinauthor=D.+K.+Toshauthor=C.+Xiaoauthor=R.+A.+Pi%C3%B1olauthor=Z.+Chenauthor=D.+Salveminiauthor=O.+Gavrilovaauthor=K.+A.+Jacobsonauthor=M.+L.+Reitman&title=Peripheral+adenosine+A3+receptor+activation+causes+regulated+hypothermia+in+mice+that+is+dependent+on+central+histamine+H1+receptors&doi=10.1124%2Fjpet.115.229872"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1124%2Fjpet.115.229872&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.115.229872%26sid%3Dliteratum%253Aachs%26aulast%3DCarlin%26aufirst%3DJ.%2BL.%26aulast%3DTosh%26aufirst%3DD.%2BK.%26aulast%3DXiao%26aufirst%3DC.%26aulast%3DPi%25C3%25B1ol%26aufirst%3DR.%2BA.%26aulast%3DChen%26aufirst%3DZ.%26aulast%3DSalvemini%26aufirst%3DD.%26aulast%3DGavrilova%26aufirst%3DO.%26aulast%3DJacobson%26aufirst%3DK.%2BA.%26aulast%3DReitman%26aufirst%3DM.%2BL.%26atitle%3DPeripheral%2520adenosine%2520A3%2520receptor%2520activation%2520causes%2520regulated%2520hypothermia%2520in%2520mice%2520that%2520is%2520dependent%2520on%2520central%2520histamine%2520H1%2520receptors%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2016%26volume%3D356%26spage%3D475%26epage%3D483%26doi%3D10.1124%2Fjpet.115.229872" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group">Schaddelee, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Read, K. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cleypool, C. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">IJzerman, A. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Danhof, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Boer, A. G.</span><span> </span><span class="NLM_article-title">Brain penetration of synthetic adenosine A<sub>1</sub> receptor agonists in situ: role of the rENT1 nucleoside transporter and binding to blood constituents</span> <span class="citation_source-journal">Eur. J. Pharm. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">59</span><span class="NLM_x">–</span> <span class="NLM_lpage">66</span><span class="refDoi"> DOI: 10.1016/j.ejps.2004.09.010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00141&amp;key=10.1016%2Fj.ejps.2004.09.010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00141&amp;key=15626578" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00141&amp;key=1%3ACAS%3A528%3ADC%252BD2MXjtlek" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2005&pages=59-66&author=M.+P.+Schaddeleeauthor=K.+D.+Readauthor=C.+G.+Cleypoolauthor=A.+P.+IJzermanauthor=M.+Danhofauthor=A.+G.+de+Boer&title=Brain+penetration+of+synthetic+adenosine+A1+receptor+agonists+in+situ%3A+role+of+the+rENT1+nucleoside+transporter+and+binding+to+blood+constituents&doi=10.1016%2Fj.ejps.2004.09.010"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Brain penetration of synthetic adenosine A1 receptor agonists in situ: role of the rENT1 nucleoside transporter and binding to blood constituents</span></div><div class="casAuthors">Schaddelee, Marloes P.; Read, Kevin D.; Cleypool, Cindy G. J.; IJzerman, Adriaan P.; Danhof, Meindert; de Boer, Albertus G.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmaceutical Sciences</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">59-66</span>CODEN:
                <span class="NLM_cas:coden">EPSCED</span>;
        ISSN:<span class="NLM_cas:issn">0928-0987</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The blood-brain barrier (BBB) transport of synthetic A1 receptor agonists was studied in an in situ brain perfusion model in the presence and absence of the selective nucleoside transport inhibitor S-(4-nitrobenzyl)-6-thioinosine (NBTI).  For 8-methylamino-N6cyclopentyladenosine (MCPA), N6-cyclopentyladenosine (CPA), 2'deoxy-N6-cyclopentyladenosine (2'dCPA) and 5'deoxy-N6-cyclopentyl adenosine (5'dCPA) the brain uptake clearance was low with values of 0.0045±0.0012, 0.018±0.0020, 0.022±0.0028 and 0.12±0.054 mL min-1 g-1, resp.  In the presence of an av. NBTI plasma concn. of 2.6±0.3 μg ml-1 (NBTI dose: 3 mg kg-1 i.v.) the values of the brain uptake clearance were 0.0062±0.0012, 0.013±0.0017, 0.014±0.0030 and 0.13±0.066 mL min-1 g-1, resp. and not significantly different from the values in the absence of NBTI.  In a sep. expt. the brain uptake of MCPA from phosphate buffered saline (PBS) and whole blood were compared.  The brain uptake clearance from whole blood (0.0012±0.001 mL min-1 g-1) was significantly lower than from PBS (0.0045±0.0012 mL min-1 g-1).  The results of these studies show that the rENT1 nucleoside transporter does not contribute significantly to the transport of synthetic A1 receptor agonists across the BBB and that binding to blood constituents restricts the brain uptake.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrdpHIWCMORV7Vg90H21EOLACvtfcHk0lg5MInzIg3LEg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXjtlek&md5=fcba7778b896837bf68903986339ca21</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1016%2Fj.ejps.2004.09.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejps.2004.09.010%26sid%3Dliteratum%253Aachs%26aulast%3DSchaddelee%26aufirst%3DM.%2BP.%26aulast%3DRead%26aufirst%3DK.%2BD.%26aulast%3DCleypool%26aufirst%3DC.%2BG.%26aulast%3DIJzerman%26aufirst%3DA.%2BP.%26aulast%3DDanhof%26aufirst%3DM.%26aulast%3Dde%2BBoer%26aufirst%3DA.%2BG.%26atitle%3DBrain%2520penetration%2520of%2520synthetic%2520adenosine%2520A1%2520receptor%2520agonists%2520in%2520situ%253A%2520role%2520of%2520the%2520rENT1%2520nucleoside%2520transporter%2520and%2520binding%2520to%2520blood%2520constituents%26jtitle%3DEur.%2520J.%2520Pharm.%2520Sci.%26date%3D2005%26volume%3D24%26spage%3D59%26epage%3D66%26doi%3D10.1016%2Fj.ejps.2004.09.010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">De Backer, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Biston, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Devriendt, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Madl, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chochrad, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aldecoa, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brasseur, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Defrance, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gottignies, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vincent, J. L.</span><span> </span><span class="NLM_article-title">for the SOAP II Investigators. Comparison of dopamine and norepinephrine in the treatment of shock</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">362</span><span class="NLM_x">, </span> <span class="NLM_fpage">779</span><span class="NLM_x">–</span> <span class="NLM_lpage">789</span><span class="refDoi"> DOI: 10.1056/NEJMoa0907118</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00141&amp;key=10.1056%2FNEJMoa0907118" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00141&amp;key=20200382" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00141&amp;key=1%3ACAS%3A528%3ADC%252BC3cXivV2hu7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=362&publication_year=2010&pages=779-789&author=D.+De+Backerauthor=P.+Bistonauthor=J.+Devriendtauthor=C.+Madlauthor=D.+Chochradauthor=C.+Aldecoaauthor=A.+Brasseurauthor=P.+Defranceauthor=P.+Gottigniesauthor=J.+L.+Vincent&title=for+the+SOAP+II+Investigators.+Comparison+of+dopamine+and+norepinephrine+in+the+treatment+of+shock&doi=10.1056%2FNEJMoa0907118"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit43aR"><div class="casContent"><span class="casTitleNuber">43a</span><div class="casTitle"><span class="NLM_cas:atitle">Comparison of dopamine and norepinephrine in the treatment of shock</span></div><div class="casAuthors">De Backer, Daniel; Biston, Patrick; Devriendt, Jacques; Madl, Christian; Chochrad, Didier; Aldecoa, Cesar; Brasseur, Alexandre; Defrance, Pierre; Gottignies, Philippe; Vincent, Jean-Louis</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">362</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">779-789</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">BACKGROUND: Both dopamine and norepinephrine are recommended as first-line vasopressor agents in the treatment of shock.  There is a continuing controversy about whether one agent is superior to the other.  METHODS: In this multicenter, randomized trial, we assigned patients with shock to receive either dopamine or norepinephrine as first-line vasopressor therapy to restore and maintain blood pressure.  When blood pressure could not be maintained with a dose of 20 μg per kg of body wt. per min for dopamine or a dose of 0.19 μg per kg per min for norepinephrine, open-label norepinephrine, epinephrine, or vasopressin could be added.  The primary outcome was the rate of death at 28 days after randomization; secondary end points included the no. of days without need for organ support and the occurrence of adverse events.  RESULTS: The trial included 1679 patients, of whom 858 were assigned to dopamine and 821 to norepinephrine.  The baseline characteristics of the groups were similar.  There was no significant between-group difference in the rate of death at 28 days (52.5% in the dopamine group and 48.5% in the norepinephrine group; odds ratio with dopamine, 1.17; 95% confidence interval, 0.97 to 1.42).  However, there were more arrhythmic events among the patients treated with dopamine than among those treated with norepinephrine (207 events [24.1%] vs. 102 events [12.4%]).  A subgroup anal. showed that dopamine, as compared with norepinephrine, was assocd. with an increased rate of death at 28 days among the 280 patients with cardiogenic shock but not among the 1044 patients with septic shock or the 263 with hypovolemic shock.  CONCLUSIONS: Although there was no significant difference in the rate of death between patients with shock who were treated with dopamine as the first-line vasopressor agent and those who were treated with norepinephrine, the use of dopamine was assocd. with a greater no. of adverse events.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoQ5-QE097VVbVg90H21EOLACvtfcHk0lg5MInzIg3LEg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXivV2hu7k%253D&md5=c15a9e328e3e2b6cebde508844f4e2d0</span></div><a href="/servlet/linkout?suffix=cit43a&amp;dbid=16384&amp;doi=10.1056%2FNEJMoa0907118&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMoa0907118%26sid%3Dliteratum%253Aachs%26aulast%3DDe%2BBacker%26aufirst%3DD.%26aulast%3DBiston%26aufirst%3DP.%26aulast%3DDevriendt%26aufirst%3DJ.%26aulast%3DMadl%26aufirst%3DC.%26aulast%3DChochrad%26aufirst%3DD.%26aulast%3DAldecoa%26aufirst%3DC.%26aulast%3DBrasseur%26aufirst%3DA.%26aulast%3DDefrance%26aufirst%3DP.%26aulast%3DGottignies%26aufirst%3DP.%26aulast%3DVincent%26aufirst%3DJ.%2BL.%26atitle%3Dfor%2520the%2520SOAP%2520II%2520Investigators.%2520Comparison%2520of%2520dopamine%2520and%2520norepinephrine%2520in%2520the%2520treatment%2520of%2520shock%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2010%26volume%3D362%26spage%3D779%26epage%3D789%26doi%3D10.1056%2FNEJMoa0907118" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit43b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Kamiya, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sato, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nozaki, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Akiya, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okazaki, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takahashi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mizuno, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shimizu, W.</span><span> </span><span class="NLM_article-title">Renal effects of added low-dose dopamine in acute heart failure patients with diuretic resistance to natriuretic peptide</span> <span class="citation_source-journal">J. Cardiovasc. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">65</span><span class="NLM_x">, </span> <span class="NLM_fpage">282</span><span class="NLM_x">–</span> <span class="NLM_lpage">288</span><span class="refDoi"> DOI: 10.1097/FJC.0000000000000193</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00141&amp;key=10.1097%2FFJC.0000000000000193" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=2015&pages=282-288&author=M.+Kamiyaauthor=N.+Satoauthor=A.+Nozakiauthor=M.+Akiyaauthor=H.+Okazakiauthor=Y.+Takahashiauthor=K.+Mizunoauthor=W.+Shimizu&title=Renal+effects+of+added+low-dose+dopamine+in+acute+heart+failure+patients+with+diuretic+resistance+to+natriuretic+peptide&doi=10.1097%2FFJC.0000000000000193"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43b&amp;dbid=16384&amp;doi=10.1097%2FFJC.0000000000000193&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252FFJC.0000000000000193%26sid%3Dliteratum%253Aachs%26aulast%3DKamiya%26aufirst%3DM.%26aulast%3DSato%26aufirst%3DN.%26aulast%3DNozaki%26aufirst%3DA.%26aulast%3DAkiya%26aufirst%3DM.%26aulast%3DOkazaki%26aufirst%3DH.%26aulast%3DTakahashi%26aufirst%3DY.%26aulast%3DMizuno%26aufirst%3DK.%26aulast%3DShimizu%26aufirst%3DW.%26atitle%3DRenal%2520effects%2520of%2520added%2520low-dose%2520dopamine%2520in%2520acute%2520heart%2520failure%2520patients%2520with%2520diuretic%2520resistance%2520to%2520natriuretic%2520peptide%26jtitle%3DJ.%2520Cardiovasc.%2520Pharmacol.%26date%3D2015%26volume%3D65%26spage%3D282%26epage%3D288%26doi%3D10.1097%2FFJC.0000000000000193" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group">Adir, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sznajder, J. I.</span><span> </span><span class="NLM_article-title">Regulation of lung edema clearance by dopamine</span> <span class="citation_source-journal">Isr. Med. Assoc. J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">47</span><span class="NLM_x">–</span> <span class="NLM_lpage">50</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00141&amp;key=12592959" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00141&amp;key=1%3ACAS%3A528%3ADC%252BD3sXhs12isrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2003&pages=47-50&author=Y.+Adirauthor=J.+I.+Sznajder&title=Regulation+of+lung+edema+clearance+by+dopamine"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Regulation of lung edema clearance by dopamine</span></div><div class="casAuthors">Adir, Yochai; Sznajder, Jacob Iasha</div><div class="citationInfo"><span class="NLM_cas:title">Israel Medical Association Journal</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">47-50</span>CODEN:
                <span class="NLM_cas:coden">IMAJCX</span>;
        ISSN:<span class="NLM_cas:issn">1565-1088</span>.
    
            (<span class="NLM_cas:orgname">Israel Medical Association</span>)
        </div><div class="casAbstract">A review on the mechanisms of dopamine regulation of Na,K-ATPase and lung edema clearance.  In the kidney, dopamine inhibits Na,K-ATPase, which results in natriuresis because less Na+ is reabsorbed by the proximal and distal tubules.  In contrast, dopamine stimulates Na,K-ATPase activity in the alveolar epithelium, leading to the increased alveolar fluid resorption.  Dopamine increases alveolar fluid resorption not only in normal alveolar epithelium but also in models of lung injury.  Thus, dopamine can be of clin. relevance for the treatment of patients with acute hypoxemic respiratory failure due to pulmonary edema.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGryPAd5dnRSHrVg90H21EOLACvtfcHk0lgZqA03K54kSw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXhs12isrs%253D&md5=dff00a85d391142ab10e992d944190dc</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAdir%26aufirst%3DY.%26aulast%3DSznajder%26aufirst%3DJ.%2BI.%26atitle%3DRegulation%2520of%2520lung%2520edema%2520clearance%2520by%2520dopamine%26jtitle%3DIsr.%2520Med.%2520Assoc.%2520J.%26date%3D2003%26volume%3D5%26spage%3D47%26epage%3D50" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group">Willems, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buylaert, W. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lefebvre, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bogaert, M. G.</span><span> </span><span class="NLM_article-title">Neuronal dopamine receptors on autonomic ganglia and sympathetic nerves and dopamine receptors in the gastrointestinal system</span> <span class="citation_source-journal">Pharmacol. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1985</span><span class="NLM_x">, </span> <span class="NLM_volume">37</span><span class="NLM_x">, </span> <span class="NLM_fpage">165</span><span class="NLM_x">–</span> <span class="NLM_lpage">216</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=1985&pages=165-216&author=J.+L.+Willemsauthor=W.+A.+Buylaertauthor=R.+A.+Lefebvreauthor=M.+G.+Bogaert&title=Neuronal+dopamine+receptors+on+autonomic+ganglia+and+sympathetic+nerves+and+dopamine+receptors+in+the+gastrointestinal+system"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWillems%26aufirst%3DJ.%2BL.%26aulast%3DBuylaert%26aufirst%3DW.%2BA.%26aulast%3DLefebvre%26aufirst%3DR.%2BA.%26aulast%3DBogaert%26aufirst%3DM.%2BG.%26atitle%3DNeuronal%2520dopamine%2520receptors%2520on%2520autonomic%2520ganglia%2520and%2520sympathetic%2520nerves%2520and%2520dopamine%2520receptors%2520in%2520the%2520gastrointestinal%2520system%26jtitle%3DPharmacol.%2520Rev.%26date%3D1985%26volume%3D37%26spage%3D165%26epage%3D216" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group">Fang, Z. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tosh, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanaka, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krausz, K. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Connor, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobson, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gonzalez, F. J.</span><span> </span><span class="NLM_article-title">Metabolic mapping of A<sub>3</sub> adenosine receptor agonist MRS5980</span> <span class="citation_source-journal">Biochem. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">97</span><span class="NLM_x">, </span> <span class="NLM_fpage">215</span><span class="NLM_x">–</span> <span class="NLM_lpage">223</span><span class="refDoi"> DOI: 10.1016/j.bcp.2015.07.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00141&amp;key=10.1016%2Fj.bcp.2015.07.007" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=97&publication_year=2015&pages=215-223&author=Z.+Z.+Fangauthor=D.+K.+Toshauthor=N.+Tanakaauthor=H.+Wangauthor=K.+W.+Krauszauthor=R.+O%E2%80%99Connorauthor=K.+A.+Jacobsonauthor=F.+J.+Gonzalez&title=Metabolic+mapping+of+A3+adenosine+receptor+agonist+MRS5980&doi=10.1016%2Fj.bcp.2015.07.007"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1016%2Fj.bcp.2015.07.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bcp.2015.07.007%26sid%3Dliteratum%253Aachs%26aulast%3DFang%26aufirst%3DZ.%2BZ.%26aulast%3DTosh%26aufirst%3DD.%2BK.%26aulast%3DTanaka%26aufirst%3DN.%26aulast%3DWang%26aufirst%3DH.%26aulast%3DKrausz%26aufirst%3DK.%2BW.%26aulast%3DO%25E2%2580%2599Connor%26aufirst%3DR.%26aulast%3DJacobson%26aufirst%3DK.%2BA.%26aulast%3DGonzalez%26aufirst%3DF.%2BJ.%26atitle%3DMetabolic%2520mapping%2520of%2520A3%2520adenosine%2520receptor%2520agonist%2520MRS5980%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2015%26volume%3D97%26spage%3D215%26epage%3D223%26doi%3D10.1016%2Fj.bcp.2015.07.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group">Baell, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holloway, G. A.</span><span> </span><span class="NLM_article-title">New substructure filters for removal of pan assay interference compounds (PAINS) from screening libraries and for their exclusion in bioassays</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">2719</span><span class="NLM_x">–</span> <span class="NLM_lpage">2740</span><span class="refDoi"> DOI: 10.1021/jm901137j</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm901137j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00141&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsF2qsLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=2719-2740&author=J.+B.+Baellauthor=G.+A.+Holloway&title=New+substructure+filters+for+removal+of+pan+assay+interference+compounds+%28PAINS%29+from+screening+libraries+and+for+their+exclusion+in+bioassays&doi=10.1021%2Fjm901137j"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">New Substructure Filters for Removal of Pan Assay Interference Compounds (PAINS) from Screening Libraries and for Their Exclusion in Bioassays</span></div><div class="casAuthors">Baell, Jonathan B.; Holloway, Georgina A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2719-2740</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">This report describes a no. of substructural features which can help to identify compds. that appear as frequent hitters (promiscuous compds.) in many biochem. high throughput screens.  The compds. identified by such substructural features are not recognized by filters commonly used to identify reactive compds.  Even though these substructural features were identified using only one assay detection technol., such compds. have been reported to be active from many different assays.  In fact, these compds. are increasingly prevalent in the literature as potential starting points for further exploration, whereas they may not be.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGro_JARcceWjLVg90H21EOLACvtfcHk0lgJk1SFTcwYSA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsF2qsLw%253D&md5=fbf397aa4910753c550425708c866fd2</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1021%2Fjm901137j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm901137j%26sid%3Dliteratum%253Aachs%26aulast%3DBaell%26aufirst%3DJ.%2BB.%26aulast%3DHolloway%26aufirst%3DG.%2BA.%26atitle%3DNew%2520substructure%2520filters%2520for%2520removal%2520of%2520pan%2520assay%2520interference%2520compounds%2520%2528PAINS%2529%2520from%2520screening%2520libraries%2520and%2520for%2520their%2520exclusion%2520in%2520bioassays%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D2719%26epage%3D2740%26doi%3D10.1021%2Fjm901137j" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group">Eshleman, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carmolli, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cumbay, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martens, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neve, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Janowsky, A.</span><span> </span><span class="NLM_article-title">Characteristics of drug interactions with recombinant biogenic amine transporters expressed in the same cell type</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">289</span><span class="NLM_x">, </span> <span class="NLM_fpage">877</span><span class="NLM_x">–</span> <span class="NLM_lpage">885</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00141&amp;key=10215666" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00141&amp;key=1%3ACAS%3A528%3ADyaK1MXislGisrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=289&publication_year=1999&pages=877-885&author=A.+J.+Eshlemanauthor=M.+Carmolliauthor=M.+Cumbayauthor=C.+R.+Martensauthor=K.+A.+Neveauthor=A.+Janowsky&title=Characteristics+of+drug+interactions+with+recombinant+biogenic+amine+transporters+expressed+in+the+same+cell+type"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Characteristics of drug interactions with recombinant biogenic amine transporters expressed in the same cell type</span></div><div class="casAuthors">Eshleman, Amy J.; Carmolli, Marya; Cumbay, Medhane; Martens, Carey R.; Neve, Kim A.; Janowsky, Aaron</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">289</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">877-885</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">The effects of drugs on the uptake of [3H]neurotransmitter by and the binding of [125I]3β-(4-iodophenyl)tropane-2β-carboxylic acid Me ester ([125I]RTI-55) to the recombinant human dopamine (hDAT), serotonin (hSERT), or norepinephrine (hNET) transporters stably expressed in human embryonic kidney 293 cells were studied.  RTI-55 had similar affinity for the hDAT and hSERT and lower affinity for hNET (Kd = 1.83, 0.98, and 12.1 nM, resp.).  Kinetic anal. of [125I]RTI-55 binding indicated that the dissocn. rate (k-1) was significantly lower for hSERT and the assocn. rate (k+1) was significantly lower for hNET compared with the hDAT.  The potency of drugs at blocking [3H]neurotransmitter uptake was highly correlated with potency at blocking radioligand binding for hDAT and hSERT.  Substrates were more potent at the inhibition of [3H]neurotransmitter uptake than radioligand binding.  The potency of drugs was highly correlated between displacement of [3H]nisoxetine (Kd = 6.0 nM) and [125I]RTI-55 from the hNET, suggesting that these radioligands recognize similar sites on the transporter protein.  The correlation obsd. between inhibitory potency for uptake and binding of either ligand at the hNET was lower than correlations between uptake and binding for hDAT and hSERT.  The present results indicate that the cocaine analog [125I]RTI-55 has unique binding properties at each of the transporters and that the use of recombinant transporters expressed by a single cell type can provide a powerful screening tool for drugs interacting with biogenic amine transporters, such as possible cocaine antagonists.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpnn_1UJqie3bVg90H21EOLACvtfcHk0lgJk1SFTcwYSA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXislGisrg%253D&md5=c808b4d81da86e57460406d2163c5e65</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DEshleman%26aufirst%3DA.%2BJ.%26aulast%3DCarmolli%26aufirst%3DM.%26aulast%3DCumbay%26aufirst%3DM.%26aulast%3DMartens%26aufirst%3DC.%2BR.%26aulast%3DNeve%26aufirst%3DK.%2BA.%26aulast%3DJanowsky%26aufirst%3DA.%26atitle%3DCharacteristics%2520of%2520drug%2520interactions%2520with%2520recombinant%2520biogenic%2520amine%2520transporters%2520expressed%2520in%2520the%2520same%2520cell%2520type%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D1999%26volume%3D289%26spage%3D877%26epage%3D885" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit49"><span><span class="NLM_contrib-group">Bradford, M. M.</span><span> </span><span class="NLM_article-title">A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding</span> <span class="citation_source-journal">Anal. Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1976</span><span class="NLM_x">, </span> <span class="NLM_volume">72</span><span class="NLM_x">, </span> <span class="NLM_fpage">248</span><span class="NLM_x">–</span> <span class="NLM_lpage">254</span><span class="refDoi"> DOI: 10.1016/0003-2697(76)90527-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00141&amp;key=10.1016%2F0003-2697%2876%2990527-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00141&amp;key=942051" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00141&amp;key=1%3ACAS%3A528%3ADyaE28XksVehtrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=72&publication_year=1976&pages=248-254&author=M.+M.+Bradford&title=A+rapid+and+sensitive+method+for+the+quantitation+of+microgram+quantities+of+protein+utilizing+the+principle+of+protein-dye+binding&doi=10.1016%2F0003-2697%2876%2990527-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding</span></div><div class="casAuthors">Bradford, Marion M.</div><div class="citationInfo"><span class="NLM_cas:title">Analytical Biochemistry</span>
        (<span class="NLM_cas:date">1976</span>),
    <span class="NLM_cas:volume">72</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">248-54</span>CODEN:
                <span class="NLM_cas:coden">ANBCA2</span>;
        ISSN:<span class="NLM_cas:issn">0003-2697</span>.
    </div><div class="casAbstract">A protein detn. method that involves the binding of coomassie Brilliant Blue G 250 to protein is described.  The binding of the dye to protein causes a shift in the absorption max. of the dye from 465 to 595 nm, and it is the increase in absorption at 595 nm that is monitored.  This assay is very reproducible and rapid with the dye binding process virtually complete in ∼ 2 min with good color stability for 1 hr.  There is little or no interference from cations such as Na+ or K+ nor from carbohydrates such as sucrose.  A small amt. of color is developed in the presence of strongly alk. buffering agents, but the assay may be run accurately by the use of proper buffer controls.  The only components found to give excessive interfering color in the assay are relatively large amts. of detergents such as Na dodecyl sulfate, Triton X 100, and commercial glassware detergents.  Interference by small amts. of detergent may be eliminated by the use of proper control.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrN_T_d0trcNrVg90H21EOLACvtfcHk0lgJk1SFTcwYSA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE28XksVehtrY%253D&md5=43f388a493becc4193c7a49d9de0e1db</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1016%2F0003-2697%2876%2990527-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0003-2697%252876%252990527-3%26sid%3Dliteratum%253Aachs%26aulast%3DBradford%26aufirst%3DM.%2BM.%26atitle%3DA%2520rapid%2520and%2520sensitive%2520method%2520for%2520the%2520quantitation%2520of%2520microgram%2520quantities%2520of%2520protein%2520utilizing%2520the%2520principle%2520of%2520protein-dye%2520binding%26jtitle%3DAnal.%2520Biochem.%26date%3D1976%26volume%3D72%26spage%3D248%26epage%3D254%26doi%3D10.1016%2F0003-2697%2876%2990527-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22a','cit22b'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43a','cit43b'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48'],'ref49':['cit49']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 12 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Dilip K. Tosh, Veronica Salmaso, Harsha Rao, Ryan Campbell, Amelia Bitant, Zhan-Guo Gao, John A. Auchampach, <span class="NLM_string-name hlFld-ContribAuthor">Kenneth A. Jacobson</span>. </span><span class="cited-content_cbyCitation_article-title">Direct Comparison of (N)-Methanocarba and Ribose-Containing 2-Arylalkynyladenosine Derivatives as A3 Receptor Agonists. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2020,</strong> <em>11 </em>
                                    (10)
                                     , 1935-1941. <a href="https://doi.org/10.1021/acsmedchemlett.9b00637" title="DOI URL">https://doi.org/10.1021/acsmedchemlett.9b00637</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsmedchemlett.9b00637&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsmedchemlett.9b00637%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDirect%252BComparison%252Bof%252B%252528N%252529-Methanocarba%252Band%252BRibose-Containing%252B2-Arylalkynyladenosine%252BDerivatives%252Bas%252BA3%252BReceptor%252BAgonists%26aulast%3DTosh%26aufirst%3DDilip%2BK.%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D2019%26date%3D20122019%26date%3D07022020%26date%3D14022020%26volume%3D11%26issue%3D10%26spage%3D1935%26epage%3D1941" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Dilip
K. Tosh, Antonella Ciancetta, Philip Mannes, Eugene Warnick, Aaron Janowsky, Amy J. Eshleman, Elizabeth Gizewski, Tarsis F. Brust, Laura M. Bohn, John A. Auchampach, Zhan-Guo Gao, <span class="NLM_string-name hlFld-ContribAuthor">Kenneth A. Jacobson</span>. </span><span class="cited-content_cbyCitation_article-title">Repurposing of a Nucleoside Scaffold from Adenosine Receptor Agonists to Opioid Receptor Antagonists. </span><span class="cited-content_cbyCitation_journal-name">ACS Omega</span><span> <strong>2018,</strong> <em>3 </em>
                                    (10)
                                     , 12658-12678. <a href="https://doi.org/10.1021/acsomega.8b01237" title="DOI URL">https://doi.org/10.1021/acsomega.8b01237</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsomega.8b01237&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsomega.8b01237%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Omega%26atitle%3DRepurposing%252Bof%252Ba%252BNucleoside%252BScaffold%252Bfrom%252BAdenosine%252BReceptor%252BAgonists%252Bto%252BOpioid%252BReceptor%252BAntagonists%26aulast%3DTosh%26aufirst%3DDilip%2BK.%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D04062018%26date%3D19092018%26volume%3D3%26issue%3D10%26spage%3D12658%26epage%3D12678" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sabina  Podlewska</span>, <span class="hlFld-ContribAuthor ">Ryszard  Bugno</span>, <span class="hlFld-ContribAuthor ">Enza  Lacivita</span>, <span class="hlFld-ContribAuthor ">Marcello  Leopoldo</span>, <span class="hlFld-ContribAuthor ">Andrzej J.  Bojarski</span>, <span class="hlFld-ContribAuthor ">Jadwiga  Handzlik</span>. </span><span class="cited-content_cbyCitation_article-title">Low Basicity as a Characteristic for Atypical Ligands of Serotonin Receptor 5-HT2. </span><span class="cited-content_cbyCitation_journal-name">International Journal of Molecular Sciences</span><span> <strong>2021,</strong> <em>22 </em>
                                    (3)
                                     , 1035. <a href="https://doi.org/10.3390/ijms22031035" title="DOI URL">https://doi.org/10.3390/ijms22031035</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/ijms22031035&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fijms22031035%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Journal%2520of%2520Molecular%2520Sciences%26atitle%3DLow%252BBasicity%252Bas%252Ba%252BCharacteristic%252Bfor%252BAtypical%252BLigands%252Bof%252BSerotonin%252BReceptor%252B5-HT2%26aulast%3DPodlewska%26aufirst%3DSabina%26date%3D2021%26date%3D2021%26volume%3D22%26issue%3D3%26spage%3D1035" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kenneth A.  Jacobson</span>, <span class="hlFld-ContribAuthor ">Veronica  Salmaso</span>, <span class="hlFld-ContribAuthor ">R. Rama  Suresh</span>, <span class="hlFld-ContribAuthor ">Dilip K.  Tosh</span>. </span><span class="cited-content_cbyCitation_article-title">Expanding the repertoire of methanocarba nucleosides from purinergic signaling to diverse targets. </span><span class="cited-content_cbyCitation_journal-name">RSC Medicinal Chemistry</span><span> <strong>2021,</strong> <em>9 </em><a href="https://doi.org/10.1039/D1MD00167A" title="DOI URL">https://doi.org/10.1039/D1MD00167A</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D1MD00167A&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD1MD00167A%26sid%3Dliteratum%253Aachs%26jtitle%3DRSC%2520Medicinal%2520Chemistry%26atitle%3DExpanding%252Bthe%252Brepertoire%252Bof%252Bmethanocarba%252Bnucleosides%252Bfrom%252Bpurinergic%252Bsignaling%252Bto%252Bdiverse%252Btargets%26aulast%3DJacobson%26aufirst%3DKenneth%2BA.%26date%3D2021%26date%3D2021%26volume%3D9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Weiwei  Xue</span>, <span class="hlFld-ContribAuthor ">Tingting  Fu</span>, <span class="hlFld-ContribAuthor ">Guoxun  Zheng</span>, <span class="hlFld-ContribAuthor ">Gao  Tu</span>, <span class="hlFld-ContribAuthor ">Yang  Zhang</span>, <span class="hlFld-ContribAuthor ">Fengyuan  Yang</span>, <span class="hlFld-ContribAuthor ">Lin  Tao</span>, <span class="hlFld-ContribAuthor ">Lixia  Yao</span>, <span class="hlFld-ContribAuthor ">Feng  Zhu</span>. </span><span class="cited-content_cbyCitation_article-title">Recent Advances and Challenges of the Drugs Acting on Monoamine Transporters. </span><span class="cited-content_cbyCitation_journal-name">Current Medicinal Chemistry</span><span> <strong>2020,</strong> <em>27 </em>
                                    (23)
                                     , 3830-3876. <a href="https://doi.org/10.2174/0929867325666181009123218" title="DOI URL">https://doi.org/10.2174/0929867325666181009123218</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.2174/0929867325666181009123218&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.2174%2F0929867325666181009123218%26sid%3Dliteratum%253Aachs%26jtitle%3DCurrent%2520Medicinal%2520Chemistry%26atitle%3DRecent%252BAdvances%252Band%252BChallenges%252Bof%252Bthe%252BDrugs%252BActing%252Bon%252BMonoamine%252BTransporters%26aulast%3DXue%26aufirst%3DWeiwei%26date%3D2020%26volume%3D27%26issue%3D23%26spage%3D3830%26epage%3D3876" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Biebele  Abel</span>, <span class="hlFld-ContribAuthor ">Dilip K.  Tosh</span>, <span class="hlFld-ContribAuthor ">Stewart R.  Durell</span>, <span class="hlFld-ContribAuthor ">Megumi  Murakami</span>, <span class="hlFld-ContribAuthor ">Shahrooz  Vahedi</span>, <span class="hlFld-ContribAuthor ">Kenneth A.  Jacobson</span>, <span class="hlFld-ContribAuthor ">Suresh V.  Ambudkar</span>. </span><span class="cited-content_cbyCitation_article-title">Evidence for the Interaction of A
              3
              Adenosine Receptor Agonists at the Drug-Binding Site(s) of Human P-glycoprotein (ABCB1). </span><span class="cited-content_cbyCitation_journal-name">Molecular Pharmacology</span><span> <strong>2019,</strong> <em>96 </em>
                                    (2)
                                     , 180-192. <a href="https://doi.org/10.1124/mol.118.115295" title="DOI URL">https://doi.org/10.1124/mol.118.115295</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1124/mol.118.115295&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1124%2Fmol.118.115295%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Pharmacology%26atitle%3DEvidence%252Bfor%252Bthe%252BInteraction%252Bof%252BA%252B3%252BAdenosine%252BReceptor%252BAgonists%252Bat%252Bthe%252BDrug-Binding%252BSite%252528s%252529%252Bof%252BHuman%252BP-glycoprotein%252B%252528ABCB1%252529%26aulast%3DAbel%26aufirst%3DBiebele%26date%3D2019%26date%3D2019%26volume%3D96%26issue%3D2%26spage%3D180%26epage%3D192" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Vikas  Navratna</span>, <span class="hlFld-ContribAuthor ">Eric  Gouaux</span>. </span><span class="cited-content_cbyCitation_article-title">Insights into the mechanism and pharmacology of neurotransmitter sodium symporters. </span><span class="cited-content_cbyCitation_journal-name">Current Opinion in Structural Biology</span><span> <strong>2019,</strong> <em>54 </em>, 161-170. <a href="https://doi.org/10.1016/j.sbi.2019.03.011" title="DOI URL">https://doi.org/10.1016/j.sbi.2019.03.011</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.sbi.2019.03.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.sbi.2019.03.011%26sid%3Dliteratum%253Aachs%26jtitle%3DCurrent%2520Opinion%2520in%2520Structural%2520Biology%26atitle%3DInsights%252Binto%252Bthe%252Bmechanism%252Band%252Bpharmacology%252Bof%252Bneurotransmitter%252Bsodium%252Bsymporters%26aulast%3DNavratna%26aufirst%3DVikas%26date%3D2019%26volume%3D54%26spage%3D161%26epage%3D170" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Vikas  Navratna</span>, <span class="hlFld-ContribAuthor ">Dilip K.  Tosh</span>, <span class="hlFld-ContribAuthor ">Kenneth A.  Jacobson</span>, <span class="hlFld-ContribAuthor ">Eric  Gouaux</span>, . </span><span class="cited-content_cbyCitation_article-title">Thermostabilization and purification of the human dopamine transporter (hDAT) in an inhibitor and allosteric ligand bound conformation. </span><span class="cited-content_cbyCitation_journal-name">PLOS ONE</span><span> <strong>2018,</strong> <em>13 </em>
                                    (7)
                                     , e0200085. <a href="https://doi.org/10.1371/journal.pone.0200085" title="DOI URL">https://doi.org/10.1371/journal.pone.0200085</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1371/journal.pone.0200085&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1371%2Fjournal.pone.0200085%26sid%3Dliteratum%253Aachs%26jtitle%3DPLOS%2520ONE%26atitle%3DThermostabilization%252Band%252Bpurification%252Bof%252Bthe%252Bhuman%252Bdopamine%252Btransporter%252B%252528hDAT%252529%252Bin%252Ban%252Binhibitor%252Band%252Ballosteric%252Bligand%252Bbound%252Bconformation%26aulast%3DNavratna%26aufirst%3DVikas%26date%3D2018%26date%3D2018%26volume%3D13%26issue%3D7%26spage%3De0200085" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lizi  Xia</span>, <span class="hlFld-ContribAuthor ">Athina  Kyrizaki</span>, <span class="hlFld-ContribAuthor ">Dilip K.  Tosh</span>, <span class="hlFld-ContribAuthor ">Tirsa T.  van Duijl</span>, <span class="hlFld-ContribAuthor ">Jacomina Cornelia  Roorda</span>, <span class="hlFld-ContribAuthor ">Kenneth A.  Jacobson</span>, <span class="hlFld-ContribAuthor ">Adriaan P.  IJzerman</span>, <span class="hlFld-ContribAuthor ">Laura H.  Heitman</span>. </span><span class="cited-content_cbyCitation_article-title">A binding kinetics study of human adenosine A3 receptor agonists. </span><span class="cited-content_cbyCitation_journal-name">Biochemical Pharmacology</span><span> <strong>2018,</strong> <em>153 </em>, 248-259. <a href="https://doi.org/10.1016/j.bcp.2017.12.026" title="DOI URL">https://doi.org/10.1016/j.bcp.2017.12.026</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bcp.2017.12.026&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bcp.2017.12.026%26sid%3Dliteratum%253Aachs%26jtitle%3DBiochemical%2520Pharmacology%26atitle%3DA%252Bbinding%252Bkinetics%252Bstudy%252Bof%252Bhuman%252Badenosine%252BA3%252Breceptor%252Bagonists%26aulast%3DXia%26aufirst%3DLizi%26date%3D2018%26volume%3D153%26spage%3D248%26epage%3D259" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kenneth A.  Jacobson</span>, <span class="hlFld-ContribAuthor ">Dilip K.  Tosh</span>, <span class="hlFld-ContribAuthor ">Zhan-Guo  Gao</span>, <span class="hlFld-ContribAuthor ">Jinha  Yu</span>, <span class="hlFld-ContribAuthor ">Rama R.  Suresh</span>, <span class="hlFld-ContribAuthor ">Harsha  Rao</span>, <span class="hlFld-ContribAuthor ">Romeo  Romagnoli</span>, <span class="hlFld-ContribAuthor ">Pier Giovanni  Baraldi</span>, <span class="hlFld-ContribAuthor ">Mojgan  Aghazadeh Tabrizi</span>. </span><span class="cited-content_cbyCitation_article-title">Medicinal Chemistry of the A3 Adenosine Receptor. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2018,</strong>,, 169-198. <a href="https://doi.org/10.1007/978-3-319-90808-3_7" title="DOI URL">https://doi.org/10.1007/978-3-319-90808-3_7</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/978-3-319-90808-3_7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F978-3-319-90808-3_7%26sid%3Dliteratum%253Aachs%26atitle%3DMedicinal%252BChemistry%252Bof%252Bthe%252BA3%252BAdenosine%252BReceptor%26aulast%3DJacobson%26aufirst%3DKenneth%2BA.%26date%3D2018%26date%3D2018%26spage%3D169%26epage%3D198%26pub%3DSpringer%2520International%2520Publishing%26atitle%3DThe%252BAdenosine%252BReceptors%26aulast%3DBorea%26aufirst%3DPier%2BAndrea%26date%3D2018%26volume%3D11" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mei-Yan  Wang</span>, <span class="hlFld-ContribAuthor ">Ning  Wang</span>, <span class="hlFld-ContribAuthor ">Xiao-Fang  Liu</span>, <span class="hlFld-ContribAuthor ">Chang  Qiao</span>, <span class="hlFld-ContribAuthor ">Liang-Nian  He</span>. </span><span class="cited-content_cbyCitation_article-title">Tungstate catalysis: pressure-switched 2- and 6-electron reductive functionalization of CO
              2
              with amines and phenylsilane. </span><span class="cited-content_cbyCitation_journal-name">Green Chemistry</span><span> <strong>2018,</strong> <em>20 </em>
                                    (7)
                                     , 1564-1570. <a href="https://doi.org/10.1039/C7GC03416D" title="DOI URL">https://doi.org/10.1039/C7GC03416D</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C7GC03416D&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC7GC03416D%26sid%3Dliteratum%253Aachs%26jtitle%3DGreen%2520Chemistry%26atitle%3DTungstate%252Bcatalysis%25253A%252Bpressure-switched%252B2-%252Band%252B6-electron%252Breductive%252Bfunctionalization%252Bof%252BCO%252B2%252Bwith%252Bamines%252Band%252Bphenylsilane%26aulast%3DWang%26aufirst%3DMei-Yan%26date%3D2018%26date%3D2018%26volume%3D20%26issue%3D7%26spage%3D1564%26epage%3D1570" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kenneth A.  Jacobson</span>, <span class="hlFld-ContribAuthor ">Dilip K.  Tosh</span>, <span class="hlFld-ContribAuthor ">Kiran S.  Toti</span>, <span class="hlFld-ContribAuthor ">Antonella  Ciancetta</span>. </span><span class="cited-content_cbyCitation_article-title">Polypharmacology of conformationally locked methanocarba nucleosides. </span><span class="cited-content_cbyCitation_journal-name">Drug Discovery Today</span><span> <strong>2017,</strong> <em>22 </em>
                                    (12)
                                     , 1782-1791. <a href="https://doi.org/10.1016/j.drudis.2017.07.013" title="DOI URL">https://doi.org/10.1016/j.drudis.2017.07.013</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.drudis.2017.07.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.drudis.2017.07.013%26sid%3Dliteratum%253Aachs%26jtitle%3DDrug%2520Discovery%2520Today%26atitle%3DPolypharmacology%252Bof%252Bconformationally%252Blocked%252Bmethanocarba%252Bnucleosides%26aulast%3DJacobson%26aufirst%3DKenneth%2BA.%26date%3D2017%26volume%3D22%26issue%3D12%26spage%3D1782%26epage%3D1791" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.7b00141/20170407/images/medium/jm-2017-00141h_0009.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.7b00141/20170407/images/large/jm-2017-00141h_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00141&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="cht1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Chart 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.7b00141/20170407/images/medium/jm-2017-00141h_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.7b00141/20170407/images/large/jm-2017-00141h_0001.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Chart 1. Structures of Potent A<sub>3</sub>AR Agonists That Displayed Activity at hDAT</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.7b00141/20170407/images/large/jm-2017-00141h_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00141&amp;id=cht1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.7b00141/20170407/images/medium/jm-2017-00141h_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.7b00141/20170407/images/large/jm-2017-00141h_0005.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of (<i>N</i>)-Methanocarba 5′-Esters <b>9</b>–<b>21</b>, Carboxylate <b>22</b>, and Extended Amide <b>8</b> Derivatives<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.7b00141/20170407/images/large/jm-2017-00141h_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00141&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions (% yields): (i) 2-chloro or 2-bromo-5-ethynylthiophene, Pd(Ph<sub>3</sub>P)<sub>2</sub>Cl<sub>2</sub>, CuI, Et<sub>3</sub>N, DMF, rt, 82–83%; (ii) 10%TFA, MeOH, 70 °C, 90–91%; (iii) for <b>22</b>, 1 N NaOH, MeOH, rt, 82%; (iv) for <b>8</b>, ethylenediamine, MeOH, rt, 71%; (v) for <b>14</b>–<b>21</b>, ROH, DCC, DMAP, DMF, rt, 51–59%; (vi) for <b>9</b>, <b>11</b>, MeONa, MeOH, rt, 69%.</p></p></figure><figure data-id="sch2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.7b00141/20170407/images/medium/jm-2017-00141h_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.7b00141/20170407/images/large/jm-2017-00141h_0006.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of 5′-Ester and 5′-Methylamides <b>27</b>–<b>29</b> in the Riboside Series<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.7b00141/20170407/images/large/jm-2017-00141h_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00141&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions (% yields): (i) 2,2-dimethoxypropane, acetone, <i>p</i>-TSA, rt, 91%; (ii) RNH<sub>2</sub>, Et<sub>3</sub>N, MeOH, rt, 83–85%; (iii) PDC, DMF, 40 °C, 67–68%; (iv) for <b>41</b>, <b>42</b>, RNH<sub>2</sub>, HATU, DIPEA, DMF, rt, 68–69%; (v) for <b>43</b>, MeOH, DCC, DMAP, DMF, rt, 52%; (vi) 2-chloro-5-ethynylthiophene, Pd(Ph<sub>3</sub>P)<sub>2</sub>Cl<sub>2</sub>, CuI, Et<sub>3</sub>N, DMF, rt, 82-84%; (iv) 10% TFA, MeOH, 70 °C, 90–91%.</p></p></figure><figure data-id="sch3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.7b00141/20170407/images/medium/jm-2017-00141h_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.7b00141/20170407/images/large/jm-2017-00141h_0007.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of 3-Deaza-(<i>N</i>)-methanocarbanucleosides <b>6</b> and <b>13</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.7b00141/20170407/images/large/jm-2017-00141h_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00141&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions (% yields): (i) 3-deaza-2-bromo-6-chloropurine, Ph<sub>3</sub>P, DIAD, THF, 69%; (ii) MeNH<sub>2</sub>·HCl, DIPEA, isopropanol, 125 °C, microwave, 76%; (iii) 40% MeNH<sub>2</sub>, MeOH, rt; (iv) 5-chloro-2-ethynylthiophene, PdCl<sub>2</sub>(Ph<sub>3</sub>P)<sub>2</sub>, CuI, DMF, 130 °C, μwave, 63%; (v) 10%TFA, MeOH, 70 °C, 90–91%.</p></p></figure><figure data-id="fig1" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.7b00141/20170407/images/medium/jm-2017-00141h_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.7b00141/20170407/images/large/jm-2017-00141h_0002.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Drug-induced enhancement of [<sup>3</sup>H]<b>24</b> binding to hDAT (PDSP) by (<i>N</i>)-methanocarba analogues (representative of 2–5 determinations): (A) 3-deaza-5′-methylamide <b>6</b>; (B) 5′-ethyl ester <b>10</b> and 2-(5-bromothienylethynyl)-5′-methyl ester <b>11</b>; (C) 2-(5-chlorothienylethynyl)-5′-<i>N</i>-(2-aminoethyl)-carboxamide <b>8</b> and its 5′-ethyl ester analogue <b>10</b>; (D) 5′-<i>n</i>-propyl ester <b>14</b> and 5′-carboxylic acid <b>22</b>. Comparison with binding inhibition by 1-[2-[bis(4-fluorophenyl)methoxy]ethyl]-4-(3 phenylpropyl)-piperazine (GBR12909, <b>30</b>) is shown.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.7b00141/20170407/images/large/jm-2017-00141h_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00141&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.7b00141/20170407/images/medium/jm-2017-00141h_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.7b00141/20170407/images/large/jm-2017-00141h_0003.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. (A) Drug-induced enhancement of [<sup>3</sup>H]<b>24</b> binding to hDAT (PDSP) by ribosides <b>27</b>–<b>29</b> (representative of 4 determinations) in comparison to weak enhancers (<i>N</i>)-methanocarba 5′-<i>N</i>-(2-aminoethyl)-carboxamide <b>8</b> and 5′-isopropyl ester <b>15</b>. Comparison with binding inhibition by <b>30</b> is shown.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.7b00141/20170407/images/large/jm-2017-00141h_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00141&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.7b00141/20170407/images/medium/jm-2017-00141h_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.7b00141/20170407/images/large/jm-2017-00141h_0004.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Drug-induced enhancement or inhibition of [<sup>125</sup>I]<b>23</b> binding and [<sup>3</sup>H]<b>26</b> binding to HEK-hDAT, HEK-hNET, and HEK-hSERT cell membranes.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.7b00141/20170407/images/large/jm-2017-00141h_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00141&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i65">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_08643" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_08643" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 49 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Little, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ford, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Symons-Liguori, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Janes, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doyle, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xie, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luongo, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tosh, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maione, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bannister, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dickenson, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vanderah, T. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Porreca, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobson, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salvemini, D.</span><span> </span><span class="NLM_article-title">Endogenous adenosine A<sub>3</sub> receptor activation selectively alleviates persistent pain states</span> <span class="citation_source-journal">Brain</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">138</span><span class="NLM_x">, </span> <span class="NLM_fpage">28</span><span class="NLM_x">–</span> <span class="NLM_lpage">35</span><span class="refDoi"> DOI: 10.1093/brain/awu330</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00141&amp;key=10.1093%2Fbrain%2Fawu330" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00141&amp;key=25414036" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00141&amp;key=1%3ACAS%3A280%3ADC%252BC2M3pvFersw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=138&publication_year=2015&pages=28-35&author=J.+W.+Littleauthor=A.+Fordauthor=A.+M.+Symons-Liguoriauthor=Z.+Chenauthor=K.+Janesauthor=T.+Doyleauthor=J.+Xieauthor=L.+Luongoauthor=D.+K.+Toshauthor=S.+Maioneauthor=K.+Bannisterauthor=A.+Dickensonauthor=T.+W.+Vanderahauthor=F.+Porrecaauthor=K.+A.+Jacobsonauthor=D.+Salvemini&title=Endogenous+adenosine+A3+receptor+activation+selectively+alleviates+persistent+pain+states&doi=10.1093%2Fbrain%2Fawu330"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Endogenous adenosine A3 receptor activation selectively alleviates persistent pain states</span></div><div class="casAuthors">Little Joshua W; Ford Amanda; Chen Zhoumou; Janes Kali; Doyle Timothy; Salvemini Daniela; Symons-Liguori Ashley M; Xie Jennifer; Vanderah Todd W; Porreca Frank; Luongo Livio; Maione Sabatino; Tosh Dillip K; Jacobson Kenneth A; Bannister Kirsty; Dickenson Anthony H</div><div class="citationInfo"><span class="NLM_cas:title">Brain : a journal of neurology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">138</span>
        (<span class="NLM_cas:issue">Pt 1</span>),
    <span class="NLM_cas:pages">28-35</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Chronic pain is a global burden that promotes disability and unnecessary suffering.  To date, efficacious treatment of chronic pain has not been achieved.  Thus, new therapeutic targets are needed.  Here, we demonstrate that increasing endogenous adenosine levels through selective adenosine kinase inhibition produces powerful analgesic effects in rodent models of experimental neuropathic pain through the A3 adenosine receptor (A3AR, now known as ADORA3) signalling pathway.  Similar results were obtained by the administration of a novel and highly selective A3AR agonist.  These effects were prevented by blockade of spinal and supraspinal A3AR, lost in A3AR knock-out mice, and independent of opioid and endocannabinoid mechanisms.  A3AR activation also relieved non-evoked spontaneous pain behaviours without promoting analgesic tolerance or inherent reward.  Further examination revealed that A3AR activation reduced spinal cord pain processing by decreasing the excitability of spinal wide dynamic range neurons and producing supraspinal inhibition of spinal nociception through activation of serotonergic and noradrenergic bulbospinal circuits.  Critically, engaging the A3AR mechanism did not alter nociceptive thresholds in non-neuropathy animals and therefore produced selective alleviation of persistent neuropathic pain states.  These studies reveal A3AR activation by adenosine as an endogenous anti-nociceptive pathway and support the development of A3AR agonists as novel therapeutics to treat chronic pain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTV_nDN4yfcy0Q0lWbKiCflfW6udTcc2eY1VreJ8HMOQ7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2M3pvFersw%253D%253D&md5=85411b662ffef21c0fc58f0549845716</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1093%2Fbrain%2Fawu330&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fbrain%252Fawu330%26sid%3Dliteratum%253Aachs%26aulast%3DLittle%26aufirst%3DJ.%2BW.%26aulast%3DFord%26aufirst%3DA.%26aulast%3DSymons-Liguori%26aufirst%3DA.%2BM.%26aulast%3DChen%26aufirst%3DZ.%26aulast%3DJanes%26aufirst%3DK.%26aulast%3DDoyle%26aufirst%3DT.%26aulast%3DXie%26aufirst%3DJ.%26aulast%3DLuongo%26aufirst%3DL.%26aulast%3DTosh%26aufirst%3DD.%2BK.%26aulast%3DMaione%26aufirst%3DS.%26aulast%3DBannister%26aufirst%3DK.%26aulast%3DDickenson%26aufirst%3DA.%26aulast%3DVanderah%26aufirst%3DT.%2BW.%26aulast%3DPorreca%26aufirst%3DF.%26aulast%3DJacobson%26aufirst%3DK.%2BA.%26aulast%3DSalvemini%26aufirst%3DD.%26atitle%3DEndogenous%2520adenosine%2520A3%2520receptor%2520activation%2520selectively%2520alleviates%2520persistent%2520pain%2520states%26jtitle%3DBrain%26date%3D2015%26volume%3D138%26spage%3D28%26epage%3D35%26doi%3D10.1093%2Fbrain%2Fawu330" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Tosh, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Finley, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paoletta, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moss, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, Z. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gizewski, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Auchampach, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salvemini, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobson, K. A.</span><span> </span><span class="NLM_article-title">In vivo phenotypic screening for treating chronic neuropathic pain: Modification of C2-arylethynyl group of conformationally constrained A<sub>3</sub> adenosine receptor agonists</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">9901</span><span class="NLM_x">–</span> <span class="NLM_lpage">9914</span><span class="refDoi"> DOI: 10.1021/jm501021n</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm501021n" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00141&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvFOhtrjF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=9901-9914&author=D.+K.+Toshauthor=A.+Finleyauthor=S.+Paolettaauthor=S.+M.+Mossauthor=Z.+G.+Gaoauthor=E.+Gizewskiauthor=J.+Auchampachauthor=D.+Salveminiauthor=K.+A.+Jacobson&title=In+vivo+phenotypic+screening+for+treating+chronic+neuropathic+pain%3A+Modification+of+C2-arylethynyl+group+of+conformationally+constrained+A3+adenosine+receptor+agonists&doi=10.1021%2Fjm501021n"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">In Vivo Phenotypic Screening for Treating Chronic Neuropathic Pain: Modification of C2-Arylethynyl Group of Conformationally Constrained A3 Adenosine Receptor Agonists</span></div><div class="casAuthors">Tosh, Dilip K.; Finley, Amanda; Paoletta, Silvia; Moss, Steven M.; Gao, Zhan-Guo; Gizewski, Elizabeth T.; Auchampach, John A.; Salvemini, Daniela; Jacobson, Kenneth A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">9901-9914</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">(N)-Methanocarba adenosine 5'-methyluronamides contg. 2-arylethynyl groups were synthesized as A3 adenosine receptor (AR) agonists and screened in vivo (po) for redn. of neuropathic pain.  A small N6-Me group maintained binding affinity, with human > mouse A3AR and MW < 500 and other favorable physicochem. properties.  Emax (maximal efficacy in a mouse chronic constriction injury pain model) of previously characterized A3AR agonist, 2-(3,4-difluorophenylethynyl)-N6-(3-chlorobenzyl) deriv. 6a, MRS5698, was surpassed.  More efficacious analogs (in vivo) contained the following C2-arylethynyl groups: pyrazin-2-yl 23 (binding Ki, hA3AR, nM 1.8), fur-2-yl 27 (0.6), thien-2-yl 32 (0.6) and its 5-chloro 33, MRS5980 (0.7) and 5-bromo 34 (0.4) equiv., and physiol. unstable ferrocene 36, MRS5979 (2.7). 33 and 36 displayed particularly long in vivo duration (>3 h).  Selected analogs were docked to an A3AR homol. model to explore the environment of receptor-bound C2 and N6 groups.  Various analogs bound with μM affinity at off-target biogenic amine (M2, 5HT2A, β3, 5HT2B, 5HT2C, and α2C) or other receptors.  Thus, we have expanded the structural range of orally active A3AR agonists for chronic pain treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoQCo4JjAXTTLVg90H21EOLACvtfcHk0ljPa0f8La2dXg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvFOhtrjF&md5=d9f3f36c4c107a289cef7f4deb9b70ce</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1021%2Fjm501021n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm501021n%26sid%3Dliteratum%253Aachs%26aulast%3DTosh%26aufirst%3DD.%2BK.%26aulast%3DFinley%26aufirst%3DA.%26aulast%3DPaoletta%26aufirst%3DS.%26aulast%3DMoss%26aufirst%3DS.%2BM.%26aulast%3DGao%26aufirst%3DZ.%2BG.%26aulast%3DGizewski%26aufirst%3DE.%26aulast%3DAuchampach%26aufirst%3DJ.%26aulast%3DSalvemini%26aufirst%3DD.%26aulast%3DJacobson%26aufirst%3DK.%2BA.%26atitle%3DIn%2520vivo%2520phenotypic%2520screening%2520for%2520treating%2520chronic%2520neuropathic%2520pain%253A%2520Modification%2520of%2520C2-arylethynyl%2520group%2520of%2520conformationally%2520constrained%2520A3%2520adenosine%2520receptor%2520agonists%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D9901%26epage%3D9914%26doi%3D10.1021%2Fjm501021n" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Janowsky, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eshleman, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tosh, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobson, K. A.</span><span> </span><span class="NLM_article-title">Rigid adenine nucleoside derivatives as novel modulators of the human sodium symporters for dopamine and other neurotransmitters</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">357</span><span class="NLM_x">, </span> <span class="NLM_fpage">24</span><span class="NLM_x">–</span> <span class="NLM_lpage">35</span><span class="refDoi"> DOI: 10.1124/jpet.115.229666</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00141&amp;key=10.1124%2Fjpet.115.229666" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00141&amp;key=26813929" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00141&amp;key=1%3ACAS%3A528%3ADC%252BC28XpvVeksLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=357&publication_year=2016&pages=24-35&author=A.+Janowskyauthor=A.+Eshlemanauthor=D.+K.+Toshauthor=K.+A.+Jacobson&title=Rigid+adenine+nucleoside+derivatives+as+novel+modulators+of+the+human+sodium+symporters+for+dopamine+and+other+neurotransmitters&doi=10.1124%2Fjpet.115.229666"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Rigid adenine nucleoside derivatives as novel modulators of the human sodium symporters for dopamine and norepinephrine</span></div><div class="casAuthors">Janowsky, Aaron; Tosh, Dilip K.; Eshleman, Amy J.; Jacobson, Kenneth A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">357</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">24-35</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">1521-0103</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Thirty-two congeneric rigid adenine nucleoside derivs. contg. a North (N)-methanocarba ribose substitution and a 2-arylethynyl group either enhanced (up to 760% of control) or inhibited [125I] Me (1R,2S,3S)-3-(4-iodophenyl)-8-methyl-8-azabicyclo[3.2.1]octane-2-carboxylate (RTI-55) binding at the human dopamine (DA) transporter (DAT) and inhibited DA uptake.  Several nucleosides also enhanced [3H]mazindol [(±)-5-(4-chlorophenyl)-3,5-dihydro-2H-imidazo[2,1-a]isoindol-5-ol] binding to the DAT.  The combination of binding enhancement and functional inhibition suggests possible allosteric interaction with the tropanes.  The structure-activity relationship of this novel class of DAT ligands was explored: small N6-substition (Me or ethyl) was favored, while the N1 of the adenine ring was essential.  Effective terminal aryl groups include thien-2-yl (compds. 9 and 16), with EC50 values of 35.1 and 9.1 nM, resp., in [125I]RTI-55 binding enhancement, and 3,4-difluorophenyl as in the most potent DA uptake inhibitor (compd. 6) with an IC50 value of 92 nM (3-fold more potent than cocaine), but not nitrogen heterocycles.  Several compds. inhibited or enhanced binding at the norepinephrine transporter (NET) and serotonin transporter (SERT) and inhibited function in the micromolar range; truncation at the 4'-position in compd. 23 allowed for weak inhibition of the SERT.  We have not yet eliminated adenosine receptor affinity from this class of DAT modulators, but we identified modifications that remove DAT inhibition as an off-target effect of potent adenosine receptor agonists.  Thus, we have identified a new class of allosteric DAT ligands, rigidified adenosine derivs., and explored their initial structural requirements.  They display a very atypical pharmacol. profile, i.e., either enhancement by increasing affinity or inhibition of radioligand binding at the DAT, and in some cases the NET and SERT, and inhibition of neurotransmitter uptake.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpPsPBvjbGFirVg90H21EOLACvtfcHk0ljoeTQBb4S4Vg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XpvVeksLk%253D&md5=85e74bccf374daae3cf785982a35cabb</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1124%2Fjpet.115.229666&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.115.229666%26sid%3Dliteratum%253Aachs%26aulast%3DJanowsky%26aufirst%3DA.%26aulast%3DEshleman%26aufirst%3DA.%26aulast%3DTosh%26aufirst%3DD.%2BK.%26aulast%3DJacobson%26aufirst%3DK.%2BA.%26atitle%3DRigid%2520adenine%2520nucleoside%2520derivatives%2520as%2520novel%2520modulators%2520of%2520the%2520human%2520sodium%2520symporters%2520for%2520dopamine%2520and%2520other%2520neurotransmitters%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2016%26volume%3D357%26spage%3D24%26epage%3D35%26doi%3D10.1124%2Fjpet.115.229666" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">LeVine, M. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cuendet, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khelashvili, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weinstein, H.</span><span> </span><span class="NLM_article-title">Allosteric mechanisms of molecular machines at the membrane: Transport by sodium-coupled symporters</span> <span class="citation_source-journal">Chem. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">116</span><span class="NLM_x">, </span> <span class="NLM_fpage">6552</span><span class="NLM_x">–</span> <span class="NLM_lpage">6587</span><span class="refDoi"> DOI: 10.1021/acs.chemrev.5b00627</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.chemrev.5b00627" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00141&amp;key=1%3ACAS%3A528%3ADC%252BC28XislCisro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=116&publication_year=2016&pages=6552-6587&author=M.+V.+LeVineauthor=M.+A.+Cuendetauthor=G.+Khelashviliauthor=H.+Weinstein&title=Allosteric+mechanisms+of+molecular+machines+at+the+membrane%3A+Transport+by+sodium-coupled+symporters&doi=10.1021%2Facs.chemrev.5b00627"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Allosteric mechanisms of molecular machines at the membrane: Transport by sodium-coupled symporters</span></div><div class="casAuthors">LeVine, Michael V.; Cuendet, Michel A.; Khelashvili, George; Weinstein, Harel</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Reviews (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">116</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">6552-6587</span>CODEN:
                <span class="NLM_cas:coden">CHREAY</span>;
        ISSN:<span class="NLM_cas:issn">0009-2665</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review. Solute transport across cell.  Membranes is ubiquitous in biol. as an essential physiol. process.  Secondary active transporters couple the unfavorable process of solute transport against its concn. gradient to the energetically favorable transport of one or several ions.  The study of such transporters over several decades indicates that their function involves complex allosteric mechanisms that are progressively being revealed in atomistic detail.  The authors focus on 2 well-characterized Na+-coupled symporters: the bacterial amino acid transporter LeuT, which is the prototype for the "gated pore" mechanism in the mammalian synaptic monoamine transporters, and the archaeal GltPh, which is the prototype for the "elevator" mechanism in the mammalian excitatory amino acid transporters.  The authors present evidence for the role of allostery in the context of a quant. formalism that can reconcile biochem. and biophys. data and thereby connects directly to recent insights into the mol. structure and dynamics of these proteins.  The authors demonstrate that, while the structures and mechanisms of these transporters are very different, the available data suggest a common role of specific models of allostery in their functions.  The authors argue that such allosteric mechanisms appear essential not only for Na+-coupled symport in general but also for the function of other types of mol. machines in the membrane.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqOq5BWdTGA1rVg90H21EOLACvtfcHk0ljoeTQBb4S4Vg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XislCisro%253D&md5=2c8581906caf99f8c962e60dc2401181</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1021%2Facs.chemrev.5b00627&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.chemrev.5b00627%26sid%3Dliteratum%253Aachs%26aulast%3DLeVine%26aufirst%3DM.%2BV.%26aulast%3DCuendet%26aufirst%3DM.%2BA.%26aulast%3DKhelashvili%26aufirst%3DG.%26aulast%3DWeinstein%26aufirst%3DH.%26atitle%3DAllosteric%2520mechanisms%2520of%2520molecular%2520machines%2520at%2520the%2520membrane%253A%2520Transport%2520by%2520sodium-coupled%2520symporters%26jtitle%3DChem.%2520Rev.%26date%3D2016%26volume%3D116%26spage%3D6552%26epage%3D6587%26doi%3D10.1021%2Facs.chemrev.5b00627" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Vaughan, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Foster, J. D.</span><span> </span><span class="NLM_article-title">Mechanisms of dopamine transporter regulation in normal and disease states</span> <span class="citation_source-journal">Trends Pharmacol. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">34</span><span class="NLM_x">, </span> <span class="NLM_fpage">489</span><span class="NLM_x">–</span> <span class="NLM_lpage">496</span><span class="refDoi"> DOI: 10.1016/j.tips.2013.07.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00141&amp;key=10.1016%2Fj.tips.2013.07.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00141&amp;key=23968642" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00141&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtlWjurvM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2013&pages=489-496&author=R.+A.+Vaughanauthor=J.+D.+Foster&title=Mechanisms+of+dopamine+transporter+regulation+in+normal+and+disease+states&doi=10.1016%2Fj.tips.2013.07.005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Mechanisms of dopamine transporter regulation in normal and disease states</span></div><div class="casAuthors">Vaughan, Roxanne A.; Foster, James D.</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Pharmacological Sciences</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">489-496</span>CODEN:
                <span class="NLM_cas:coden">TPHSDY</span>;
        ISSN:<span class="NLM_cas:issn">0165-6147</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  The dopamine (DA) transporter (DAT) controls the spatial and temporal dynamics of DA neurotransmission by driving reuptake of extracellular transmitter into presynaptic neurons.  Many diseases such as depression, bipolar disorder, Parkinson's disease (PD), and attention deficit hyperactivity disorder (ADHD) are assocd. with abnormal DA levels, implicating DAT as a factor in their etiol.  Medications used to treat these disorders and many addictive drugs target DAT and enhance dopaminergic signaling by suppressing transmitter reuptake.  We now understand that the transport and binding properties of DAT are regulated by complex and overlapping mechanisms that provide neurons with the ability to modulate DA clearance in response to physiol. demands.  These processes are controlled by endogenous signaling pathways and affected by exogenous transporter ligands, demonstrating their importance for normal neurotransmission, drug abuse, and disease treatments.  Increasing evidence supports the disruption of these mechanisms in DA disorders, implicating dysregulation of transport in disease etiologies and suggesting these processes as potential points for therapeutic manipulation of DA availability.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoINuFoGhhzULVg90H21EOLACvtfcHk0lhSKLgnp3BXHw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtlWjurvM&md5=c6618175177119359f7af0987e2e0b37</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1016%2Fj.tips.2013.07.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tips.2013.07.005%26sid%3Dliteratum%253Aachs%26aulast%3DVaughan%26aufirst%3DR.%2BA.%26aulast%3DFoster%26aufirst%3DJ.%2BD.%26atitle%3DMechanisms%2520of%2520dopamine%2520transporter%2520regulation%2520in%2520normal%2520and%2520disease%2520states%26jtitle%3DTrends%2520Pharmacol.%2520Sci.%26date%3D2013%26volume%3D34%26spage%3D489%26epage%3D496%26doi%3D10.1016%2Fj.tips.2013.07.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Wang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goehring, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, K. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Penmatsa, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ressler, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gouaux, E.</span><span> </span><span class="NLM_article-title">Structural basis for action by diverse antidepressants on biogenic amine transporters</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">503</span><span class="NLM_x">, </span> <span class="NLM_fpage">141</span><span class="NLM_x">–</span> <span class="NLM_lpage">145</span><span class="refDoi"> DOI: 10.1038/nature12648</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00141&amp;key=10.1038%2Fnature12648" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00141&amp;key=24121440" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00141&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhslSnsLrE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=503&publication_year=2013&pages=141-145&author=H.+Wangauthor=A.+Goehringauthor=K.+H.+Wangauthor=A.+Penmatsaauthor=R.+Resslerauthor=E.+Gouaux&title=Structural+basis+for+action+by+diverse+antidepressants+on+biogenic+amine+transporters&doi=10.1038%2Fnature12648"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Structural basis for action by diverse antidepressants on biogenic amine transporters</span></div><div class="casAuthors">Wang, Hui; Goehring, April; Wang, Kevin H.; Penmatsa, Aravind; Ressler, Ryan; Gouaux, Eric</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">503</span>
        (<span class="NLM_cas:issue">7474</span>),
    <span class="NLM_cas:pages">141-145</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The biogenic amine transporters (BATs) regulate endogenous neurotransmitter concns. and are targets for a broad range of therapeutic agents including selective serotonin reuptake inhibitors (SSRIs), serotonin-noradrenaline reuptake inhibitors (SNRIs) and tricyclic antidepressants (TCAs).  Because eukaryotic BATs are recalcitrant to crystallog. anal., the authors' understanding of the mechanism of these inhibitors and antidepressants is limited.  LeuT is a bacterial homolog of BATs and has proven to be a valuable paradigm for understanding relationships between their structure and function.  However, because only approx. 25% of the amino acid sequence of LeuT is in common with that of BATs, and as LeuT is a promiscuous amino acid transporter, it does not recapitulate the pharmacol. properties of BATs.  Indeed, SSRIs and TCAs bind in the extracellular vestibule of LeuT and act as non-competitive inhibitors of transport.  By contrast, multiple studies demonstrate that both TCAs and SSRIs are competitive inhibitors for eukaryotic BATs and bind to the primary binding pocket.  Here the authors engineered LeuT to harbor human BAT-like pharmacol. by mutating key residues around the primary binding pocket.  The final LeuBAT mutant binds the SSRI sertraline with a binding const. of 18 nM and displays high-affinity binding to a range of SSRIs, SNRIs and a TCA.  The authors detd. 12 crystal structures of LeuBAT in complex with four classes of antidepressants.  The chem. diverse inhibitors have a remarkably similar mode of binding in which they straddle transmembrane helix (TM) 3, wedge between TM3/TM8 and TM1/TM6, and lock the transporter in a sodium- and chloride-bound outward-facing open conformation.  Together, these studies define common and simple principles for the action of SSRIs, SNRIs and TCAs on BATs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp8AMnfh2-Af7Vg90H21EOLACvtfcHk0lhSKLgnp3BXHw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhslSnsLrE&md5=26cc6cf173fdf20ec20d928d02f05193</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1038%2Fnature12648&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature12648%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DH.%26aulast%3DGoehring%26aufirst%3DA.%26aulast%3DWang%26aufirst%3DK.%2BH.%26aulast%3DPenmatsa%26aufirst%3DA.%26aulast%3DRessler%26aufirst%3DR.%26aulast%3DGouaux%26aufirst%3DE.%26atitle%3DStructural%2520basis%2520for%2520action%2520by%2520diverse%2520antidepressants%2520on%2520biogenic%2520amine%2520transporters%26jtitle%3DNature%26date%3D2013%26volume%3D503%26spage%3D141%26epage%3D145%26doi%3D10.1038%2Fnature12648" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Wang, K. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Penamasta, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gouaux, E.</span><span> </span><span class="NLM_article-title">Neurotransmitter and psychostimulant recognition by the dopamine transporter</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">521</span><span class="NLM_x">, </span> <span class="NLM_fpage">322</span><span class="NLM_x">–</span> <span class="NLM_lpage">327</span><span class="refDoi"> DOI: 10.1038/nature14431</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00141&amp;key=10.1038%2Fnature14431" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00141&amp;key=25970245" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00141&amp;key=1%3ACAS%3A528%3ADC%252BC2MXht1WltbbK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=521&publication_year=2015&pages=322-327&author=K.+H.+Wangauthor=A.+Penamastaauthor=E.+Gouaux&title=Neurotransmitter+and+psychostimulant+recognition+by+the+dopamine+transporter&doi=10.1038%2Fnature14431"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Neurotransmitter and psychostimulant recognition by the dopamine transporter</span></div><div class="casAuthors">Wang, Kevin H.; Penmatsa, Aravind; Gouaux, Eric</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">521</span>
        (<span class="NLM_cas:issue">7552</span>),
    <span class="NLM_cas:pages">322-327</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Na+/Cl--coupled biogenic amine transporters are the primary targets of therapeutic and abused drugs, ranging from antidepressants to the psychostimulants cocaine and amphetamines, and to their cognate substrates.  Here we det. X-ray crystal structures of the Drosophila melanogaster dopamine transporter (dDAT) bound to its substrate dopamine, a substrate analog 3,4-dichlorophenethylamine, the psychostimulants D-amphetamine and methamphetamine, or to cocaine and cocaine analogs.  All ligands bind to the central binding site, located approx. halfway across the membrane bilayer, in close proximity to bound sodium and chloride ions.  The central binding site recognizes three chem. distinct classes of ligands via conformational changes that accommodate varying sizes and shapes, thus illustrating mol. principles that distinguish substrates from inhibitors in biogenic amine transporters.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrWbqTaT0RDD7Vg90H21EOLACvtfcHk0licsj5TO8M7IQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXht1WltbbK&md5=1784d5fd0e7e1ddbe8346c96aaf98a00</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1038%2Fnature14431&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature14431%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DK.%2BH.%26aulast%3DPenamasta%26aufirst%3DA.%26aulast%3DGouaux%26aufirst%3DE.%26atitle%3DNeurotransmitter%2520and%2520psychostimulant%2520recognition%2520by%2520the%2520dopamine%2520transporter%26jtitle%3DNature%26date%3D2015%26volume%3D521%26spage%3D322%26epage%3D327%26doi%3D10.1038%2Fnature14431" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Newman, A. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kulkarni, S.</span><span> </span><span class="NLM_article-title">Probes for the dopamine transporter: New leads toward a cocaine-abuse therapeutic—A focus on analogues of benztropine and rimcazole</span> <span class="citation_source-journal">Med. Res. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">429</span><span class="NLM_x">–</span> <span class="NLM_lpage">464</span><span class="refDoi"> DOI: 10.1002/med.10014</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00141&amp;key=10.1002%2Fmed.10014" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00141&amp;key=12210554" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00141&amp;key=1%3ACAS%3A528%3ADC%252BD38XntFSlsrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2002&pages=429-464&author=A.+H.+Newmanauthor=S.+Kulkarni&title=Probes+for+the+dopamine+transporter%3A+New+leads+toward+a+cocaine-abuse+therapeutic%E2%80%94A+focus+on+analogues+of+benztropine+and+rimcazole&doi=10.1002%2Fmed.10014"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Probes for the dopamine transporter: new leads toward a cocaine-abuse therapeutic-a focus on analogues of benztropine and rimcazole</span></div><div class="casAuthors">Newman, Amy Hauck; Kulkarni, Santosh</div><div class="citationInfo"><span class="NLM_cas:title">Medicinal Research Reviews</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">429-464</span>CODEN:
                <span class="NLM_cas:coden">MRREDD</span>;
        ISSN:<span class="NLM_cas:issn">0198-6325</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">A review.  To discover a cocaine-abuse pharmacotherapeutic, extensive investigation has been directed toward elucidating the mol. mechanisms underlying the reinforcing effects of this psychostimulant drug.  The results of these studies have been consistent with the inhibition of dopamine uptake, at the dopamine transporter (DAT), which results in a rapid and excessive accumulation of extracellular dopamine in the synapse as being the mechanism primarily responsible for the locomotor stimulant actions of cocaine.  Nevertheless, investigation of the serotonin (SERT) and norepinephrine (NET) transporters, as well as other receptor systems, with which cocaine either directly or indirectly interacts, has suggested that the DAT is not solely responsible for the reinforcing effects of cocaine.  To further elucidate the roles of these systems in the reinforcing effects of cocaine, selective mol. probes, in the form of drug mols., have been designed, synthesized, and characterized.  Many of these compds. bind potently and selectively to the DAT, block dopamine reuptake, and are behaviorally cocaine-like in animal models of psychostimulant abuse.  However, there have been exceptions noted in several classes of dopamine uptake inhibitors that demonstrate behavioral profiles that are distinctive from cocaine.  Structure-activity relationships between chem. diverse dopamine uptake inhibitors have suggested that different binding interactions, at the mol. level on the DAT, as well as divergent actions at the other monoamine transporters may be related to the differing pharmacol. actions of these compds., in vivo.  These studies suggest that novel dopamine uptake inhibitors, which are structurally and pharmacol. distinct from cocaine, may be developed as potential cocaine-abuse therapeutics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpOGbPZx-2NDLVg90H21EOLACvtfcHk0licsj5TO8M7IQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XntFSlsrY%253D&md5=cf29fc5d8ae60b5aed61055c64c10888</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1002%2Fmed.10014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fmed.10014%26sid%3Dliteratum%253Aachs%26aulast%3DNewman%26aufirst%3DA.%2BH.%26aulast%3DKulkarni%26aufirst%3DS.%26atitle%3DProbes%2520for%2520the%2520dopamine%2520transporter%253A%2520New%2520leads%2520toward%2520a%2520cocaine-abuse%2520therapeutic%25E2%2580%2594A%2520focus%2520on%2520analogues%2520of%2520benztropine%2520and%2520rimcazole%26jtitle%3DMed.%2520Res.%2520Rev.%26date%3D2002%26volume%3D22%26spage%3D429%26epage%3D464%26doi%3D10.1002%2Fmed.10014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Carroll, F. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Howard, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Howell, L. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fox, B. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuhar, M. J.</span><span> </span><span class="NLM_article-title">Development of the dopamine transporter selective RTI-336 as a pharmacotherapy for cocaine abuse</span> <span class="citation_source-journal">AAPS J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">E196</span><span class="NLM_x">–</span> <span class="NLM_lpage">E203</span><span class="refDoi"> DOI: 10.1208/aapsj080124</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00141&amp;key=10.1208%2Faapsj080124" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2006&pages=E196-E203&author=F.+I.+Carrollauthor=J.+L.+Howardauthor=L.+L.+Howellauthor=B.+S.+Foxauthor=M.+J.+Kuhar&title=Development+of+the+dopamine+transporter+selective+RTI-336+as+a+pharmacotherapy+for+cocaine+abuse&doi=10.1208%2Faapsj080124"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1208%2Faapsj080124&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1208%252Faapsj080124%26sid%3Dliteratum%253Aachs%26aulast%3DCarroll%26aufirst%3DF.%2BI.%26aulast%3DHoward%26aufirst%3DJ.%2BL.%26aulast%3DHowell%26aufirst%3DL.%2BL.%26aulast%3DFox%26aufirst%3DB.%2BS.%26aulast%3DKuhar%26aufirst%3DM.%2BJ.%26atitle%3DDevelopment%2520of%2520the%2520dopamine%2520transporter%2520selective%2520RTI-336%2520as%2520a%2520pharmacotherapy%2520for%2520cocaine%2520abuse%26jtitle%3DAAPS%2520J.%26date%3D2006%26volume%3D8%26spage%3DE196%26epage%3DE203%26doi%3D10.1208%2Faapsj080124" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Enman, N. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arthur, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ward, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perrine, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Unterwald, E. M.</span><span> </span><span class="NLM_article-title">Anhedonia, reduced cocaine reward, and dopamine dysfunction in a rat model of posttraumatic stress disorder</span> <span class="citation_source-journal">Biol. Psychiatry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">78</span><span class="NLM_x">, </span> <span class="NLM_fpage">871</span><span class="NLM_x">–</span> <span class="NLM_lpage">879</span><span class="refDoi"> DOI: 10.1016/j.biopsych.2015.04.024</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00141&amp;key=10.1016%2Fj.biopsych.2015.04.024" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00141&amp;key=26115790" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00141&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtVKmtL7E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=78&publication_year=2015&pages=871-879&author=N.+M.+Enmanauthor=K.+Arthurauthor=S.+J.+Wardauthor=S.+A.+Perrineauthor=E.+M.+Unterwald&title=Anhedonia%2C+reduced+cocaine+reward%2C+and+dopamine+dysfunction+in+a+rat+model+of+posttraumatic+stress+disorder&doi=10.1016%2Fj.biopsych.2015.04.024"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Anhedonia, Reduced Cocaine Reward, and Dopamine Dysfunction in a Rat Model of Posttraumatic Stress Disorder</span></div><div class="casAuthors">Enman, Nicole M.; Arthur, Kayti; Ward, Sara J.; Perrine, Shane A.; Unterwald, Ellen M.</div><div class="citationInfo"><span class="NLM_cas:title">Biological Psychiatry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">78</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">871-879</span>CODEN:
                <span class="NLM_cas:coden">BIPCBF</span>;
        ISSN:<span class="NLM_cas:issn">0006-3223</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Posttraumatic stress disorder (PTSD) co-occurs with substance use disorders at high rates, but the neurobiol. basis of this relationship is largely unknown.  PTSD and drug addiction each involve dysregulation of brain reward circuitry; therefore, the identification of pathol. of the mesolimbic dopamine system may aid in understanding their functional relationship.  Dopamine reward dysfunction also may be relevant to the mechanisms underlying the PTSD symptoms of anhedonia and emotional numbing.  Single-prolonged stress (SPS) was used as a rat model of PTSD, and a series of behavioral and neuropharmacol. assays were applied to assess the impact of SPS on reward, cocaine intake, and components of the striatal dopamine system.  Exposure to SPS increased anhedonia-like behaviors and decreased the rewarding properties of cocaine compared with control handling.  Altered cocaine intake during extended access self-administration sessions was obsd. in rats exposed to SPS, further suggesting a difference in the reinforcing properties of cocaine following severe stress.  SPS reduced tissue content of dopamine and its metabolites in the striatum, as well as altered striatal dopamine transporter and D2, but not D1, receptor densities.  These results support a role for altered dopaminergic transmission in reduced reward function in PTSD.  Pathol. of the dopamine system and the degrdn. of reward processes may contribute to PTSD symptomol. and have implications for co-occurring psychiatric disorders such as substance abuse or depression.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoW2c5VLzyCybVg90H21EOLACvtfcHk0ljfsHJYGPUOkA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtVKmtL7E&md5=24343f7c7032fe261d1ff07c668c5dcf</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1016%2Fj.biopsych.2015.04.024&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.biopsych.2015.04.024%26sid%3Dliteratum%253Aachs%26aulast%3DEnman%26aufirst%3DN.%2BM.%26aulast%3DArthur%26aufirst%3DK.%26aulast%3DWard%26aufirst%3DS.%2BJ.%26aulast%3DPerrine%26aufirst%3DS.%2BA.%26aulast%3DUnterwald%26aufirst%3DE.%2BM.%26atitle%3DAnhedonia%252C%2520reduced%2520cocaine%2520reward%252C%2520and%2520dopamine%2520dysfunction%2520in%2520a%2520rat%2520model%2520of%2520posttraumatic%2520stress%2520disorder%26jtitle%3DBiol.%2520Psychiatry%26date%3D2015%26volume%3D78%26spage%3D871%26epage%3D879%26doi%3D10.1016%2Fj.biopsych.2015.04.024" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Sakrikar, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mazei-Robison, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mergy, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richtand, N. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Han, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamilton, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bowton, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Galli, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Veenstra-VanderWeele, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gill, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blakely, R. D.</span><span> </span><span class="NLM_article-title">Attention deficit/hyperactivity disorder-derived coding variation in the dopamine transporter disrupts microdomain targeting and trafficking regulation</span> <span class="citation_source-journal">J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">32</span><span class="NLM_x">, </span> <span class="NLM_fpage">5385</span><span class="NLM_x">–</span> <span class="NLM_lpage">5397</span><span class="refDoi"> DOI: 10.1523/JNEUROSCI.6033-11.2012</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00141&amp;key=10.1523%2FJNEUROSCI.6033-11.2012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00141&amp;key=22514303" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00141&amp;key=1%3ACAS%3A528%3ADC%252BC38Xms1akt70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2012&pages=5385-5397&author=D.+Sakrikarauthor=M.+S.+Mazei-Robisonauthor=M.+A.+Mergyauthor=N.+W.+Richtandauthor=Q.+Hanauthor=P.+J.+Hamiltonauthor=E.+Bowtonauthor=A.+Galliauthor=J.+Veenstra-VanderWeeleauthor=M.+Gillauthor=R.+D.+Blakely&title=Attention+deficit%2Fhyperactivity+disorder-derived+coding+variation+in+the+dopamine+transporter+disrupts+microdomain+targeting+and+trafficking+regulation&doi=10.1523%2FJNEUROSCI.6033-11.2012"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Attention deficit/hyperactivity disorder-derived coding variation in the dopamine transporter disrupts microdomain targeting and trafficking regulation</span></div><div class="casAuthors">Sakrikar, Dhananjay; Mazei-Robison, Michelle S.; Mergy, Marc A.; Richtand, Nathan W.; Han, Qiao; Hamilton, Peter J.; Bowton, Erica; Galli, Aurelio; Veenstra-VanderWeele, Jeremy; Gill, Michael; Blakely, Randy D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">5385-5397</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">Attention deficit/hyperactivity disorder (ADHD) is the most commonly diagnosed disorder of school-age children.  Although genetic and brain-imaging studies suggest a contribution of altered dopamine (DA) signaling in ADHD, evidence of signaling perturbations contributing to risk is largely circumstantial.  The presynaptic, cocaine- and amphetamine (AMPH)-sensitive DA transporter (DAT) constrains DA availability at presynaptic and postsynaptic receptors following vesicular release and is targeted by the most commonly prescribed ADHD therapeutics.  Using polymorphism discovery approaches with an ADHD cohort, we identified a hDAT (human DAT) coding variant, R615C, located in the distal C terminus of the transporter, a region previously implicated in constitutive and regulated transporter trafficking.  Here, we demonstrate that, whereas wild-type DAT proteins traffic in a highly regulated manner, DAT 615C proteins recycle constitutively and demonstrate insensitivity to the endocytic effects of AMPH and PKC (protein kinase C) activation.  The disrupted regulation of DAT 615C parallels a redistribution of the transporter variant away from GM1 ganglioside- and flotillin1-enriched membranes, and is accompanied by altered CaMKII (calcium/calmodulin-dependent protein kinase II) and flotillin-1 interactions.  Using C-terminal peptides derived from wild-type DAT and the R615C variant, we establish that the DAT 615C C terminus can act dominantly to preclude AMPH regulation of wild-type DAT.  Mutagenesis of DAT C-terminal sequences suggests that phosphorylation of T613 may be important in sorting DAT between constitutive and regulated pathways.  Together, our studies support a coupling of DAT microdomain localization with transporter regulation and provide evidence of perturbed DAT activity and DA signaling as a risk determinant for ADHD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp031GMAXShX7Vg90H21EOLACvtfcHk0lgPatomB1_n4g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xms1akt70%253D&md5=cbac9ba57278990fd07a30a328f8cef2</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.6033-11.2012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.6033-11.2012%26sid%3Dliteratum%253Aachs%26aulast%3DSakrikar%26aufirst%3DD.%26aulast%3DMazei-Robison%26aufirst%3DM.%2BS.%26aulast%3DMergy%26aufirst%3DM.%2BA.%26aulast%3DRichtand%26aufirst%3DN.%2BW.%26aulast%3DHan%26aufirst%3DQ.%26aulast%3DHamilton%26aufirst%3DP.%2BJ.%26aulast%3DBowton%26aufirst%3DE.%26aulast%3DGalli%26aufirst%3DA.%26aulast%3DVeenstra-VanderWeele%26aufirst%3DJ.%26aulast%3DGill%26aufirst%3DM.%26aulast%3DBlakely%26aufirst%3DR.%2BD.%26atitle%3DAttention%2520deficit%252Fhyperactivity%2520disorder-derived%2520coding%2520variation%2520in%2520the%2520dopamine%2520transporter%2520disrupts%2520microdomain%2520targeting%2520and%2520trafficking%2520regulation%26jtitle%3DJ.%2520Neurosci.%26date%3D2012%26volume%3D32%26spage%3D5385%26epage%3D5397%26doi%3D10.1523%2FJNEUROSCI.6033-11.2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Miller, L. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leitl, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Banks, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blough, B. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Negus, S. S.</span><span> </span><span class="NLM_article-title">Effects of the triple monoamine uptake inhibitor amitifadine on pain-related depression of behavior and mesolimbic dopamine release in rats</span> <span class="citation_source-journal">Pain</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">156</span><span class="NLM_x">, </span> <span class="NLM_fpage">175</span><span class="NLM_x">–</span> <span class="NLM_lpage">184</span><span class="refDoi"> DOI: 10.1016/j.pain.0000000000000018</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00141&amp;key=10.1016%2Fj.pain.0000000000000018" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=156&publication_year=2015&pages=175-184&author=L.+L.+Millerauthor=M.+D.+Leitlauthor=M.+L.+Banksauthor=B.+E.+Bloughauthor=S.+S.+Negus&title=Effects+of+the+triple+monoamine+uptake+inhibitor+amitifadine+on+pain-related+depression+of+behavior+and+mesolimbic+dopamine+release+in+rats&doi=10.1016%2Fj.pain.0000000000000018"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1016%2Fj.pain.0000000000000018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pain.0000000000000018%26sid%3Dliteratum%253Aachs%26aulast%3DMiller%26aufirst%3DL.%2BL.%26aulast%3DLeitl%26aufirst%3DM.%2BD.%26aulast%3DBanks%26aufirst%3DM.%2BL.%26aulast%3DBlough%26aufirst%3DB.%2BE.%26aulast%3DNegus%26aufirst%3DS.%2BS.%26atitle%3DEffects%2520of%2520the%2520triple%2520monoamine%2520uptake%2520inhibitor%2520amitifadine%2520on%2520pain-related%2520depression%2520of%2520behavior%2520and%2520mesolimbic%2520dopamine%2520release%2520in%2520rats%26jtitle%3DPain%26date%3D2015%26volume%3D156%26spage%3D175%26epage%3D184%26doi%3D10.1016%2Fj.pain.0000000000000018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Wu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bellvé, K. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fogarty, K. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haley, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Melikian, H. E.</span><span> </span><span class="NLM_article-title">Ack1 is a dopamine transporter endocytic brake that rescues a trafficking-dysregulated ADHD coding variant</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">112</span><span class="NLM_x">, </span> <span class="NLM_fpage">15480</span><span class="NLM_x">–</span> <span class="NLM_lpage">15485</span><span class="refDoi"> DOI: 10.1073/pnas.1512957112</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00141&amp;key=10.1073%2Fpnas.1512957112" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=112&publication_year=2015&pages=15480-15485&author=S.+Wuauthor=K.+D.+Bellv%C3%A9author=K.+E.+Fogartyauthor=E.+Haleyauthor=H.+E.+Melikian&title=Ack1+is+a+dopamine+transporter+endocytic+brake+that+rescues+a+trafficking-dysregulated+ADHD+coding+variant&doi=10.1073%2Fpnas.1512957112"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1512957112&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1512957112%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DS.%26aulast%3DBellv%25C3%25A9%26aufirst%3DK.%2BD.%26aulast%3DFogarty%26aufirst%3DK.%2BE.%26aulast%3DHaley%26aufirst%3DE.%26aulast%3DMelikian%26aufirst%3DH.%2BE.%26atitle%3DAck1%2520is%2520a%2520dopamine%2520transporter%2520endocytic%2520brake%2520that%2520rescues%2520a%2520trafficking-dysregulated%2520ADHD%2520coding%2520variant%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2015%26volume%3D112%26spage%3D15480%26epage%3D15485%26doi%3D10.1073%2Fpnas.1512957112" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Sharma, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Santra, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dutta, A.</span><span> </span><span class="NLM_article-title">Triple reuptake inhibitors as potential next-generation antidepressants: a new hope?</span> <span class="citation_source-journal">Future Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">2385</span><span class="NLM_x">–</span> <span class="NLM_lpage">2406</span><span class="refDoi"> DOI: 10.4155/fmc.15.134</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00141&amp;key=10.4155%2Ffmc.15.134" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00141&amp;key=26619226" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00141&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhvFKlu77I" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2015&pages=2385-2406&author=H.+Sharmaauthor=S.+Santraauthor=A.+Dutta&title=Triple+reuptake+inhibitors+as+potential+next-generation+antidepressants%3A+a+new+hope%3F&doi=10.4155%2Ffmc.15.134"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Triple reuptake inhibitors as potential next-generation antidepressants: a new hope?</span></div><div class="casAuthors">Sharma, Horrick; Santra, Soumava; Dutta, Aloke</div><div class="citationInfo"><span class="NLM_cas:title">Future Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">2385-2406</span>CODEN:
                <span class="NLM_cas:coden">FMCUA7</span>;
        ISSN:<span class="NLM_cas:issn">1756-8919</span>.
    
            (<span class="NLM_cas:orgname">Future Science Ltd.</span>)
        </div><div class="casAbstract">The current therapy for depression is less than ideal with remission rates of only 25-35% and a slow onset of action with other assocd. side effects.  The persistence of anhedonia originating from depressed dopaminergic activity is one of the most treatment-resistant symptoms of depression.  Therefore, it has been hypothesized that triple reuptake inhibitors (TRIs) with potency to block dopamine reuptake in addn. to serotonin and norepinephrine transporters should produce higher efficacy.  The current review comprehensively describes the development of TRIs and discusses the importance of evaluation of in vivo transporter occupancy of TRIs, which should correlate with efficacy in humans.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrShosMLktZJbVg90H21EOLACvtfcHk0li-o1CQhcELNA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhvFKlu77I&md5=1130f331ad0e8ecfcdf5a8c3fe915596</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.4155%2Ffmc.15.134&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4155%252Ffmc.15.134%26sid%3Dliteratum%253Aachs%26aulast%3DSharma%26aufirst%3DH.%26aulast%3DSantra%26aufirst%3DS.%26aulast%3DDutta%26aufirst%3DA.%26atitle%3DTriple%2520reuptake%2520inhibitors%2520as%2520potential%2520next-generation%2520antidepressants%253A%2520a%2520new%2520hope%253F%26jtitle%3DFuture%2520Med.%2520Chem.%26date%3D2015%26volume%3D7%26spage%3D2385%26epage%3D2406%26doi%3D10.4155%2Ffmc.15.134" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Santra, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sharma, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vedachalam, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Antonio, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reith, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dutta, A.</span><span> </span><span class="NLM_article-title">Development of potent dopamine-norepinephrine uptake inhibitors (DNRIs) based on a (2S,4R,5R)-2-benzhydryl-5-((4-methoxybenzyl)amino)tetrahydro-2H-pyran-4-ol molecular template</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">821</span><span class="NLM_x">–</span> <span class="NLM_lpage">828</span><span class="refDoi"> DOI: 10.1016/j.bmc.2014.12.040</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00141&amp;key=10.1016%2Fj.bmc.2014.12.040" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00141&amp;key=25593099" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00141&amp;key=1%3ACAS%3A528%3ADC%252BC2MXltVClsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2015&pages=821-828&author=S.+Santraauthor=H.+Sharmaauthor=S.+Vedachalamauthor=T.+Antonioauthor=M.+Reithauthor=A.+Dutta&title=Development+of+potent+dopamine-norepinephrine+uptake+inhibitors+%28DNRIs%29+based+on+a+%282S%2C4R%2C5R%29-2-benzhydryl-5-%28%284-methoxybenzyl%29amino%29tetrahydro-2H-pyran-4-ol+molecular+template&doi=10.1016%2Fj.bmc.2014.12.040"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Development of potent dopamine-norepinephrine uptake inhibitors (DNRIs) based on a (2S,4R,5R)-2-benzhydryl-5-((4-methoxybenzyl)amino)tetrahydro-2H-pyran-4-ol molecular template</span></div><div class="casAuthors">Santra, Soumava; Sharma, Horrick; Vedachalam, Seenuvasan; Antonio, Tamara; Reith, Maarten; Dutta, Aloke</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">821-828</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Current therapy of depression is less than ideal with remission rates of only 25-35% and response rates of 45-60%.  It has been hypothesized that a dysfunctional dopaminergic system in the mesocorticolimbic pathway in depressive disorder may lead to development of anhedonia assocd. with loss of pleasure and interest along with loss of motivation.  The current antidepressants do not address dopamine dysfunction which might explain their low efficacy.  In this report, we have described an SAR study on our pyran-based triple reuptake inhibitors (TRIs) which are being investigated as the next-generation antidepressants.  In the present work we demonstrate that our lead TRIs can be modified with appropriate arom. substitutions to display a highly potent SSRI profile for compds. 2a and 4a (Ki (SERT); 0.71 and 2.68 nM, resp.) or a potent DNRI profile for compds. 6b and 6h (Ki (DAT/NET); 8.94/4.76 and 13/7.37 nM, resp.).  Compds. 4g-4i exhibited potencies at all three monoamine transporters.  The results provide insights into the structural requirements for developing selective dual- and triple-uptake inhibitors from a unique pyran mol. template for an effective management of depression and related disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpIEOmzHoWe3bVg90H21EOLACvtfcHk0li-o1CQhcELNA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXltVClsQ%253D%253D&md5=0a5a3ddbf26efdc8e9dc9c6664a4a962</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2014.12.040&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2014.12.040%26sid%3Dliteratum%253Aachs%26aulast%3DSantra%26aufirst%3DS.%26aulast%3DSharma%26aufirst%3DH.%26aulast%3DVedachalam%26aufirst%3DS.%26aulast%3DAntonio%26aufirst%3DT.%26aulast%3DReith%26aufirst%3DM.%26aulast%3DDutta%26aufirst%3DA.%26atitle%3DDevelopment%2520of%2520potent%2520dopamine-norepinephrine%2520uptake%2520inhibitors%2520%2528DNRIs%2529%2520based%2520on%2520a%2520%25282S%252C4R%252C5R%2529-2-benzhydryl-5-%2528%25284-methoxybenzyl%2529amino%2529tetrahydro-2H-pyran-4-ol%2520molecular%2520template%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2015%26volume%3D23%26spage%3D821%26epage%3D828%26doi%3D10.1016%2Fj.bmc.2014.12.040" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Lavretsky, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reinlieb, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">St. Cyr, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siddarth, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ercoli, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Senturk, D.</span><span> </span><span class="NLM_article-title">Combined citalopram and methylphenidate improved treatment response compared to either drug alone in geriatric depression: a randomized double-blind, placebo-controlled trial</span> <span class="citation_source-journal">Am. J. Psychiatry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">172</span><span class="NLM_x">, </span> <span class="NLM_fpage">561</span><span class="NLM_x">–</span> <span class="NLM_lpage">569</span><span class="refDoi"> DOI: 10.1176/appi.ajp.2014.14070889</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00141&amp;key=10.1176%2Fappi.ajp.2014.14070889" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00141&amp;key=25677354" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00141&amp;key=1%3ACAS%3A280%3ADC%252BC2MrltVyrsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=172&publication_year=2015&pages=561-569&author=H.+Lavretskyauthor=M.+Reinliebauthor=N.+St.+Cyrauthor=P.+Siddarthauthor=L.+M.+Ercoliauthor=D.+Senturk&title=Combined+citalopram+and+methylphenidate+improved+treatment+response+compared+to+either+drug+alone+in+geriatric+depression%3A+a+randomized+double-blind%2C+placebo-controlled+trial&doi=10.1176%2Fappi.ajp.2014.14070889"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Citalopram, methylphenidate, or their combination in geriatric depression: a randomized, double-blind, placebo-controlled trial</span></div><div class="casAuthors">Lavretsky Helen; Reinlieb Michelle; St Cyr Natalie; Siddarth Prabha; Ercoli Linda M; Senturk Damla</div><div class="citationInfo"><span class="NLM_cas:title">The American journal of psychiatry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">172</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">561-9</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">OBJECTIVE:  The authors evaluated the potential of methylphenidate to improve antidepressant response to citalopram, as assessed by clinical and cognitive outcomes, in elderly depressed patients.  METHOD:  The authors conducted a 16-week randomized double-blind placebo-controlled trial for geriatric depression in 143 older outpatients diagnosed with major depression comparing treatment response in three treatment groups: methylphenidate plus placebo (N=48), citalopram plus placebo (N=48), and citalopram plus methylphenidate (N=47).  The primary outcome measure was change in depression severity.  Remission was defined as a score of 6 or less on the Hamilton Depression Rating Scale.  Secondary outcomes included measures of anxiety, apathy, quality of life, and cognition.  RESULTS:  Daily doses ranged from 20 mg to 60 mg for citalopram (mean=32 mg) and from 5 mg to 40 mg for methylphenidate (mean=16 mg).  All groups showed significant improvement in depression severity and in cognitive performance.  However, the improvement in depression severity and the Clinical Global Impressions improvement score was more prominent in the citalopram plus methylphenidate group compared with the other two groups.  Additionally, the rate of improvement in the citalopram plus methylphenidate group was significantly higher than that in the citalopram plus placebo group in the first 4 weeks of the trial.  The groups did not differ in cognitive improvement or number of side effects.  CONCLUSIONS:  Combined treatment with citalopram and methylphenidate demonstrated an enhanced clinical response profile in mood and well-being, as well as a higher rate of remission, compared with either drug alone.  All treatments led to an improvement in cognitive functioning, although augmentation with methylphenidate did not offer additional benefits.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSxB3aT0-0XOHqj_yg7twvpfW6udTcc2eax4tlAyLbH7rntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2MrltVyrsA%253D%253D&md5=0b3a2039c3f946ab4fc0d4a575b90e14</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1176%2Fappi.ajp.2014.14070889&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1176%252Fappi.ajp.2014.14070889%26sid%3Dliteratum%253Aachs%26aulast%3DLavretsky%26aufirst%3DH.%26aulast%3DReinlieb%26aufirst%3DM.%26aulast%3DSt.%2BCyr%26aufirst%3DN.%26aulast%3DSiddarth%26aufirst%3DP.%26aulast%3DErcoli%26aufirst%3DL.%2BM.%26aulast%3DSenturk%26aufirst%3DD.%26atitle%3DCombined%2520citalopram%2520and%2520methylphenidate%2520improved%2520treatment%2520response%2520compared%2520to%2520either%2520drug%2520alone%2520in%2520geriatric%2520depression%253A%2520a%2520randomized%2520double-blind%252C%2520placebo-controlled%2520trial%26jtitle%3DAm.%2520J.%2520Psychiatry%26date%3D2015%26volume%3D172%26spage%3D561%26epage%3D569%26doi%3D10.1176%2Fappi.ajp.2014.14070889" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Malhi, G. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Byrow, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bassett, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boyce, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hopwood, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lyndon, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mulder, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Porter, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Singh, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murray, G.</span><span> </span><span class="NLM_article-title">Stimulants for depression: On the up and up?</span> <span class="citation_source-journal">Aust. N. Z. J. Psychiatry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">203</span><span class="NLM_x">–</span> <span class="NLM_lpage">207</span><span class="refDoi"> DOI: 10.1177/0004867416634208</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00141&amp;key=10.1177%2F0004867416634208" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00141&amp;key=26906078" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00141&amp;key=1%3ACAS%3A280%3ADC%252BC28jjsFGgtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2016&pages=203-207&author=G.+S.+Malhiauthor=Y.+Byrowauthor=D.+Bassettauthor=P.+Boyceauthor=M.+Hopwoodauthor=W.+Lyndonauthor=R.+Mulderauthor=R.+Porterauthor=A.+Singhauthor=G.+Murray&title=Stimulants+for+depression%3A+On+the+up+and+up%3F&doi=10.1177%2F0004867416634208"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Stimulants for depression: On the up and up?</span></div><div class="casAuthors">Malhi Gin S; Byrow Yulisha; Bassett Darryl; Boyce Philip; Hopwood Malcolm; Lyndon William; Mulder Roger; Porter Richard; Singh Ajeet; Murray Greg</div><div class="citationInfo"><span class="NLM_cas:title">The Australian and New Zealand journal of psychiatry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">203-7</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The use of traditional psychostimulants (methylphenidate and dexamphetamine) and stimulant-like drugs (modafinil and armodafinil) for the treatment of depression is a growing concern given the lack of research evidence supporting their effectiveness.  The current article describes the role of stimulants in treating depression--specifically their risks and benefits and their potential use alongside antidepressants.  Clinically, the rapid amelioration of depressive symptoms with traditional psychostimulants is often dramatic but short-lived, and this suggests that they likely operate via different mechanisms to conventional antidepressants.  More importantly, there is little evidence from randomised controlled trials supporting their efficacy in treating depression, although modafinil has been shown to be effective in reducing prominent depressive symptoms, such as fatigue.  Research is urgently required to clarify psychostimulants' mechanisms of action and to evaluate their long-term benefits and risks in the treatment of major and bipolar depression.  Ultimately, specificity of action needs to be determined to inform the sophisticated clinical use of psychostimulants in the management of depression.  Until then they should only be prescribed if absolutely necessary, and even then their prescription should be facilitatory and time limited unless it is for investigational purposes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcS-EuZu54KphsuCWE5mhx1RfW6udTcc2eZC5YulzaL8bLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC28jjsFGgtw%253D%253D&md5=f7319212793eb64084c011264cc9fc70</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1177%2F0004867416634208&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F0004867416634208%26sid%3Dliteratum%253Aachs%26aulast%3DMalhi%26aufirst%3DG.%2BS.%26aulast%3DByrow%26aufirst%3DY.%26aulast%3DBassett%26aufirst%3DD.%26aulast%3DBoyce%26aufirst%3DP.%26aulast%3DHopwood%26aufirst%3DM.%26aulast%3DLyndon%26aufirst%3DW.%26aulast%3DMulder%26aufirst%3DR.%26aulast%3DPorter%26aufirst%3DR.%26aulast%3DSingh%26aufirst%3DA.%26aulast%3DMurray%26aufirst%3DG.%26atitle%3DStimulants%2520for%2520depression%253A%2520On%2520the%2520up%2520and%2520up%253F%26jtitle%3DAust.%2520N.%2520Z.%2520J.%2520Psychiatry%26date%3D2016%26volume%3D50%26spage%3D203%26epage%3D207%26doi%3D10.1177%2F0004867416634208" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Tosh, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deflorian, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Phan, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, Z. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wan, T. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gizewski, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Auchampach, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobson, K. A.</span><span> </span><span class="NLM_article-title">Structure-guided design of A<sub>3</sub> adenosine receptor-selective nucleosides: Combination of 2-arylethynyl and bicyclo[3.1.0]hexane substitutions</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">4847</span><span class="NLM_x">–</span> <span class="NLM_lpage">4860</span><span class="refDoi"> DOI: 10.1021/jm300396n</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm300396n" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00141&amp;key=1%3ACAS%3A528%3ADC%252BC38XmsFygu74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=4847-4860&author=D.+K.+Toshauthor=F.+Deflorianauthor=K.+Phanauthor=Z.+G.+Gaoauthor=T.+C.+Wanauthor=E.+Gizewskiauthor=J.+A.+Auchampachauthor=K.+A.+Jacobson&title=Structure-guided+design+of+A3+adenosine+receptor-selective+nucleosides%3A+Combination+of+2-arylethynyl+and+bicyclo%5B3.1.0%5Dhexane+substitutions&doi=10.1021%2Fjm300396n"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-Guided Design of A3 Adenosine Receptor-Selective Nucleosides: Combination of 2-Arylethynyl and Bicyclo[3.1.0]hexane Substitutions</span></div><div class="casAuthors">Tosh, Dilip K.; Deflorian, Francesca; Phan, Khai; Gao, Zhan-Guo; Wan, Tina C.; Gizewski, Elizabeth; Auchampach, John A.; Jacobson, Kenneth A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">4847-4860</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">(N)-Methanocarba adenosine 5'-methyluronamides contg. known A3 AR (adenosine receptor)-enhancing modifications, i.e., 2-(arylethynyl)adenine and N6-Me or N6-(3-substituted-benzyl), were nanomolar full agonists of human (h) A3AR and highly selective (Ki ∼0.6 nM, N6-Me 2-(halophenylethynyl) analogs).  Combined 2-arylethynyl-N6-3-chlorobenzyl substitutions preserved A3AR affinity/selectivity in the (N)-methanocarba series (e.g., 3,4-difluoro full agonist MRS5698, Ki 3 nM, human and mouse A3) better than that for ribosides.  Polyarom. 2-ethynyl N6-3-chlorobenzyl analogs, such as potent linearly extended 2-p-biphenylethynyl MRS5679 (Ki hA3 3.1 nM; A1, A2A, inactive) and fluorescent 1-pyrene adduct MRS5704 (Ki hA3 68.3 nM), were conformationally rigid; receptor docking identified a large, mainly hydrophobic binding region.  The vicinity of receptor-bound C2 groups was probed by homol. modeling based on recent x-ray structure of an agonist-bound A2AAR, with a predicted helical rearrangement requiring an agonist-specific outward displacement of TM2 resembling opsin.  Thus, the x-ray structure of related A2AAR is useful in guiding the design of new A3AR agonists.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpMpTThMrry7bVg90H21EOLACvtfcHk0liUwNFFMWTBYA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XmsFygu74%253D&md5=e01c27247742c9d20ee7ff753a2de88c</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1021%2Fjm300396n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm300396n%26sid%3Dliteratum%253Aachs%26aulast%3DTosh%26aufirst%3DD.%2BK.%26aulast%3DDeflorian%26aufirst%3DF.%26aulast%3DPhan%26aufirst%3DK.%26aulast%3DGao%26aufirst%3DZ.%2BG.%26aulast%3DWan%26aufirst%3DT.%2BC.%26aulast%3DGizewski%26aufirst%3DE.%26aulast%3DAuchampach%26aufirst%3DJ.%2BA.%26aulast%3DJacobson%26aufirst%3DK.%2BA.%26atitle%3DStructure-guided%2520design%2520of%2520A3%2520adenosine%2520receptor-selective%2520nucleosides%253A%2520Combination%2520of%25202-arylethynyl%2520and%2520bicyclo%255B3.1.0%255Dhexane%2520substitutions%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D4847%26epage%3D4860%26doi%3D10.1021%2Fjm300396n" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Tosh, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Padia, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salvemini, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobson, K. A.</span><span> </span><span class="NLM_article-title">Efficient, large-scale synthesis and preclinical studies of MRS5698, a highly selective A<sub>3</sub> adenosine receptor agonist that protects against chronic neuropathic pain</span> <span class="citation_source-journal">Purinergic Signalling</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">371</span><span class="NLM_x">–</span> <span class="NLM_lpage">387</span><span class="refDoi"> DOI: 10.1007/s11302-015-9459-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00141&amp;key=10.1007%2Fs11302-015-9459-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00141&amp;key=26111639" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00141&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtVyhsL7J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2015&pages=371-387&author=D.+K.+Toshauthor=J.+Padiaauthor=D.+Salveminiauthor=K.+A.+Jacobson&title=Efficient%2C+large-scale+synthesis+and+preclinical+studies+of+MRS5698%2C+a+highly+selective+A3+adenosine+receptor+agonist+that+protects+against+chronic+neuropathic+pain&doi=10.1007%2Fs11302-015-9459-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Efficient, large-scale synthesis and preclinical studies of MRS5698, a highly selective A3 adenosine receptor agonist that protects against chronic neuropathic pain</span></div><div class="casAuthors">Tosh, Dilip K.; Padia, Janak; Salvemini, Daniela; Jacobson, Kenneth A.</div><div class="citationInfo"><span class="NLM_cas:title">Purinergic Signalling</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">371-387</span>CODEN:
                <span class="NLM_cas:coden">PSUIA9</span>;
        ISSN:<span class="NLM_cas:issn">1573-9538</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">We reported that 2-(3,4-difluorophenylethynyl)-N6-3-chlorobenzyl (N)-methanocarba adenosine deriv. 1 (MRS5698) binds selectively to human and mouse A3 adenosine receptors (A3ARs, Ki 3 nM).  It is becoming an important pharmacol. tool for defining A3AR effects and is orally active in a chronic neuropathic pain model.  Here, we introduce a new synthetic route for MRS5698 from D-ribose, suitable for a scale-up on a multi-gram scale, and we measure in vitro and in vivo ADME-Tox parameters.  MRS5698 was very stable in vitro, failed to inhibit CYPs at <10 μM, and was largely bound to plasma proteins.  It was well tolerated in the rat at doses of ≤200 mg/kg i.p.  A 1 mg/kg i.p. dose in the mouse displayed t1/2 of 1.09 h and plasma Cmax of 204 nM at 1 h with an AUC of 213 ng × h/mL.  CACO-2 bidirectional transport studies suggested intestinal efflux of MRS5698 (efflux ratio 86).  Although the oral %F is only 5 %, the beneficial effect to reverse pain lasted for at least 2 h in the CCI model in rats, using the same vehicle for oral administration of a high dose.  The stability, low toxicity, lack of CYP interaction, pharmacokinetic half-life, and in vivo efficacy suggest that MRS5698 is a preferred compd. for further consideration as a treatment for neuropathic pain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqu82TREqapwLVg90H21EOLACvtfcHk0liUwNFFMWTBYA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtVyhsL7J&md5=0d810ff59dc5011f0ae25e7f8d6d24c4</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1007%2Fs11302-015-9459-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs11302-015-9459-2%26sid%3Dliteratum%253Aachs%26aulast%3DTosh%26aufirst%3DD.%2BK.%26aulast%3DPadia%26aufirst%3DJ.%26aulast%3DSalvemini%26aufirst%3DD.%26aulast%3DJacobson%26aufirst%3DK.%2BA.%26atitle%3DEfficient%252C%2520large-scale%2520synthesis%2520and%2520preclinical%2520studies%2520of%2520MRS5698%252C%2520a%2520highly%2520selective%2520A3%2520adenosine%2520receptor%2520agonist%2520that%2520protects%2520against%2520chronic%2520neuropathic%2520pain%26jtitle%3DPurinergic%2520Signalling%26date%3D2015%26volume%3D11%26spage%3D371%26epage%3D387%26doi%3D10.1007%2Fs11302-015-9459-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Paoletta, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tosh, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salvemini, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobson, K. A.</span><span> </span><span class="NLM_article-title">Structural probing of off-target G protein-coupled receptor activities within a series of adenosine/adenine congeners</span> <span class="citation_source-journal">PLoS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">e97858</span><span class="refDoi"> DOI: 10.1371/journal.pone.0097858</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00141&amp;key=10.1371%2Fjournal.pone.0097858" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2014&pages=e97858&author=S.+Paolettaauthor=D.+K.+Toshauthor=D.+Salveminiauthor=K.+A.+Jacobson&title=Structural+probing+of+off-target+G+protein-coupled+receptor+activities+within+a+series+of+adenosine%2Fadenine+congeners&doi=10.1371%2Fjournal.pone.0097858"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0097858&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0097858%26sid%3Dliteratum%253Aachs%26aulast%3DPaoletta%26aufirst%3DS.%26aulast%3DTosh%26aufirst%3DD.%2BK.%26aulast%3DSalvemini%26aufirst%3DD.%26aulast%3DJacobson%26aufirst%3DK.%2BA.%26atitle%3DStructural%2520probing%2520of%2520off-target%2520G%2520protein-coupled%2520receptor%2520activities%2520within%2520a%2520series%2520of%2520adenosine%252Fadenine%2520congeners%26jtitle%3DPLoS%2520One%26date%3D2014%26volume%3D9%26spage%3De97858%26doi%3D10.1371%2Fjournal.pone.0097858" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Tosh, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crane, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paoletta, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, Z. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gizewski, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Auchampach, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salvemini, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobson, K. A.</span><span> </span><span class="NLM_article-title">Rigidified A<sub>3</sub> adenosine receptor agonists: 1-Deaza modification maintains high in vivo efficacy</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">804</span><span class="NLM_x">–</span> <span class="NLM_lpage">808</span><span class="refDoi"> DOI: 10.1021/acsmedchemlett.5b00150</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsmedchemlett.5b00150" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00141&amp;key=1%3ACAS%3A528%3ADC%252BC2MXovVSiurY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2015&pages=804-808&author=D.+K.+Toshauthor=S.+Craneauthor=Z.+Chenauthor=S.+Paolettaauthor=Z.+G.+Gaoauthor=E.+Gizewskiauthor=J.+A.+Auchampachauthor=D.+Salveminiauthor=K.+A.+Jacobson&title=Rigidified+A3+adenosine+receptor+agonists%3A+1-Deaza+modification+maintains+high+in+vivo+efficacy&doi=10.1021%2Facsmedchemlett.5b00150"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Rigidified A3 Adenosine Receptor Agonists: 1-Deazaadenine Modification Maintains High in Vivo Efficacy</span></div><div class="casAuthors">Tosh, Dilip K.; Crane, Steven; Chen, Zhoumou; Paoletta, Silvia; Gao, Zhan-Guo; Gizewski, Elizabeth; Auchampach, John A.; Salvemini, Daniela; Jacobson, Kenneth A.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">804-808</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Substitution of rigidified A3 adenosine receptor (AR) agonists with a 2-((5-chlorothiophen-2-yl)ethynyl) or a 2-(4-(5-chlorothiophen-2-yl)-1H-1,2,3-triazol-1-yl) group provides prolonged protection in a model of chronic neuropathic pain.  These agonists contain a bicyclo[3.1.0]hexane ((N)-methanocarba) ring system in place of ribose, which adopts a receptor-preferred conformation.  N6-Small alkyl derivs. were newly optimized for A3AR affinity and the effects of a 1-deaza-adenine modification probed.  1-Deaza-N6-Et alkyne MRS7144 (Ki 1.7 nM) and 1-aza N6-Pr alkyne (I; MRS7154, Ki 1.1 nM) were highly efficacious in vivo.  Thus, the presence of N1 is not required for nanomolar binding affinity or potent, long-lasting functional activity.  Docking of 1-deaza compds. to a receptor homol. model confirmed a similar binding mode as previously reported 1-aza derivs.  This is the first demonstration in nonribose adenosine analogs that the 1-deaza modification can maintain high A3AR affinity, selectivity, and efficacy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrN4NlfzNSFvrVg90H21EOLACvtfcHk0lgQsqQKKIcIng"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXovVSiurY%253D&md5=837fb9f8bbbe84ce0de05b4bcb793b1a</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1021%2Facsmedchemlett.5b00150&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsmedchemlett.5b00150%26sid%3Dliteratum%253Aachs%26aulast%3DTosh%26aufirst%3DD.%2BK.%26aulast%3DCrane%26aufirst%3DS.%26aulast%3DChen%26aufirst%3DZ.%26aulast%3DPaoletta%26aufirst%3DS.%26aulast%3DGao%26aufirst%3DZ.%2BG.%26aulast%3DGizewski%26aufirst%3DE.%26aulast%3DAuchampach%26aufirst%3DJ.%2BA.%26aulast%3DSalvemini%26aufirst%3DD.%26aulast%3DJacobson%26aufirst%3DK.%2BA.%26atitle%3DRigidified%2520A3%2520adenosine%2520receptor%2520agonists%253A%25201-Deaza%2520modification%2520maintains%2520high%2520in%2520vivo%2520efficacy%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2015%26volume%3D6%26spage%3D804%26epage%3D808%26doi%3D10.1021%2Facsmedchemlett.5b00150" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Bressi, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choe, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hough, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buckner, F. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">VanVoorhis, W. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verlinde, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hol, W. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gelb, M. H.</span><span> </span><span class="NLM_article-title">Adenosine analogues as inhibitors of Trypanosoma brucei phosphoglycerate kinase: elucidation of a novel binding mode for a 2-amino-<i>N</i><sup>6</sup>-substituted adenosine</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">43</span><span class="NLM_x">, </span> <span class="NLM_fpage">4135</span><span class="NLM_x">–</span> <span class="NLM_lpage">4150</span><span class="refDoi"> DOI: 10.1021/jm000287a</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm000287a" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2000&pages=4135-4150&author=J.+C.+Bressiauthor=J.+Choeauthor=M.+T.+Houghauthor=F.+S.+Bucknerauthor=W.+C.+VanVoorhisauthor=C.+L.+Verlindeauthor=W.+G.+Holauthor=M.+H.+Gelb&title=Adenosine+analogues+as+inhibitors+of+Trypanosoma+brucei+phosphoglycerate+kinase%3A+elucidation+of+a+novel+binding+mode+for+a+2-amino-N6-substituted+adenosine&doi=10.1021%2Fjm000287a"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22a&amp;dbid=16384&amp;doi=10.1021%2Fjm000287a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm000287a%26sid%3Dliteratum%253Aachs%26aulast%3DBressi%26aufirst%3DJ.%2BC.%26aulast%3DChoe%26aufirst%3DJ.%26aulast%3DHough%26aufirst%3DM.%2BT.%26aulast%3DBuckner%26aufirst%3DF.%2BS.%26aulast%3DVanVoorhis%26aufirst%3DW.%2BC.%26aulast%3DVerlinde%26aufirst%3DC.%2BL.%26aulast%3DHol%26aufirst%3DW.%2BG.%26aulast%3DGelb%26aufirst%3DM.%2BH.%26atitle%3DAdenosine%2520analogues%2520as%2520inhibitors%2520of%2520Trypanosoma%2520brucei%2520phosphoglycerate%2520kinase%253A%2520elucidation%2520of%2520a%2520novel%2520binding%2520mode%2520for%2520a%25202-amino-N6-substituted%2520adenosine%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2000%26volume%3D43%26spage%3D4135%26epage%3D4150%26doi%3D10.1021%2Fjm000287a" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit22b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Joshi, B. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Melman, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mackman, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobson, K. A.</span><span> </span><span class="NLM_article-title">Synthesis of ethyl (1<i>S</i>,2<i>R</i>,3<i>S</i>,4<i>S,</i>5<i>S</i>)-2,3-<i>O</i>-(isopropylidene)-4-hydroxy-bicyclo[3.1.0]hexane-carboxylate from L-ribose: A versatile chiral synthon for preparation of adenosine and P2 receptor ligands</span> <span class="citation_source-journal">Nucleosides, Nucleotides Nucleic Acids</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">279</span><span class="NLM_x">–</span> <span class="NLM_lpage">291</span><span class="refDoi"> DOI: 10.1080/15257770701845253</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00141&amp;key=10.1080%2F15257770701845253" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00141&amp;key=18260011" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00141&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhs1WmsL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2008&pages=279-291&author=B.+V.+Joshiauthor=A.+Melmanauthor=R.+L.+Mackmanauthor=K.+A.+Jacobson&title=Synthesis+of+ethyl+%281S%2C2R%2C3S%2C4S%2C5S%29-2%2C3-O-%28isopropylidene%29-4-hydroxy-bicyclo%5B3.1.0%5Dhexane-carboxylate+from+L-ribose%3A+A+versatile+chiral+synthon+for+preparation+of+adenosine+and+P2+receptor+ligands&doi=10.1080%2F15257770701845253"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22bR"><div class="casContent"><span class="casTitleNuber">22b</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of Ethyl (1S,2R,3S,4S,5S)-2,3-O-(Isopropylidene)-4-Hydroxy-Bicyclo[3.1.0]Hexane-Carboxylate from L-Ribose: A Versatile Chiral Synthon for Preparation of Adenosine and P2 Receptor Ligands</span></div><div class="casAuthors">Joshi, Bhalchandra V.; Melman, Artem; Mackman, Richard L.; Jacobson, Kenneth A.</div><div class="citationInfo"><span class="NLM_cas:title">Nucleosides, Nucleotides & Nucleic Acids</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">279-291</span>CODEN:
                <span class="NLM_cas:coden">NNNAFY</span>;
        ISSN:<span class="NLM_cas:issn">1525-7770</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis, Inc.</span>)
        </div><div class="casAbstract">Substitution of the ribose moiety of various nucleosides and nucleotides with the (N)-methanocarba ring system increases the potency and selectivity as ligands at certain subtypes of adenosine and P2 receptors.  A key intermediate, Et (1S,2R,3S,4S,5S)-2,3-O-(isopropylidene)-4-hydroxybicyclo[3.1.0]hexane-carboxylate (I), has been prepd. starting from L-ribose as a readily available, enantiopure building block.  L-Ribose was converted to the corresponding 5'-iodo deriv., which was cleaved reductively with Zn.  Improvements were made in subsequent steps corresponding to a published route to biol. important (N)-methanocarba 5'-uronamido nucleoside II, and new steps were added to prep. related 5'-nucleotide III.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrsF6DdREPJmrVg90H21EOLACvtfcHk0lhxAmFoMC1VgA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhs1WmsL4%253D&md5=5ef140fa1779a146d0a1700d352c9720</span></div><a href="/servlet/linkout?suffix=cit22b&amp;dbid=16384&amp;doi=10.1080%2F15257770701845253&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F15257770701845253%26sid%3Dliteratum%253Aachs%26aulast%3DJoshi%26aufirst%3DB.%2BV.%26aulast%3DMelman%26aufirst%3DA.%26aulast%3DMackman%26aufirst%3DR.%2BL.%26aulast%3DJacobson%26aufirst%3DK.%2BA.%26atitle%3DSynthesis%2520of%2520ethyl%2520%25281S%252C2R%252C3S%252C4S%252C5S%2529-2%252C3-O-%2528isopropylidene%2529-4-hydroxy-bicyclo%255B3.1.0%255Dhexane-carboxylate%2520from%2520L-ribose%253A%2520A%2520versatile%2520chiral%2520synthon%2520for%2520preparation%2520of%2520adenosine%2520and%2520P2%2520receptor%2520ligands%26jtitle%3DNucleosides%252C%2520Nucleotides%2520Nucleic%2520Acids%26date%3D2008%26volume%3D27%26spage%3D279%26epage%3D291%26doi%3D10.1080%2F15257770701845253" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Besnard, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruda, G. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Setola, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abecassis, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodriguiz, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, X. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Norval, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sassano, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shin, A. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Webster, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simeons, F. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stojanovski, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prat, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seidah, N. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Constam, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bickerton, G. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Read, K. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wetsel, W. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gilbert, I. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roth, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hopkins, A. L.</span><span> </span><span class="NLM_article-title">Automated design of ligands to polypharmacological profiles</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">492</span><span class="NLM_x">, </span> <span class="NLM_fpage">215</span><span class="NLM_x">–</span> <span class="NLM_lpage">220</span><span class="refDoi"> DOI: 10.1038/nature11691</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00141&amp;key=10.1038%2Fnature11691" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00141&amp;key=23235874" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00141&amp;key=1%3ACAS%3A528%3ADC%252BC38XhvVamurfN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=492&publication_year=2012&pages=215-220&author=J.+Besnardauthor=G.+F.+Rudaauthor=V.+Setolaauthor=K.+Abecassisauthor=R.+M.+Rodriguizauthor=X.+P.+Huangauthor=S.+Norvalauthor=M.+F.+Sassanoauthor=A.+I.+Shinauthor=L.+A.+Websterauthor=F.+R.+Simeonsauthor=L.+Stojanovskiauthor=A.+Pratauthor=N.+G.+Seidahauthor=D.+B.+Constamauthor=G.+R.+Bickertonauthor=K.+D.+Readauthor=W.+C.+Wetselauthor=I.+H.+Gilbertauthor=B.+L.+Rothauthor=A.+L.+Hopkins&title=Automated+design+of+ligands+to+polypharmacological+profiles&doi=10.1038%2Fnature11691"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Automated design of ligands to polypharmacological profiles</span></div><div class="casAuthors">Besnard, Jeremy; Ruda, Gian Filippo; Setola, Vincent; Abecassis, Keren; Rodriguiz, Ramona M.; Huang, Xi-Ping; Norval, Suzanne; Sassano, Maria F.; Shin, Antony I.; Webster, Lauren A.; Simeons, Frederick R. C.; Stojanovski, Laste; Prat, Annik; Seidah, Nabil G.; Constam, Daniel B.; Bickerton, G. Richard; Read, Kevin D.; Wetsel, William C.; Gilbert, Ian H.; Roth, Bryan L.; Hopkins, Andrew L.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">492</span>
        (<span class="NLM_cas:issue">7428</span>),
    <span class="NLM_cas:pages">215-220</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The clin. efficacy and safety of a drug is detd. by its activity profile across many proteins in the proteome.  However, designing drugs with a specific multi-target profile is both complex and difficult.  Therefore methods to design drugs rationally a priori against profiles of several proteins would have immense value in drug discovery.  Here is described a new approach for the automated design of ligands against profiles of multiple drug targets.  The method is demonstrated by the evolution of an approved acetylcholinesterase inhibitor drug donepezil (I) into brain-penetrable ligands with either specific polypharmacol. or exquisite selectivity profiles for G-protein-coupled receptors.  Overall, 800 ligand-target predictions of prospectively designed ligands were tested exptl., of which 75% were confirmed to be correct.  Target engagement in vivo is also demonstrated.  The approach can be a useful source of drug leads when multi-target profiles are required to achieve either selectivity over other drug targets or a desired polypharmacol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqNu5bwrBD3tbVg90H21EOLACvtfcHk0lhxAmFoMC1VgA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhvVamurfN&md5=ace6cced250cf968d327b482a5bf1798</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1038%2Fnature11691&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature11691%26sid%3Dliteratum%253Aachs%26aulast%3DBesnard%26aufirst%3DJ.%26aulast%3DRuda%26aufirst%3DG.%2BF.%26aulast%3DSetola%26aufirst%3DV.%26aulast%3DAbecassis%26aufirst%3DK.%26aulast%3DRodriguiz%26aufirst%3DR.%2BM.%26aulast%3DHuang%26aufirst%3DX.%2BP.%26aulast%3DNorval%26aufirst%3DS.%26aulast%3DSassano%26aufirst%3DM.%2BF.%26aulast%3DShin%26aufirst%3DA.%2BI.%26aulast%3DWebster%26aufirst%3DL.%2BA.%26aulast%3DSimeons%26aufirst%3DF.%2BR.%26aulast%3DStojanovski%26aufirst%3DL.%26aulast%3DPrat%26aufirst%3DA.%26aulast%3DSeidah%26aufirst%3DN.%2BG.%26aulast%3DConstam%26aufirst%3DD.%2BB.%26aulast%3DBickerton%26aufirst%3DG.%2BR.%26aulast%3DRead%26aufirst%3DK.%2BD.%26aulast%3DWetsel%26aufirst%3DW.%2BC.%26aulast%3DGilbert%26aufirst%3DI.%2BH.%26aulast%3DRoth%26aufirst%3DB.%2BL.%26aulast%3DHopkins%26aufirst%3DA.%2BL.%26atitle%3DAutomated%2520design%2520of%2520ligands%2520to%2520polypharmacological%2520profiles%26jtitle%3DNature%26date%3D2012%26volume%3D492%26spage%3D215%26epage%3D220%26doi%3D10.1038%2Fnature11691" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Wu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gu, H. H.</span><span> </span><span class="NLM_article-title">Molecular cloning of the mouse dopamine transporter and pharmacological comparison with the human homologue</span> <span class="citation_source-journal">Gene</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">233</span><span class="NLM_x">, </span> <span class="NLM_fpage">163</span><span class="NLM_x">–</span> <span class="NLM_lpage">170</span><span class="refDoi"> DOI: 10.1016/S0378-1119(99)00143-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00141&amp;key=10.1016%2FS0378-1119%2899%2900143-2" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=233&publication_year=1999&pages=163-170&author=X.+Wuauthor=H.+H.+Gu&title=Molecular+cloning+of+the+mouse+dopamine+transporter+and+pharmacological+comparison+with+the+human+homologue&doi=10.1016%2FS0378-1119%2899%2900143-2"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1016%2FS0378-1119%2899%2900143-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0378-1119%252899%252900143-2%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DX.%26aulast%3DGu%26aufirst%3DH.%2BH.%26atitle%3DMolecular%2520cloning%2520of%2520the%2520mouse%2520dopamine%2520transporter%2520and%2520pharmacological%2520comparison%2520with%2520the%2520human%2520homologue%26jtitle%3DGene%26date%3D1999%26volume%3D233%26spage%3D163%26epage%3D170%26doi%3D10.1016%2FS0378-1119%2899%2900143-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Cheng, Y. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prusoff, W. H.</span><span> </span><span class="NLM_article-title">Relationship between inhibition constant (K1) and concentration of inhibitor which causes 50% inhibition (I50) of an enzymatic-reaction</span> <span class="citation_source-journal">Biochem. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1973</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">3099</span><span class="NLM_x">–</span> <span class="NLM_lpage">3108</span><span class="refDoi"> DOI: 10.1016/0006-2952(73)90196-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00141&amp;key=10.1016%2F0006-2952%2873%2990196-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00141&amp;key=4202581" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00141&amp;key=1%3ACAS%3A528%3ADyaE2cXhtVGgs7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=1973&pages=3099-3108&author=Y.+C.+Chengauthor=W.+H.+Prusoff&title=Relationship+between+inhibition+constant+%28K1%29+and+concentration+of+inhibitor+which+causes+50%25+inhibition+%28I50%29+of+an+enzymatic-reaction&doi=10.1016%2F0006-2952%2873%2990196-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Relation between the inhibition constant K1) and the concentration of inhibitor which causes fifty per cent inhibition (I50) of an enzymic reaction</span></div><div class="casAuthors">Cheng, Yung-Chi; Prusoff, William H.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Pharmacology</span>
        (<span class="NLM_cas:date">1973</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">3099-108</span>CODEN:
                <span class="NLM_cas:coden">BCPCA6</span>;
        ISSN:<span class="NLM_cas:issn">0006-2952</span>.
    </div><div class="casAbstract">The Ki and I50 values are equal where the kinetics are non- or uncompetitive, but not where they are competitive.  The relation between the 2 values was analyzed for non- and uncompetitive bi- and monosubstrate reactions and for competitive bisubstrate reactions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqodFY_8msz57Vg90H21EOLACvtfcHk0lj_DSizrZfugw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE2cXhtVGgs7c%253D&md5=fe7175ca300d8f4085df87af37f8656c</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1016%2F0006-2952%2873%2990196-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0006-2952%252873%252990196-2%26sid%3Dliteratum%253Aachs%26aulast%3DCheng%26aufirst%3DY.%2BC.%26aulast%3DPrusoff%26aufirst%3DW.%2BH.%26atitle%3DRelationship%2520between%2520inhibition%2520constant%2520%2528K1%2529%2520and%2520concentration%2520of%2520inhibitor%2520which%2520causes%252050%2525%2520inhibition%2520%2528I50%2529%2520of%2520an%2520enzymatic-reaction%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D1973%26volume%3D22%26spage%3D3099%26epage%3D3108%26doi%3D10.1016%2F0006-2952%2873%2990196-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Beardsley, P. M.; Shelton, K. L.</span><span> </span><span class="NLM_article-title">Prime-, stress-, and cue-induced reinstatement of extinguished drug-reinforced responding in rats: cocaine as the prototypical drug of abuse</span>.  <span class="citation_source-journal">Curr. Protocols Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span>Chapter 9 (Unit 9.39),  <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">40</span>. DOI: <span class="refDoi"> DOI: 10.1002/0471142301.ns0939s61</span> .</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00141&amp;key=10.1002%2F0471142301.ns0939s61" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2012&pages=1-40&author=P.+M.+Beardsley&author=K.+L.+Shelton&title=Prime-%2C+stress-%2C+and+cue-induced+reinstatement+of+extinguished+drug-reinforced+responding+in+rats%3A+cocaine+as+the+prototypical+drug+of+abuse&doi=10.1002%2F0471142301.ns0939s61"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1002%2F0471142301.ns0939s61&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F0471142301.ns0939s61%26sid%3Dliteratum%253Aachs%26aulast%3DBeardsley%26aufirst%3DP.%2BM.%26atitle%3DPrime-%252C%2520stress-%252C%2520and%2520cue-induced%2520reinstatement%2520of%2520extinguished%2520drug-reinforced%2520responding%2520in%2520rats%253A%2520cocaine%2520as%2520the%2520prototypical%2520drug%2520of%2520abuse%26jtitle%3DCurr.%2520Protocols%2520Neurosci.%26date%3D2012%26spage%3D1%26epage%3D40%26doi%3D10.1002%2F0471142301.ns0939s61" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Bennett, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xie, Y. K.</span><span> </span><span class="NLM_article-title">A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man</span> <span class="citation_source-journal">Pain</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1988</span><span class="NLM_x">, </span> <span class="NLM_volume">33</span><span class="NLM_x">, </span> <span class="NLM_fpage">87</span><span class="NLM_x">–</span> <span class="NLM_lpage">107</span><span class="refDoi"> DOI: 10.1016/0304-3959(88)90209-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00141&amp;key=10.1016%2F0304-3959%2888%2990209-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00141&amp;key=2837713" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00141&amp;key=1%3ACAS%3A280%3ADyaL1c3kslGhsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=1988&pages=87-107&author=G.+J.+Bennettauthor=Y.+K.+Xie&title=A+peripheral+mononeuropathy+in+rat+that+produces+disorders+of+pain+sensation+like+those+seen+in+man&doi=10.1016%2F0304-3959%2888%2990209-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man</span></div><div class="casAuthors">Bennett Gary J; Xie Y-K</div><div class="citationInfo"><span class="NLM_cas:title">Pain</span>
        (<span class="NLM_cas:date">1988</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">87-107</span>
        ISSN:<span class="NLM_cas:issn">0304-3959</span>.
    </div><div class="casAbstract">A peripheral mononeuropathy was produced in adult rats by placing loosely constrictive ligatures around the common sciatic nerve.  The postoperative behavior of these rats indicated that hyperalgesia, allodynia and, possibly, spontaneous pain (or dysesthesia) were produced.  Hyperalgesic responses to noxious radiant heat were evident on the second postoperative day and lasted for over 2 months.  Hyperalgesic responses to chemogenic pain were also present.  The presence of allodynia was inferred from the nocifensive responses evoked by standing on an innocuous, chilled metal floor or by innocuous mechanical stimulation, and by the rats' persistence in holding the hind paw in a guarded position.  The presence of spontaneous pain was suggested by a suppression of appetite and by the frequent occurrence of apparently spontaneous nocifensive responses.  The affected hind paw was abnormally warm or cool in about one-third of the rats.  About one-half of the rats developed grossly overgrown claws on the affected side.  Experiments with this animal model may advance our understanding of the neural mechanisms of neuropathic pain disorders in humans.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSvFbgQgoOLbwWRJ3OJdH_qfW6udTcc2eY6fTr7n2EUs7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaL1c3kslGhsw%253D%253D&md5=b65eee81b7058ce686a014eee46ead80</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1016%2F0304-3959%2888%2990209-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0304-3959%252888%252990209-6%26sid%3Dliteratum%253Aachs%26aulast%3DBennett%26aufirst%3DG.%2BJ.%26aulast%3DXie%26aufirst%3DY.%2BK.%26atitle%3DA%2520peripheral%2520mononeuropathy%2520in%2520rat%2520that%2520produces%2520disorders%2520of%2520pain%2520sensation%2520like%2520those%2520seen%2520in%2520man%26jtitle%3DPain%26date%3D1988%26volume%3D33%26spage%3D87%26epage%3D107%26doi%3D10.1016%2F0304-3959%2888%2990209-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">Tosh, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ciancetta, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Warnick, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crane, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, Z. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobson, K. A.</span><span> </span><span class="NLM_article-title">Structure-based scaffold repurposing for G protein-coupled receptors: Transformation of adenosine derivatives into 5HT<sub>2B</sub>/5 HT<sub>2C</sub> serotonin receptor antagonists</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">59</span><span class="NLM_x">, </span> <span class="NLM_fpage">11006</span><span class="NLM_x">–</span> <span class="NLM_lpage">11026</span><span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b01183</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b01183" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=11006-11026&author=D.+K.+Toshauthor=A.+Ciancettaauthor=E.+Warnickauthor=S.+Craneauthor=Z.+G.+Gaoauthor=K.+A.+Jacobson&title=Structure-based+scaffold+repurposing+for+G+protein-coupled+receptors%3A+Transformation+of+adenosine+derivatives+into+5HT2B%2F5+HT2C+serotonin+receptor+antagonists&doi=10.1021%2Facs.jmedchem.6b01183"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b01183&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b01183%26sid%3Dliteratum%253Aachs%26aulast%3DTosh%26aufirst%3DD.%2BK.%26aulast%3DCiancetta%26aufirst%3DA.%26aulast%3DWarnick%26aufirst%3DE.%26aulast%3DCrane%26aufirst%3DS.%26aulast%3DGao%26aufirst%3DZ.%2BG.%26aulast%3DJacobson%26aufirst%3DK.%2BA.%26atitle%3DStructure-based%2520scaffold%2520repurposing%2520for%2520G%2520protein-coupled%2520receptors%253A%2520Transformation%2520of%2520adenosine%2520derivatives%2520into%25205HT2B%252F5%2520HT2C%2520serotonin%2520receptor%2520antagonists%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D11006%26epage%3D11026%26doi%3D10.1021%2Facs.jmedchem.6b01183" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Fishman, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cohen, S.</span><span> </span><span class="NLM_article-title">The A<sub>3</sub> adenosine receptor (A<sub>3</sub>AR): therapeutic target and predictive biological marker in rheumatoid arthritis</span> <span class="citation_source-journal">Clin. Rheumatol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">35</span><span class="NLM_x">, </span> <span class="NLM_fpage">2359</span><span class="refDoi"> DOI: 10.1007/s10067-016-3202-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00141&amp;key=10.1007%2Fs10067-016-3202-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00141&amp;key=26886128" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00141&amp;key=1%3ACAS%3A280%3ADC%252BC28jhsVCktA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2016&pages=2359&author=P.+Fishmanauthor=S.+Cohen&title=The+A3+adenosine+receptor+%28A3AR%29%3A+therapeutic+target+and+predictive+biological+marker+in+rheumatoid+arthritis&doi=10.1007%2Fs10067-016-3202-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">The A3 adenosine receptor (A3AR): therapeutic target and predictive biological marker in rheumatoid arthritis</span></div><div class="casAuthors">Fishman Pnina; Cohen Shira</div><div class="citationInfo"><span class="NLM_cas:title">Clinical rheumatology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">2359-62</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The Gi protein-associated A3 adenosine receptor (A3AR) is over-expressed in inflammatory cells, and this high expression is also reflected in the peripheral blood mononuclear cells of patients with autoimmune inflammatory diseases such as rheumatoid arthritis, psoriasis, and Crohn's disease.  CF101, a selective agonist with high affinity to the A3AR, is known to induce robust anti-inflammatory effect in experimental animal models of adjuvant-, collagen-, and tropomyosin-induced arthritis.  The effect is mediated via a definitive molecular mechanism entailing deregulation of the nuclear factor-κB (NF-κB) and the Wnt signal transduction pathways resulting in apoptosis of inflammatory cells.  CF101 was found to be safe and well tolerated in all preclinical, phase I, and phase II human clinical studies.  In two phase II clinical studies where CF101 was administered to rheumatoid arthritis (RA) patients as a stand-alone drug, a significant anti-rheumatic effect and a direct significant correlation were found between receptor expression at baseline and patients' response to the drug, suggesting that A3AR may be utilized as a predictive biomarker.  The A3AR is a promising therapeutic target in rheumatoid arthritis and can be used also as a biological marker to predict patients' response to CF101.  This is a unique type of a personalized medicine approach which may pave the way for a safe and efficacious treatment for this patient population.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQeChpzptz2mVHFYivNCdPRfW6udTcc2eYtTlj-GTQtTrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC28jhsVCktA%253D%253D&md5=0b2af53772d34d132cc949069d6744e6</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1007%2Fs10067-016-3202-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs10067-016-3202-4%26sid%3Dliteratum%253Aachs%26aulast%3DFishman%26aufirst%3DP.%26aulast%3DCohen%26aufirst%3DS.%26atitle%3DThe%2520A3%2520adenosine%2520receptor%2520%2528A3AR%2529%253A%2520therapeutic%2520target%2520and%2520predictive%2520biological%2520marker%2520in%2520rheumatoid%2520arthritis%26jtitle%3DClin.%2520Rheumatol.%26date%3D2016%26volume%3D35%26spage%3D2359%26doi%3D10.1007%2Fs10067-016-3202-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group">Borea, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gessi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Merighi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Varani, K.</span><span> </span><span class="NLM_article-title">Adenosine as a multi-signalling guardian angel in human diseases: When, where and how does it exert its protective effects?</span> <span class="citation_source-journal">Trends Pharmacol. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">37</span><span class="NLM_x">, </span> <span class="NLM_fpage">419</span><span class="NLM_x">–</span> <span class="NLM_lpage">434</span><span class="refDoi"> DOI: 10.1016/j.tips.2016.02.006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00141&amp;key=10.1016%2Fj.tips.2016.02.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00141&amp;key=26944097" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00141&amp;key=1%3ACAS%3A528%3ADC%252BC28XjtFCnsbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=2016&pages=419-434&author=P.+A.+Boreaauthor=S.+Gessiauthor=S.+Merighiauthor=K.+Varani&title=Adenosine+as+a+multi-signalling+guardian+angel+in+human+diseases%3A+When%2C+where+and+how+does+it+exert+its+protective+effects%3F&doi=10.1016%2Fj.tips.2016.02.006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">adenosine as a multi-signalling guardian angel in human diseases- when, where and how does it exert its protective effects?</span></div><div class="casAuthors">Borea, Pier Andrea; Gessi, Stefania; Merighi, Stefania; Varani, Katia</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Pharmacological Sciences</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">37</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">419-434</span>CODEN:
                <span class="NLM_cas:coden">TPHSDY</span>;
        ISSN:<span class="NLM_cas:issn">0165-6147</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">The importance of adenosine for human health cannot be overstated.  Indeed, this ubiquitous nucleoside is an integral component of ATP, and regulates the function of every tissue and organ in the body.  Acting via receptor-dependent and -independent mechanisms [the former mediated via four G-protein-coupled receptors (GPCRs), A1, A2A, A2B, and A3,], it has a significant role in protecting against cell damage in areas of increased tissue metab., and combating organ dysfunction in numerous pathol. states.  Accordingly, raised levels of adenosine have been demonstrated in epilepsy, ischemia, pain, inflammation, and cancer, in which its behavior can be likened to that of a guardian angel, even though there are instances in which overprodn. of adenosine is pathol.  In this review, we condense the current body of knowledge on the issue, highlighting when, where, and how adenosine exerts its protective effects in both the brain and the periphery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpgDDQVG7TTXbVg90H21EOLACvtfcHk0liEuJT41sH0vA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XjtFCnsbo%253D&md5=f94a42e9f9bbb2bf41af97ed31649b22</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1016%2Fj.tips.2016.02.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tips.2016.02.006%26sid%3Dliteratum%253Aachs%26aulast%3DBorea%26aufirst%3DP.%2BA.%26aulast%3DGessi%26aufirst%3DS.%26aulast%3DMerighi%26aufirst%3DS.%26aulast%3DVarani%26aufirst%3DK.%26atitle%3DAdenosine%2520as%2520a%2520multi-signalling%2520guardian%2520angel%2520in%2520human%2520diseases%253A%2520When%252C%2520where%2520and%2520how%2520does%2520it%2520exert%2520its%2520protective%2520effects%253F%26jtitle%3DTrends%2520Pharmacol.%2520Sci.%26date%3D2016%26volume%3D37%26spage%3D419%26epage%3D434%26doi%3D10.1016%2Fj.tips.2016.02.006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group">Janes, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Symons-Liguori, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobson, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salvemini, D.</span><span> </span><span class="NLM_article-title">Identification of A<sub>3</sub> adenosine receptor agonists as novel non-narcotic analgesics</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">173</span><span class="NLM_x">, </span> <span class="NLM_fpage">1253</span><span class="NLM_x">–</span> <span class="NLM_lpage">1267</span><span class="refDoi"> DOI: 10.1111/bph.13446</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00141&amp;key=10.1111%2Fbph.13446" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00141&amp;key=26804983" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00141&amp;key=1%3ACAS%3A528%3ADC%252BC28Xjs1GntLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=173&publication_year=2016&pages=1253-1267&author=K.+Janesauthor=A.+M.+Symons-Liguoriauthor=K.+A.+Jacobsonauthor=D.+Salvemini&title=Identification+of+A3+adenosine+receptor+agonists+as+novel+non-narcotic+analgesics&doi=10.1111%2Fbph.13446"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of A3 adenosine receptor agonists as novel non-narcotic analgesics</span></div><div class="casAuthors">Janes, K.; Symons-Liguori, A. M.; Jacobson, K. A.; Salvemini, D.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">173</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1253-1267</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">1476-5381</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">A review.  Chronic pain neg. impacts the quality of life in a variety of patient populations.  The current therapeutic repertoire is inadequate in managing patient pain and warrants the development of new therapeutics.  Adenosine and its four cognate receptors (A1, A2A, A2B and A3) have important roles in physiol. and pathophysiol. states, including chronic pain.  Preclin. and clin. studies have revealed that while adenosine and agonists of the A1 and A2A receptors have antinociceptive properties, their therapeutic utility is limited by adverse cardiovascular side effects.  In contrast, our understanding of the A3 receptor is only in its infancy, but exciting preclin. observations of A3 receptor antinociception, which have been bolstered by clin. trials of A3 receptor agonists in other disease states, suggest pain relief without cardiovascular side effects and with sufficient tolerability.  Our goal herein is to briefly discuss adenosine and its receptors in the context of pathol. pain and to consider the current data regarding A3 receptor-mediated antinociception.  We will highlight recent findings regarding the impact of the A3 receptor on pain pathways and examine the current state of selective A3 receptor agonists used for these studies.  The adenosine-to-A3 receptor pathway represents an important endogenous system that can be targeted to provide safe, effective pain relief from chronic pain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoByiVq79FXFbVg90H21EOLACvtfcHk0ljsZrD8XlftWg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xjs1GntLk%253D&md5=57571a415519ba45b91ea6de738840dc</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1111%2Fbph.13446&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fbph.13446%26sid%3Dliteratum%253Aachs%26aulast%3DJanes%26aufirst%3DK.%26aulast%3DSymons-Liguori%26aufirst%3DA.%2BM.%26aulast%3DJacobson%26aufirst%3DK.%2BA.%26aulast%3DSalvemini%26aufirst%3DD.%26atitle%3DIdentification%2520of%2520A3%2520adenosine%2520receptor%2520agonists%2520as%2520novel%2520non-narcotic%2520analgesics%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2016%26volume%3D173%26spage%3D1253%26epage%3D1267%26doi%3D10.1111%2Fbph.13446" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group">Welsch, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Snyder, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stockwell, B. R.</span><span> </span><span class="NLM_article-title">Privileged scaffolds for library design and drug discovery</span> <span class="citation_source-journal">Curr. Opin. Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">347</span><span class="NLM_x">–</span> <span class="NLM_lpage">361</span><span class="refDoi"> DOI: 10.1016/j.cbpa.2010.02.018</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00141&amp;key=10.1016%2Fj.cbpa.2010.02.018" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00141&amp;key=20303320" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00141&amp;key=1%3ACAS%3A528%3ADC%252BC3cXmvVWqsLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2010&pages=347-361&author=M.+E.+Welschauthor=S.+A.+Snyderauthor=B.+R.+Stockwell&title=Privileged+scaffolds+for+library+design+and+drug+discovery&doi=10.1016%2Fj.cbpa.2010.02.018"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Privileged scaffolds for library design and drug discovery</span></div><div class="casAuthors">Welsch, Matthew E.; Snyder, Scott A.; Stockwell, Brent R.</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Chemical Biology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">347-361</span>CODEN:
                <span class="NLM_cas:coden">COCBF4</span>;
        ISSN:<span class="NLM_cas:issn">1367-5931</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">This review explores the concept of using privileged scaffolds to identify biol. active compds. through building chem. libraries.  We hope to accomplish three main objectives: to provide one of the most comprehensive listings of privileged scaffolds; to reveal through four selected examples the present state of the art in privileged scaffold library synthesis (in hopes of inspiring new and even more creative approaches); and also to offer some thoughts on how new privileged scaffolds might be identified and exploited.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqWQPxdsWawiLVg90H21EOLACvtfcHk0ljsZrD8XlftWg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXmvVWqsLs%253D&md5=fd0c2a642f063fd6f42f2c34fd186f8a</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1016%2Fj.cbpa.2010.02.018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cbpa.2010.02.018%26sid%3Dliteratum%253Aachs%26aulast%3DWelsch%26aufirst%3DM.%2BE.%26aulast%3DSnyder%26aufirst%3DS.%2BA.%26aulast%3DStockwell%26aufirst%3DB.%2BR.%26atitle%3DPrivileged%2520scaffolds%2520for%2520library%2520design%2520and%2520drug%2520discovery%26jtitle%3DCurr.%2520Opin.%2520Chem.%2520Biol.%26date%3D2010%26volume%3D14%26spage%3D347%26epage%3D361%26doi%3D10.1016%2Fj.cbpa.2010.02.018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group">Coleman, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Green, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gouaux, E.</span><span> </span><span class="NLM_article-title">X-ray structures and mechanism of the human serotonin transporter</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">532</span><span class="NLM_x">, </span> <span class="NLM_fpage">334</span><span class="NLM_x">–</span> <span class="NLM_lpage">339</span><span class="refDoi"> DOI: 10.1038/nature17629</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00141&amp;key=10.1038%2Fnature17629" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00141&amp;key=27049939" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00141&amp;key=1%3ACAS%3A528%3ADC%252BC28Xlsl2gtrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=532&publication_year=2016&pages=334-339&author=J.+A.+Colemanauthor=E.+M.+Greenauthor=E.+Gouaux&title=X-ray+structures+and+mechanism+of+the+human+serotonin+transporter&doi=10.1038%2Fnature17629"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">X-ray structures and mechanism of the human serotonin transporter</span></div><div class="casAuthors">Coleman, Jonathan A.; Green, Evan M.; Gouaux, Eric</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">532</span>
        (<span class="NLM_cas:issue">7599</span>),
    <span class="NLM_cas:pages">334-339</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The serotonin transporter (SERT) terminates serotonergic signaling through the sodium- and chloride-dependent reuptake of neurotransmitter into presynaptic neurons.  SERT is a target for antidepressant and psychostimulant drugs, which block reuptake and prolong neurotransmitter signaling.  Here the authors report x-ray crystallog. structures of human SERT at 3.15 Å resoln. bound to the antidepressants (S)-citalopram or paroxetine.  Antidepressants lock SERT in an outward-open conformation by lodging in the central binding site, located between transmembrane helixes 1, 3, 6, 8 and 10, directly blocking serotonin binding.  The authors further identify the location of an allosteric site in the complex as residing at the periphery of the extracellular vestibule, interposed between extracellular loops 4 and 6 and transmembrane helixes 1, 6, 10 and 11.  Occupancy of the allosteric site sterically hinders ligand unbinding from the central site, providing an explanation for the action of (S)-citalopram as an allosteric ligand.  These structures define the mechanism of antidepressant action in SERT, and provide blueprints for future drug design.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrYAxl5tROCorVg90H21EOLACvtfcHk0lgrv5RV3j33yw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xlsl2gtrY%253D&md5=e4fa11a1e5abdd7b39f44375506aa249</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1038%2Fnature17629&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature17629%26sid%3Dliteratum%253Aachs%26aulast%3DColeman%26aufirst%3DJ.%2BA.%26aulast%3DGreen%26aufirst%3DE.%2BM.%26aulast%3DGouaux%26aufirst%3DE.%26atitle%3DX-ray%2520structures%2520and%2520mechanism%2520of%2520the%2520human%2520serotonin%2520transporter%26jtitle%3DNature%26date%3D2016%26volume%3D532%26spage%3D334%26epage%3D339%26doi%3D10.1038%2Fnature17629" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group">Beuming, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kniazeff, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bergmann, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shi, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gracia, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raniszewska, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newman, A. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Javitch, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weinstein, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gether, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loland, C. J.</span><span> </span><span class="NLM_article-title">The binding sites for cocaine and dopamine in the dopamine transporter overlap</span> <span class="citation_source-journal">Nat. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">780</span><span class="NLM_x">–</span> <span class="NLM_lpage">789</span><span class="refDoi"> DOI: 10.1038/nn.2146</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00141&amp;key=10.1038%2Fnn.2146" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00141&amp;key=18568020" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00141&amp;key=1%3ACAS%3A528%3ADC%252BD1cXns1Omsrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2008&pages=780-789&author=T.+Beumingauthor=J.+Kniazeffauthor=M.+L.+Bergmannauthor=L.+Shiauthor=L.+Graciaauthor=K.+Raniszewskaauthor=A.+H.+Newmanauthor=J.+A.+Javitchauthor=H.+Weinsteinauthor=U.+Getherauthor=C.+J.+Loland&title=The+binding+sites+for+cocaine+and+dopamine+in+the+dopamine+transporter+overlap&doi=10.1038%2Fnn.2146"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">The binding sites for cocaine and dopamine in the dopamine transporter overlap</span></div><div class="casAuthors">Beuming, Thijs; Kniazeff, Julie; Bergmann, Marianne L.; Shi, Lei; Gracia, Luis; Raniszewska, Klaudia; Newman, Amy Hauck; Javitch, Jonathan A.; Weinstein, Harel; Gether, Ulrik; Loland, Claus J.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Neuroscience</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">780-789</span>CODEN:
                <span class="NLM_cas:coden">NANEFN</span>;
        ISSN:<span class="NLM_cas:issn">1097-6256</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Beuming and colleagues detd. that the binding site for cocaine overlaps with that of dopamine on the dopamine transporter.  Detailed modeling and mutagenesis expts. revealed that this site is deeply buried amongst several transmembrane domains.  Cocaine is a widely abused substance with psychostimulant effects that are attributed to inhibition of the dopamine transporter (DAT).  We present mol. models for DAT binding of cocaine and cocaine analogs constructed from the high-resoln. structure of the bacterial transporter homolog LeuT.  Our models suggest that the binding site for cocaine and cocaine analogs is deeply buried between transmembrane segments 1, 3, 6 and 8, and overlaps with the binding sites for the substrates dopamine and amphetamine, as well as for benztropine-like DAT inhibitors.  We validated our models by detailed mutagenesis and by trapping the radiolabeled cocaine analog [3H]CFT in the transporter, either by crosslinking engineered cysteines or with an engineered Zn2+-binding site that was situated extracellularly to the predicted common binding pocket.  Our data demonstrate the mol. basis for the competitive inhibition of dopamine transport by cocaine.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGogCWenpzRZ47Vg90H21EOLACvtfcHk0lgrv5RV3j33yw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXns1Omsrw%253D&md5=7f96344e92478939540d84a37eaf3a70</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1038%2Fnn.2146&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnn.2146%26sid%3Dliteratum%253Aachs%26aulast%3DBeuming%26aufirst%3DT.%26aulast%3DKniazeff%26aufirst%3DJ.%26aulast%3DBergmann%26aufirst%3DM.%2BL.%26aulast%3DShi%26aufirst%3DL.%26aulast%3DGracia%26aufirst%3DL.%26aulast%3DRaniszewska%26aufirst%3DK.%26aulast%3DNewman%26aufirst%3DA.%2BH.%26aulast%3DJavitch%26aufirst%3DJ.%2BA.%26aulast%3DWeinstein%26aufirst%3DH.%26aulast%3DGether%26aufirst%3DU.%26aulast%3DLoland%26aufirst%3DC.%2BJ.%26atitle%3DThe%2520binding%2520sites%2520for%2520cocaine%2520and%2520dopamine%2520in%2520the%2520dopamine%2520transporter%2520overlap%26jtitle%3DNat.%2520Neurosci.%26date%3D2008%26volume%3D11%26spage%3D780%26epage%3D789%26doi%3D10.1038%2Fnn.2146" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group">Mortensen, O. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kortagere, S.</span><span> </span><span class="NLM_article-title">Designing modulators of monoamine transporters using virtual screening techniques</span> <span class="citation_source-journal">Front. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">223</span><span class="refDoi"> DOI: 10.3389/fphar.2015.00223</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00141&amp;key=10.3389%2Ffphar.2015.00223" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00141&amp;key=26483692" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00141&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtFals7rL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2015&pages=223&author=O.+V.+Mortensenauthor=S.+Kortagere&title=Designing+modulators+of+monoamine+transporters+using+virtual+screening+techniques&doi=10.3389%2Ffphar.2015.00223"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Designing modulators of monoamine transporters using virtual screening techniques</span></div><div class="casAuthors">Mortensen, Ole V.; Kortagere, Sandhya</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in Pharmacology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">223/1-223/8</span>CODEN:
                <span class="NLM_cas:coden">FPRHAU</span>;
        ISSN:<span class="NLM_cas:issn">1663-9812</span>.
    
            (<span class="NLM_cas:orgname">Frontiers Media S.A.</span>)
        </div><div class="casAbstract">The plasma-membrane monoamine transporters (MATs), including the serotonin (SERT), norepinephrine (NET) and dopamine (DAT) transporters, serve a pivotal role in limiting monoamine-mediated neurotransmission through the reuptake of their resp. monoamine neurotransmitters.  The transporters are the main target of clin. used psychostimulants and antidepressants.  Despite the availability of several potent and selective MAT substrates and inhibitors the continuing need for therapeutic drugs to treat brain disorders involving aberrant monoamine signaling provides a compelling reason to identify novel ways of targeting and modulating the MATs.  Designing novel modulators of MAT function have been limited by the lack of three dimensional structure information of the individual MATs.  However, crystal structures of LeuT, a bacterial homolog of MATs, in a substrate-bound occluded, substrate-free outward-open, and an apo inward-open state and also with competitive and non-competitive inhibitors have been detd.  In addn., several structures of the Drosophila DAT have also been resolved.  Together with computational modeling and exptl. data gathered over the past decade, these structures have dramatically advanced our understanding of several aspects of SERT, NET, and DAT transporter function, including some of the mol. determinants of ligand interaction at orthosteric substrate and inhibitor binding pockets.  In addn. progress has been made in the understanding of how allosteric modulation of MAT function can be achieved.  Here we will review all the efforts up to date that has been made through computational approaches employing structural models of MATs to design small mol. modulators to the orthosteric and allosteric sites using virtual screening techniques.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpX21DhH3SLwbVg90H21EOLACvtfcHk0lhnczgVvWsyMg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtFals7rL&md5=6a51e8c9fc431c5ffa220c49129b0242</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.3389%2Ffphar.2015.00223&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffphar.2015.00223%26sid%3Dliteratum%253Aachs%26aulast%3DMortensen%26aufirst%3DO.%2BV.%26aulast%3DKortagere%26aufirst%3DS.%26atitle%3DDesigning%2520modulators%2520of%2520monoamine%2520transporters%2520using%2520virtual%2520screening%2520techniques%26jtitle%3DFront.%2520Pharmacol.%26date%3D2015%26volume%3D6%26spage%3D223%26doi%3D10.3389%2Ffphar.2015.00223" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group">Paczkowski, F. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sharpe, I. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dutertre, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewis, R. J.</span><span> </span><span class="NLM_article-title">chi-Conotoxin and tricyclic antidepressant interactions at the norepinephrine transporter define a new transporter model</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">282</span><span class="NLM_x">, </span> <span class="NLM_fpage">17837</span><span class="NLM_x">–</span> <span class="NLM_lpage">17844</span><span class="refDoi"> DOI: 10.1074/jbc.M610813200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00141&amp;key=10.1074%2Fjbc.M610813200" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=282&publication_year=2007&pages=17837-17844&author=F.+A.+Paczkowskiauthor=I.+A.+Sharpeauthor=S.+Dutertreauthor=R.+J.+Lewis&title=chi-Conotoxin+and+tricyclic+antidepressant+interactions+at+the+norepinephrine+transporter+define+a+new+transporter+model&doi=10.1074%2Fjbc.M610813200"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M610813200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M610813200%26sid%3Dliteratum%253Aachs%26aulast%3DPaczkowski%26aufirst%3DF.%2BA.%26aulast%3DSharpe%26aufirst%3DI.%2BA.%26aulast%3DDutertre%26aufirst%3DS.%26aulast%3DLewis%26aufirst%3DR.%2BJ.%26atitle%3Dchi-Conotoxin%2520and%2520tricyclic%2520antidepressant%2520interactions%2520at%2520the%2520norepinephrine%2520transporter%2520define%2520a%2520new%2520transporter%2520model%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2007%26volume%3D282%26spage%3D17837%26epage%3D17844%26doi%3D10.1074%2Fjbc.M610813200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group">Bruns, R. F.</span><span> </span><span class="NLM_article-title">Adenosine receptor activation in human fibroblasts: nucleoside agonists and antagonists</span> <span class="citation_source-journal">Can. J. Physiol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1980</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">673</span><span class="NLM_x">–</span> <span class="NLM_lpage">691</span><span class="refDoi"> DOI: 10.1139/y80-110</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00141&amp;key=10.1139%2Fy80-110" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00141&amp;key=6253037" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00141&amp;key=1%3ACAS%3A528%3ADyaL3cXls1Sqtb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=1980&pages=673-691&author=R.+F.+Bruns&title=Adenosine+receptor+activation+in+human+fibroblasts%3A+nucleoside+agonists+and+antagonists&doi=10.1139%2Fy80-110"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Adenosine receptor activation in human fibroblasts:  nucleoside agonists and antagonists</span></div><div class="casAuthors">Bruns, Robert F.</div><div class="citationInfo"><span class="NLM_cas:title">Canadian Journal of Physiology and Pharmacology</span>
        (<span class="NLM_cas:date">1980</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">673-91</span>CODEN:
                <span class="NLM_cas:coden">CJPPA3</span>;
        ISSN:<span class="NLM_cas:issn">0008-4212</span>.
    </div><div class="casAbstract">Adenosine  [58-61-7] (ED50 15 μM) causes a 50-fold increase in intracellular cyclic AMP in the VA13 human fibroblast line.  A total of 128 nucleosides was tested as agonists and antagonists.  Eight classes of compds. were found: full agonists (14 compds.), weak agonists (20), high-efficacy partial agonists (16), low-efficacy partial agonists (7), competitive inhibitors (11), noncompetitive inhibitors (3), partial agonist - noncompetitive inhibitors (3), and inactive compds. (54).  The noncompetitive inhibitors antagonized the responses to adenosine, isoproterenol, and prostaglandin E1 and thus may have been adenylate cyclase inhibitors.  The most potent noncompetitive inhibitor, 2',5'-dideoxyadenosine  [6698-26-6] was a partial inhibitor, reducing the response to isoproterenol by only 77% even at very high concns.  The most potent agonists, partial agonists, and pure antagonists had apparent affinities of about 5 μM.  Although all positions were important for affinity at the adenosine receptor, only the 3'- and 5'-positions and to a much lesser extent the 6- and 8-positions had an effect on efficacy.  The receptor tolerated bulky groups at the 6-position of adenosine, had an Et-sized pocket near the 5'-position, and had little bulk tolerance towards modifications at other positions.  Among the full agonists, only one 5'-deriv. and one 2-position deriv. had higher apparent affinity than adenosine.  Studies with conformationally restricted agonists and antagonists showed that adenosine must be in the anti conformation in order to bind to the receptor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoKRAqZBkQJY7Vg90H21EOLACvtfcHk0lhnczgVvWsyMg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL3cXls1Sqtb4%253D&md5=1851e7bb2c11b84bddafc934515169fb</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1139%2Fy80-110&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1139%252Fy80-110%26sid%3Dliteratum%253Aachs%26aulast%3DBruns%26aufirst%3DR.%2BF.%26atitle%3DAdenosine%2520receptor%2520activation%2520in%2520human%2520fibroblasts%253A%2520nucleoside%2520agonists%2520and%2520antagonists%26jtitle%3DCan.%2520J.%2520Physiol.%2520Pharmacol.%26date%3D1980%26volume%3D58%26spage%3D673%26epage%3D691%26doi%3D10.1139%2Fy80-110" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group">Tosh, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Phan, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, Z. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gakh, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deflorian, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abagyan, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stevens, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobson, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Katritch, V.</span><span> </span><span class="NLM_article-title">Optimization of adenosine 5′-carboxamide derivatives as adenosine receptor agonists using structure-based ligand design and fragment-based searching</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">4297</span><span class="NLM_x">–</span> <span class="NLM_lpage">4308</span><span class="refDoi"> DOI: 10.1021/jm300095s</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm300095s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=4297-4308&author=D.+K.+Toshauthor=K.+Phanauthor=Z.+G.+Gaoauthor=A.+Gakhauthor=F.+Xuauthor=F.+Deflorianauthor=R.+Abagyanauthor=R.+C.+Stevensauthor=K.+A.+Jacobsonauthor=V.+Katritch&title=Optimization+of+adenosine+5%E2%80%B2-carboxamide+derivatives+as+adenosine+receptor+agonists+using+structure-based+ligand+design+and+fragment-based+searching&doi=10.1021%2Fjm300095s"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1021%2Fjm300095s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm300095s%26sid%3Dliteratum%253Aachs%26aulast%3DTosh%26aufirst%3DD.%2BK.%26aulast%3DPhan%26aufirst%3DK.%26aulast%3DGao%26aufirst%3DZ.%2BG.%26aulast%3DGakh%26aufirst%3DA.%26aulast%3DXu%26aufirst%3DF.%26aulast%3DDeflorian%26aufirst%3DF.%26aulast%3DAbagyan%26aufirst%3DR.%26aulast%3DStevens%26aufirst%3DR.%2BC.%26aulast%3DJacobson%26aufirst%3DK.%2BA.%26aulast%3DKatritch%26aufirst%3DV.%26atitle%3DOptimization%2520of%2520adenosine%25205%25E2%2580%25B2-carboxamide%2520derivatives%2520as%2520adenosine%2520receptor%2520agonists%2520using%2520structure-based%2520ligand%2520design%2520and%2520fragment-based%2520searching%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D4297%26epage%3D4308%26doi%3D10.1021%2Fjm300095s" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group">Bruss, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wieland, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bonisch, H.</span><span> </span><span class="NLM_article-title">Molecular cloning and functional expression of the mouse dopamine transporter</span> <span class="citation_source-journal">J. Neural Transm.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">106</span><span class="NLM_x">, </span> <span class="NLM_fpage">657</span><span class="NLM_x">–</span> <span class="NLM_lpage">662</span><span class="refDoi"> DOI: 10.1007/s007020050187</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00141&amp;key=10.1007%2Fs007020050187" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=106&publication_year=1999&pages=657-662&author=M.+Brussauthor=A.+Wielandauthor=H.+Bonisch&title=Molecular+cloning+and+functional+expression+of+the+mouse+dopamine+transporter&doi=10.1007%2Fs007020050187"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1007%2Fs007020050187&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs007020050187%26sid%3Dliteratum%253Aachs%26aulast%3DBruss%26aufirst%3DM.%26aulast%3DWieland%26aufirst%3DA.%26aulast%3DBonisch%26aufirst%3DH.%26atitle%3DMolecular%2520cloning%2520and%2520functional%2520expression%2520of%2520the%2520mouse%2520dopamine%2520transporter%26jtitle%3DJ.%2520Neural%2520Transm.%26date%3D1999%26volume%3D106%26spage%3D657%26epage%3D662%26doi%3D10.1007%2Fs007020050187" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group">Melman, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joshi, B. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, Z. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Castro, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heller, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jeong, L. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobson, K. A.</span><span> </span><span class="NLM_article-title">Selective A<sub>3</sub> adenosine receptor antagonists derived from nucleosides containing a bicyclo[3.1.0]hexane ring system</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">8546</span><span class="NLM_x">–</span> <span class="NLM_lpage">8556</span><span class="refDoi"> DOI: 10.1016/j.bmc.2008.08.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00141&amp;key=10.1016%2Fj.bmc.2008.08.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00141&amp;key=18752961" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00141&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtFantL3K" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2008&pages=8546-8556&author=A.+Melmanauthor=B.+Wangauthor=B.+V.+Joshiauthor=Z.+G.+Gaoauthor=S.+de+Castroauthor=C.+L.+Hellerauthor=S.+K.+Kimauthor=L.+S.+Jeongauthor=K.+A.+Jacobson&title=Selective+A3+adenosine+receptor+antagonists+derived+from+nucleosides+containing+a+bicyclo%5B3.1.0%5Dhexane+ring+system&doi=10.1016%2Fj.bmc.2008.08.007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Selective A3 adenosine receptor antagonists derived from nucleosides containing a bicyclo[3.1.0]hexane ring system</span></div><div class="casAuthors">Melman, Artem; Wang, Ben; Joshi, Bhalchandra V.; Gao, Zhan-Guo; de Castro, Sonia; Heller, Cara L.; Kim, Soo-Kyung; Jeong, Lak Shin; Jacobson, Kenneth A.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">8546-8556</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">We have prepd. 5'-modified derivs. of adenosine and a corresponding (N)-methanocarba nucleoside series contg. a bicyclo[3.1.0]hexane ring system in place of the ribose moiety.  The compds. were examd. in binding assays at three subtypes of adenosine receptors (ARs) and in functional assays at the A3 AR.  The H-bonding ability of a group of 9-riboside derivs. contg. a 5'-uronamide moiety was reduced by modification of the NH; however these derivs. did not display the desired activity as selective A3 AR antagonists, as occurs with 5'-N,N-dimethyluronamides.  However, truncated (N)-methanocarba analogs lacking a 4'-hydroxymethyl group were highly potent and selective antagonists of the human A3 AR.  The compds. were synthesized from D-ribose using a reductive free radical decarboxylation of a 5'-carboxy intermediate.  A less efficient synthetic approach began with L-ribose, which was similar to the published synthesis of (N)-methanocarba A3AR agonists.  Compds. 33b-39b (N 6-3-halobenzyl and related arylalkyl derivs.) were potent A3AR antagonists with binding K i values of 0.7-1.4 nM.  In a functional assay of [35S]GTPγS binding, 33b (3-iodobenzyl) completely inhibited stimulation by NECA with a K B of 8.9 nM.  Thus, a highly potent and selective series of A3AR antagonists has been described.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoCKshPwkRmvbVg90H21EOLACvtfcHk0li9SmzcYAdY4A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtFantL3K&md5=8f2e48da21c5e8a1f3f067d30b03fcae</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2008.08.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2008.08.007%26sid%3Dliteratum%253Aachs%26aulast%3DMelman%26aufirst%3DA.%26aulast%3DWang%26aufirst%3DB.%26aulast%3DJoshi%26aufirst%3DB.%2BV.%26aulast%3DGao%26aufirst%3DZ.%2BG.%26aulast%3Dde%2BCastro%26aufirst%3DS.%26aulast%3DHeller%26aufirst%3DC.%2BL.%26aulast%3DKim%26aufirst%3DS.%2BK.%26aulast%3DJeong%26aufirst%3DL.%2BS.%26aulast%3DJacobson%26aufirst%3DK.%2BA.%26atitle%3DSelective%2520A3%2520adenosine%2520receptor%2520antagonists%2520derived%2520from%2520nucleosides%2520containing%2520a%2520bicyclo%255B3.1.0%255Dhexane%2520ring%2520system%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2008%26volume%3D16%26spage%3D8546%26epage%3D8556%26doi%3D10.1016%2Fj.bmc.2008.08.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group">Carlin, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tosh, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xiao, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piñol, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salvemini, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gavrilova, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobson, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reitman, M. L.</span><span> </span><span class="NLM_article-title">Peripheral adenosine A<sub>3</sub> receptor activation causes regulated hypothermia in mice that is dependent on central histamine H<sub>1</sub> receptors</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">356</span><span class="NLM_x">, </span> <span class="NLM_fpage">475</span><span class="NLM_x">–</span> <span class="NLM_lpage">483</span><span class="refDoi"> DOI: 10.1124/jpet.115.229872</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00141&amp;key=10.1124%2Fjpet.115.229872" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=356&publication_year=2016&pages=475-483&author=J.+L.+Carlinauthor=D.+K.+Toshauthor=C.+Xiaoauthor=R.+A.+Pi%C3%B1olauthor=Z.+Chenauthor=D.+Salveminiauthor=O.+Gavrilovaauthor=K.+A.+Jacobsonauthor=M.+L.+Reitman&title=Peripheral+adenosine+A3+receptor+activation+causes+regulated+hypothermia+in+mice+that+is+dependent+on+central+histamine+H1+receptors&doi=10.1124%2Fjpet.115.229872"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1124%2Fjpet.115.229872&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.115.229872%26sid%3Dliteratum%253Aachs%26aulast%3DCarlin%26aufirst%3DJ.%2BL.%26aulast%3DTosh%26aufirst%3DD.%2BK.%26aulast%3DXiao%26aufirst%3DC.%26aulast%3DPi%25C3%25B1ol%26aufirst%3DR.%2BA.%26aulast%3DChen%26aufirst%3DZ.%26aulast%3DSalvemini%26aufirst%3DD.%26aulast%3DGavrilova%26aufirst%3DO.%26aulast%3DJacobson%26aufirst%3DK.%2BA.%26aulast%3DReitman%26aufirst%3DM.%2BL.%26atitle%3DPeripheral%2520adenosine%2520A3%2520receptor%2520activation%2520causes%2520regulated%2520hypothermia%2520in%2520mice%2520that%2520is%2520dependent%2520on%2520central%2520histamine%2520H1%2520receptors%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2016%26volume%3D356%26spage%3D475%26epage%3D483%26doi%3D10.1124%2Fjpet.115.229872" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group">Schaddelee, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Read, K. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cleypool, C. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">IJzerman, A. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Danhof, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Boer, A. G.</span><span> </span><span class="NLM_article-title">Brain penetration of synthetic adenosine A<sub>1</sub> receptor agonists in situ: role of the rENT1 nucleoside transporter and binding to blood constituents</span> <span class="citation_source-journal">Eur. J. Pharm. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">59</span><span class="NLM_x">–</span> <span class="NLM_lpage">66</span><span class="refDoi"> DOI: 10.1016/j.ejps.2004.09.010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00141&amp;key=10.1016%2Fj.ejps.2004.09.010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00141&amp;key=15626578" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00141&amp;key=1%3ACAS%3A528%3ADC%252BD2MXjtlek" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2005&pages=59-66&author=M.+P.+Schaddeleeauthor=K.+D.+Readauthor=C.+G.+Cleypoolauthor=A.+P.+IJzermanauthor=M.+Danhofauthor=A.+G.+de+Boer&title=Brain+penetration+of+synthetic+adenosine+A1+receptor+agonists+in+situ%3A+role+of+the+rENT1+nucleoside+transporter+and+binding+to+blood+constituents&doi=10.1016%2Fj.ejps.2004.09.010"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Brain penetration of synthetic adenosine A1 receptor agonists in situ: role of the rENT1 nucleoside transporter and binding to blood constituents</span></div><div class="casAuthors">Schaddelee, Marloes P.; Read, Kevin D.; Cleypool, Cindy G. J.; IJzerman, Adriaan P.; Danhof, Meindert; de Boer, Albertus G.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmaceutical Sciences</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">59-66</span>CODEN:
                <span class="NLM_cas:coden">EPSCED</span>;
        ISSN:<span class="NLM_cas:issn">0928-0987</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The blood-brain barrier (BBB) transport of synthetic A1 receptor agonists was studied in an in situ brain perfusion model in the presence and absence of the selective nucleoside transport inhibitor S-(4-nitrobenzyl)-6-thioinosine (NBTI).  For 8-methylamino-N6cyclopentyladenosine (MCPA), N6-cyclopentyladenosine (CPA), 2'deoxy-N6-cyclopentyladenosine (2'dCPA) and 5'deoxy-N6-cyclopentyl adenosine (5'dCPA) the brain uptake clearance was low with values of 0.0045±0.0012, 0.018±0.0020, 0.022±0.0028 and 0.12±0.054 mL min-1 g-1, resp.  In the presence of an av. NBTI plasma concn. of 2.6±0.3 μg ml-1 (NBTI dose: 3 mg kg-1 i.v.) the values of the brain uptake clearance were 0.0062±0.0012, 0.013±0.0017, 0.014±0.0030 and 0.13±0.066 mL min-1 g-1, resp. and not significantly different from the values in the absence of NBTI.  In a sep. expt. the brain uptake of MCPA from phosphate buffered saline (PBS) and whole blood were compared.  The brain uptake clearance from whole blood (0.0012±0.001 mL min-1 g-1) was significantly lower than from PBS (0.0045±0.0012 mL min-1 g-1).  The results of these studies show that the rENT1 nucleoside transporter does not contribute significantly to the transport of synthetic A1 receptor agonists across the BBB and that binding to blood constituents restricts the brain uptake.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrdpHIWCMORV7Vg90H21EOLACvtfcHk0lj462GefrDe6Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXjtlek&md5=fcba7778b896837bf68903986339ca21</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1016%2Fj.ejps.2004.09.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejps.2004.09.010%26sid%3Dliteratum%253Aachs%26aulast%3DSchaddelee%26aufirst%3DM.%2BP.%26aulast%3DRead%26aufirst%3DK.%2BD.%26aulast%3DCleypool%26aufirst%3DC.%2BG.%26aulast%3DIJzerman%26aufirst%3DA.%2BP.%26aulast%3DDanhof%26aufirst%3DM.%26aulast%3Dde%2BBoer%26aufirst%3DA.%2BG.%26atitle%3DBrain%2520penetration%2520of%2520synthetic%2520adenosine%2520A1%2520receptor%2520agonists%2520in%2520situ%253A%2520role%2520of%2520the%2520rENT1%2520nucleoside%2520transporter%2520and%2520binding%2520to%2520blood%2520constituents%26jtitle%3DEur.%2520J.%2520Pharm.%2520Sci.%26date%3D2005%26volume%3D24%26spage%3D59%26epage%3D66%26doi%3D10.1016%2Fj.ejps.2004.09.010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">De Backer, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Biston, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Devriendt, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Madl, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chochrad, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aldecoa, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brasseur, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Defrance, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gottignies, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vincent, J. L.</span><span> </span><span class="NLM_article-title">for the SOAP II Investigators. Comparison of dopamine and norepinephrine in the treatment of shock</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">362</span><span class="NLM_x">, </span> <span class="NLM_fpage">779</span><span class="NLM_x">–</span> <span class="NLM_lpage">789</span><span class="refDoi"> DOI: 10.1056/NEJMoa0907118</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00141&amp;key=10.1056%2FNEJMoa0907118" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00141&amp;key=20200382" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00141&amp;key=1%3ACAS%3A528%3ADC%252BC3cXivV2hu7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=362&publication_year=2010&pages=779-789&author=D.+De+Backerauthor=P.+Bistonauthor=J.+Devriendtauthor=C.+Madlauthor=D.+Chochradauthor=C.+Aldecoaauthor=A.+Brasseurauthor=P.+Defranceauthor=P.+Gottigniesauthor=J.+L.+Vincent&title=for+the+SOAP+II+Investigators.+Comparison+of+dopamine+and+norepinephrine+in+the+treatment+of+shock&doi=10.1056%2FNEJMoa0907118"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit43aR"><div class="casContent"><span class="casTitleNuber">43a</span><div class="casTitle"><span class="NLM_cas:atitle">Comparison of dopamine and norepinephrine in the treatment of shock</span></div><div class="casAuthors">De Backer, Daniel; Biston, Patrick; Devriendt, Jacques; Madl, Christian; Chochrad, Didier; Aldecoa, Cesar; Brasseur, Alexandre; Defrance, Pierre; Gottignies, Philippe; Vincent, Jean-Louis</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">362</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">779-789</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">BACKGROUND: Both dopamine and norepinephrine are recommended as first-line vasopressor agents in the treatment of shock.  There is a continuing controversy about whether one agent is superior to the other.  METHODS: In this multicenter, randomized trial, we assigned patients with shock to receive either dopamine or norepinephrine as first-line vasopressor therapy to restore and maintain blood pressure.  When blood pressure could not be maintained with a dose of 20 μg per kg of body wt. per min for dopamine or a dose of 0.19 μg per kg per min for norepinephrine, open-label norepinephrine, epinephrine, or vasopressin could be added.  The primary outcome was the rate of death at 28 days after randomization; secondary end points included the no. of days without need for organ support and the occurrence of adverse events.  RESULTS: The trial included 1679 patients, of whom 858 were assigned to dopamine and 821 to norepinephrine.  The baseline characteristics of the groups were similar.  There was no significant between-group difference in the rate of death at 28 days (52.5% in the dopamine group and 48.5% in the norepinephrine group; odds ratio with dopamine, 1.17; 95% confidence interval, 0.97 to 1.42).  However, there were more arrhythmic events among the patients treated with dopamine than among those treated with norepinephrine (207 events [24.1%] vs. 102 events [12.4%]).  A subgroup anal. showed that dopamine, as compared with norepinephrine, was assocd. with an increased rate of death at 28 days among the 280 patients with cardiogenic shock but not among the 1044 patients with septic shock or the 263 with hypovolemic shock.  CONCLUSIONS: Although there was no significant difference in the rate of death between patients with shock who were treated with dopamine as the first-line vasopressor agent and those who were treated with norepinephrine, the use of dopamine was assocd. with a greater no. of adverse events.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoQ5-QE097VVbVg90H21EOLACvtfcHk0lgTRDmzVlB_bg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXivV2hu7k%253D&md5=c15a9e328e3e2b6cebde508844f4e2d0</span></div><a href="/servlet/linkout?suffix=cit43a&amp;dbid=16384&amp;doi=10.1056%2FNEJMoa0907118&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMoa0907118%26sid%3Dliteratum%253Aachs%26aulast%3DDe%2BBacker%26aufirst%3DD.%26aulast%3DBiston%26aufirst%3DP.%26aulast%3DDevriendt%26aufirst%3DJ.%26aulast%3DMadl%26aufirst%3DC.%26aulast%3DChochrad%26aufirst%3DD.%26aulast%3DAldecoa%26aufirst%3DC.%26aulast%3DBrasseur%26aufirst%3DA.%26aulast%3DDefrance%26aufirst%3DP.%26aulast%3DGottignies%26aufirst%3DP.%26aulast%3DVincent%26aufirst%3DJ.%2BL.%26atitle%3Dfor%2520the%2520SOAP%2520II%2520Investigators.%2520Comparison%2520of%2520dopamine%2520and%2520norepinephrine%2520in%2520the%2520treatment%2520of%2520shock%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2010%26volume%3D362%26spage%3D779%26epage%3D789%26doi%3D10.1056%2FNEJMoa0907118" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit43b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Kamiya, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sato, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nozaki, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Akiya, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okazaki, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takahashi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mizuno, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shimizu, W.</span><span> </span><span class="NLM_article-title">Renal effects of added low-dose dopamine in acute heart failure patients with diuretic resistance to natriuretic peptide</span> <span class="citation_source-journal">J. Cardiovasc. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">65</span><span class="NLM_x">, </span> <span class="NLM_fpage">282</span><span class="NLM_x">–</span> <span class="NLM_lpage">288</span><span class="refDoi"> DOI: 10.1097/FJC.0000000000000193</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00141&amp;key=10.1097%2FFJC.0000000000000193" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=2015&pages=282-288&author=M.+Kamiyaauthor=N.+Satoauthor=A.+Nozakiauthor=M.+Akiyaauthor=H.+Okazakiauthor=Y.+Takahashiauthor=K.+Mizunoauthor=W.+Shimizu&title=Renal+effects+of+added+low-dose+dopamine+in+acute+heart+failure+patients+with+diuretic+resistance+to+natriuretic+peptide&doi=10.1097%2FFJC.0000000000000193"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43b&amp;dbid=16384&amp;doi=10.1097%2FFJC.0000000000000193&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252FFJC.0000000000000193%26sid%3Dliteratum%253Aachs%26aulast%3DKamiya%26aufirst%3DM.%26aulast%3DSato%26aufirst%3DN.%26aulast%3DNozaki%26aufirst%3DA.%26aulast%3DAkiya%26aufirst%3DM.%26aulast%3DOkazaki%26aufirst%3DH.%26aulast%3DTakahashi%26aufirst%3DY.%26aulast%3DMizuno%26aufirst%3DK.%26aulast%3DShimizu%26aufirst%3DW.%26atitle%3DRenal%2520effects%2520of%2520added%2520low-dose%2520dopamine%2520in%2520acute%2520heart%2520failure%2520patients%2520with%2520diuretic%2520resistance%2520to%2520natriuretic%2520peptide%26jtitle%3DJ.%2520Cardiovasc.%2520Pharmacol.%26date%3D2015%26volume%3D65%26spage%3D282%26epage%3D288%26doi%3D10.1097%2FFJC.0000000000000193" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group">Adir, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sznajder, J. I.</span><span> </span><span class="NLM_article-title">Regulation of lung edema clearance by dopamine</span> <span class="citation_source-journal">Isr. Med. Assoc. J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">47</span><span class="NLM_x">–</span> <span class="NLM_lpage">50</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00141&amp;key=12592959" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00141&amp;key=1%3ACAS%3A528%3ADC%252BD3sXhs12isrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2003&pages=47-50&author=Y.+Adirauthor=J.+I.+Sznajder&title=Regulation+of+lung+edema+clearance+by+dopamine"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Regulation of lung edema clearance by dopamine</span></div><div class="casAuthors">Adir, Yochai; Sznajder, Jacob Iasha</div><div class="citationInfo"><span class="NLM_cas:title">Israel Medical Association Journal</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">47-50</span>CODEN:
                <span class="NLM_cas:coden">IMAJCX</span>;
        ISSN:<span class="NLM_cas:issn">1565-1088</span>.
    
            (<span class="NLM_cas:orgname">Israel Medical Association</span>)
        </div><div class="casAbstract">A review on the mechanisms of dopamine regulation of Na,K-ATPase and lung edema clearance.  In the kidney, dopamine inhibits Na,K-ATPase, which results in natriuresis because less Na+ is reabsorbed by the proximal and distal tubules.  In contrast, dopamine stimulates Na,K-ATPase activity in the alveolar epithelium, leading to the increased alveolar fluid resorption.  Dopamine increases alveolar fluid resorption not only in normal alveolar epithelium but also in models of lung injury.  Thus, dopamine can be of clin. relevance for the treatment of patients with acute hypoxemic respiratory failure due to pulmonary edema.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGryPAd5dnRSHrVg90H21EOLACvtfcHk0lgTRDmzVlB_bg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXhs12isrs%253D&md5=dff00a85d391142ab10e992d944190dc</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAdir%26aufirst%3DY.%26aulast%3DSznajder%26aufirst%3DJ.%2BI.%26atitle%3DRegulation%2520of%2520lung%2520edema%2520clearance%2520by%2520dopamine%26jtitle%3DIsr.%2520Med.%2520Assoc.%2520J.%26date%3D2003%26volume%3D5%26spage%3D47%26epage%3D50" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group">Willems, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buylaert, W. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lefebvre, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bogaert, M. G.</span><span> </span><span class="NLM_article-title">Neuronal dopamine receptors on autonomic ganglia and sympathetic nerves and dopamine receptors in the gastrointestinal system</span> <span class="citation_source-journal">Pharmacol. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1985</span><span class="NLM_x">, </span> <span class="NLM_volume">37</span><span class="NLM_x">, </span> <span class="NLM_fpage">165</span><span class="NLM_x">–</span> <span class="NLM_lpage">216</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=1985&pages=165-216&author=J.+L.+Willemsauthor=W.+A.+Buylaertauthor=R.+A.+Lefebvreauthor=M.+G.+Bogaert&title=Neuronal+dopamine+receptors+on+autonomic+ganglia+and+sympathetic+nerves+and+dopamine+receptors+in+the+gastrointestinal+system"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWillems%26aufirst%3DJ.%2BL.%26aulast%3DBuylaert%26aufirst%3DW.%2BA.%26aulast%3DLefebvre%26aufirst%3DR.%2BA.%26aulast%3DBogaert%26aufirst%3DM.%2BG.%26atitle%3DNeuronal%2520dopamine%2520receptors%2520on%2520autonomic%2520ganglia%2520and%2520sympathetic%2520nerves%2520and%2520dopamine%2520receptors%2520in%2520the%2520gastrointestinal%2520system%26jtitle%3DPharmacol.%2520Rev.%26date%3D1985%26volume%3D37%26spage%3D165%26epage%3D216" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group">Fang, Z. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tosh, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanaka, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krausz, K. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Connor, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobson, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gonzalez, F. J.</span><span> </span><span class="NLM_article-title">Metabolic mapping of A<sub>3</sub> adenosine receptor agonist MRS5980</span> <span class="citation_source-journal">Biochem. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">97</span><span class="NLM_x">, </span> <span class="NLM_fpage">215</span><span class="NLM_x">–</span> <span class="NLM_lpage">223</span><span class="refDoi"> DOI: 10.1016/j.bcp.2015.07.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00141&amp;key=10.1016%2Fj.bcp.2015.07.007" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=97&publication_year=2015&pages=215-223&author=Z.+Z.+Fangauthor=D.+K.+Toshauthor=N.+Tanakaauthor=H.+Wangauthor=K.+W.+Krauszauthor=R.+O%E2%80%99Connorauthor=K.+A.+Jacobsonauthor=F.+J.+Gonzalez&title=Metabolic+mapping+of+A3+adenosine+receptor+agonist+MRS5980&doi=10.1016%2Fj.bcp.2015.07.007"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1016%2Fj.bcp.2015.07.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bcp.2015.07.007%26sid%3Dliteratum%253Aachs%26aulast%3DFang%26aufirst%3DZ.%2BZ.%26aulast%3DTosh%26aufirst%3DD.%2BK.%26aulast%3DTanaka%26aufirst%3DN.%26aulast%3DWang%26aufirst%3DH.%26aulast%3DKrausz%26aufirst%3DK.%2BW.%26aulast%3DO%25E2%2580%2599Connor%26aufirst%3DR.%26aulast%3DJacobson%26aufirst%3DK.%2BA.%26aulast%3DGonzalez%26aufirst%3DF.%2BJ.%26atitle%3DMetabolic%2520mapping%2520of%2520A3%2520adenosine%2520receptor%2520agonist%2520MRS5980%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2015%26volume%3D97%26spage%3D215%26epage%3D223%26doi%3D10.1016%2Fj.bcp.2015.07.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group">Baell, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holloway, G. A.</span><span> </span><span class="NLM_article-title">New substructure filters for removal of pan assay interference compounds (PAINS) from screening libraries and for their exclusion in bioassays</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">2719</span><span class="NLM_x">–</span> <span class="NLM_lpage">2740</span><span class="refDoi"> DOI: 10.1021/jm901137j</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm901137j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00141&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsF2qsLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=2719-2740&author=J.+B.+Baellauthor=G.+A.+Holloway&title=New+substructure+filters+for+removal+of+pan+assay+interference+compounds+%28PAINS%29+from+screening+libraries+and+for+their+exclusion+in+bioassays&doi=10.1021%2Fjm901137j"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">New Substructure Filters for Removal of Pan Assay Interference Compounds (PAINS) from Screening Libraries and for Their Exclusion in Bioassays</span></div><div class="casAuthors">Baell, Jonathan B.; Holloway, Georgina A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2719-2740</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">This report describes a no. of substructural features which can help to identify compds. that appear as frequent hitters (promiscuous compds.) in many biochem. high throughput screens.  The compds. identified by such substructural features are not recognized by filters commonly used to identify reactive compds.  Even though these substructural features were identified using only one assay detection technol., such compds. have been reported to be active from many different assays.  In fact, these compds. are increasingly prevalent in the literature as potential starting points for further exploration, whereas they may not be.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGro_JARcceWjLVg90H21EOLACvtfcHk0lhiK1rEZftetQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsF2qsLw%253D&md5=fbf397aa4910753c550425708c866fd2</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1021%2Fjm901137j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm901137j%26sid%3Dliteratum%253Aachs%26aulast%3DBaell%26aufirst%3DJ.%2BB.%26aulast%3DHolloway%26aufirst%3DG.%2BA.%26atitle%3DNew%2520substructure%2520filters%2520for%2520removal%2520of%2520pan%2520assay%2520interference%2520compounds%2520%2528PAINS%2529%2520from%2520screening%2520libraries%2520and%2520for%2520their%2520exclusion%2520in%2520bioassays%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D2719%26epage%3D2740%26doi%3D10.1021%2Fjm901137j" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group">Eshleman, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carmolli, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cumbay, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martens, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neve, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Janowsky, A.</span><span> </span><span class="NLM_article-title">Characteristics of drug interactions with recombinant biogenic amine transporters expressed in the same cell type</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">289</span><span class="NLM_x">, </span> <span class="NLM_fpage">877</span><span class="NLM_x">–</span> <span class="NLM_lpage">885</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00141&amp;key=10215666" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00141&amp;key=1%3ACAS%3A528%3ADyaK1MXislGisrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=289&publication_year=1999&pages=877-885&author=A.+J.+Eshlemanauthor=M.+Carmolliauthor=M.+Cumbayauthor=C.+R.+Martensauthor=K.+A.+Neveauthor=A.+Janowsky&title=Characteristics+of+drug+interactions+with+recombinant+biogenic+amine+transporters+expressed+in+the+same+cell+type"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Characteristics of drug interactions with recombinant biogenic amine transporters expressed in the same cell type</span></div><div class="casAuthors">Eshleman, Amy J.; Carmolli, Marya; Cumbay, Medhane; Martens, Carey R.; Neve, Kim A.; Janowsky, Aaron</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">289</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">877-885</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">The effects of drugs on the uptake of [3H]neurotransmitter by and the binding of [125I]3β-(4-iodophenyl)tropane-2β-carboxylic acid Me ester ([125I]RTI-55) to the recombinant human dopamine (hDAT), serotonin (hSERT), or norepinephrine (hNET) transporters stably expressed in human embryonic kidney 293 cells were studied.  RTI-55 had similar affinity for the hDAT and hSERT and lower affinity for hNET (Kd = 1.83, 0.98, and 12.1 nM, resp.).  Kinetic anal. of [125I]RTI-55 binding indicated that the dissocn. rate (k-1) was significantly lower for hSERT and the assocn. rate (k+1) was significantly lower for hNET compared with the hDAT.  The potency of drugs at blocking [3H]neurotransmitter uptake was highly correlated with potency at blocking radioligand binding for hDAT and hSERT.  Substrates were more potent at the inhibition of [3H]neurotransmitter uptake than radioligand binding.  The potency of drugs was highly correlated between displacement of [3H]nisoxetine (Kd = 6.0 nM) and [125I]RTI-55 from the hNET, suggesting that these radioligands recognize similar sites on the transporter protein.  The correlation obsd. between inhibitory potency for uptake and binding of either ligand at the hNET was lower than correlations between uptake and binding for hDAT and hSERT.  The present results indicate that the cocaine analog [125I]RTI-55 has unique binding properties at each of the transporters and that the use of recombinant transporters expressed by a single cell type can provide a powerful screening tool for drugs interacting with biogenic amine transporters, such as possible cocaine antagonists.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpnn_1UJqie3bVg90H21EOLACvtfcHk0lhmYBt1X3Qp1A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXislGisrg%253D&md5=c808b4d81da86e57460406d2163c5e65</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DEshleman%26aufirst%3DA.%2BJ.%26aulast%3DCarmolli%26aufirst%3DM.%26aulast%3DCumbay%26aufirst%3DM.%26aulast%3DMartens%26aufirst%3DC.%2BR.%26aulast%3DNeve%26aufirst%3DK.%2BA.%26aulast%3DJanowsky%26aufirst%3DA.%26atitle%3DCharacteristics%2520of%2520drug%2520interactions%2520with%2520recombinant%2520biogenic%2520amine%2520transporters%2520expressed%2520in%2520the%2520same%2520cell%2520type%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D1999%26volume%3D289%26spage%3D877%26epage%3D885" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit49"><span><span class="NLM_contrib-group">Bradford, M. M.</span><span> </span><span class="NLM_article-title">A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding</span> <span class="citation_source-journal">Anal. Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1976</span><span class="NLM_x">, </span> <span class="NLM_volume">72</span><span class="NLM_x">, </span> <span class="NLM_fpage">248</span><span class="NLM_x">–</span> <span class="NLM_lpage">254</span><span class="refDoi"> DOI: 10.1016/0003-2697(76)90527-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00141&amp;key=10.1016%2F0003-2697%2876%2990527-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00141&amp;key=942051" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00141&amp;key=1%3ACAS%3A528%3ADyaE28XksVehtrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=72&publication_year=1976&pages=248-254&author=M.+M.+Bradford&title=A+rapid+and+sensitive+method+for+the+quantitation+of+microgram+quantities+of+protein+utilizing+the+principle+of+protein-dye+binding&doi=10.1016%2F0003-2697%2876%2990527-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding</span></div><div class="casAuthors">Bradford, Marion M.</div><div class="citationInfo"><span class="NLM_cas:title">Analytical Biochemistry</span>
        (<span class="NLM_cas:date">1976</span>),
    <span class="NLM_cas:volume">72</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">248-54</span>CODEN:
                <span class="NLM_cas:coden">ANBCA2</span>;
        ISSN:<span class="NLM_cas:issn">0003-2697</span>.
    </div><div class="casAbstract">A protein detn. method that involves the binding of coomassie Brilliant Blue G 250 to protein is described.  The binding of the dye to protein causes a shift in the absorption max. of the dye from 465 to 595 nm, and it is the increase in absorption at 595 nm that is monitored.  This assay is very reproducible and rapid with the dye binding process virtually complete in ∼ 2 min with good color stability for 1 hr.  There is little or no interference from cations such as Na+ or K+ nor from carbohydrates such as sucrose.  A small amt. of color is developed in the presence of strongly alk. buffering agents, but the assay may be run accurately by the use of proper buffer controls.  The only components found to give excessive interfering color in the assay are relatively large amts. of detergents such as Na dodecyl sulfate, Triton X 100, and commercial glassware detergents.  Interference by small amts. of detergent may be eliminated by the use of proper control.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrN_T_d0trcNrVg90H21EOLACvtfcHk0lhmYBt1X3Qp1A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE28XksVehtrY%253D&md5=43f388a493becc4193c7a49d9de0e1db</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1016%2F0003-2697%2876%2990527-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0003-2697%252876%252990527-3%26sid%3Dliteratum%253Aachs%26aulast%3DBradford%26aufirst%3DM.%2BM.%26atitle%3DA%2520rapid%2520and%2520sensitive%2520method%2520for%2520the%2520quantitation%2520of%2520microgram%2520quantities%2520of%2520protein%2520utilizing%2520the%2520principle%2520of%2520protein-dye%2520binding%26jtitle%3DAnal.%2520Biochem.%26date%3D1976%26volume%3D72%26spage%3D248%26epage%3D254%26doi%3D10.1016%2F0003-2697%2876%2990527-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i61"><a href="/doi/suppl/10.1021/acs.jmedchem.7b00141">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_84003"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a class="ext-link" href="/">ACS Publications website</a> at DOI: <a class="ext-link" href="/doi/abs/10.1021/acs.jmedchem.7b00141">10.1021/acs.jmedchem.7b00141</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">NMR analysis and mass spectra of selected synthesized compounds, additional synthetic schemes and procedures, and off-target (PDSP) screening results (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.7b00141/suppl_file/jm7b00141_si_001.pdf">PDF</a>)</p></li><li><p class="inline">SMILES data (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.7b00141/suppl_file/jm7b00141_si_002.csv">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b00141/suppl_file/jm7b00141_si_001.pdf">jm7b00141_si_001.pdf (2.54 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b00141/suppl_file/jm7b00141_si_002.csv">jm7b00141_si_002.csv (2.57 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.7b00141&amp;pbContext=%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.7b00141%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2017.60.issue-7" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.7b00141" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                2MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"67991690a9813c8e","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
